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Abstract
This thesis focuses on the requirement for new methodologies to incorporate 11C into biologically
active compounds for Positron Emission Tomography (PET). The use of PET has expanded over
recent years as a valuable imaging technique for the study of drug delivery as well as the study of
neurological diseases and oncology. The short half-life of 11C (20.4 min) limits its use to
approximately 1 hour therefore rapid chemistry is required to radiolabel tracer molecules before use
in vivo. Chapter 1 includes an overview of the literature in the areas of PET radiochemistry, transition
metal-catalysed carbonylation, N-heterocyclic carbenes, hemilabile ligands, titanium and zirconium
imido complexes and nickel-/palladium-catalysed carboxylations.
Chapters 2 and 3 detail the investigations of a palladium-catalysed carbonylation reaction for the
formation of amides commonly found in biologically active compounds. N-benzylbenzamide was
synthesised in a model reaction which tested a range of diphosphine ligands and N-heterocyclic
carbenes. The best performing systems were taken forward to be tested with [11C]CO in the
radiochemistry laboratories at the GSK Clinical Imaging Centre at Hammersmith Hospital with
excellent radiochemical purities of [11C]N-benzylbenzamide (99 %) and good radiochemical yields (55
%). Hemilabile phosphorus-thioether (P-S) and phosphorus-ether (P-O) bidentate ligands were also
investigated in the synthesis of N-benzylbenzamide and compared to diphosphine ligands in this
reaction and new palladium catalysts were prepared with novel P-S ligands.
[11C]CO2 was examined as a potentially useful source of [
11C] for radiolabelling as research into
transition metal-mediated processes to activate CO2 for environmental reasons has grown in recent
years. Chapter 4 investigates some recent literature detailing nickel- and palladium-catalysed
carboxylation of organozinc halides in the synthesis of carboxylic acids. Titanium and zirconium
imido complexes were synthesised with the intention of forming [11C]isocyanate precursors - this
work is described in Chapter 5. A range of work has been carried out and potential future studies in
all these areas are specified at the end of the thesis.
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1 Introduction
1.1 Positron Emission Tomography
Molecular imaging unites molecular biology and in vivo imaging, which allows for the visualisation of
events at a molecular level in a non-invasive manner. Positron emission tomography (PET) is a form
of molecular imaging frequently used for clinical diagnosis of disease, biomedical research and drug
development. Other structural imaging techniques give anatomical information (X-ray, ultrasound,
MRI) whereas PET imaging is unique in that it can give a deeper understanding of biochemical and
physiological processes in vitro and in vivo. A combination of these modalities can give the greatest
amount of information. Hence, nowadays the majority of PET scanners are run in series with a CT
scanner so the PET images can be overlaid with a more accurate structural image.
PET works by employing radioisotopes (e.g. 18F, 11C, 15O, 13N) to label target compounds that can be
tracked in real time when administered to a patient. The value and breadth of its applications as an
imaging tool are growing rapidly. PET is primarily used in clinical oncology[1] and neurology;[2]
however research of cardiovascular function can also be facilitated with PET studies.[3] As a truly
multidisciplinary science it has footholds in chemistry, biology, physics and mathematics; from
radiolabelling to computer modelling.
Improving the efficiency of drug development is of great economical interest to the pharmaceutical
industry and can be achieved through PET by gaining a greater understanding of drug-receptor-
enzyme interactions. PET allows for the evaluation of drug candidates to be assessed in man at an
earlier stage in the drug development process. Toxic and potent compounds can be administered
with no pharmacological or toxicological effects due to the extremely small doses needed (less than
10 nmol) because of the high specific activities of the radioisotopes. Although 18F is the most
commonly used radioisotope, the growth in radiolabelling chemistry with other radioisotopes is
desirable as compounds can be labelled without dramatically altering their biological activity. This is
in contrast to other imaging techniques like MRI which often involves attaching compounds to a
framework coordinated to gadolinium. The main drawback of PET is the short half-life times of the
isotopes, which mean that incorporation, purification and formulation must be rapid and that the
cyclotron and laboratories must be in close proximity to the imaging facility. These factors mean that
PET imaging is a more expensive technique to implement than most, which has limited it from
widespread use.
Chapter 1 - Introduction
3
1.1.1 The Mechanism of PET Imaging
The half-life times of commonly used isotopes in PET are detailed in Table 1.1. The timescale for
total synthesis of the radiolabelled product ready for administration to the patient is about 3 half-life
times. The challenge for chemists in PET is to develop new methodologies to improve the rate of
incorporation of the radionuclide into target compounds.
Table 1.1 Commonly used radionuclides in PET and their half-lives, nuclear reactions, primary precursors and
decay product.
Radionuclide Half-life
t1/2 (min)
Nuclear Reaction Product Decay Product
11C 20.4 14N(p,α)11C [11C]CO2, [
11C]CH4
11B
18F 110 18O(p,α)18F [18F]F2,
18F- 13C
13N 9.97 16O(p,α)13N [13N]NO2, [
13N]NH3
15N
15O 2.04 15N(p,α)15O [15O]O2
18O
The position of the nuclide-containing compound being traced can be obtained from these
radionuclides as they are positron-emitting isotopes. A positron is the anti-matter particle of an
electron and on emission it recombines with another electron in close proximity to it (approx. 3
mm). The isotopes emit the positron with differing amounts of energy, specific to that isotope,
which dictates how far the positron travels before annihilation with an electron. The annihilation
event produces two γ-rays at an angle of incidence of approximately 180o (Figure 1.1). The subject
under investigation is placed in a circular scanner which can detect the two γ-rays simultaneously 
and trace them back to the site of annihilation. Millions of annihilation events can produce an image
illustrating the contrast of areas with high and low concentrations of the radiolabelled material.
Figure 1.1 A schematic illustrating the annihilation event and resultant γ
The radionuclides are produced
particles such as protons or α-particles.
biomedical studies, are formed by the bombardment
18O,respectively. In the case of 11
target containing 14N leads to emiss
Figure
More detailed accounts of the overall impact and effectiveness of PET
research and drug discovery and the chemistry related to it
reviews.[4] Furthermore, a detailed review of current
PET for all radioisotopes has been
Chapter 1
-rays, which are detected and used to
construct a PET image.
in a cyclotron when a gas is bombarded with
11C and 18F, the most commonly used positron emitters for
of protons with
C, bombardment of a proton accelerated by the cyclotron
ion of a helium nucleus and 11C (Figure 1.2).
1.2 Production of 11C in a cyclotron.
in the worlds of biomedical
can be found in several
research into the chemistry of
described by Miller et al.[5]
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accelerated charged
purified 14N and
, on to a
comprehensive
radiolabelling for
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1.1.2 [11C]Radiolabelling
18F has been used extensively to label 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG), a glucose
derivative, which can be used to image the metabolism of sugars around the body and is particularly
useful in oncology as it accumulates in tumours. The greater biocompatibility of 11C compared to 18F
makes it a highly desirable radionuclide to work with; however, the reduced half-life means that
time is even more limited. It is necessary to have a cyclotron, hot cells and scanner in the same
building reducing the economic viability for widespread usage as previously mentioned.
After the 11C has formed in the cyclotron it mixes with trace amounts of O2 or H2 in the reaction
chamber to form one of the two primary synthons; [11C]CO2 and [
11C]CH4. From these primary
synthons other secondary precursors can be formed. Some of these transformations are detailed in
Figure 1.3.
Figure 1.3 11C precursors used in PET radiolabelling from the primary synthons, [11C]CO2 and [
11C]CH4.
[5]
[11C]Methylation using [11C]CH3I is the most commonly used method for the incorporation of
11C into
organic molecules for radiolabelling.[6] [11C]CH3I can be synthesised via two routes. The ‘wet’ method
uses lithium aluminium hydride to reduce [11C]CO2 followed by reaction with hydroiodic acid. Gas-
solid iodination is also possible to directly prepare it from [11C]CH4 and iodine vapour via a radical
mechanism. This latter method eliminates the lowering of specific activity which can occur when
using the highly reactive lithium aluminium hydride. [11C]CH3OTf has been also used due to its
increased reactivity.[7] Nucleophilic reactions with amine, alcohol, ether or thioether functional
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groups and [11C]CH3I are simple and lead to rapid incorporation of the radioisotope into an organic
fragment. N-, O- and S-selective methylations have been used to label a range of drug molecules and
biologically active molecules such as [11C]Pittsburg Compound B used to image amyloid plaques in
patients with Alzheimer’s disease[8] and raclopride for imaging the dopamine receptor (Figure 1.4).[9]
Figure 1.4 Synthesis of [11C]raclopride via O-selective [11C] methylation.
The captive solvent method traps the [11C]CH3I in a solution of the precursor as it is passed through a
narrow-bore stainless-steel or polymer loop where the reaction takes place. The ‘loop’ method
works extremely well for a simple O-methylation like that of raclopride formation without the need
for cooling giving good radiochemical yields and purities in short reaction times (> 5 min).
Palladium-mediated [11C]methylation and specifically Stille and Suzuki-Miyaura cross-coupling
reactions have been studied more recently as an efficient method of C-C bond forming
methylation.[10] Stannanes used as reagents in Stille couplings have fair functional group tolerance
however their toxicity may be an issue for in vivo use. Palladium-mediated reactions with
alkenylzirconocenes and [11C]CH3I have also been reported (Figure 1.5).
[11] The alkynes were
converted to the corresponding alkenylzirconocenes followed by transmetallation with Pd(PPh3)4
and cross-coupling with [11C]CH3I. [
11C]2-methylpropenylbenzene was produced in 70 %
radiochemical yield when palladium was used compared to poorer results obtained from nickel and
platinum alternatives. A range of other alkynes were tested with good radiochemical yields except
where esters and nitro groups were employed, due to poor functional group compatibility with the
Schwartz reagent in the hydrozirconation reaction.
Figure 1.5 Synthesis of [11C]2-methylpropenylbenzene via alkenylzirconocene and palladium cross-coupling.
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1.2 Radiolabelling with [11C]Carbon Monoxide
The interest in radiolabelling with [11C]carbon monoxide has increased over recent years partly due
to its synthetic versatility and the abundance of carbonyl-containing functionalities in biological
active target molecules.[12] Furthermore, [11C]CO is an attractive precursor for PET radiolabelling
because of its facile and rapid conversion from [11C]CO2 using a Zn or Mo reductant.
[13] The major
drawback of using [11C]CO is the poor solubility of carbon monoxide in common organic solvents,
which is accentuated in PET by the picomolar amounts of [11C]CO produced from the cyclotron and
used in the radiolabelling process.
Concentration of [11C]CO is a necessary process to guarantee good 11C incorporation and high
radiochemical yields (RCY). This issue can be overcome through recirculation of the [11C]CO gas[14] or
the use of HPLC microautoclave systems which increase the pressure and therefore enhance the key
[11C]carbon monoxide insertion step. The effectiveness of microautoclave apparatus has been
utilised most extensively by Långström and co-workers.[12, 15] Chemical complexation is also a
method of improving [11C]CO reactivity by increasing its solubility at low partial pressures. BH3.THF
has illustrated the ability to reversibly bind [11C]CO. THF is displaced when [11C]CO is bubbled
through at -78 oC and released at elevated temperatures due to water in the solvent mixture. This
process using the preconcentrated [11C]CO was used in a palladium carbonylative cross-coupling
reaction with RCYs of 47 % at best.[16] A copper(I) complex with a tris(pyrazolyl)borate ligand has
been found to be a more reliable chemical trapping agent with trapping efficiencies of > 95 %
compared to < 1 % in solvent alone.[17] Similarly this preconcentration method has been applied to
aminocarbonylation reactions with RCYs of up to 67 %.
Palladium-catalysed carbonylation reactions are widespread in chemistry and are used to cross-
couple a variety of organic halides and nucleophiles with the incorporation of a carbonyl group. In
PET radiolabelling, palladium-mediated carbonylation reactions (picomolar equivalents of [11C]CO
mean that the catalyst is actually in vast excess, as are the reagents, so it can be considered as a
palladium-mediated rather than palladium-catalysed reaction) have been widely applied in Suzuki,
Stille and carboamination type reactions.
Palladium-catalysed carbonylative Stille coupling reactions employ organostannanes and alkyl/aryl
halides or triflates with bulky monodentate phosphine ligands (eg. [Pd(P(o-Tol)3)2]). This method has
been successfully applied to PET radiolabelling of vinyl/alkyl/aryl [11C]ketones.[14] Diaryliodonium
salts have also been shown to be particularly effective as substrates in this reaction coupled with
aryltributylstannanes to yield a range of substituted [11C]benzophenones in high radiochemical
yield.[18] It was shown that the choice of solvent (DME-water (4:1 v/v)) was crucial for the adequate
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trapping of [11C]CO and reactivity of the palladium-mediated procedure.[19] Affirmation of this
technique was obtained from further studies with aryl- and alkyl-stannanes and iodides using HPLC
microautoclave apparatus which produced [11C]ketones very effectively.[20]
A similar procedure for the [11C]radiolabelling of ketones is possible with Suzuki carbonylation
reactions.[13a] These use less toxic boronic acid and esters rather than tin reagents to facilitate the
final cross-coupling step and a Pd(0) complex to catalyse the reaction. A range of heteroaryl and aryl
triflates have been used in conjunction with alkyl and aryl boronic acids and esters to label
compounds, usually with the need for base (lithium bromide) to improve the radiochemical yield.[21]
Organic bases such as tetrabutylammonium fluoride and potassium tert-butoxide were found to be
more suitable bases, in this case for alkyl and aryl boronic acids respectively.[22]
Figure 1.6 Suzuki carbonylative cross-coupling of boronic acids and aryl halides or triflates.
There has been a relatively large number of studies into the formation of [11C]amides due to their
frequent occurrence in biologically active compounds used in PET. Långström et al. have extensively
studied palladium-mediated [11C]carboxyamination as a route to [11C]amides, combining a wide
range of organic halides or triflates with amines.[23] tetrakis(Triphenylphosphine) palladium has been
used in the microautoclave system to assist in [11C]CO incorporation. A range of primary and
secondary amines as well as hydrazines have been used to synthesise [11C]amides and
[11C]hydrazides.[24]
Weakly nucleophilic amines such as aniline and indole lead to poorer radiochemical yields of
products in these reactions and therefore in some cases have required activation. The activation of
amines has been achieved from the formation of organo-tin amine reagents,[25] lithiation of amines
with nbutyl lithium[26] or lithium bis(trimethylsilyl)amide[25] and addition of 1,2,2,6,6-
pentamethylpiperidine (pempidine).[27] Aromatic analogues of [11C]-WAY-100635 (Figure 1.7) used to
image 5-HT1A-subtype serotonin receptors was achieved by formation of the lithiated amide in
situ.[26] Radiochemical yields were significantly enhanced due to the activation of the amide
illustrating the importance of the nucleophilicity of the amine in the final reductive elimination step.
Furthermore, analogues of DAA1106, a potent and selective ligand for the peripheral
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benzodiazepine receptor, have been successfully prepared from initial lithiation of the
corresponding amine.[28]
Figure 1.7 Framework of analogues of [11C]WAY-100635.
Other improvements to [11C]carboxyamination reactions have involved the use of multiphase gas-
liquid microfluidic devices, which increase the surface area-to-volume ratio and therefore the
amount of [11C]CO being incorporated. A microtube has been packed with a palladium catalyst on a
solid silica support, then addition of the reagents and [11C]CO at the entrance to the tube yield a
range of amides prepared in modest to good radiochemical yield.[29] This method highlights again the
necessity to increase the reactivity of the [11C]CO due to its poor solubility and very small quantities
used for PET imaging. There is potential to use microfluidic chip devices which could exploit a similar
technique of increasing the surface area-to-volume ratio as a method to improve the mixing of liquid
and gas reagents.[30] Layers of soda lime glass plates or ceramic layers with very fine channels
running through them can be heated and reagents forced through them to increase the pressure
and therefore solubility of the [11C]CO and enhance the reaction. A high throughput catalyst
screening study has shown the facile methodology and miniaturisation of the chemistry.[31] This
method is ideal for PET as very small amounts of reagents are used on the PET scale, and the devices
are small which means they can be easily enclosed in lead and they are suitable for automation.
There are many other [11C]carbonyl-containing compounds that have been synthesised through
palladium-mediated reactions for PET. For example, [11C]benzylacetate was prepared from [11C]CO,
tetrakis(triphenylphosphine)palladium, benzyl alcohol and methyl iodide for the imaging glial
metabolism of acetate to glutamate and glutamine.[32] In a similar manner, ammonium hydroxides
can be used as nucleophilic sources to force reductive elimination of the palladium-acyl intermediate
to synthesise [11C]carboxylic acids.[33] The use of [11C]CO allows for higher specific activities of
[11C]carboxylic acid compared to methods with [11C]CO2 which are more typically used (section
1.5.4). Radiochemical yields are poor when alkyl reagents are employed because of competing β-
hydride elimination.
Furthermore, [11C]alkyl halides have been prepared by palladium-mediated hydroxycarbonylation of
an alkene with water followed by reduction and conversion to the alkyl iodide using lithium
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aluminium hydride and hydriodic acid.[34] This route has been explored as it negates the use of air
sensitive Grignard reagents which are normally used in conjunction with [11C]CO2 to form the pseudo
[11C]carboxylic acid followed by reduction and conversion to alkyl iodide.[35]
[11C]Acrylamides can be synthesised either in a two step reaction, from acetylene via the vinyl
carboxylic acid in a hydroxycarbonylation under acidic conditions or from an vinyl halide and an
amine in a one pot reaction more suitable for automation in PET (Figure 1.8).[36]
Figure 1.8 Synthesis of [11C]acrylamide from acetylene and vinyl iodide (dba = dibenzylideneacetone).
Rhodium-mediated reactions also give an alternative pathway for the incorporation of [11C]CO into
organic molecules. Rhodium complexes of the structure [RhCl(COD)(phosphine)] have generally been
used to synthesise [11C]malonates,[37] [11C]hydroxyureas,[38] [11C]carbamates[39] and
[11C]diphenylureas.[39]
The synthesis of diethyl [11C]malonate has been achieved from ethyl diazoacetate, ethanol, a
rhodium precursor and dppe.[37] The reaction is driven by the concerted loss of nitrogen gas which
leads to complexation to the rhodium. It was postulated that the [11C]CO will then insert into the Rh-
C bond and will either proceed via a rhodium [11C]ketene intermediate or free [11C]ketene. Both of
these intermediates can undergo nucleophilic attack to give the final product (Figure 1.9). Diethyl
[11C]malonate was isolated in 20 % radiochemical yield and remains the only route to [11C]malonates
labelled in the carbonyl position.
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Figure 1.9 Synthesis of diethyl [11C]malonate.
[11C]Diphenylurea and [11C]ethylphenylcarbamate were prepared from similar Rh(I) complexes and
phenylazide with [11C]CO under microautoclave conditions.[39] Again the reaction is driven by the loss
of nitrogen gas and rhodium [11C]isocyanate is formed as an intermediate. Nucleophilic attack with
aniline or lithium ethoxide (ethanol was too weak a nucleophile in this case) of the [11C]carbonyl
resulted in the formation of [11C]diphenylurea or [11C]ethylphenylcarbamate respectively. Free
isocyanate can also be eliminated from the rhodium complex prior to nucleophilic attack (Figure
1.10). The same mechanism was assumed when O-(trimethylsilyl)hydroxylamine was used as the
nucleophile to synthesise 1-hydroxy-3-phenyl[11C]urea.[38]
Figure 1.10 Synthesis of [11C]diphenylurea, [11C]ethylphenylcarbamate and 1-hydroxy-3-phenyl[11C]urea.
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This method for the synthesis of asymmetric [11C]ureas is of particular interest due to some of the
problems of more traditional methods of synthesis such as Grignards and [11C]CO2 and
[11C]phosgenation which is discussed in more detail in section 1.3. More recently, this rhodium-
mediated methodology has been used to prepare eight derivatives of N-phenyl-N’-4-(4-
quinolyloxy)phenylurea from the corresponding azide and amine to image angiogenic processes in
reference to tumour growth.[40]
Selenium-mediated carbonylations have also shown to give moderate to good radiochemical yields
of [11C]ureas and [11C]carbamates.[41] The poor solubility of selenium was overcome by forming a
complex of selenium with tetrabutylammonium fluoride (TBAF). The reaction is assumed to proceed
by trapping the carbon monoxide and sequential nucleophilic attack of alcohols and amines.
Free-radical photoinitiated carbonylation reactions have also shown to be of use in 11C radiolabelling
for PET. This method is of interest due to the high tolerance of other functional groups and the
possibility to build alkyl frameworks without the hindrance of β-hydride elimination. Alkyl 
[11C]amides,[42] [11C]esters,[43] and [11C]carboxylic acids[43b, 44] have all been prepared in high pressure
apparatus with a sapphire window for irradiation with UV light.[44]
1.3 Radiolabelling with [11C]Carbon Dioxide
As the primary synthon produced by the cyclotron it would be advantageous to be able to
manipulate [11C]CO2 directly into target organic compounds to shorten reaction times. One of the
key issues with using this synthon in PET radiolabelling is the contamination from atmospheric CO2.
Isotopic dilution with 12CO2 is difficult to avoid especially when using highly reactive reagents such as
Grignard reagents. The resultant low specific activity means that there is less Bq of radioactivity per
Kg of compound resulting in a poorer image. Some of these issues are starting to be resolved with
the use of milder reagents which are less likely to be contaminated with 12CO2 due to their reduced
reactivity.
Organometallic Grignard reagents can be used to form [11C]carboxymagnesium halides from
[11C]CO2, which can be converted further to [
11C]carboxylic acids on hydrolysis or [11C]acyl halides,
another useful and reactive precursor. A simple synthesis of aliphatic [11C]amides has been achieved
from reaction of an alkylmagnesium bromide and [11C]CO2 to form the [
11C]carboxymagnesium
halide which reacts with amine in THF to give the labelled product. Reactions were carried out over a
5 min timeframe and gave radiochemical yields of 15-60 %.[45] Both aromatic and aliphatic
[11C]amides can also be prepared from [11C]carboxymagnesium halides under microwave-enhanced
conditions in good RCY with primary amines but reactions were less successful with secondary
amines.[46]
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Figure 1.11 Synthesis of [11C]amides from Grignard reagent and primary/secondary amines.
This method has been put to use in the radiolabelling of the 5HT1A receptor antagonist WAY100635
(Figure 1.12).[47] Cyclohexylmagnesium chloride was reacted with [11C]CO2 before conversion of the
[11C]carboxymagnesium chloride to an [11C]acyl chloride by SOCl2 and then reacted with the
corresponding amine precursor.
Figure 1.12 [11C]WAY100635, labelled in the carbonyl position.
Methylmagnesium bromide and chloride have been used to synthesise [11C]acetate using a ‘loop’
method.[48] [11C]Acetate is used as a tracer to observe cells’ oxidative metabolism, which is
particularly relevant in prostate and liver oncology studies. Lithium aluminium hydride is another
very reactive reagent capable of reducing [11C]CO2 into a useful precursor such as [
11C]formaldehyde
which can react with primary amines to form useful target compounds such as [11C]1,2,3,4-
tetrahydro-β-carboline derivatives, known to inhibit monoamine oxidase A (MAO-A) (Figure 1.13).[49]
N
H
R''
NH2
N
H
11C
NH
R''
R' R'
11C
O
H H
HCOOH
100 oC
+
Figure 1.13 Synthesis of a [11C]1,2,3,4-tetrahydro-β-carboline derivative from [11C]formaldehyde.
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Lithium aluminium hydride can be used to reduce [11C]CO2 to be converted with HI into [
11C]-labelled
ethyl, propyl and butyl iodides to be used as precursors for further radiolabelling experiments.[35]
[11C]urea is a valuable intermediate that can be used for the labelling of organic compounds for PET
via [11C]uracil. It has been synthesised from lithium bis(trimethylsilyl)amide (LBTMSA) first forming
an isocyanate that reacts with another mole of LBTMSA to give [11C]urea.[50] Another radiolabelling
procedure to form [11C]urea is the oxidation of [11C]cyanide to [11C]cyanate and then conversion to
[11C]urea or through [11C]phosgene ([11C]COCl2).
[51]
The synthesis of asymmetric ureas is of particular interest to the radiochemical community because
of the challenging synthesis and their more frequent appearance in biologically important molecules
such as GI181771, an agonist of a cholecystokinin (mammalian hormone) receptor (CCK-A),
potentially useful for the treatment of obesity.[52] Most commonly used amines are reacted with
[11C]phosgene to first form the [11C]carbamyl chloride which can then be reacted on with another
amine in a one pot process with minimal amounts of symmetrical urea being formed in the first
step.[53] However, [11C]phosgene synthesis requires a two step procedure (Figure 1.14) which greatly
extends the overall reaction time and decreases the radioactivity of the final product. Furthermore,
it is highly reactive, toxic and the synthesis has problems with reliability and reproducibility.
Figure 1.14 Synthesis of [11C]phosgene.
[11C]isocyanates have also been prepared via [11C]phosgenation of N-organo-sulphinylamines and
N,N’-organourea derivatives as a route to radiolabelled assymmetric ureas.[54] [11C]isocyanates are
versatile precursors and have been used to synthesise [11C]carbamates as well. The method
employed to synthesise the intermediate [11C]isocyanate was again [11C]phosgenation however
[11C]methyl isocyanate was formed from N,N’-bis(trimethylsilyl)amine giving good radiochemical
yields obtained in approximately 10 min.[55]
A one-pot reaction that uses [11C]CO2 directly to prepare [
11C]ureas, [11C]carbamates and
[11C]isocyanates without the use of [11C]phosgene is highly desirable. At low temperatures it is
possible to form a carbamate salt from aniline and [11C]CO2 in the presence of base which can then
be dehydrated to [11C]phenylisocyanate with phosphorylchloride (Figure 1.15).[56] Excess aniline
present means that the disubstituted [11C]urea is formed in up to 90 % radiochemical yield in 10 min.
[11C]dibenzylurea can react on with another mole of phosphorylchloride to form
[11C]diphenylcarbodiimide as an unwanted side product. The conditions were optimised to reduce
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the side product and increase the radiochemical yield. The method was also shown to be applicable
with aliphatic amines. Unfortunately only symmetric ureas could be labelled in this way and the
phosphorylchoride reagent is not compatible with some functional groups. Furthermore, as with
[11C]phosgenation methods, low specific activities due to contamination with atmospheric CO2
persist in being a limitation to widespread use.
Figure 1.15 Synthesis of [11C]phenylisocyanate from aniline.[56]
[11C]isocyanate derivatives have been synthesised from the reaction of phenyltriphenyl
phosphinimine and [11C]CO2 under mild conditions (Figure 1.16).
[57] After trapping of the [11C]CO2 at –
60 oC in THF the phenyltriphenylphosphinimine was added and heated for 6 min. The intermediate
[11C]isocyanate was not isolated but the addition of amine meant that the radiochemical yield of the
[11C]urea could give an indication of the effectiveness of the reaction.
Figure 1.16 Radiochemical synthesis of [11C]ureas from phenyltriphenylphosphinimine.
[11C]ureas derived from benzylamine, aniline, npropylamine and 5-methoxy-tryptamine were
synthesised in radiochemical yields ranging from 45-49 %, except for the aromatic derivative formed
from aniline which was only produced in 8 % radiochemical yield as might be expected from the
decreased reactivity of an aromatic amine. The key limitation of this work is the instability of other
organo-triphenylphosphinimines which are hydroscopic and air sensitive and therefore limits the
scope for expansion of this work to substrates that do not benefit for resonance stabilisation.
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Specific activities are not calculated but the milder reagents may reduce isotopic dilution compared
to reactions involving [11C]phosgene.
Fixation agents such as 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) have shown to be of great use
when implemented in the activation of [11C]CO2 for the synthesis of [
11C]carbamates.[58] The agent
works as a trapping agent as well as a catalyst in a solution of DBU at room temperature with 95 %
trapping of [11C]CO2 in the solution. Benzyl chloride and benzylamine were also combined in solution
so that they can react with the carbamate salt formed to give the target radiolabelled product.
Figure 1.17 shows a potential mechanism for this, however, it has been noted that a more complex
series of equilibria may actually take place.
Figure 1.17 Potential mechanism of the incorporation of [11C]CO2 into [
11C]carbamates using DBU.
The reaction with benzylamine and benzylchloride was optimised and then applied to a range of
other organo-chlorides giving radiochemical yields of up to 77 %. 2-Tert-butylimino-2-diethylamino-
1,3-dimethyl-perhydro-1,3,2-diazaphosphorine (BEMP) has shown to be even more efficient than
DBU giving radiochemical yields of up to 93 % in the [11C]carboxymethylation of amines.[59]
GR103545 is a potent and selective agonist for the kappa opiod receptor and has been labelled using
BEMP as a fixation agent in DMF by the ‘loop’ method, which gives a higher surface area for the
[11C]CO2 to react. These systems are extremely simple, efficient and rapid methods for the direct
incorporation of 11C into [11C]carbamates from [11C]CO2. The scope for this method to be used in the
wider PET community is large due to the mild nature of the fixation agents, and therefore the higher
specific activities possible.
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1.4 Palladium-catalysed Carbonylation Reactions with Carbon Monoxide
The use of palladium catalysts in synthetic organic chemistry is now widespread in reactions coupling
aryl halides/triflates with a wide range of nucleophiles. A shift from linear synthetic schemes to
parallel synthesis with cross-coupling reactions in the final stages is advantageous as it gives greater
synthetic flexibility. Exploration of this area led to the possibility of forming carbonyl-containing
compounds whilst coupling two moieties together if the reaction is exposed to carbon monoxide
during the reaction and a nucleophilic substrate is employed.
Carbon monoxide is attractive to industry as an inexpensive feedstock which can be used to give a
wide range of products in the agrochemical, pharmaceutical and fine chemical industries.[60]
Palladium-catalysed reductive carbonylation is used to synthesise aldehydes from aryl or vinyl
halides which act as intermediates to biologically active molecules and was first carried out by Heck
in 1974.[61] Furthermore, oxidative carbonylation reactions catalysed by palladium complexes can
synthesise ureas from amines and nitroarenes without the use of phosgene.[62] This review will focus
on the synthesis of carboxylic acid derivatives and carbonylative cross-coupling reactions using
transmetallating agents rather than reductive and oxidative carbonylations.[63]
Figure 1.18 General synthesis of carboxylic acid derivatives from palladium-catalysed carbonylation.
Palladium-catalysed carbonylation reactions of aryl and vinyl halides were first described by Richard
Heck in the 1970s.[64] He described the formation of acylpalladium intermediates from atmospheric
pressure of carbon monoxide and palladium(II) complexes which were then converted into a variety
of carbonyl containing products depending on the nucleophile used to eliminate the acylated
fragment from the metal centre. Since then, developments have generally focused on optimising the
reaction so that chlorides are employed and reaction conditions are milder and therefore more
suitable for scale up and industrial application.[65]
The general catalytic cycle for the carbonylation of aryl halides is shown in Figure 1.19. There is still
some uncertainty about the final stages of the mechanism, but essentially the cycle can be summed
up in the following steps; i) active catalyst formation (Pd(0)); ii) oxidative addition of aryl
halide/triflate; iii) CO binding to palladium centre; iv) carbonyl insertion into Pd-C bond; v)
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nucleophilic attack of carbonyl and elimination of the product.[65] It has been proposed that
nucleophilic attack occurs prior to carbonyl insertion into the Pd-Ar bond, which forms a carbamate
or carboxylate ligand and then reductive elimination releases the final product.[66] Conventionally
however, migratory insertion of the carbonyl group is thought to lead to a vacant site which can be
stabilised either by the return of a phosphine which had previously dissociated or addition of
another carbon monoxide under higher pressures leading to double carbonylation products such as
α-keto amides and esters. 
Figure 1.19 Catalytic cycle of Pd mediated carbonylation of an aryl halide.
There are many factors governing the exact mechanism of any carbonylation reaction, which range
from electronic and steric effects of the ancillary ligand, aryl halide and nucleophile, to effects of
solvent and base.[67] A base is often employed in carbonylation reactions to aid the initial reduction
of the palladium(II) catalyst, the reductive elimination step through concentration of the nucleophilic
anion and to neutralise acid by-products. The solvent can affect the stabilisation of intermediates in
solution. The carbon monoxide pressure has also been shown to be integral to the mechanism,
leading to double carbonylation in some cases such as when microreactors have been used to carry
out this reaction.[66, 68] Additionally, the ligand has been shown to affect double carbonylation
especially when (tri-tert-butyl)phosphine is employed.[69]
Chelating diphosphine ligands have found broad use in palladium-catalysed reactions, including
carbonylations, due to the chelate effect.[70] The bite angle has been hypothesised to be of great
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importance in many catalytic reactions such as rhodium-catalysed hydroformylation and nickel
hydrocyanation.[71] Albaneze-Walker et al. postulated a range of possible transition states which the
active catalyst would need to go through before carbonyl insertion (Figure 1.20).[72] The lability of
monodentate phosphines is well known and dissociation of a phosphine, in monodentate phosphine
palladium catalysed (Pd(PPh3)4) carbonylations, prior to carbon monoxide insertion is expected. In
the case of diphosphines, however, the dissociation is entropically disfavoured due to the chelate
effect so a five-membered transition state is plausible before the acyl complex forms. In the case of
the carbonylation of 2-chloropyridine to a methyl ester a diphosphine bite angle of 90 o was shown
to give highest yields, which suggests that the five membered transition state will hold a geometry
where it can be best stabilised by a chelating ligand with this bite angle. Therefore, if the
intermediate had a square pyramidal geometry a diphosphine with a bite angle of approximately 90o
would be optimal. Other factors affecting the structure of the five-membered intermediate are the
approach of the carbon monoxide, equatorial or axial (equatorial normally being favoured for carbon
monoxide as more backbonding is possible due to an increased electron density in the xy plane of d8
metals) and cis arrangement of the carbonyl group to the aryl for facile insertion. It was not
determined for certain which transition state is most likely as all of them (I-IV) have reasons for and
against them forming. Other studies, however, have shown that Xantphos with a bite angle of
approximately 110 o works particularly efficiently as a chelating phosphine in the synthesis of
Weinreb amides, primary and secondary amides and methyl esters.[73]
Figure 1.20 Proposed pathways for carbonylations using diphosphines.[72]
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Palladium-catalysed carbonylations have been exploited to form a variety of products such as esters
(alcohols), amides (amines), carboxylic acids (water), ketones (organometallic reagents) and
aldehydes (hydrides) by altering the nucleophile in the reaction.
Organometallic reagents can provide a nucleophilic source of carbon which attacks the acyl
palladium complex to reductively eliminate the cross-coupled product. Stille,[74] Sonogashira[75] and
Suzuki-Miyaura[76] carbonylative coupling reactions have been used to give a wide variety of aryl and
alkynyl ketones.[63] Suzuki-Miyaura carbonylations using boronic acids have also been shown to
effectively synthesise α-pyridyl ketones.[77] In this case the phenyl boronic acid acts as a carbon
nucleophile in the final carbonylation step. The main issue with this type of carbonylation is that it is
in competition with the direct coupling of the substrate to the boronic acid without insertion of the
carbonyl group. Variation of conditions can greatly alter the selectivity of the reaction, with 100 %
conversion and high selectivities for the carbonyl product being achieved after altering the carbon
monoxide pressure, the heat and ancillary ligand ([PdCl2(PPh3)2] and [PdCl2(PCy3)2]).
Hydroxycarbonylation[78] and alkoxycarbonylation[72, 79] (one of the first reactions of this kind
explored by Heck[64a]) are important reactions for the synthesis of aldehydes and esters respectively,
however, the focus of this review will be aminocarbonylations.
Aminocarbonylation is a very valuable route to amides from three components; an aryl halide,
carbon monoxide and a primary or secondary amine. As with all these processes the simplicity and
effectiveness of these reactions makes them suitable for industry and have particular relevance in
pharmaceuticals. Initial reports from Heck used 1.5 mol % of [PdX2(PPh3)2] (X = Br, I) at 100
oC and 1
atm carbon monoxide.[64b] These conditions gave good conversions although only aryl iodides and
bromides were used in this study. Attempts to create an efficient system with aryl chlorides are of
interest due to their increased economic viability relevant for industry.
Harsher conditions were required when aryl chlorides were used due to their slower rate of
oxidative addition. An increase in temperature to 150 oC or 175 oC and carbon monoxide pressure
(75 psi) were required to achieve better conversion of the less reactive aryl chlorides in the oxidative
addition step.[80] A more robust ligand set such as bis(diisopropylphosphino)propane (dippp) is also
necessary to prevent dissociation of the monoligated phosphines and formation of elemental
palladium.[70a]
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Figure 1.21 Proposed mechanism for the aminocarbonylations using sodium phenoxide (L = 1,3-
bis(dicyclohexylphosphino)propane (dcpp)).[81]
Additives such as sodium iodide have been used to promote the reaction with electron deficient aryl
chlorides; however, they were not efficient with electron rich substrates.[82] More recently Buchwald
has shown that sodium phenoxide works well as an additive in aminocarbonylation reactions (Figure
1.21).[81] Firstly, it acts as a reductant to form the active catalyst ready for oxidative addition. It also
plays a more important role forming an intermediate ester by removing the acyl unit from the metal
centre. Furthermore, it can act as a Brønsted base catalysing the formation of the amide product.
This route is thought to increase the yield by offering a lower energy pathway. The use of sodium
phenoxide meant that an atmospheric pressure of carbon monoxide could be used at 100 oC on a
range of aryl chlorides and primary and secondary amines with good yields (65-99 %). Heteroaryl
chlorides were also used in this study, illustrating the wide scope of this reaction under these
conditions. Another study focussing on heteroaryl bromides used di-tert-butylphosphinoferrocene
as the ligand under low pressures of carbon monoxide and chiral amines gave yields of 65-91 % in
relatively short reaction times but at elevated temperatures (145 oC) and excess phosphine (8
eq.).[83] Heteroaromatic moieties are widespread in organic synthesis and manipulation of heteroaryl
halides to synthesise amides is important. One such example is the potentially bioactive (potential
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selective inhibitor of protein kinase C) amide derivatives of 3-bromoindolylmaleimide have been
prepared from aminocarbonylation of the maleimide ring.[84] CataCXium A (di-1-adamantyl-n-
buytlphosphine) and [Pd(OAc)2], the reagents and base at 5-15 bar pressure of carbon monoxide
gave yields between 32-70 % of amide product.
Microfluidic reactors have found applications in many areas of organic synthesis thanks to the
increased surface area-to-volume ratio and heat transport capable with these devices.[85]
Carbonylation reactions can benefit from their increased interfacial gas-liquid contact area because
of the poor solubility of carbon monoxide which affects reactions carried out at atmospheric
pressure of carbon monoxide. Aminocarbonylations have been achieved by combining the
substrates and carbon monoxide on a glass fabricated microfluidic chip.[86] Furthermore, due to the
facile nature of this methodology rapid catalyst screening was undertaken of a model
aminocarbonylation reaction demonstrating the significant improvement in yield when
[PdCl2(Xantphos)] is used at low temperatures (100-120
oC).[31] As previously mentioned 4,5-
bis(diphenylphosphino)-9,9-dimethylxanthene (Xantphos) has been very effectively used before in
palladium-catalysed aminocarbonylation to synthesise Weinreb amides, benzamides and methyl
esters.[73] Some of these reactions could be performed at room temperature and atmospheric
pressure of carbon monoxide.[87]
The scope of applications for the palladium-catalysed carbonylation reaction is vast, for example
ferrocene derivatives of amides and α-ketoamides have been prepared.[88] Intramolecular
aminocarbonylations are an efficient route to lactones,[89] lactams and thiolactones.[90] Primary
amines can also be formed via aminocarbonylation, but the major drawback is the necessity to work
with two toxic gases; NH3 and CO.
[91] However, alternative routes have shown to be successful with
formamide[92] and inorganic salts such as ammonium chloride.[65]
1.4.1 N-Heterocyclic Carbenes
N-Heterocyclic carbenes (NHCs) were synthesised and applied in transition metal coordination
chemistry as early as 1968 by Öfele and Wanzlick.[93] However, it was not until 1991 and Arduengo’s
seminal work in this area that the popularity of NHCs as ligands began to increase dramatically over
the subsequent two decades.[94] In his work the first stable crystalline free carbene was prepared
from removal of the proton on the central carbon (N-C1-N) of the imidazolium salt, N, N’-bis(1-
adamantyl) imidazolium chloride (IAd.HCl), with a simple base.[95] A few years later, Hermann et al.
showed that NHCs can act as sigma donors to transition metals and could be applied in coordination
chemistry and catalysis.[96] As ligands they are less reactive than Schrock or Fischer carbenes when
bound to metals and generally act as ancillary ligands. Since then there has been a surge in the use
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of NHCs in many areas of organometallic chemistry with a great deal of success particularly as
ancillary ligands in reactions normally catalysed by palladium-phosphine systems. One of the most
well-known expansions of a catalyst series is within olefin metathesis with a range of new
generations of Grubbs catalysts (Figure 1.22).[97]
Figure 1.22 Second-generation Grubbs catalyst.Structure and Electronics of N-Heterocyclic Carbenes
As with all ancillary ligands in catalysis, the stereoelectronic parameters of NHCs are the key to
rationalisation of the activity of the catalyst.[98] Electronically, NHCs have been thought of as
‘phosphine mimics’, having been shown to yield good results when employed in similar roles to
phosphines as two electron neutral donors; however, this analogy does not always fit.[99] NHCs are
stronger σ-donors than phosphines which is evident from the IR stretches of CO ligands in some 
iridium carbonyl compounds that have been systematically studied.[100] An increase in the σ-
donation translates to increased stability of the metal complex and to the ability to withstand
greater pressures and temperatures as well as its robustness to air and moisture. Increased electron
density directed onto the metal centre can also mean a faster rate of oxidative addition, often the
rate determining step, and therefore overall a faster rate of reaction.
Backbonding from the metal to the NHC is not as evident or as widely understood as the π-acceptor 
properties of phosphines. There is a consensus that the back donation to NHCs is negligible,[101]
however, the amount of electron density donated into metal orbitals is still a matter of debate with
some spectroscopic and DFT studies suggesting a fair synergic contribution to bonding.[102] The
molecular orbital diagram suggests that versatility in the bonding structure is possible which has
been backed up by experimental observations.[103]
Chapter 1 - Introduction
24
Figure 1.23 Frontier orbitals of NHCs (a), phosphines (c) and their interaction with a transition metal atom’s d
orbitals (b). Blue – σ-bonding from ligand to metal. Red – π-bonding from metal to ligand. Figure taken from a 
review by Kantchev et al.[94c]
Steric interactions between NHCs and the metal centre also differ greatly from phosphines which
have their steric bulk directly attached to the donor atom, whereas NHCs’ substituents sit one atom
away. Figure 1.24 illustrates the implications of this on the crowding around the metal centre. A
pocket can be created around the metal centre which can influence the metal’s coordination sphere
and help stabilise the metal centre. This is particularly evident in sterically demanding NHCs such as
bioxazoline-derived carbenes (IBiox).[104] The C3v symmetry of tri-substituted phosphines means that
rotation has little effect on the sterics about the metal centre; however, the planar fan-shaped
nature of NHCs means that rotation can have a significant steric effect and the whole volume of that
rotation must be taken into account. A systematic method for quantifying the space around the
metal centre similar to the Tolman cone angle has been developed. The concept works by calculating
the buried volume, which is the percentage volume of the ligand confined inside a sphere of 3 Å in
radius with the palladium centre in the middle.[105]
Chapter 1 - Introduction
25
M
P
N N
M
Figure 1.24 Schematic illustrating the difference in sterics exerted by the R groups about the metal centre.
The implication of the remoteness of the substituents is that steric and electronic properties can be
varied almost independently. Variation of the organyl (R) groups attached to the nitrogen atoms has
little electronic effect on the ligands donor ability, but changes in the ring structure can affect the
electronic properties more. A study of benzimidazoles, where electron withdrawing and donating
substituents were attached to the benzyl ring, illustrated that increased electron density in the ring
aided oxidative addition whereas the steric bulk of the R groups affected reductive elimination in the
Suzuki-Miyaura reaction of aryl chlorides and aryl boronic acids.[106]
The most commonly used R groups which allow for steric alteration about the metal centre are 2,6-
diisopropylphenyl, 2,4,6-trimethylphenyl or adamantyl groups due to the additional stabilisation
they provide to the overall structure; however, there is a whole library of NHCs with a variety of R
groups. The backbone (C4-C5) can be double or single bonded giving rise to two classes of NHC, either
unsaturated or saturated respectively. Some of the 4,5-dihydroimidazolium and imidazolium
hydrochloride salts are illustrated in Figure 1.25 along with their shorthand nomenclature.
Figure 1.25 4,5-Dihydroimidazolium and imidazolium hydrochloride salts.[107]
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Synthesis and Complexation of N-Heterocyclic Carbenes
Despite the stability of free NHCs in comparison to other carbenes, they are still sensitive to air and
moisture and require handling in a glovebox. Imidazolium salts can be deprotonated to form an NHC
with a simple base. In catalytic reactions the salts are normally applied directly in situ with the
palladium source because there is commonly a basic environment in the reaction mixture which can
aid the formation of the free NHC. Unsaturated imidazolium salts can be prepared from glyoxal,
formaldehyde and the corresponding amine in the presence of a strong acid.[103a, 108]
Chloromethylethyl ether can also be used instead of formaldehyde in this reaction.[107b] This
procedure has been used to synthesise a range of unsaturated symmetrically substituted
imidazolium salts.
Figure 1.26 General synthesis of an unsaturated imidazolium hydrochloride salt.
The synthesis of symmetrical saturated dihydroimidazolium salts can be achieved via oxalamide (B)
or diazabutadiene (A) intermediates. The diazabutadiene route (A) is known to be affective in the
synthesis of SIMes.HCl and SIPr.HCl,[107b, c] whereas SIAd.HCl can only be synthesised from
oxalamides due to issues with the reduction of the diazabutadiene to N,N’-di(1-adamantyl)ethane-
1,2-diamine (Figure 1.27).[107a]
Figure 1.27 Synthesis of saturated dihydroimidazolium salts via oxalamides or diazabutadienes.
Chapter 1 - Introduction
27
A more recent development in the preparation of saturated NHC frameworks sees the use of
disubstituted formamidines with dibromoethane or 1,3,2-dioxathiolane-2,2-dioxide as a di-
electrophile.[109] This methodology has been shown to have wide scope as five-, six-, and seven-
membered imidazole rings and imidazolium salts with a functionalised backbone (benzimidazoles)
have been prepared from this method by varying the dihalo-substrate.
Figure 1.28 Synthesis of saturated dihydroimidazolium hydrobromide salts from diarylformamidine and
dibromoethane.
These methods can only be used to synthesise the symmetrically-substituted derivatives.
Independent variation of the R groups is possible with sequential addition of two amines to
ethylchlorooxoacetate to produce the oxalamide which can be reduced and cyclised as before
(Figure 1.27).[107a, 110] The synthesis of unsymmetrical unsaturated imidazolium salts can be prepared
from N-alkylation of alky/aryl imidazoles with an alkyl halide.[111] This route has given rise to a range
of pendant arm functionalised NHCs with groups such as phosphines,[112] ethers,[113] amines,[108a]
amides,[114] thioethers,[115] ferrocenyl,[116] pyridinyl,[113] NHCs[117] and a range of anionic groups
tethered[118] to one or both of the nitrogen atoms on the imidazolium ring.Applications of N-Heterocyclic Carbenes
NHCs have shown potential as ancillary ligands for many palladium-catalysed reactions.[94c, 94f, g]
Some of the cross-coupling reactions that have utilised NHCs include Suzuki-Miyaura reactions,[119]
Sonogashira cross-coupling[120] and Buchwald-Hartwig amination.[121] NHCs have been used in
palladium-catalysed oxidative carbonylation of amines too, employing a copper co-catalyst to
synthesise ureas,[122] carbamates,[123] carbonates[124], polycarbonates[125] and 2-oxazolidinones.[126]
The use of NHCs in carbonylation reactions of aryl halides described in section 1.4 is a relatively
unexplored area.[127] Infrequent use of NHCs in palladium-catalysed carbonylation reactions may be
partly due to the potential for catalyst degradation via NHC elimination to form an acylated
imidazolium salt. Insertion of carbon monoxide into the M-NHC bond has been shown to be facile in
the case of a methyl substituted imidazolium salt.[128]
Some work has been carried out investigating the use of NHCs in palladium-catalysed carbonylative
Suzuki-Miyaura cross-coupling reactions to synthesise ketones. High selectivity for the carbonyl
product is necessary because direct coupling without carbon monoxide insertion to give the biaryl
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product occurs as a side reaction. Castanet et al. have explored the carbonylative cross-coupling of
functionalised pyridine halides and aryl boronic acids.[129] The optimal conditions realised for
bromopyridines and reactions were typically carried out at 140 oC and 50 bar carbon monoxide in
dioxane, with Cs2CO3 acting as the base. The imidazolium salt, IMes.HCl, at a 2:1 stoichiometry with
Pd(OAc)2 was shown to give greatest activity and selectivity. Overall yields for this reaction with
bromoderivatives were very good; however, there were still lower yields with chlorinated pyridines
and even more so with deactivated pyridines such as dichloropyridines. High percentage conversion
in carbonylation reactions with chloropyridines was shown to be heavily dependent on the
imidazolium salt to palladium molar ratio as well as the nature of the imidazolium salt used with
conversions ranging from 30-88 %.
Figure 1.29 Palladium-NHC catalysed carbonylation of pyridyl halides and aryl boronic acids.
Another study into carbonylative Suzuki-Miyaura reactions employed a palladium catalyst containing
an unsymmetrical NHC and triphenylphosphine to synthesise aryl ketones successfully with good
chemoselectivity.[130] Sodium tetraphenylborate and phenyl boronic acid were used as a phenylating
agent. Excellent yields were obtained with a range of iodoarenes in dioxane at 100 oC using K2CO3 as
a base. High pressures were not required for these transformations with 1 atm of carbon monoxide
being employed in all cases. This is particularly impressive as other studies have shown that an
increase in carbon monoxide pressure is necessary to prevent biaryl production and improve
selectivity. Atmospheric pressure of carbon monoxide was also employed in the work of Andrus
which employed aryl diazonium ions and aryl boronic acids.[131] SIMes.HCl was used with Pd(OAc)2 in
1:1 stoichiometry to give yields of a range of aryl ketones in 74-90 % after 5 h.
The same laboratories of Andrus et al. have performed more work with aryl diazonium salts in the
only reported production of amides through palladium-catalysed carbonylation with NHCs.[132] The
methodology used is not like the standard ‘Heck’ aminocarbonylation studied with palladium-
phosphine catalysts. Arylamides are produced from a four component reaction of ammonia as a
saturated solution in THF with aryl boronates or boronic acids, aryl diazonium tetrafluoroborate and
carbon monoxide catalysed by [Pd(OAc)2] and SIPr.HCl. A complex mechanistic pathway is postulated
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which can give rise to the four products being observed; two amides, biaryl product and arylaniline
(Figure 1.30).
Figure 1.30 Multiple products from carbonylative cross-coupling of diazonium tetrafluoroborate and
phenylboronic acid.
It is postulated that the aryl diazonium salt oxidative adds to the active Pd(0) catalyst and is followed
by coordination of ammonia and migration of the aryl group to NH gives a palladium-amine
intermediate. Subsequently, carbon monoxide coordinates to the metal centre and transmetalation
attaches the aryl group of the boronic acid to the metal. Migration of the aryl group to the carbonyl
provides a palladium-acyl complex which undergoes reductive elimination to give the product. The
multiple components and steps in this catalytic cycle mean that several products are produced and
selectivity for the desired amide product could only be achieved by increasing the pressure of carbon
monoxide up to 10 bar.
1.4.2 Hemilabile Phosphine Ligands
Hemilabile ligands are hybrid chelating ligands which contain two or more different functionalities
with different chemical properties. The differentiation between the donor atoms is important so
that they can interact in different ways with a metal centre; typically one donor atom is
substitutionally more labile than the other. This hemilability about a metal centre is of interest in
coordination and organometallic chemistry as it can affect the electronics and other ligands in the
complex. Furthermore, the ‘opening and closing’ mechanism that these ligands are capable of
provides a free coordination site as well as stability of the starting material and other intermediates.
Often soft and hard donor atoms are used in hybrid chelating ligands as they can interact differently
with metals in various oxidation states and at different ends of the periodic table. Phosphines are
frequently used as one of the functionalities due to its soft donor properties and strong bonding
with late transition metals. Comparatively harder donors such as amines, ethers, thioethers or
phosphine oxides[133] can be paired with phosphines in one chelating structure to give ligands with
hemilabile properties.
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P,N,[134] P,O[135] and P,S[136] hemilabile ligands have been prepared with a variety of backbone
structures and when bound to metals have found use in homogeneous catalysis[137], functional
materials[138] as well as small-molecule (ie. carbon monoxide) sensing.[139] Although the scope and
importance of P,N ligands is large, the applications and significance of P,O and P,S ligands will be
described herein.
P,O ligands can be realised in a wide range of species with an endless variety of backbone structures
possible within each group. Most commonly encountered are phosphine-ethers (I) which contain a
phosphine group and an ether group, which can be incorporated into an acyclic structure (II) or
polyether chain. Phosphinoalcohols (III, IV) can easily be deprotonated to give an anionic-neutral
hybrid P,O donor ligand. Carbonyl containing functions such as ketones (V) and aldehydes (VII) can
also be used as a source of oxygen yielding α-ketoylids (VIII) and β-ketophosphines, which can be 
treated with base to yield phosphinoenolates (VI). Another class of P,O ligand is the
phosphinocarboxylates which contain a phosphine group with either a carboxylic acid group (IX) or
an ester group (X). For more detail on all of these species and their synthesis see the comprehensive
review by Lindner, and references therein.[135]
R2P
OR'
R2P
O
R2P
OH
OH
PR2
PR2
O
R2P
R'
O
R2P
R'
O
R3P
R'
O
R2P
OEt
O
R2P
OH
O
I II III IV
V VI VII VIII
IX X
Figure 1.31 A selection of potential P,O ligand structures.
Complexation of these ligands has been carried out with a range of transition metals such as,
chromium, cobalt, nickel,[135] ruthenium,[140] rhodium,[141] niobium, tantalum, tungsten,[142] palladium
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and platinum.[143] The attraction of using hemilabile ligands in catalysis is the potential to provide a
free coordination site at the metal centre during the reaction as the more substitutionally labile
component dissociates, whilst still having a stable starting material. Rhodium and cobalt containing
complexes with phosphine-ether hemilabile ligands have been studied in the carbonylation of
methanol to synthesise acetic acid or acetaldehyde.[144] The ‘opening and closing’ mechanism has
been illustrated for P,O ligands in this reaction (Figure 1.32).[135] The mechanism aides in the
oxidative addition and methyl migration steps, allowing for reductive elimination.
Figure 1.32 Carbonylation of methanol to acetic acid with a phosphine-ether rhodium complex.
Other catalytic applications of P,O ligands include olefin polymerisation, hydrogenation and
amination. For example CO-ethene copolymerisation has been carried out with 1,1’- and 1,2-
substituted phosphine-ferrocenecarboxylic acid ligands in palladium(II) complexes giving semi-
alternating polyketones with extra-ethylene incorporation of 4.3 %.[145] A phosphine-ether ferrocene
ligand was shown to give excellent yields (97 % GC yield) after short periods of time in the amination
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of aryl bromides with diminished amount of hydride elimination product compared with the
diphosphine equivalent.[146]
Suzuki-Miyaura cross-coupling of 4-bromotoluene and phenyl boronic acid is another protocol which
has been studied using a P,O ligand with a ferrocene backbone coordinated to palladium which was
tested as a catalyst with the biaryl product being synthesised in 73-89 % isolated yield.[147] The
ferrocene was substituted with a diphenylphoshine and a methoxy group directly on the
cyclopentadienyl ring. The coordination chemistry was explored with metals such as palladium,
platinum, nickel, copper and rhodium.
A more unusual phosphine-amide ligand has been used to test a range of hindered or heteroatomic
aryl chlorides in yields < 88 %.[148] A new class of P,O ligand, Bphos, was simply prepared from a
commercially available tertiary benzamide by directed ortho-lithiation and treatment with ClPR2.
Pd2(dba)3 and
tbutyl-substituted Bphos were shown to give an efficient reaction at low catalyst
loadings (0.05 %). Other P,O-substituted ferrocene ligands containing acetal functions have been
used in Suzuki couplings.[149] Furthermore, some products from the oxidative addition of aryl iodide
to a P,O ferrocene palladium complex have been isolated.[150] It was shown from stoichiometric
reactions that four different structures formed and three of them were coordinated via the
phosphorus atom showing the ‘opening’ action of the P,O ligand. The major product either an iodide
bridged complex or a square planar P,O chelated palladium complex with phenyl and iodide
coordinated changed with different R groups on the ligand.
P,S ligands are most broadly encountered in two forms; either phosphine-thiols or phosphine-
thioethers. Other classifications of P,S ligand include, phosphine-thioformamides, phosphine-
thioformates and diphosphine monosulphides.[136] Phosphine-thiols consist of a phosphine moiety
and a thiol group which on deprotonation and complexation gives a thiolate (S-) donor as illustrated
in the P,S ferrocenyl ligated nickel complex in Figure 1.33.[151]
Figure 1.33 Complexation of 1-(diphenylphosphino)-1’-(thiol)ferrocene with nickel.[151]
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The corresponding phosphine-thioether substituted ferrocene has also been prepared with either
methyl or mesityl groups.[152] In addition to complexation with palladium, platinium and nickel, the
ligand showed promise in the catalysis of Suzuki-Miyuara cross-coupling producing 4-methylbiphenyl
in combination with a Pd(0) precursor in 80 % isolated yield. The ferrocene backbone has also been
exploited to produce chiral P,S ligands with the potential to be used in enantioselective catalysis
such as allylic alkylation and the Heck reaction.[153] Palladium complexes of chiral P,S ligands with a
BINAP framework have been shown to be effective in the asymmetric allylic alkylation of 1,3-
diphenylpropenyl acetate with dimethyl malonate, producing enantiomeric excesses of 72-96 %.[154]
Several other palladium complexes containing phosphine-thioether ligands have shown catalytic
activity towards olefinic couplings of aryl halides and alkenes,[155] Suzuki cross-coupling reactions[156]
and CO/ethene copolymerisation.[157]
As encountered with P,O ligands, phosphine-thioether compounds have found application in the
carbonylation of methanol when coordinated to rhodium. Many industrial protocols have been
developed to achieve acetic acid synthesis using methanol from synthesis gas and carbon monoxide
derived from natural gas as economically viable feedstocks. The cobalt-based BASF process was
initially used but has now been superseded by nickel catalysts, the Monsanto process (Rh) and
Cativa process (Ir).[158] Activities have been observed under industrial conditions (185 oC and 70 bar
of CO) by Baker et al. using cis-[RhI(CO)(Ph2PCH2P(S)Ph2)] as the active catalyst for methanol
carbonylation with an 8-fold improvement from the same reaction with diphosphine ligands.[159]
Kinetic, crystallographic and theoretical data suggests that the intact chelate structure of the P,S
ligand coordinated to the rhodium centre is present for the entire reaction in this case unlike the
hemilabile activity shown by P,O ligands.[160] Furthermore, there is the proposal that the placement
of the sulphur atom trans to the carbon monoxide promotes migratory insertion.
Figure 1.34 Palladium phosphine-thioether complex suspended on a silica support.
There are many examples of P,S ligands complexed to palladium in the literature, however, the
studies into the palladium-catalysed carbonylation of aryl halides using P,S ligands are scarce. Silica-
supported phosphine-thioether palladium complexes have been used as catalysis in the
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carbonylation of substituted aryl iodides and bromides with aniline and n-butyl alcohol.[161] Products
were synthesised in up to 91 % isolated yield.
1.5 Transition Metal Activation of CO2
Carbon dioxide is very thermodynamically stable and kinetically inert, furthermore, its linear
geometry means that overall the molecule is apolar. Coordination to a metal centre populates the
LUMO orbital of CO2 which lengthens the C-O bond lengths and lowers the activation energy
increasing the rate of reaction of CO2 with other substrates. Carbon dioxide contains 16 electrons
and is sp hybridised, it also contains two π molecular orbitals which are orthogonal to each other 
which can affect the bonding modalities. There are three bonding modes of CO2 to one metal centre
illustrated in Figure 1.35.
Figure 1.35 Bonding modes of CO2 at a transition metal centre; A) η
1
(C); B) η
2
(C, O); C) η
1(O).
Reaction of transition metal coordinated CO2 can occur with an R-X (organohalide, alkene, alkynyl)
substrate to yield RCO2X. The mechanism can take place by addition of CO2 and R-X simultaneously
to the metal centre or by one first then the other. In each case the elimination yields the desired
product. The first transition metal to be isolated that contained a coordinated CO2 molecule was
Aresta’s complex, [Ni(η2-CO2)(PCy3)2], promoting research into the coordination of CO2 and other
new reactions involving transition metals.[162]
There are several other methods of incorporating CO2 into organic compounds with the use of
transition metals,[163] eg. the simultaneous oxidative coupling of an unsaturated compound and CO2
forming a metallacycle[164] and insertion reactions into M-H, M-O, M-N, M-P, M-Si, M-C.[165] The
extensive amount of research into all of these areas have been detailed in a range of reviews (and
references therein).[165-166]
1.5.1 Titanium Imido Species
The imide functionality has shown to be of wide use in early transition metal complexes as ancillary
ligands and as reactive moieties in their own right.[167] The dianionic ((NR)2-) terminal imido ligand
acts as a four electron π-donor and is particularly compatible with early transition metal complexes 
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and complexes in high oxidation states due to their significant σ-donor properties. Group IV metals 
and particularly titanium have been shown to provide versatile reagents with the imido functionality
as well as being good catalysts. They have been employed as precursors to thin metal nitride films
for metal organic chemical vapour deposition methods (MOCVD).[168]
Imido ligands have been utilised as ancillary ligands in olefin metathesis, perhaps best known are
catalysts of the form [M(NAr)(CHR)(OR’)2] (M = Mo or W, Ar = 2,6-diisopropylphenyl and R’ = bulky
alkyl or aryl),[169] and Ziegler-Natta olefin polymerisation catalysts[170] such as the
bis(imido)chromium(VI) compounds.[171] Recent debate over the innocence of the imido ligand in the
polymerisation process has prompted investigation into the reactivity of these ligands especially
with saturated small molecules.
The high polarity of the Ti=NR bond increases the reactivity of the imide functionality, especially
given a low-coordination environment. Cycloaddition reactions of the imide group with saturated
substrates have been widely examined (discussed in 1.5.2 and 1.5.3) and can lead to rapid extrusion
of the imido containing organic product.
The first structurally characterised terminal titanium imido compound was isolated in 1990 by
Roesky[172] and Rothwell[173] in the complexes [Ph2PN=TiCl2(py)3] and [(ArO)2Ti=NPh(py)2]
respectively. A wide range of protocols have been developed in order to synthesise the titanium
imide structure through dehydrohalogenation, deprotonation and α-hydrogen abstractions, 
trimethylsilyl chloride elimination reactions, α-hydrogen migration. For a more detailed summary of 
the synthesis of titanium imido complexes see the comprehensive review by Mindiola.[174]
One route is via primary amide salts such as LiNHR which aid in the formation of low-coordinate
terminal titanium imides via elimination of an inorganic salt which is simple to remove during work
up. Figure 1.36 shows the use of methyl lithium to synthesise a terminal imide by
dehydrohalogenation driven by the production of methane.[175]
Figure 1.36 Synthesis of a titanium imide complex by dehydrohalogenation.
In a similar fashion a pre-ligated titanium chloride compound can have a primary amide
incorporated followed by transmetalation of an alkyl reagent forming [(L)nTi(NHR)(R)] as an
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intermediate species. The extrusion of RH will then occur either spontaneously over time, after
thermolysis or by exposure to UV light to produce the titanium imide product.[176]
Generally terminal titanium imide complexes are prepared from titanium tetrachloride and the
corresponding primary amines with a donor ligand (pyridine, triphenylphosphine oxide) which could
play several roles such as α-hydrogen deprotonation, displacement of the ligated amine and 
prevention of dimerisation. Triphenylphosphine oxide was shown to be important in forming the
titanium imide complex illustrated in Figure 1.37.[168]
Figure 1.37 Synthesis of [TiCl2(N
tBu)(OPPh3)2] illustrating the key role played by PPh3O.
Mountford et al. have developed a similar strategy to synthesise a general precursor as a route to a
range of other titanium imide complexes. It was decided that due to the facile reduction of Ti(IV) to
Ti(III) that the imido function should be incorporated first into the starting material before any
ancillary ligands.[177] Titanium tetrachloride is treated with an excess of tbutylamine (6 eq.) which
promotes the formation of [Ti(NHtBu)2Cl2] and the ammonium salt. Pyridine is added to form either a
five or six coordinate [(py)nCl2Ti=N
tBu] complex.[178] Transmetalation reactions with a range of ligand
precursors has been shown to give an excellent route to a wide range of titanium complexes
containing the imide functionality with differing ancillary ligands.[179] Additionally the tbutyl group
can be exchanged by treatment with arylamines, so that a range of imide derivatives can be
prepared. Examples of imido exchange reactions include the imido groups of, 4-methylphenyl, 4-
nitrophenyl, 2,6-dimethylphenyl, 2,6-diisopropylphenyl and triphenylsilyl having been prepared from
this starting material (Figure 1.38).[180]
Figure 1.38 Synthesis of [TiCl2(py)3(N
tBu)] and exchange reaction with an arylamide.[180b]
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A similar range of complexes have been reached through a different route starting with titanium
tetra(dimethylamide) and reacting with a wide range of amines in the presence of excess
chlorotrimethylsilane to yield the corresponding imide complexes in a one-pot reaction (Figure
1.39).[181]
Figure 1.39 Synthesis of [TiCl2(py)3(NR)] from titanium tetra(dimethylamide).
An extensive array of titanium imide derivatives have been synthesised in the last two decades. As
with all forms of coordination chemistry it is of interest to investigate the ancillary ligand groups to
assess the impact on the structure and reactivity of other groups and the complex as a whole.
Titanium imide complexes have been prepared with classic cyclopentadienyl ligands,[182] amidinates,
bi-and tri-dentate amines, tris(pyrazolyl)hydroborate ligands,[177] β-diketiminate ligands,[183] pendant
arm functionalised benzamidinates[184], constrained-geometry carboranyl ligands,[185] α-diimines,[186]
tetraaza macrocyclic ligands,[187] cyclooctatetraenyl ligands,[188] and N-heterocyclic carbenes[189] to
name but a few! The ubiquity of Mountford’s precursor has been exploited to prepare some of these
complexes which are illustrated in Figure 1.40.
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Figure 1.40 Some examples of titanium imido compounds synthesised from [Ti(NtBu)(py)3Cl2].
1.5.2 Reactivity of Titanium Imido Species with Unsaturated Substrates
The titanium imide moiety has been shown to be very reactive with a range of saturated substrates;
alkenes, allenes, alkynes, nitriles, phosphaalkynes, isocyanides, carbodiimides.[179, 190] The same
intermolecular [2+2] cycloaddition mechanism occurs in each case and has been exploited to form
many catalytic cycles via extrusion of the organic product from the intermediate metallocycle
followed by recycling of the titanium to the active catalyst. In this review however, the focus will be
on the reactivity of titanium imides with carbonyl-containing compounds and especially carbon
dioxide.
Mountford et al. have carried out a series of studies to assess the reactivity of the imide function in
titanium imido complexes with several saturated organic compounds such as alkyl and aryl
isocyanates, carbon dioxide and as well as isoelectronic isothiocyanates and carbon disulphide. The
variation of the ancillary ligand sets and organic group attached to the imide was shown to be of
particular interest.
Initial studies explored tetraaza macrocyclic titanium and zirconium imide and hydrazido complexes
and their reactivity with phenyl- and tolyl-isocyanate and carbon dioxide.[191] The imido group on the
titanium complex was shown to react with CO2 yielding a N,O bound carbamato complex after 30
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minutes of stirring at 1.1 atm CO2 at room temperature. Conversion to the metallocycle product was
efficient and in good yield (85-88 %). Crystals were able to be grown and analysed by X-ray
diffraction crystallography (Figure 1.41).
Figure 1.41 Molecular structure of [Ti{N(Tol)C(O)O)(Me4taa)] with hydrogen atoms omitted.
Complexes containing the carbamato moiety were isolated from the tbutyl and tolyl imide containing
complexes and were observed to be light sensitive in solution and solid state, initiating retro-
cycloaddition and the production of the isocyanate after 5 days in ambient light. The relative stability
of the carbamato intermediate is most likely due to the higher coordination achieved and the stable
nature of the chelating macrocycle. This stability does not lend itself to systems where the extrusion
of the organic product is desired.
Several amidinate-cyclopentadienyl ligand sets have also been used to support titanium imido
species which undergo the same cycloaddition reaction with CO2.
[192] In this case, the formation of
the carbamato complex was achieved after 10 minutes of CO2 (1 atm) in 60 % yield. The release of
isocyanate via retrocycloaddition was observed over a 12 hour period also producing the dimeric
bridging oxo complex (Figure 1.42). The same reaction was also carried out with an aryl imide
titanium complex with the same ancillary ligand set. The carbamate containing intermediate was
formed in 66 % yield after 3 min but continual storage under CO2 lead to double insertion into the Ti-
N bond. It is postulated that this could be due to the resonance stabilising effect of the aryl group on
the nitrogen atom in a highly polarised transition state.
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Figure 1.42 tButylisocyanate formation from a titanium imide complex with a Cp-amidinate ligand set.
This work was extended with the amidinate-cyclopentadienyl ligand set to show reactivity with CS2,
COS, PhNO, ketones, aldehydes and imines.[193] The aryl imido groups again were shown to be more
prone to double insertion than the tbutyl imide titanium complexes.
A more in depth study was carried out to investigate the effect of a pendant alkyl chain attached to
the amidinate ligand.[194] Decomposition of the carbamate intermediate was observed after an hour
in this case, with the exact reasoning for the increased rate of isocyanate extrusion being unclear.
Another set of titanium tbutyl imide complexes were synthesised with an amidinate and C5H4Me
unit. These were shown to give even faster extrusion of the organic product which was attributed to
the reduced steric stabilisation of the C5H4Me compared to complexes containing C5Me5.
In the reactions of titanium cyclooctatriene (COT) imide complexes with CO2, it was shown that the
isocyanate could be produced after retro-cycloaddition from a carbamato-containing intermediate
and continued stirring at room temperature for 14 hours.[195] The intermediate was observed to have
formed from 1H NMR spectroscopy, to be produced quantitatively and then to disappear with the
extrusion of isocyanate. As the organic product was produced an insoluble light brown powder
precipitated out of solution which was identified as a titanium oxo species, likely to be the oxo
bridged dimer due to the insolubility observed (previously isolated terminal oxo titanium complexes
of this type displayed greater solubility in organic solvents). It was also interesting to note that the R
group on the imide functionality played an important role in this reaction. An aryl imide slowed
isocyanate formation compared to the alkyl alternative, possibly due to stabilisation of the
intermediate metallocycle. Further reactions were carried out with CS2, isocyanates and
isothiocyanates and DFT calculations were undertaken.
More recently terminal titanium hydrazides have been shown to exhibit the same reactivity with
CO2, nitriles and isocyanates as seen previously with titanium imides.
[196] Double insertion of CO2 was
observed for these reactions when Ti=N-N(Ar) and Ti=N-N(Me) were employed without
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retrocycloaddition. This could be due to the stabilisation of the additional nitrogen atom in the
ligand compared to the imide functionality, as has been observed with arylimide ligands.[192]
This series of investigations by Mountford has illustrated the effect of the ancillary ligand set and
imide group on retrocycloaddition and the production of isocyanate. Further DFT calculations and
theoretical studies have been carried on the model reaction of titanium alkyl and aryl imides which
have indicated that it may be the steric bulk of the tbutyl group compared to the aryl group rather
than their electronic properties which are forcing the extrusion of the organic product.[197]
A ketiminate titanium imido complex was synthesised from the reaction of 2 equivalents of
Li[OC(Me)(CH)C(Me)N(Ar)] with [TiCl2py3(N
tBu)] and was shown to form a terminal oxo product after
12 h in a pressurised reaction vessel of CO2.
[198] Unfortunately only the oxo-titanium product was
reported and no identification or quantification of organic products was carried out. It was reported
that the same titanium-oxo product could be achieved from reaction with phenyl isocyanate and
after heating to 95 oC for 12 h.
The metathetical reaction of converting CO2 into isocyanates rather than just focusing on the
cycloaddition to the titanium imide function has been highlighted by Mindiola et al.[199] A zwitteronic
titanium imide, [Ti(NAr)(nacnac)(CH3)][B(C6F5)3] (nacnac
- = [ArNC(tBu)]2CH, Ar = 2,6-
diisopropylphenyl) has been shown to yield quantatative amounts of aryl isocyanate under mild
conditions. The borane is critical in abstracting a methide on the precursor complex to prevent
acetate formation from insertion of CO2 into the Ti-CH3 bond. Interestingly it was observed that,
even on treatment with excess CO2, double insertion of CO2 did not occur as before when an aryl
imide group was employed. It was also shown that the isocyanate could be reacted with excess
starting material to form the corresponding imide which may be an issue if wishing to pursue this
method for synthesis of [11C]isocyanates for PET radiolabelling (Figure 1.43).
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Figure 1.43 Synthesis of isocyanate and carbodiimide from CO2 from zwitterionic titanium imido complex (L =
nacnac-, Ar = 2,6-diisopropylphenyl).
1.5.3 Other Metal Imido Complexes and their reactivity with Unsaturated Substrates
The chemistry of transition metal imides from across the periodic table is well established.[200] The
reactivity of the imide group with carbon dioxide and other carbonyl containing compounds in [2+2]
cycloaddition reactions has been studied with a range of complexes.
Bergman et al. have carried out a body of work investigating zirconium imide complexes
([Cp2Zr=NR]) and their potential for cycloaddition reactions with a variety of unsaturated
substrates.[201] The monomeric imide complex, [Cp2Zr(N
tBu)(thf)], was used to assess the reactivity of
the Zr=N bond towards organic carbonyl compounds such as ketones, aldehydes, isocyanates and
ketenes.[202] It was found that reactions of ketones and aldehydes with the Zr imide complex gave
quantitative amounts of the corresponding imine spontaneously at room temperature (Figure 1.44).
The expected intermediate carbamate complex was observed for two of the ketones in a 1H NMR
study. The zirconium oxo species form a series of oligomers which were difficult to characterise due
to their insolubility in most organic solvents.
Figure 1.44 Synthesis of an imine from a ketone or aldehyde using [Cp2Zr(N
tBu)(thf)] as a reagent.
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This activation of CO2 has been observed in other imido-containing complexes such as
(pentamethylcyclopentadienyl)iridium tert-butylimide forming a carbamato intermediate which was
collected as red crystals that were identified by X-ray diffraction.[203] However, extrusion of the
isocyanate product was not observed or attempted. In addition, it was also shown that this complex
could be synthesised from the reaction of the dimeric bridging oxo complex and tert-
butylisocyanate. Transition metals which are less electron poor than the group IV metals can
perform the cycloaddition either from the imide with CO2 releasing an isocyanate or from the oxo
complex reacting with isocyanate and releasing CO2. For example, the oxo species of tungsten and
molybdenum compounds have been reacted with isocyanates to give the corresponding imido
species.[204] The thermodynamic stability of the titanium and zirconium oxo products makes this
process not viable.
It is important to note that if other M-N bonds are present in the ancillary ligand set, the imido
functionality may not be the only point of insertion for the CO2 molecule. Figure 1.45 illustrates the
major product from the reaction of CO2 with an in situ generated cationic tungsten imide species.
[205]
The CO2 could have also inserted into the W-Me bond as well as the W-Namide bond followed by 1,3-
migration of the SiMe3 group. DFT calculations were carried out on this insertion process to
rationalise the outcome.
Figure 1.45 Insertion of CO2 into the W-Namide bond and SiMe3 1,3-migration.
The tantalum complex, [Ta(C5Me5)2(N
tBu)(thf)]+[B(C6F5)4]
-, has also been shown to undergo [2+2]
cycloaddition reactions with CO2 and, rather than the carbamato complex normally seen as the
product, a complex containing a terminally N-bound isocyanate group ([Ta(C5Me5)2(NCO)(OH)]
+
[B(C6F5)4]
- ) was observed and identified through X-ray diffraction.[206] The tbutyl group had been
removed and the reasoning behind this outcome is unclear.
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An aryloxide-substituted triazacyclononane ligand was used to support a uranium(V) mesityl-imide
complex.[207] Reaction of the imido moiety with CO2 produced a terminal oxo product of uranium and
the mesityl-isocyanate within minutes of vigorous stirring at room temperature. A reduction of the
steric bulk around the imido functionality was investigated by using the phenyl imide derivative.
When CO2 was added to the solution a brown solid precipitated out immediately. X-ray diffraction
analysis showed that a diphenyl ureate uranium complex had formed. It was postulated that the
carbamato complex first forms and then an additional metathesis reaction with another equivalent
of uranium imide complex results in the ureate complex.
1.5.4 Carboxylic acids from Direct Incorporation of CO2 under Mild Conditions
The last decade has seen a growth of research into the synthesis of carboxylic acids from CO2 as a
sustainable carbon neutral feedstock. Typically organolithium or Grignard reagents are used and are
very reactive and effective however their use is limited by functional group compatibility issues.
Therefore, routes to aryl and alkyl carboxylic acids from CO2 have been sought with organometallic
catalysts and reagents under mild conditions.[163, 208]
Activation of CO2 under milder conditions was first achieved with allyl stannanes and a palladium
catalyst at high pressures (33 atm).[209] Substrate limitations meant that the reaction was not
explored further and the area of research lay dormant for quite a few years until in 2006 Isawawa
reported carboxylations of aryl- and alkenyl-boronic esters with rhodium catalysts under
atmospheric pressure of CO2.
[210] The insertion of CO2 into a Rh-C bond was reported as far back as
the 1970s,[211] but this was the first time a catalytic cycle had been established to synthesise a variety
of carboxylic acids in good yields (70-90 %). Functional groups such as esters, ketones, nitriles and
BOC protected amines were all tolerated under reaction conditions; however, boronic esters with
bromo, nitro, alkynyl and vinyl groups were not. The mechanism for this reaction (Figure 1.46)
illustrates the initial transmetallaton from [Rh(I)] with ArB(OR)2 and insertion of CO2 into the Rh-Ar
bond before elimination through another transmetallation step of the boronic ester which produces
the carboxylic acid on hydrolysis.
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Figure 1.46 Synthesis of aryl carboxylic acid from rhodium catalysed carboxylation of boronic esters.
Soon after this work was completed, Iwasawa[212] and Hou[213] produced similar studies at the same
time investigating copper instead of rhodium systems as catalysts in the carboxylation reaction of
boronic esters with better functional group tolerances. Iwasawa found that [Cu(I)] precursors with
diphosphines and nitrogen donors, such as bisoxazoline, gave the best catalytic activities in DMF at
90 oC. It was also shown that three equivalents of cesium fluoride were necessary for the best yields
(60-99 %) with a wide range of aryl and alkenyl boronic esters. The mechanism was thought to be
similar to that of the rhodium carbonylation process and cesium fluoride was proposed to promote
the transmetallation step by forming fluoroborates from the boronic esters.
The alternative copper-based system developed by Hou and co-workers used a N-heterocyclic
carbene copper(I) catalyst in THF at 70 oC and atmospheric pressure of CO2.
[213] Firstly, the copper
complex was formed in situ from copper iodide(I) and IPr.HCl until it was shown that the [(IPr)CuCl]
could perform equally as well even under lower catalyst loadings. As before, it was shown that the
copper is much less sensitive than the rhodium systems with carboxylations being carried out with
boronic esters bearing alkenes, aldehydes, nitro groups, oxiranes and alkynes. Potassium tert-
butoxide was used as an additive which plays a crucial role in the mechanism (Figure 1.47).
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Figure 1.47 Potential mechanism for the carboxylation of boronic esters with [(IPr)CuCl].
The mechanism was assembled from information obtained from stoichiometric reactions which
were carried out to isolate copper intermediates at different stages of the reaction. Complexes 1, 2
and 3 were all isolated and crystal structures were obtained of 2 and 3. The pre-catalyst [(IPr)CuCl]
undergoes metathesis with potassium tert-butoxide to give complex 1, which then transmetallates
giving the organocopper complex 2. CO2 inserts into the Cu-Ar bond producing complex 3, which
then eliminates the potassium carboxylate with the help of another equivalent of potassium tert-
butoxide to regenerate the active catalyst. The potassium salt yields the carboxylic acid on
hydrolysis. More recently, support for the postulated mechanism has been established by DFT
calculations and the insertion of CO2 into the Cu-Ar bond was proposed to be the rate determining
step.[214]
A similar system has been employed to carboxylate C-H bonds directly using a gold N-heterocyclic
carbene catalyst.[215] Aromatic heterocycles such as oxazoles, thiazoles, pyrimidine and fluoro- and
chloro-arenes were all shown to be compatible with this reaction. The optimised conditions showed
that [(IPr)AuOH] (1.5 mol %) with potassium hydroxide in THF at 20 oC selectively carboxylated the
most acidic proton with most yields upward of 70 %. The NHC-gold(I) complex has already shown
the ability to activate C-H bonds under mild conditions with water formed as a waste product.[216]
The mechanism for this reaction postulates that initial insertion into the C-H bond with the loss of
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water is followed by insertion of CO2 into the Au-C bond and metathesis with KOH regenerates the
active catalyst and produces the potassium carboxylate product. The significance of this
breakthrough of direct carboxylation was recently highlighted in an article in Nature Chemistry.[217]
A nickel system for carboxylation under mild conditions has also been developed which allows for
the synthesis of aliphatic carboxylic acids with organozinc reagents,[218] which is less possible with
the methods previously described due to β-hydride elimination.  A combination of [Ni(acac)2] and
PCy3 was found to give the best performing catalyst system and alkyl zinc iodide-lithium chloride
adducts were used as transmetallation reagents. The lithium chloride in these reagents appears to
play a crucial role although the details of its role are not yet fully understood,[219] but it is suggested
that the LiCl aids formation of the monomeric organozinc halide which accelerates the
transmetallation step. The reactions were carried out under a balloon pressure of CO2 at room
temperature for 3 hours.
Figure 1.48. Possible reaction mechanism for the carboxylation of RZnI.LiCl [218].
Figure 1.48 illustrates the proposed mechanism for the carboxylation of RZnILiCl with a nickel
catalyst. Once the nickel(II) source has been reduced to nickel(0), carbon dioxide oxidatively adds, to
form a η2-coordinated complex, 3. The organozinc halide then reacts to form intermediate 4 through
transmetallation. Reductive elimination of the zinc carboxylate, which can be transformed into acid,
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happens before β-hydride elimination can occur. The bulky electron donating phosphines that are 
used are necessary for effective coordination of the CO2, increased electron density on the oxygen
atoms in 3 which improves transmetallation and steric bulk which invokes rapid reductive
elimination.
Another study was published almost at the same time which used Aresta’s complex ([Ni(η2-
CO2)(PCy3)2])
[162] and aryl and alkyl zinc reagents to perform the same reaction. Phenyl zinc bromide
with a range of functionalities were prepared in very good yields (75-90 %).[220] This study also
investigated palladium sources, which could also perform this reaction but in lower yields. It was
found that [Pd2(dba)3] was not as active as [Pd(OAc)2] due to competitive binding between dba and
CO2. Again the bulky tricyclohexylphosphine was the most effective ligand due to its steric bulk and
electron donating ability.
Similarly a palladium catalysed direct carboxylation of aryl bromides has been achieved at
atmospheric CO2 with Et2Zn present as a transmetallation agent.
[221] A bulky diphosphinobiphenyl
ligand and palladium acetate in DMA were shown to give the highest yields. Although this
methodology gives a facile new route to carboxylic acids without the preparation of organozinc
substrates there are selectivity issues i.e. two side products are formed due to transmetallation after
oxidative addition of the aryl halide and prior to CO2 insertion. The reductive carboxylation of
alkynes to selectively yield β,γ-unsaturated carboxylic acids with a silyl pincer diphosphine palladium 
complex, CO2 and triethylaluminum or diethylzinc illustrates another transformation where carbon
monoxide has been manipulated under mild conditions.[222]
The past three years has seen a huge increase in interest into these kinds of carboxylations as
researchers realise the potential of CO2 as a C1 feedstock. The scope for this new area of
organometallic chemistry is vast within academia and industry.
1.6 Thesis Aims and Objectives
The significance, scope and potential of PET as an imaging technique in drug development,
biomedical research and disease diagnosis cannot be overstated. Improving the methodology for the
rapid incorporation of [11C] into target molecules is important to open up new opportunities for
radiolabelling that can be appreciated by the PET community and consequently society as a whole.
This introduction has given a general overview of [11C]radiolabelling for PET with special interest in
[11C]CO and [11C]CO2 as labelling precursors. Areas of the literature not relating to PET radiolabelling
which hold potential for transition metal activation of carbon monoxide and carbon dioxide have
also been highlighted.
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This work sets out to develop new methods and improve existing methods for radiolabelling with
[11C]CO and [11C]CO2. The work with carbon monoxide will focus on improving palladium-mediated
carbonylations of amines by varying the ancillary ligand set. NHCs have become widely used as
ligands in a range of areas of homogeneous catalysis; however, their use in carbonylation reactions
has received little attention. Therefore, some of this work, discussed in Chapter 2, aims to
investigate their use in palladium-catalysed carbonylation as well as exploring their use in PET
radiolabelling. The aim of Chapter 3 is to explore P,S and P,O hemilabile ligands in a model
palladium-catalysed aminocarbonylation reaction, compare them to other diphosphine ligands and
to design new ligand structures for this application.
Activation of carbon dioxide for use as a C1 feedstock in organic synthesis is of interest to industry,
for environmental and economic reasons. The challenge to activate this thermodynamically stable
molecule is also of academic interest. Transition metals are capable of lowering activation energies,
altering polarity and therefore increasing reactivity of many small molecules. The research into
transition metal activation of carbon dioxide has expanded in recent years and some new protocols
could be valuable to the PET community to improve radiolabelling with [11C]CO2 under mild
conditions. Recent research into carboxylation using palladium or nickel catalysts under mild
conditions is one such area of research which could be transferred to PET radiolabelling. This
chemistry is explored in Chapter 4 where organozinc halides are carboxylated with carbon dioxide
using nickel and palladium catalysts. The aim is to develop a suitable system for PET and apply it with
[11C]CO2 to test its viability.
Finally, the work in Chapter 5 sets out to investigate titanium imido species which have shown
reactivity towards carbon dioxide through cycloaddition reactions. Other imido containing
compounds have also shown this reactivity however, group IV metals have been shown to readily
extrude isocyanate as a product. The synthesis of [11C]isocyanate is very useful in PET for the
labelling of unsymmetrical [11C]ureas and therefore it is hoped that these imido reagents could be
used in PET radiolabelling for that purpose.
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2 Synthesis of N-Benzylbenzamide via Palladium-
Catalysed/Mediated Carbonylation: A Study of N-Heterocyclic
Carbenes as Ligands
2.1 Introduction and Aims
The amide functionality has an extensive presence in all areas of chemistry from agrochemicals to
pharmaceuticals. The effectiveness of palladium-catalysed carbonylation reactions using carbon
monoxide and amines to synthesise amides has lead to their widespread use in industry.[1] The
biologically active nature of many amide-containing compounds makes them particularly relevant
for drug development. In PET, the labeling of amide containing compounds is often necessary for
drug candidates and other biologically active compounds used in medical studies. Issues with the
poor solubility of carbon monoxide in common organic solvents means that it has not been used as
widely as other 11C precursors such as [11C]CH3I. Recent developments in the pre-concentration of
[11C]carbon monoxide, however, have made it a more viable synthon for radiolabelling and opened
avenues for more general use without the need for autoclave apparatus. Palladium mediated
carbonylations are the major route to radiolabelled [11C]amides and other [11C]carbonyl-containing
compounds.
In industry the optimisation of the synthesis of amides through carbonylations, particularly when
using aryl chlorides and less nucleophilic amines, is sought after. Although the use of aryl chlorides is
not as essential in PET, the efficiency of the reaction is. The optimisation of the ligands and
palladium complexes used would be advantageous due to the short timeframe of the radiolabelling
reactions, as the ancillary ligand set in any catalytic reaction can play a fundamental role in
increasing the rate of reaction. Therefore, this work sets out to investigate the model carbonylation
reaction between iodobenzene and benzylamine to yield N-benzylbenzamide and the effect of the
catalyst on the reaction.
Diphosphine palladium complexes have proven to be successful in a wide variety of homogeneous
cross-coupling reactions such as hydroformylation and Suzuki reactions as discussed in detail in
Chapter 1. Furthermore, diphosphine ligands have been shown to be particularly adept at catalysing
carbonylation reactions with carbon monoxide.[2] NHCs have been used in other cross-coupling
reactions as ligands such as Suzuki-Miyaura couplings, but research is still being carried out to assess
how innocent these ancillary ligands are under carbon monoxide.[3]
A range of diphosphines were chosen to be screened as well as Pd(0) and Pd(II) triphenylphosphine
complexes as standards. Furthermore, a range of saturated and unsaturated N-heterocyclic carbenes
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(NHCs) were tested with three different palladium sources, [Pd2(dba)3], [Pd(OAc)2] and [PdCl2], in 1:1
and 2:1 stoichiometries. The structures of all the ligands and complexes utilised in this study are
outlined in Figure 2.1. The palladium-NHC complexes have been formed in situ for ease of use.
IPr.HCl (2.1) and IAd.HCl (2.2) were prepared from literature methods and synthesis of SIAd.HCl was
attempted. The pre-complexed palladium-NHC system (2.3) was also synthesised.
Figure 2.1 Ligands and complexes used in palladium catalysed carbonylation screening (Mes = 2,4,6-
trimethylphenyl, ‘S’ prefix refers to the saturated analogue).
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As a crucial component to this work it was necessary to test the palladium-NHC systems in
carbonylation reactions under PET-type conditions: using micromolar amounts of reagent and
picomolar amounts of [11C]CO. The best performing catalytic systems from these screenings were
chosen for testing using the facilities at the Hammersmith Hospital, Clinical Imaging Centre and were
carried out in collaboration with Dr. S. Kealey.
2.2 Synthesis and Complexation of Imidazolium Chlorides
Although a range of symmetric and asymmetric imidazolium chloride salts are available
commercially, some of the derivatives which involve a non-trivial synthesis are still very expensive.
Some of the imidazolium salts detailed in Figure 2.1 were purchased from Sigma-Aldrich (IMes.HCl,
SIMes.HCl and SIPr.HCl) and IAd.HCl (2.2) and IPr.HCl (2.1) were synthesised from literature
methods.[4] The attempted synthesis of SIAd.HCl was also carried out via two methods.[5]
Complexation of IMes was carried out via direct deprotonation of the imidazolium hydrochloride salt
and via a silver transfer agent.
2.2.1 Synthesis of N,N’-bis(diisopropylphenyl) imidazolium chloride (IPr.HCl) (2.1) and
N,N’-bis(1-adamantyl)imidazolium chloride (IAd.HCl) (2.2)
Figure 2.2 Synthesis of aromatic imidazolium chlorides.
The synthesis of electrophilic stabilised carbenes in the form of N-heterocyclic carbenes was first
achieved by Arduengo in 1991 by deprotonation of an imidazolium salt.[6] The synthesis of aromatic
imidazolium salts is carried out from a diimine which can be synthesised from glyoxal and the
functionally desired primary amine in an acid catalysed reaction. Cyclisation with
chloromethylethylether under inert conditions at 40 oC gives the imidazolium salt.[4a] This method
was employed to synthesise N, N’-bis(diisopropylphenyl)imidazolium chloride (IPr.HCl) 2.1 and N, N’-
bis(1-adamantyI)imidazolium chloride (IAd.HCl) 2.2 as per literature methods. The imine formation
step was higher yielding in both cases than the cyclisation step with yields of 93 % and 81 % of imine
for 2.1 and 2.2 and yields of 45 % and 47 % for the cyclised product, respectively.
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2.2.2 Characterisation of 2.1 and 2.2
HA and HB
HC
HD
HE
HF
HG
HF
HG
HC
HD
HE
HA and HB
Figure 2.3 1H NMR spectrum of IPr.HCl 2.1 in DMSO-d6.
Figure 2.3 shows the 1H NMR spectrum of IPr.HCl (2.1) dissolved in DMSO-d6. The isopropyl groups
give rise to two doublets in different environments which indicates that there is no free rotation
about the N-Ar bond. Only one environment for the isopropyl methyl protons is observed in the
imine starting material at 1.19 ppm. If the phenyl rings are perpendicular to the plane of the
imidazole ring, which is likely due to sterics, then the two methyl groups (HA and HB) on each of the
isopropyl groups will be in different environments giving rise to two sets of doublets. The proton
attached to the central carbon on the isopropyl groups is observed as a quintet at 2.35 ppm (HC).
The phenyl group protons in the meta (HD) and para (HE) positions can be observed as a doublet at
7.52 ppm and a triplet at 7.68 ppm, respectively. The protons on the backbone (HF) appear as a
deshielded singlet at 8.58 ppm due to the aromaticity on the imidazole ring. The central proton in
the C1 position (HG) is characteristic of this complex and can be observed at 10.24 ppm. The data
from the 1H NMR spectrum is in agreement with that reported in the literature.[4a]
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The 13C {1H} NMR spectrum of 2.1 shows a very deshielded resonance for C1 at 145 ppm as
expected. In the electrospray mass spectrum the molecular ion minus the chloride ion can be
observed at 389 amu.
The characteristic resonances in the 1H NMR spectrum of 2.2 of the C1 proton and the backbone
protons can be observed at 9.14 ppm and 8.09 ppm, respectively, indicating that the salt had
formed. Furthermore, the protons attached to the adamantyl groups have been deshielded
compared to the imine starting material, as is observed in the literature.[4b]
2.2.3 Attempted synthesis of N, N’-bis(1-adamantyl)-4,5-dihydroimidazolinium chloride
(SIAd. HCl)
The first NHC to be isolated was formed from the deprotonation of IAd.HCl [7], however the
saturated analogue (SIAd.HCl) is not used as widely due to difficulties involved in the synthetic
protocol.Synthesis via N, N’-Bis-(1-adamantylamino)ethane (Method A)[4b]
In initial attempts to synthesise SIAd.HCl, the aryl imidazolium salt protocol used to synthesise salts
such as SIPr.HCl was applied to the adamantyl analogue, shown in Figure 2.4 (Method A).[4b] Glyoxal-
bis-(1-adamantyl)imine, the same starting material used in the synthesis of IAd.HCl, was reduced
with sodium borohydride to form N,N’-bis(1-adamantylamino)ethane in moderate yield (23 %). The
1H NMR spectrum showed the CH2 protons at 2.65 ppm, compared to the CH protons of the starting
material at 7.90 ppm, and no sign of any unreacted starting material. The NH protons were not
observed, possibly due to typical N-H broadening. The mass spectrum confirmed the molecular ion
at 329 amu as well as the fragmentation of an adamantyl group at 195 amu.
Figure 2.4 Synthesis of SIAd. HCl (Method A, Ad = adamantyl)[4b]
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The final step of cyclisation was more problematic. After 1 h 30 min of heating N, N’-bis(1-
adamantylamino)ethane to reflux with triethylorthoformate and ammonium chloride, only starting
material was observed in the 1H NMR spectrum. Prolonged heating at reflux still yielded no
detectable product. The 1H NMR spectrum did not contain the characteristic deshielded proton peak
(N(CH)N) which would be conclusive that the ring had formed. This method was not successful so
another protocol from the literature was attempted.Synthesis via N,N’-bis(1-adamantyl)oxamide (Method B)[5]
A second method from the literature was employed as illustrated in Figure 2.5.[5] In this method
oxalyl chloride was added to 1-adamantylamine with base to form N,N’-bis(1-adamantyl)oxamide in
moderate yield (44 %). It was characterised by 1H NMR spectroscopy with the only NH protons in the
spectrum observed at 7.27 ppm which agrees with the literature value. However, it was difficult to
reduce using BH3SMe2. This was attempted twice, but on both occasions the
1H NMR spectra of the
crude reaction mixture indicated that the molecule had been broken down in some way as there is
no evidence for the alkyl protons on the backbone which would be expected to be seen at 2.57 ppm
and the NH protons at 3.45 ppm.[5] Instead there were unknown resonances at 9.45 ppm and 3.29
ppm and adamantyl resonances between 1.64-2.14 ppm. It can be concluded that the reduction had
not occurred and N,N'-di(1-adamantyl)ethane-1,2-diamine dihydrochloride had not formed.
Figure 2.5 Synthesis of SIAd (Method B).
In conclusion, the synthesis of SIAd.HCl has proven not to be trivial. Another method using
formamidines, detailed in Chapter 6, could provide a new route to alkyl-substituted saturated 4,5-
dihydroimidazolium salts.
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2.2.4 Synthesis of dichloro(bis[1,3-bis(2,4,6-trimethylphenyl)imidazol-2-
ylidene])palladium(II) (2.3)
The yield of dichloro(bis[1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene])palladium(II) initially
obtained from the direct deprotonation of IMes.HCl and complexation with palladium chloride
(method A) was low and therefore a silver complex was used as a transfer agent (method B and C) to
achieve better yields.Direct deprotonation and complexation of IMes.HCl (Method A)
Figure 2.6 Complexation of IMes.HCl with palladium chloride to form 2.3 (Method A).[8]
Complexation of IMes.HCl was carried out in THF at 70 oC with palladium chloride and cesium
carbonate, which acts as a base to deprotonate the central carbon of the imidazolium hydrochloride
and allow for complexation to the palladium centre. This procedure was chosen as it was the most
direct and facile route to the palladium complex and similar to those conditions taken to synthesise
palladium-NHC complexes in situ as catalysts in cross-coupling reactions. Purification was carried out
by column chromatography (first fraction eluted from DCM).
Complex 2.3 was characterised by 1H NMR spectroscopy, electrospray mass spectrometry and
elemental analysis. The 1H NMR spectrum no longer showed the C1 proton observed at 11.01 ppm
in the free salt. The protons on the methyl groups in the ortho and para positions are in different
environments and therefore are observed as two singlets as 1.94 ppm and 2.47 ppm, respectively.
The imidazole ring backbone CH2 protons are observed as a singlet at 6.76 ppm. The electrospray
mass spectrum shows the molecular ion peak plus a sodium ion at 809 amu. The free ligand can also
be seen at 305 amu. Elemental analysis also concludes that 2.3 had been formed. Very stringent
measures were necessary in carrying out these reactions due to the air and moisture sensitivity of
the deprotonated imidazolium salt, which is being formed in this reaction; this is reflected in the
poor yield (23 %).
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Complexation via a silver transfer agent (Method B and C)
Other strategies have been employed in order to form palladium-NHC complexes in better yields.
One such route involves forming the silver complex first as a transfer metal before complexation of
the ligand to palladium.[9] This route was attempted with IMes.HCl as illustrated in Figure 2.7. Silver
oxide is used to deprotonate the hydrochloride salt and complex the silver, producing silver chloride
which precipitates out of the DCM solution. In method B the silver complex is isolated but the
transfer to palladium is not effective. So the reaction was carried out without isolation of the
intermediate and better yields were achieved (method C).
Figure 2.7 Complexation of IMes.HCl with a silver transfer agent to form 2.3.
The intermediate formed from complexation to silver is evident from the 1H NMR spectrum as the
C1 proton found at 11.01 ppm in the free IMes.HCl is no longer present. A mass spectrum was
required to confirm complexation of the final product with palladium as the 1H NMR spectrum was
very similar to the spectrum for [AgCl(IMes)2]. It was noted that this stage was not successful as the
mass spectrum illustrated that only silver products have been formed due to the simple isotope
patterns of the fragments seen. Silver has only two stable isotopes compared to palladium’s seven. It
is also interesting to note that a fragment at 859 amu ([Ag2Cl2Mes2]) could be the complex shown in
Figure 2.8 previously observed in the literature with different NHCs in similar complexation
reactions.[9]
Chapter 2 – A Study of N-Heterocyclic Carbenes
67
Figure 2.8 Potential structure of one of the products from synthesis of the IMes.HCl silver transfer agent.
Silver oxide was used again in method C to form the silver complex which was then reacted on
without isolation by reaction with [PdCl2(COD)] to achieve the palladium complex in excellent yield
(70 %). The 1H NMR and electrospray mass spectrum are in agreement with the literature and the
previously prepared 2.3 from method A.
Analysis of the differences in shifts between Ag- and Pd-complexed IMes and free IMes.HCl gave an
interesting insight into the electronics of this compound. The table below (Table 2.1) shows the
shifts from the 1H NMR spectra of the complexes isolated from IMes with silver and palladium and
the shifts of the protons in the free hydrochloride salt.
Table 2.1 Comparison of proton chemical shifts for free and complexed IMes . (1H NMR spectra run in CDCl3
and on a 400 MHz spectrometer).
Proton
environment
Chemical Shift (ppm)
IMes.HCl
Chemical Shift (ppm)
Ag complex
Chemical Shift (ppm)
Pd complex
o-methyl (HA) 2.17 2.05 1.93
p-methyl (HB) 2.32 2.33 2.45
m-phenyl (HC) 7.01 6.89 6.76
N(CH)2N (HD) 7.55 7.11 6.91
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The protons observed in the 1H NMR spectrum for a free ligand are normally deshielded on
complexation due to the shift of electron density onto the metal centre, although this is not the case
for aromatic compounds such as phenyl groups due to the ring effect. The greatest shielding effect is
observed on the backbone protons and secondly on the methyl groups in the ortho position of the
phenyl groups (HA) which point towards the imidazolium ring. The aromatic phenyl groups have their
own induced magnetic field which increases the net magnetic field ‘felt’ by the protons. When
electron density is removed from the system the induced magnetic field is weaker which, also
weakens the deshielding effect.
In the case of the IMes backbone (HD) the overall trend is a shift up field, implying that they have
been shielded. Therefore, there is evidence of aromaticity in the imidazole ring. The π electrons on 
the ring system can induce their own magnetic field which causes the protons attached to the ring to
feel a larger effective magnetic field. Donation of electrons to the metal leads to a decrease in
electron density in the aromatic system which will reduce the induced magnetic field and therefore
reduce the level of deshielding and shift the 1H NMR peak up field. The shifting of resonances on
complexation seems to be more pronounced in the palladium rather than the silver complex which
may indicate better NHC sp2 orbital overlap with palladium d orbitals.
2.3 Palladium-catalysed Carbonylation Reactions
A series of 4,5-dihydroimidazolium and imidazolium salts were tested as ligands as well as palladium
catalysts with phosphine and diphosphine ligands (Figure 2.1). Diphosphines are generally favoured
in carbonylation reactions to monodentate phosphines[10] and it has been suggested that the bite
angle plays a key role in improving the rate of related reactions.[11]
2.3.1 General Method
A model reaction was used in order to evaluate the effect of the catalyst system on the formation of
amide. In this case iodobenzene and benzylamine (used in excess as the solvent) were combined
with 2 mol% of palladium and ligand either under constant flow of carbon monoxide from a manifold
or under static 0.2 bar pressure of carbon monoxide to synthesise N-benzylbenzamide (Figure 2.9) at
100 oC or 150 oC.
Figure 2.9 The model palladium-catalysed carbonylation reaction for the formation of N-benzylbenzamide.
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Carbonylation reactions were carried out on a Radley’s multi-reactor carousel connected to a carbon
monoxide manifold which meant that up to 12 reactions could be carried out simultaneously under
the same conditions. To reduce human error only 6 reactions were carried out at one time. Once
catalyst and benzylamine had been heated to temperature iodobenzene was added at 30 second
intervals to successive vials. Each reaction was sampled (1 mL) in the same manner after 10 min and
2 h and analysed by GC. It was of interest to see how these catalysts performed in the first 10 min as
radiolabelling needs to take place as efficiently and rapidly as possible and 10 min is a good general
timeframe for a PET radiolabelling reaction which gives enough time for the other steps necessary
for clinical trials whilst maintaining the highest level of radioactivity possible. Samples were also
taken from the same reaction after 2 h to maintain consistency and to observe any potential
anomalies. An assumption was made that the initial sample taken after 10 min would not affect the
yield of the second sampling after 2 h.
Pd-NHC species were prepared in situ with imidazolinium or imidazolium salts with a palladium
precursor, [Pd2(dba)3], [PdCl2], or [Pd(OAc)2] in benzylamine in either 1:1 or 1:2 stoichiometries.
Reaction of the imidazolinium and imidazolium salts in the presence of excess benzylamine base
resulted in the deprotonation of the salts and dissolution of the Pd-NHC complex when heated to
150 oC. Control carbonylations using only the palladium precursor give considerably lower yields
after 10 min, which may suggest that deprotonation is taking place (further discussed in section
2.3.4). The relatively high temperatures used for these reactions may be expected to enhance the
yields over short time periods (10 min) and then eventually degrade the catalyst over sustained
periods at this high temperature (2 h), in some cases elemental palladium was observed.
2.3.2 Optimisation of Reaction Conditions
Initially a ‘flow’ system was used where the carbon monoxide was allowed to flow through a
manifold with a bubbler and was therefore at atmospheric pressure. The results shown in Table 2.2
illustrate some of the inconsistencies initially encountered. The inconsistencies seemed to affect a
whole run in all 6 stations of the Radley’s carousel at one time rather than individual reactions within
a run. Over four runs the yields when using [Pd(PPh3)4] ranged from 0.9 % to 8.1 % and [PdCl2(dppp)]
from 2.0 % to 15.4 % yield. These inconsistencies were observed after 2 h as well. Therefore,
conditions experienced by all of the reactions needed to be addressed, such as GC sampling,
consistent temperatures, consistent application of carbon monoxide.
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Table 2.2 Yields after 10 min from four carbonylation runs, average yields and standard deviations, illustrating
some of the inconsistencies with the ‘flow’ set up.
Catalyst
N-benzylbenzamide GC Yield %
Average
%
Standard
Deviation1 2 3 4
[Pd(PPh3)4] 3.0 0.9 8.1 1.8 3.5 2.8
[PdCl2(PPh3)2] 1.7 0.4 7.8 1.2 2.8 2.9
[PdCl2(dppf)] 1.0 1.3 8.9 1.4 3.2 3.3
[PdCl2(dppp)] 2.5 2.0 15.4 4.2 6.0 5.5
[PdCl2(BINAP)] 1.4 1.8 7.0 1.8 3.0 2.3
Pd(OAc)2, SIPr.HCl (1:1) 0.8 1.3 10.2 2.7 3.8 3.8
Pd(OAc)2, SIMes.HCl (1:1) 0.7 2.2 10.3 2.4 3.9 3.8
The GC sampling technique was tested by carrying out one run (6 stations on the Radleys carousel in
parallel) with 3 reactions using the catalyst [Pd(PPh3)4] and 3 with [PdCl2(dppp)]. The results are
shown in Table 2.3 which again indicates that in the same run a set of consistent results for one
catalyst system could be achieved. [Pd(PPh3)4] had an average yield of 6.9 % with a standard
deviation of 0.7 % and [PdCl2(dppp)] had an average yield of 8.5 % and a standard deviation of 0.3 %
after 10 min. However, unless comparable yields can be achieved in sequential runs then data can
only be compared within each run, which is not sufficient for this work.
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Table 2.3 Repeat reactions to test the GC sampling technique, at 100 oC under ‘flow’ conditions.
Catalyst
GC Yield of N-
benzylbenzamide %
10 min 120 min
[Pd(PPh3)4] 7.6 60.4
[Pd(PPh3)4] 6.0 60.0
[Pd(PPh3)4] 7.1 63.2
[PdCl2(dppp)] 8.9 60.3
[PdCl2(dppp)] 8.4 58.6
[PdCl2(dppp)] 8.1 62.7
The temperature of the reaction mixture was tested with a thermometer and the same hot plate
stirrer was used each time and was judged to be reliable. It was noted that runs had better
correlation if the flow of carbon monoxide was regulated. When the rate of flow of carbon monoxide
was kept approximately constant, two consistent runs were possible as illustrated in Table 2.4.
Table 2.4 GC yields of N-benzylbenzamide under ‘flow’ conditions at 100 oC (average of 2 runs).
Catalyst
Average GC Yield of N-
benzylbenzamide %
10 min 120 min
[Pd(PPh3)4] 5.3 ± 0.0 56.1 ± 3.9
[Pd(PPh3)2] 4.3 ± 0.5 52.9 ± 1.1
[PdCl2(dppf)] 4.5 ± 0.7 55.4 ± 2.1
[PdCl2(dppp)] 7.6 ± 1.2 58.0 ± 3.0
[PdCl2(BINAP)] 4.9 ± 0.7 51.9 ± 1.5
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Therefore, a new system was put in place where the apparatus would be closed and kept at just
above atmospheric pressure (1.2 bar) using a BOC carbon monoxide regulator. The temperature
was also increased to 150 oC for best results after 10 min. These conditions were used for the
remaining carbonylation runs.
2.3.3 Diphosphines as Ligands for Palladium-Catalysed Carbonylation
A range of widely used benchmark Pd-phosphine complexes were investigated for the model
carbonylation reaction. Monophosphine and chelating diphosphine palladium catalysts have been
widely investigated for a range of carbonylation reactions [12] and as such are useful for comparative
purposes with the palladium-NHC catalysts investigated later (section 2.3.4).
Table 2.5 GC yields of N-benzylbenzamide after 10 and 120 min at 1.2 bar CO and 150 oC (average of 3 runs)
with phosphine ligands.
# Catalyst
GC yields %
10 min 120 min
1 [Pd(PPh3)4] 17.7 ± 7.0 55.5 ± 2.3
2 [PdCl2(PPh3)2] 12.9 ± 4.9 56.1 ± 1.1
3 [PdCl2(dppf)] 14.1 ± 6.5 54.6 ± 1.8
4 [PdCl2(dppp)] 15.1 ± 5.0 56.6 ± 1.6
5 [PdCl2(BINAP)] 9.6 ± 1.7 56.5 ± 0.6
The results from the model aminocarbonylation reactions using phosphine ligands are shown in
Table 2.5. As is expected the yields of these reactions increase substantially when more heat is put
into the system; at least doubling in all cases after 10 min compared to 100 oC (Table 2.4). For
example when [Pd(PPh3)4] was employed at 100
oC under flow conditions 5.3 % was achieved and
17.7 % at 150 oC (Table 2.5, entry 1). This effect is less evident after 2 h when the yields seem to
even out overall.
In the case of tetrakis(triphenylphosphine)palladium ([Pd(PPh3)4] there is no need for reduction of
palladium(II) to form the catalytically active Pd(0) species prior to oxidative addition which could
account for it having the highest yield after 10 min (Table 2.5, entry 1) and greater than
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[PdCl2(PPh3)2] (2). Diphosphine ligands such as bis(diphenylphosphino)propane (dppp) and
bis(diphenyl phosphino)ferrocene (dppf) are used extensively in catalysis and here they show
moderate yields after 10 min (3 and 4). [PdCl2(BINAP)] was certainly the least active catalyst after 10
min (5). After 2 h, all the Pd-phosphine catalysts performed equally well giving yields of between 55-
57 %, suggesting that while the ligand-palladium system is important to the initial rate of the
reaction it does not affect the yield over the longer timeframe. The short reaction times in 11C-
radiolabelling mean that the starting period is very important to study and these results illustrate
how variable the yields can be with differing catalysts within the induction time.
2.3.4 N-Heterocyclic Carbenes as Ligands for Palladium-catalysed Carbonylation
N-Heterocyclic carbenes have been used in a wide variety of catalytic applications but examples of
their use in carbonylation reactions are still limited.[3b] The majority of reactions were carried out
using imidazolium hydrochloride salts to form the active catalyst in situ with a palladium(II) or
palladium(0) source in either 1:1 or 1:2 stoichiometry of palladium to salt. The objective was also to
examine the effect that the R groups and the saturated or unsaturated imidazole ring have on the
reaction. It has been established that the electronic backbone of the imidazole rings can affect the
rate of the oxidative addition step in the catalytic cycle.[13] Furthermore, bulky R groups such as
adamantyl can aid the reductive elimination step, whilst the electronic effect of the R group on the
system is not thought to contribute significantly.[14] The key variables that were to be addressed in
this work were;
 Saturated vs. unsaturated backbone of the imidazole ring.
 Effect of the R group.
 Pd source and oxidation state (Pd2(dba)3, Pd(OAc)2, PdCl2).
 1:2 or 1:1 stoichiometry (Pd:imidazolium salt).
 Catalyst formed in situ or preformed complexation.
Five saturated and unsaturated imidazolium chloride salts (N, N’-bis(diisopropylphenyl)-4,5-
dihydroimidazolinium chloride (SIPr.HCl), N, N’-bis(1-mesityl)-4,5-dihydroimidazolinium chloride
(SIMes.HCl), N, N’-bis(1-mesityl)imidazolium chloride (IMes.HCl), N, N’-
bis(diisopropylphenyl)imidazolium chloride (IPr.HCl) and N, N’-bis(1-adamantyl)imidazolium chloride
(IAd.HCl)) with varying electronic and steric properties (Figure 2.1) were investigated in the model
carbonylation reaction.
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Samples taken after 10 minutes
The average GC yields of N-benzylbenzamide from the 10 min screening of 33 different combinations
of NHCs and palladium sources are summarised in Table 2.6.
Table 2.6 GC yields of N-benzylbenzamide at 1.2 bar and 150 oC (average of 4 runs, a average of 3 runs, b
average of 2 runs, c one run only).
Pd:Im. HCl Im. HCl
GC Yields after 10 min (%)
Pd(OAc)2 Pd2(dba)3 PdCl2
1:1
SIPr.HCl 21.1 ± 4.6 11.9 ± 5.7 21.5 ± 5.0
SIMes.HCl 12.3 ± 4.0 16.1 ± 3.6 20.8 ± 7.4 a
IMes.HCl 19.0 ± 6.6 20.2 ± 2.6 12.4 ± 5.1
IAd.HCl 16.0 ± 0.8 b 10.9 ± 0.8 b 18.0 ± 0.2 b
IPr.HCl 12.9 c 10.2 c 9.2 c
1:2
SIPr.HCl 14.6 ± 6.0 a 19.4 ± 5.4 17.2 ± 7.3
SIMes.HCl 13.3 ± 6.0 a 19.1 ± 4.8 14.7 ± 6.2
IMes.HCl 9.0 ± 3.6 19.0 ± 5.9 a 8.9 ± 3.0
IAd.HCl 14.4 ± 6.2 b 13.0 ± 1.3 b 21.3 ± 3.0 b
IPr.HCl 8.6 c 9.8 c 8.1 c
N/A 9.8 ± 0.2 b 9.3 ± 0.1 b 9.4 ± 0.3 b
The excess of benzylamine gave a basic environment in the reactions which was assumed to aid in
the active complex formation (coordinated NHCs to palladium) although the exact structure of these
palladium complexes is unknown. Supporting data for this assumption is shown by the runs with
[Pd2(dba)3], [PdCl2] and [Pd(OAc)2] on their own giving lower yields of amide after 10 min than the
systems with 4,5-dihydroimidazolium and imidazolium hydrochloride salts. This shows a significant
overall improvement of yield when the imidazolium salts were employed after 10 min.
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The data offers up some trends but there are no immediate themes. This indicates that most of the
NHCs need to be taken on a case by case basis, with some working better with one particular
palladium source and stoichiometry than another. The yields obtained from these runs range from
8.1 % to a reasonable 21.5 % after 10 min. At both 1:1 and 1:2 stoichiometries IMes and IAd work
best with [Pd2(dba)3] and [PdCl2], respectively. This could be due to a steric interaction in forming
the active catalyst. The bulky adamantyl group would encounter more steric hindrance when used
with [Pd2(dba)3] in forming the active catalyst than [PdCl2]. This effect would not be as prevalent
with the mesityl groups of IMes.
Unfortunately, inconsistencies especially after 10 minutes continued to persist although to a lesser
degree and not from run to run as before, but within each run. Iodobenzene was added at 30 second
intervals and samples were then taken at the same time intervals to make sure all samples were
taken after the same reaction time. After 10 min, however, the rate of reaction is much faster than
at 2 h when it may be expected the rate reaction to plateau. Therefore, the margin for error in the
sampling time at 10 min is much larger. An auto-sampling device and a quench may have eliminated
this issue.Saturated versus Unsaturated Backbone
The saturated NHCs are expected to be more basic and therefore stronger sigma donors than their
unsaturated analogues which may aid the oxidation addition step. After 10 min however, it is not
easy to find a distinctive trend as evidence for this effect (results summarised in Figure 2.10).
IMes.HCl performs very well with [Pd2(dba)3] (1:1) compared to the other two palladium sources
whereas SIMes.HCl works well with [PdCl2] (1:1). On averaging the yields for all three palladium
sources, no one imidazolium salt stands out; SIMes.HCl(1:1) - 16.4 %, SIMes.HCl (1:2) - 15.7 %,
IMes.HCl (1:1) - 12.3 % and IMes.HCl (1:2) - 17.3 %.
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Figure 2.10 Bar chart comparing GC yields from SIMes.HCl and IMes.HCl after 10 minutes.
Stoichiometry
The 1:2 (Pd : NHC) reactions did not perform significantly better overall, as might be expected when
using more of a ligand like phosphine in a catalytic reaction. A larger amount of ligand can normally
help stabilise the complex. This may be because NHCs do not dissociate from the metal centre in the
same way in which phosphines do. Without this equilibrium the additional imidazolium salt in the
1:2 stoichiometric reactions has little effect and sometimes a negative effect. One notable example
is the run with [Pd(OAc)2]/IMes.HCl the average GC yield of which is reduced by half when 2
equivalents of NHC was used.
Reasoning behind this effect may be that a mono-ligated palladium is the most active catalyst and an
additional ligand may force the formation of a bis-complex. As already discussed NHCs are very good
sigma donors which can aid in the oxidative addition step; however, too much electron density can
also lead to retardation in the reductive elimination step. A sterically demanding NHC will aid
reductive elimination but in the case of the mesityl groups may not be bulky enough to overcome
the electronics of the system. When using phosphines, an extra equivalent is often added to aid the
reaction due to the lability of phosphines in palladium complexes but NHCs are more likely to stay
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attached to the palladium so an extra ligand could act as a hindrance. However, as an exception, 1:2
stoichiometry does improve the yield notably with [Pd2(dba)3]/SIMes.HCl and [Pd2(dba)3]/SIPr.HCl.R group
It may be expected that the steric bulk of the R groups attached to the nitrogens can play an
important role in the reaction as they enter the reaction sphere more than other ancillary ligands
such as phosphines (Figure 2.11).
Figure 2.11 Diagram illustrating the difference in the steric crowding around a phosphine and a NHC ligand.
Table 2.7 Table comparing the yields when imidazolium salts with differing R groups are employed in the
carbonylation reaction of benzylamine and iodobenzene. (a One run only; b Average of 4 runs; c Average of 2
runs).
Im. Salt
GC Yields after 10 min %
Pd(OAc)2 Pd2(dba)3 PdCl2
IPr.HCl (1:1) 12.9 a 10.2 a 9.2 a
IMes.HCl (1:1) 19.0 ± 6.6 b 20.2 ± 2.6 b 12.4 ± 5.1 b
IAd.HCl (1:1) 16.0 ± 0.8 c 10.9 ± 0.8 c 18.0 ± 0.2 c
Table 2.7 shows data from Table 2.6 and illustrates that such a trend between R groups could not be
seen from these results after 10 min. Averaging each of the imidazolium salts for all 3 palladium
sources gives IPr.HCl – 10.8 %, IMes.HCl – 17.2 %, IAd.HCl – 15.0 %. IMes.HCl seems to give the best
yields on average however this is at 1:1 stoichiometry. With 2 equivalents of NHC on average IAd.HCl
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performs the best overall with the three palladium sources with an average of 16.2 % compared to
8.8 % and 12.3 % for IPr.HCl and IMes.HCl respectively.Palladium Source
Across all the NHCs tested no one palladium source fared better than the others. An average of all
the NHCs at different stoichiometries gives average percentages of 15.0 ± 3.6 %, 16.2 ± 3.5% and
16.9 ± 4.3 % for Pd(OAc)2, Pd2(dba)3 and PdCl2 respectively. It might be expected that Pd2(dba)3
would perform better as it is a Pd(0) source and no reduction from Pd(II) is necessary, but this is not
the case.Pre-formed complex
The preformed catalyst, 2.3, was also tested at 150 oC and 1.2 bar carbon monoxide. The average of
two runs was taken and gave a GC yield of 4.1 ± 0.2 %. The lower yields of PdCl2(IMes)2] obtained
after 10 min compared to the in situ reactions are initially surprising. Reduction to the catalytically
active Pd(0) species may take longer compared to its in situ equivalent. There is evidence however
that having two IMes moieties on the palladium can result in too strong an electron donating effect
which can prevent reductive elimination and therefore deactivates the catalyst.[3a, 15]
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Samples Taken after 2 Hours
The samples taken after 2 hours are more consistent overall, being in the range of 54.5-60.6 % and
are in a comparable range with the other diphosphines (Table 2.5). The reactions with IPr.HCl were
only carried out once; hence the 100 % yield with [Pd(OAc)2] may be an anomaly.
Table 2.8 GC yields of N-benzylbenzamide at 1.2 bar and 150 oC (average of 4 runs, a average of 3 runs,
b average of 2 runs, c one run only).
Im. Salt
GC Yields after 2 h (%)
Pd(OAc)2 Pd2(dba)3 PdCl2
1:1
SIPr.HCl 56.4 ± 1.1 55.7 ± 2.5 57.4 ± 3.1
SIMes.HCl 55.9 ± 2.4 55.4 ± 1.4 58.4 ± 1.8 a
IMes.HCl 58.0 ± 1.3 58.1 ± 1.1 58.0 ± 1.0
IAd.HCl 54.5 ± 1.1 b 54.7 ± 0.2 b 55.9 ± 2.0 b
IPr.HCl 60.6 c 56.4 c 53.8 c
1:2
SIPr.HCl 54.8 ± 4.9 a 56.5 ± 1.7 58.2 ± 0.5
SIMes.HCl 53.8 ± 4.9 a 57.0 ± 1.2 57.7 ± 2.5
IMes.HCl 55.9 ± 6.0 57.3 ± 1.6 a 56.3 ± 2.6
IAd.HCl 55.0 ± 0.9 b 53.7 ± 0.4 b 58.2 ± 0.6 b
IPr.HCl 100.0 c 56.6 c 49.4 c
N/A 57.0 ± 0.7 b 57.0 ± 1.8 b 58.0 ± 0.3 b
The narrow range of average yields of N-benzylbenzamide after 2 h, despite the changes in ligand,
palladium source, stoichiometry, is a surprising finding. Furthermore, the similar yields when no
ligand is employed may suggest that another mechanism is in place, driving the reaction. Small
clusters or nanoparticles of palladium have been shown to take part in many different homogeneous
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catalysis reactions.[16] Dupont and co-workers have illustrated with a Hg test that Pd(II) precursors
can form ‘naked’ Pd(0) species under homogeneous catalytic conditions in the Heck reaction.[17]
Addition of Hg to the reaction mixture takes away any colloids of palladium(0) that may have formed
allowing to assess any changes in the yield. Future work may include conducting an Hg test in order
to ascertain whether palladium nanoparticles are the catalytically active species in these reactions or
not.
The standard deviations for the reactions after 2 h are a lot smaller than for the 10 min reactions as
the rate of reaction will be slower during the sampling period which means that a smaller error
arises from the taking of samples. Averaging the results for each of the palladium sources does not
show which one performs significantly better. Unlike the 10 min reactions the yields of the
palladium sources without imidazolium salts are fair, illustrating that the ligand has the greatest
effect on the rate of reaction at the crucial induction time. GC yields are the same whether 1:1 or 1:2
stoichiometry is used which indicates that 2 equivalents of NHC are not necessary to facilitate a
higher yield. IMes.HCl does perform slightly better than others with a consistent 58 % at 1:1
stoichiometry with all palladium sources.
These results suggest that unlike phosphines the direct effect of the R groups and electronics within
the NHC ligand do not play as important a role in carbonylation reactions. This is an unfortunate
finding as the ancillary ligand can act as a handle on the activity of a reaction. Potentially with a
more challenging model reaction using an aryl chloride or primary amine, differentiation between
the NHCs may be achieved to a greater degree.
The use of imidazolium salts has been shown to have a positive effect on the model carbonylation
reactions and therefore should be suitable for application in PET radiolabelling. Therefore, it was
concluded that [Pd2(dba)3]/IMes.HCl (1:1), [PdCl2]/SIPr.HCl (1:1) and [PdCl2]/IAd.HCl (1:2) would be
taken forward for testing under PET conditions as they performed best after 10 min.
2.3.5 Testing of N-Heterocyclic Carbenes for Palladium Carbonylation on a Microfluidic
Reactor
A microfluidic reactor can be defined as a device with an internal structure on the micron scale (10-
500 μm). They are adept at dealing with a wide range of reactions on small scales allowing for large 
amounts of data to be collected quickly. This is particularly useful when optimising a reaction. The
huge advantage of using a system like this for a reaction such as carbonylation is the rapid mixing
and increased diffusion rates possible in the microfluidic channels due to the greatly enhanced
surface area-to-volume ratio. Also, there is improved heat transfer from the heating block to the
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reagents compared with standard reactors because of the small convective distances and large
surface-to-volume areas.
Consequently, improved yields for carbonylation of amines have been shown to be possible with
microfluidic devices when compared to standard laboratory techniques.[18] Interest in this area is
particularly relevant to this work as microfluidic devices, like the one illustrated in Figure 2.12, are
potentially appropriate for automation into PET due to their compact size, suitability for automation
and for the small amounts of reagents required for PET.[19]
Figure 2.12 Photograph of a glass fabricated microfluidic device used in carbonylation reactions.[12a]
The microfluidic reactions were carried out in collaboration with Dr. P. W. Miller. The pre-fabricated
microfluidic devices were purchased and the apparatus set up by Dr. P. W. Miller. Pre-heating of the
palladium catalyst [Pd2(dba)3] and imidazolium salt (IMes.HCl) was necessary in a water bath at 80-
90 oC to dissolve the reagents prior to insertion to prevent clogging of the channels. The solution was
light yellow which may indicate that the active catalyst had already formed prior to the start of the
reaction. The reaction was carried out 3 times in series at 100, 120 and 150 oC.
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Figure 2.13 Schematic of the reactor set up.[12a]
The set up involved the injection of iodobenzene and catalyst dissolved in benzylamine into the
microfluidic device along with a constant stream of THF (Figure 2.13). A syringe pump was used to
keep the addition of the reagents to the device constant. As the liquid and gaseous reagents are
mixed directly on the device an annular flow regime is formed which produces a high interfacial gas-
liquid contact area. At lower temperatures (100-120 oC) there was small build up of ‘palladium black’
at the beginning of the channel where the carbon monoxide and reagents initially mix but this effect
was observed to a lesser degree at 150 oC. The model carbonylation reaction of iodobenzene and
benzylamine used previously was used for the microfluidic runs.
Table 2.9 GC yields of N-benzylbenzamide after 2 minutes residence time on a microfluidic device.
Temperature Run 1 Run 2 Run 3
Average GC
yield %
100 6.7 6.2 6.9 6.6 ± 0.3
120 18.9 18.9 18.8 18.9 ± 0.1
150 80.2 75.9 - 78.1 ± 2.2
The results (Table 2.9) illustrate the advantages of using a system with a greatly enhanced surface
area-to-volume ratio and the significant increase in yield achievable at higher temperatures. The
increase in yield from 100 oC to 120 oC is significantly less than from 120 oC to 150 oC. The increase is
exponential which follows the Arrhenius equation which underpins the relationship of temperature
on the rate of a chemical reaction. At 150 oC these results exceed the yields achieved with the batch
reactions carried out in the Radley’s carousel by a significant margin, with only 2 minutes residence
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time on the device and an average of 78.1% compared to 20.2 % at best after 10 minutes using
[Pd2(dba)3] and IMes.HCl. In collaboration with Dr. Miller a ligand screen of 12 different catalyst
systems using the same microfluidic device and conditions was carried out.[12a] Other reactions
carried out under these conditions gave similar results with the same trend of a significant increase
at 150 oC compared to 100 oC and 120 oC (Figure 2.14). [PdCl2(Xantphos)] performed outstandingly at
lower temperatures (approx. 95 % at 120 oC) and other diphosphines ranged from 45-95 % at 150 oC.
Figure 2.14 GC yields of N-benzylbenzamide from reactions on a microfluidic device with a four palladium-
phosphine catalysts.[12a]
The microfluidic runs are useful to gain a rapid insight into a ligand’s effect on a reaction. In this
case, it was shown that the [Pd2(dba)3] and IMes.HCl system is viable for use with this system at
higher temperatures and comparable to other standard palladium phosphine catalysts.
2.4 Palladium-mediated Radiolabelling using [11C]Carbon Monoxide
The reactions discussed so far have given an insight into the potential use of N-heterocyclic carbenes
as ligands in the carbonylation of amines. But can they also be applied under PET conditions? The
key difference in radiolabelling reactions is the picomolar (10-12) amounts of [11C]carbon monoxide
compared to the more usual micromolar amounts of palladium. Therefore, these reactions are
mediated by palladium rather than catalysed due to the huge excess of palladium. The regeneration
of the active catalyst is not necessary for the reaction to proceed but it is expected that the
mechanism will remain the same and the positive effects seen from different ancillary ligands can
also be observed in these reactions.
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Although [11C]carbon monoxide is a valuable resource in radiolabelling, the low reactivity of carbon
monoxide, as a result of its low solubility in most organic solvents, and high dilution in the inert
carrier gas has prevented it from widespread use in PET chemistry. Previously, these issues have
been overcome by the use of microautoclave systems which increase the pressure and therefore
enhance the key carbon monoxide insertion step effectively but these methods require
sophisticated equipment.[20] Chemical complexation can also be an effective method of improving
[11C]CO reactivity by increasing its solubility at low partial pressures. Such systems include BH3.THF
[21] and Cu(I) [22] solutions; the latter can trap [11C]CO with efficiencies of over 95 % compared to
approximately 1 % in solvent alone. The novel [11C]CO chemical trapping method, exploiting a
Cu(Tp*) complex, recently developed in our group [22] was used to test the best performing Pd-NHC
catalyst system for [11C]carbonylation radiolabelling of benzylamine and iodobenzene in the same
model reaction employed in section 2.3.
2.4.1 General Procedure
The Cu(Tp*) trapping system was chosen for the NHC carbonylation radiolabelling experiments as
the trapping process can be carried out at room temperature in a one-pot process. A solution of the
Cu(Tp*) complex was forms in situ at room temperature from copper(I) chloride and Tp* in THF. The
trapping process involves bubbling the dilute 11C/He gas stream through the solution of CuTp*, thus
forming the corresponding carbonyl complex, CuTp*[11C]CO. Excess [11C]CO not trapped by the
solution was collected in bag 1 (Figure 2.15). The cross coupling reagents (Pd precursor, ligand,
iodobenzene, benzylamine) were then added to the trapping vial and the reaction mixture heated
for 10 min. Triphenylphosphine was also added along with the reagents releasing the pre-
concentrated [11C]CO to be reacted. The reaction was quenched and the crude product mixture
analysed by analytical radio-HPLC.
Figure
The trapping efficiency of the copper
dose calibrator of the excess gas is caught in bag
Radioactivity trapped by Cu solution
has been bubbled through the trapping solution
[11C]CO % trapping = (Radioactivity trapped
Since, the aim of this study was to observe the effect o
variations in the efficiency of the trapping process were removed from these calculations by
calculating radiochemical yields based on the amount of [
amount of [11C]CO delivered to the system from the cyclotron. As such,
palladium and ligand system could be evaluated independently from the trapping.
The time of each radioactivity reading was
subsequently be calculated for the bag and vial at
of the radiolabelling experiments is shown in
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complex can be measured indirectly from the reading on the
1;
= Total radioactivity – Radioactivity in bag 1 after the [
by Cu solution/Total radioactivity) x 100
f the catalyst on
11C]CO trapped in solution rather than the
the efficiency of the
recorded so that the decay corrected radioactivity co
various points of the reaction. A typical log of one
Table 2.10.
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Table 2.10 Time and radioactivity log of a typical [11C]radiolabelling experiment.
Time Action Radioactivity
12.48 Cyclotron - End of bombardment and delivery
of 11CO2 and reduction to [
11C]CO
Bag – 0.0 MBq
12.55 [11C]CO bubbled through CuTp* solution
12.57 He sweep Bag – 2.0 MBq
12.58 Reagents added to the CuTp* solution
13.00 Start heating reaction vial TO 100/120 OC
13.10 Allow to cool
13.14 Add quench Bag – 96.0 MBq
13.17 Vial removed from hot cell and radioactivity measured Vial – 199.7 MBq
The radioactivity is corrected from the ongoing decay so that all results are comparable. So the
radioactivity at time, t, is corrected to the theoretical value at t = 0. In these calculations, t = 0 is
defined as the moment when bombardment of the target in the cyclotron has finished which is
known as the ‘End of Bombardment’ (EOB). The maximum amount of 11C is present at EOB.
The decay-corrected radioactivities can be calculated by using the following equation;
Decay corrected radioactivity (t = 0) = Radioactivity (MBq) x Exp (tLn2 / T1/2) (where, t = time
(decimal) and T1/2 = 20.38 min (half life of
11C)).
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Table 2.11 Calculation of decay-corrected radioactivity.
Time
(h:min:sec)
Time (mins
decimal)
Radioactivity
(t) /MBq
Radioactivity
(decay-corrected)
/MBq
Background bag reading 12:48:00 0.0 0.0 0.0
Bag after [11C]CO trapping 12:57:00 9.0 2.0 2.7
Bag after quench added 13:14:00 26.0 96.0 232.4
Vial after reaction 13:17:00 29.0 199.7 535.5
The radiochemical purity (RCP) is defined as the proportion of each 11C-containing compound in the
crude reaction mixture detected and measured by the radio-HPLC. A high RCP indicates good
selectivity for the desired product and will therefore increase the overall yield of labeled compound.
For this particular example illustrated in Table 2.10 and Table 2.11 the radiotrace from the HPLC is
shown in Figure 2.16.
Figure 2.16 A typical HPLC radiotrace from [11C]CO radiolabelling reactions.
Chapter 2 – A Study of N-Heterocyclic Carbenes
88
The three main products from the model carbonylation runs are 11C-labelled N-benzylbenzamide,
benzoic acid and N,N’dibenzylurea at 4.55 min (89.0 %), 0.98 min (4.6 %) and 4.06 min (5.9 %)
respectively. There is also an unknown peak that was not identified in this case as only 0.5 % was
yield of the total [11C] containing products.
Therefore, for this particular example the trapping efficiency and the RCY can be calculated as
follows;
Total Radioactivity = 535.5 + 232.4 – 0.0 = 767.9 MBq
Radioactivity trapped by Cu solution = 767.9 – 2.7 = 765.2 MBq
[11C]CO trapping % = (765.2/767.9) x 100 = 99.6 %
If the total radioactivity is taken as the amount trapped by the copper solution then,
Total radioactivity = 765.2 MBq
Incorporation of 11C into all products = (535.5/765.2) x 100 = 70.0 %
Radiochemical purity of N-benzylbenzamide = 89.0 %
Radiochemical yield of N-benzylbenzamide = (89.0 x 70.0)/100 = 62.3 %
2.4.2 Results and Discussion
The results of the radiolabelling procedure for the model carbonylation reaction using the best
performing NHC ligands (SIPr.HCl, SIAd.HCl and IMes.HCl) from the initial screening (section 2.3) as
well as the phosphine ligand dppp for comparison are shown in Table 2.12. Labelling reactions using
IMes.HCl and Pd2(dba)3 in situ at 100
oC produced three labelled products; two minor products
[11C]benzoic acid and [11C]N, N’-dibenzylurea along with the major labelled product [11C]N-
benzylbenzamide (Table 2.12, entry 4). RCYs ranged from 1.3-54.7 % with relatively large standard
deviations from the mean. At most, only 2 runs were carried out for these reactions due to time
constraints which may explain some inconsistencies. The RCPs were much more reliable with errors
3.2 % at most.
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Figure 2.17 CuTp*[11C]CO radiolabelling procedure with the model carbonylation reaction.
Table 2.12 Pd-mediated [11C]carbonylation reactions using [Cu(Tp*)11CO] and various Pd precursors and
ligands. Average of 2 runs for each entry. a Radiochemical purity determined from radio-analytical HPLC. b
Radiochemical yield based on the starting radioactivity of the [Cu(Tp*)11CO] complex and corrected for decay
to end of bombardment. c Average of 2 runs.
# Pd source Ligand
Temp.
(oC)
RCP (%)a
RCY (%)bBenzoic
acid
N,N'-
dibenzylurea
N-benzyl
benzamide
1c [PdCl2] SIPr.HCl 100 44.0 36.5 8.3 ± 0.3 3.6 ± 0.6
2 [PdCl2] IAd.HCl (1:2) 100 17.2 41.7 21.0 8.2
3 [PdCl2] IMes.HCl 100 3.8 88.6 7.6 1.3
4c [Pd2(dba)3] IMes.HCl 100 8.7 4.8 85.8 ± 3.2 54.1 ± 9.7
5 [PdCl2] IMes.HCl 120 1.6 28.1 69.1 20.3
6c [Pd2(dba)3] IMes.HCl 120 0.0 1.0 98.8 ± 1.1 54.7 ± 9.5
7c [Pd2(dba)3] dppp 120 9.5 0.0 87.3 ± 1.7 42.6 ± 13.7
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[11C]N,N’-dibenzylurea was observed in significant yield when using [PdCl2] which is in agreement
with previous findings when a Pd(II) starting material is used.[22] IMes.HCl with [PdCl2] is particularly
efficient in producing [11C]N,N’-dibenzylurea (88.1 %, entry 3) which reduces the RCY of amide to
only 1.3 %. However, where [Pd2(dba)3] is used in entry 4 only 4.8 % of urea is formed giving a larger
RCY of amide (54.1 %). Runs 1 and 2 also produce the radiolabelled urea but to a lesser degree. The
RCYs of radiolabelled amide for these runs are still low but because the large amount of benzoic acid
also formed. Interestingly the N,N’-dibenzylurea product is not observed in the corresponding cold
reactions, and the formation is attributed to the vastly different stoichiometries encountered
between the ‘cold’ and ‘hot’ regimes potentially leading to an oxidative carbonylation mechanism.[23]
It is thought that the excess amount of palladium compared to [11C]CO may cause this effect. Control
reactions have previously been carried out where no iodobenzene was used and the urea was
produced in 97 % RCP.[22] Furthermore the radiolabelling procedure was carried out without
palladium to assess the contribution of the copper to the mechanism. No products were formed,
which indicated that palladium is crucial for the reaction. However, a dual Pd/Cu mechanism cannot
be ruled out. The evidence does point towards a significant contribution from palladium(II). A
mechanism for this reaction has been postulated in Figure 2.18 as has been detailed in the
literature.[24] If Pd(II) is being reduced to Pd(0) and acts as an oxidant in the first step then a catalytic
cycle like this can be envisaged or the Pd(II) starting material could enter the catalytic cycle directly.
The large excess of reagents and palladium could mean that the PdCl2 used is simply being reduced
to Pd(0) with the production of benzylisocyanate (Figure 2.19) without necessarily a catalytic cycle or
oxidant being present.
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Figure 2.18 Proposed catalytic cycle for the synthesis of [11C]N,N’dibenzylurea.
Figure 2.19 Proposed synthesis of [11C]N,N’dibenzylurea from PdCl2.
The resultant loss of radiolabelled N-benzylbenzamide at 100 oC (Entry 3) when using [PdCl2] leads to
a lowering of the radiochemical yield compared to the yields when using [Pd2(dba)3] (Entry 4). This
could be due to the poor solubility of [PdCl2] in DMF, but also because the required oxidative
addition of iodobenzene is suppressed owing to the slower generation of the active Pd(0) catalyst
from PdCl2 compared to directly using [Pd2(dba)3]. The variation in RCPs of the runs 1-4 at 100
oC can
be better illustrated in the bar chart in Figure 2.20.
Figure
The palladiumoxidation state-directing effect, which is illustrated in the differing
amide when using Pd(II) or Pd(0)
assumed to arise for the same reasons as previously discussed.
An increase in temperature from 100
acid formed. This product is thought to form from
addition of the aqueous quench
end of the reaction, before addition of the a
elimination at higher temperatures.
IMes.HCl at 100 oC and 120 oC respectively. Run
N,N’-dibenzylurea so the purity
was also observed to reduce over the runs
most efficient in the reaction at 100
investigated further at 120 oC and compared to 1,2
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2.20 RCPs (%) of runs 1 – 4 at 100 oC.
, is also observed when comparing run 5 and 6
oC to 120 oC significantly reduces the amount
the hydrolysis of the Pd(II)
. This indicates that less of the acyl intermediate is present at the
queous quench, due to a more efficient reductive
This effect can be seen between runs 4 and
4 has more 11C incorporated into benzoic acid and
of amide is markedly lower than run 6. The amount of benzoic acid
1-3 (SIPr.HCl > SIAd.HCl > IMes.HCl) with IMes.HCl being
oC. Therefore, it was decided that this NHC would be
-bis(diphenylphosphinopropane) (dppp).
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RCPs of urea and
at 120 oC and can be
of [11C]benzoic
-acyl complex on
6 with Pd2(dba)3 and
Figure
When the ligand IMes.HCl is used (Entry
purity of [11C]N-benzylbenzamide formation is observed compared to
diphosphine, dppp, is used as the ligand (Entry
(98.8 %) formation is observed with the NHC system whereas there is still a significant amount of
[11C]benzoic acid (9.5 %) using the diphosphine which diminishes the amount of amide formed. This
indicates that the reductive elimination step is slower using dppp/
IMes.HCl/[Pd2(dba)3] which has a noticeable impact on the yield of the desired labelled amide
compound. The overall, greater efficiency may be attributed to the greater electron donating ability
of carbenes versus phosphines and their stability at higher temperatures
2.5 Conclusions
In conclusion, NHC ligands have shown to
and diphosphine ligands for palladium
period and significantly better than palladium alone after 10 min
sampled at 10 min, the diphosphine ligands tested gave average yields of betwe
the NHC systems between 8.1-21.5 % compared to
17.7 %. The same reactions after 2 h gave yields of between 55
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2.21 RCPs (%) of runs 5 – 7 at 120 oC.
6) at 120 oC a significant improvement in the radiochemical
when the chelating
7). Very high selectivity for [11C]N
[Pd
.
perform similarly to a range of commonly used phosphine
-catalysed aminocarbonylation reactions over a 2 h reaction
.[25] When reaction times were
[Pd(PPh3)4] which gave an average GC yield of
-60 % for NHC
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-benzylbenzamide
2(dba)3] than for
en 9.6-15.1 % and
-Pd catalysts. The
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similarity in yields between all catalyst systems after 2 h may be due to the formation of palladium
nanoparticles.
When applied to [11C]CO palladium-mediated aminocarbonylation reactions, using the [Cu(Tp*)]
trapping technique, the NHC ligand IMes.HCl and [Pd2(dba)3] proved to give good RCYs and excellent
RCPs of [11C]N-benzylbenzamide that surpassed a commonly used Pd-phosphine ligand system.
IAd.HCl and IPr.HCl were also used in radiolabelling reactions for the first time. N,N’-dibenzylurea
was the major product when [PdCl2] was used as the palladium precursor. The poor selectivity when
using Pd(II) compounds make them unsuitable in this radiolabelling experiment. Interestingly, there
appears to be an enhancement of the reductive elimination step when using NHC-Pd system at
higher temperatures which is evident by the suppression of [11C]benzoic acid formation. This work
has illustrated the potential for the use of NHCs in [11C]radiolabelling for PET.
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3 Synthesis of N-Benzylbenzamide via Palladium-Catalysed
Carbonylation: A Study of Hemilabile Ligands
3.1 Introduction and Aims
Chelating diphosphines have found widespread use in palladium-catalysed carbonylation reactions[1]
and other cross-coupling reactions as auxiliary ligands.[2] Hybrid ligands consist of two or more donor
moieties which have different affinities for a metal centre. The hemilabilty of these ligands arises
because one donor is substitutionally more labile than the other and can be used in catalysis to
invoke an ‘opening and closing’ mechanism which creates a free coordination site when open and
stability when closed. Late transition metals prefer to bind through a softer donor such as
phosphorus rather than something comparatively harder such as oxygen, nitrogen or sulphur.
Hemilabile ligands can change the steric environment and the electronic properties of the metal
centre simultaneously in a dynamic way.
P,O and P,S ligands have illustrated improved activity in the rhodium-catalysed carbonylation of
methanol to synthesise acetic acid.[3] In addition, as discussed in more detail in Chapter 1 there is
very little literature studying the affect of these ligands on ‘Heck’ style palladium-catalysed
carbonylations. It was decided that due to their positive employment in carbonylation of methanol
that there may be improvement in the yields of amides from aminocarbonylation reactions.
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Figure 3.1 Postulated mechanism of palladium carbonylation with a P,O ligand.[4]
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The mechanism for a hemilabile system in palladium carbonylation reactions was postulated in the
thesis of Dr. S. Kealey (former PhD student and PDRA to Prof. N. J. Long) and illustrated in Figure
3.1.[4]
After oxidative addition of an aryl halide the oxygen may become more labile due to the increased
nucleophilicity of the metal centre which opens a vacant site for the carbon monoxide to coordinate.
The square planar geometry is a preferred conformation for the palladium(II) centre rather than a
square pyramidal geometry which may form when a diphosphine is used. Migratory insertion of the
carbon monoxide forms a palladium-acyl complex which then opens up another vacant site for the
oxygen atom to re-coordinate. Reductive elimination with a nucleophile can then occur in the
normal manner. A similar reaction involving the carbonylation of methyl iodide with a P,O ligand and
a rhodium catalyst suggests a similar mechanism where the labile donor atom dissociates with the
coordination of carbon monoxide.[5]
Complexes and ligands previously developed by the Long group, and that are used in this study, have
shown potential as catalysts. 1-(Diphenylphosphino)-1’-(methylthio)ferrocene has been tested with
Pd2(dba)3 as a catalyst for Suzuki-Miyaura cross-coupling reaction producing 4-methylbiphenyl in 80
% yield and was benchmarked against 1,1’-diphenylphosphinoferrocene (dppf) (40 %) and
triphenylphosphine (90 %).[6] 1-(Diphenylphosphino)-1’-(methoxy)ferrocene was also found to be
active in this reaction with 89 % yield achieved.[7]
The aim of this work was to investigate the potential of P,S and P,O ligands and their complexes for
use in palladium-catalysed carbonylation reactions and specifically for the synthesis of amides and to
compare them to other well known chelating diphosphine ligands.
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3.2 Synthesis and Complexation of Ligands
A range of diphosphine ligands were chosen for use in this study and similar P,S and P,O ligands were
chosen and designed to gain an insight into the direct effect of the hemilabile system using ligands
with similar structures as other diphosphines, but differing electronic and steric properties. The
complexes used in this study are summarized in Figure 3.2.
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Figure 3.2 Diphosphine, phosphine-thioether and phosphine-ether palladium complexes used in this study.
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3.2.1 Synthesis of dichloro[1-(diphenylphosphino)-1’-(methylthio)ferrocene]-
palladium (II) (3.1)
1-(Diphenylphosphino)-1’-(methylthio)ferrocene and dichloro[1-(diphenylphosphino)-1’-(methylthio)
ferrocene]palladium(II) were previously prepared in the Long group by Dr. C. K. Williams.[6] The same
procedure was carried out to prepare the asymmetrically substituted phosphorus and sulphur
ferrocenediyl ligand (Figure 3.3). A solution of chlorodiphenylphosphine and dimethylsulphide in
hexane was added dropwise over 30 min to a suspension of lithiated ferrocene in hexane. An
aqueous work up was followed by column chromatography (silica, hexane : diethylether, 9:1) as the
1,1’-disubstituted diphenylphosphino and thiomethyl derivatives are also formed. 1H and 31P {1H}
NMR spectra confirmed isolation of the desired product.
Figure 3.3 Synthesis of 1-(diphenylphosphino)-1’-(methylthio)ferrocene.[6]
Complexation with palladium to synthesise 3.1 was achieved by stirring 1-(diphenylphosphino)-1’-
(methylthio)ferrocene and dichloro[1,5-cyclooctadiene]palladium(II) ([PdCl2(COD)]) in DCM together
under N2 at room temperature for 20 h (Figure 3.4). The red precipitate was collected and washed
with hexane. Recrystallisation occurred from slow diffusion of a saturated solution of the product in
DCM with diethylether giving small orange crystals suitable for X-ray diffraction studies.
Figure 3.4 Synthesis of 3.1.
3.2.2 Characterisation of 3.1
The red powder obtained was submitted for 1H and 31P{1H} NMR spectroscopy. The spectral data
agrees with that in the literature,[6] which illustrates a downfield shift of all the resonances due to
complexation. One singlet is observed in
indicate any movement of the hemilabile arm
The molecular structure of this complex, however, had not previously been resolved.
structure of 3.1 can be seen in Figure
appendices.
Table 3.1
Pd–Cl(1)
Pd–S(1)
Cl(1)–Pd–
Cl(1)–Pd–
Cl(2)–Pd–
The molecular structure shows a distorted square planar geometry around the Pd
angles for S(1)-Pd-P(12) and Cl(1
ligand and possibly the lone pair on
out of the {Pd,Cl(1),S(1),P(12)} plane. The
groups (C(13) and C(12)) are also approximately coplanar to the other atoms surrounding the Pd.
The bond lengths, Pd-P (2.26 Å) and Pd
trans to the phosphorus (2.36 Å) is
due to the larger trans influence
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the 31P{1H} NMR spectrum at 31.1 ppm which
in solution.
3.5, a list of selected bond lengths and angles is available in the
Figure 3.5 Molecular structure of 3.1
Selected bond lengths (Å) and angles (°) for 3.1.
2.2898(7) Pd–Cl(2) 2.3564(7)
2.3208(7) Pd–P(12) 2.2620(7)
Cl(2) 89.53(3) Cl(1)–Pd–S(1) 176.68(3)
P(12) 88.49(3) Cl(2)–Pd–S(1) 93.78(3)
P(12) 167.21(3) S(1)–Pd–P(12) 88.32(2)
)-Pd-P(12) being slightly less than 90 o. This is due to the chelating
sulphur increasing the Cl(2)-Pd-S(1) angle.
carbon atoms in the thiomethyl and phosphinophenyl
-S (2.32 Å), are within the expected range. The Pd
longer than the Pd-Cl bond trans to the sulphur (2.29 Å) which is
of the phosphine group. The cyclopentadienyl rings are eclipsed as
101
does not
The molecular
(II) centre with
Cl(2) lies ca. 0.54 Å
-Cl bond
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was observed for the Pt analogue of this complex.[6] All other bond lengths and angles are as
expected.
3.2.3 Synthesis of dichloro[1-(diphenylphosphino)-1’-(methoxy)ferrocene]-
palladium (II) (3.2)
1-(Diphenylphosphino)-1’-(methoxy)ferrocene and dichloro[1-(diphenylphosphino)-1’-(methoxy)
ferrocene]palladium(II) (3.2) were previously prepared by Dr. R. C. J. Atkinson in the Long group.[7]
However, a more reliable route to 3.2 has now been achieved and is reported herein. The
phosphine-thioether ferrocenediyl ligand was synthesised as per the literature and is shown in
Figure 3.6. The two step reaction uses 1, 1’-dibromoferrocene to first attach the methoxy group
using bis(trimethyl)silyl peroxide and dimethylsulphate. Lithiation with nBuLi of the bromo group and
quenching with chlorodiphenylphosphide gave the final product after purification by column
chromatography. 1H and 31P{1H} NMR spectroscopy confirmed that the correct product had been
isolated.
Figure 3.6 Synthesis of 1-(diphenylphosphino)-1’-(methoxy)ferrocene.
Complexation was achieved by adding a solution of the ligand in toluene to [PdCl2(COD)] dissolved in
DCM and stirring at room temperature. A colour change from yellow to dark red-brown occurred
within seconds. However, when attempting the 1:1.1 stoichiometry (which was used in the
literature) of palladium to ligand the solution turned very dark and then black. Elemental palladium
was recovered from the reaction mixture with no sign of the ligand in the 1H NMR spectrum. This
may be evidence that the complex is not stable in solution and that the ligand dissociates easily so
that the palladium agglomerates into clusters of elemental palladium. Ferrocene with ether
substituents are more unstable than usual due to degradation of the ferrocene structure which
could be contributing to the breakdown of the palladium complex. A 1:1.3 stoichiometry was found
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to improve the stability of the complex in solution and a dark brown powder was isolated. Because
of the increased ligand to palladium stoichiometry both the chelating complex 3.2 and bis[1-
(diphenylphosphino-κ-P)-1’-(methoxy)ferrocene] dichloropalladium(II) phosphorus bound complex 
illustrated in Figure 3.7 were formed, and characterised from TLC and 31P{1H} and 1H NMR spectra.
Figure 3.7 Synthesis of 3.2 and the bis(phosphine) byproduct.
The two products were separated by column chromatography (silica, first eluted with DCM and then
increasing the acetone : DCM ratio to 1:4) to yield 3.2 in 44 %. The spectra from 1H and 31P {1H} NMR
gave the shifts expected from the literature[7] including the downfield shift of the 31P {1H} NMR signal
from -16.98 ppm to 31.3 ppm as is anticipated from the complexation of the ligand with palladium.
The disubstituted non-chelated product, bis[1-(diphenylphosphino-κ-P)-1’-(methoxy)ferrocene] 
dichloro palladium(II) was also identified in 1H and 31P {1H} NMR spectra, the methyl protons are
more shielded than the chelating ligand (3.55 ppm) and the singlet corresponding to PPh2 is at 15.1
ppm. Recrystallisation was attempted by layering of pentane on DCM and by slow diffucion of
diethylether and DCM, however, no crystals were obtained.
3.2.4 Synthesis of 1-(diphenylphosphino)-3-(2,6-dimethyl-1-thiophenyl)
propane (3.3)
The synthesis of 3.3 (Figure 3.8) was carried out in a pre-dried bomb (500 mL round bottom flask
fitted with a Young’s tap). Firstly an excess of 1,3-dichloropropane was reacted with potassium
diphenylphosphide forming the monosubstituted 1-chloro-3-(diphenylphosphino)propane
intermediate that was not isolated. An excess was necessary for this step to reduce disubstitution.
The intermediate was heated to reflux with 2,6-dimethylbenzenethiol and cesium carbonate and
followed by 31P{1H} NMR until completion. Vacuum distillation was necessary at 150 oC to remove
excess 1,3-dichloropropane and unreacted 2,6-dimethylbenzenethiol. The product was isolated and
kept under N2 in a glove box.
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Figure 3.8 Synthesis of 3.3.
3.2.5 Characterisation of 3.3
The 1H NMR spectrum shows a multiplet at 1.63 ppm corresponding to the central CH2 group and
two triplets at 2.13 ppm and 2.75 ppm, which are the CH2 groups closest to the phosphine and
sulphur, respectively. A larger downfield shift may be expected for the CH2 closest to the thiophenyl
group due to the increased electronegativity of sulphur removing some of the electron density and
deshielding the protons on the nearest carbon. The two methyl groups are in the same environment
due to free rotation of the thiophenyl group and one singlet is observed at 2.50 ppm. The phenyl
protons of the thiophenyl and diphenylphosphino groups can be seen as a multiplet at 7.09 ppm and
7.35 ppm respectively. One singlet in the 31P {1H} NMR spectrum appears at -17.1 ppm. The mass
spectrum shows the molecular ion (364 amu) and fragmentation with the loss of 2,6-dimethylphenyl
(259 amu).
3.2.6 Synthesis of dichloro[(1-(diphenylphosphino)-3-(2,6-dimethyl-1-
thiophenyl)propane]palladium (II) (3.4)
Figure 3.9 Synthesis of 3.4.
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Compound 3.4 was synthesised from stirring [PdCl2(COD)] and 3.3 dissolved in dry DCM at room
temperature for 2 h (Figure 3.9). A yellow precipitate was formed which was collected and washed
(41 % yield). Crystals suitable for X-ray diffraction were obtained by slow diffusion of diethyl ether
into a DCM solution of 3.4.
3.2.7 Characterisation of 3.4
The 1H NMR spectrum (Figure 3.10) shows that all of the peaks have been shifted downfield
compared to the free ligand due to a deshielding effect on the protons with complexation to
palladium. The 2,6-dimethylphenyl group still has free rotation about the sulphur so only one singlet
is observed representing the two methyl groups (HD). There is some overlap between HD and HC not
previously seen due to a large downfield shift of HD from 2.50 ppm in the free ligand to 2.89 ppm in
the complex. The shift seen for the multiplet observed for the protons adjacent to the sulphur, CH2-S
(HC) is not so large only shifting downfield from 2.75 ppm to 2.86 ppm in the complex. In the phenyl
region a doublet (7.31 ppm) and triplet (7.22 ppm) are observed for the para and meta protons
respectively on the thiophenyl substituent. There are also two multiplets between 7.5-8.0 ppm
which represent the meta (HI) and ortho and para (HG and HH) from the diphenylphosphine group.
HI
HC
HG + HH
HF
HE
HD
HB
HA
CD2Cl2
Figure 3.10 1H NMR spectrum of 3.4 run in CD2Cl2.
The 31P {1H} NMR also shows the environment around the phosphorus
complexation as the singlet has shifted downfield to 9.24 ppm from
mass spectrum shows agglomeration of molecules as dimers and trimers however, the mole
is also observed (544 amu) and the free ligand (365 amu).
Table 3.2
Pd–Cl(1)
Pd–P(1)
Cl(1)–Pd–Cl(2)
Cl(1)–Pd–S(5)
Cl(2)–Pd–S(5)
The geometry around the palladium centre is
C(2)-C(3), C(3)-C(4) and C(4)-S(5)
length and symmetrical about the
expected. The Pd-Cl(1) bond trans
trans to the thiophenyl group
compared to the trans influence exerted by the sulphur.
ligand is large at 98.35 o, distorting the rest of the
there is slight pyramidal distortion as the palladium i
plane (ca. 0.09 Å).
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atom
-17.05 ppm. The electrospray
Figure 3.11 Molecular structure of 3.4.
Selected bond lengths (Å) and angles (°) for 3.4.
2.3605(8) Pd–Cl(2) 2.3063(8)
2.2383(9) Pd–S(5) 2.2789(9)
93.36(3) Cl(1)–Pd–P(1) 174.91(3)
83.55(3) Cl(2)–Pd–P(1) 84.40(3)
174.90(3) P(1)–Pd–S(5) 98.35(3)
distorted square planar. The bond lengths of
that make up the backbone of the chelating ring
central C(3). The Pd-P(1) and Pd-S(5) bond lengths
to the phosphine group (2.36 Å) is longer than the Pd
(2.31 Å) due to a slightly greater trans influence of phosphine
The P(1)-Pd-S(5) chelating bite angle of the
geometry around the palladium.
s sitting slightly out of the {Cl(1),Cl(2),P(1),S(5)}
106
has changed on
cular ion
P(1)-C(2),
are of standard
are also as
-Cl(2) group
Furthermore,
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3.2.8 Synthesis of dichloro[(1-(diphenylphosphino)-3-(2,6-dimethyl-1-
thiophenyl)ethane]palladium (II) (3.5)
The synthesis of 3.5 was achieved by stirring of 1-(diphenylphosphino)-3-(2,6-dimethyl-1-
thiophenyl)ethane and [PdCl2(COD)] in DCM at room temperature for 16 h and collection of the
yellow precipitate which had formed (72 % yield) (Figure 3.12). Thin yellow plates were formed on
recrystallisation by slow diffusion of a saturated solution of DCM with hexane.
Figure 3.12 Synthesis of 3.5.
3.2.9 Characterisation of 3.5
The NMR spectra of 3.5 show a deshielding effect on all protons from the free ligand due to the
complexation to palladium. In the 1H NMR spectrum the backbone CH2 protons give rise to two
multiplets as they are in different environments. They have both been shifted 0.2-0.3 ppm compared
to the corresponding multiplets in the spectrum of the free ligand. The methyl group protons can be
observed as a singlet at 2.62 ppm. The para- and meta-phenyl protons on the thiophenyl group can
be distinguished as a multiplet (overlaps with CDCl3 signal) and a doublet at 7.22 ppm and 7.06 ppm
respectively. The phenyl protons of the diphenyl phosphino group can also be observed at 7.52 ppm
(ortho), 7.61 ppm (para) and 7.93 ppm (meta). In the 31P {1H} NMR spectrum the singlet is observed
at 63.0 ppm which is a significant shift from the free ligand at -17.3 ppm.
Table 3.3
Pd–Cl(1)
Pd–P(1)
Cl(1)–Pd–Cl(2)
Cl(1)–Pd–S(4)
Cl(2)–Pd–S(4)
The square planar geometry around the Pd centre is
87.42 o. There is little distortion of the geometry
complexes (e.g. 3.4). The C2 backbone of
analogous compound 3.4 which
trans influence is observed in
phosphine group. The P(1)-C(2),
1.83 Å and 1.84 Å respectively).
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Figure 3.13 Molecular structure of 3.5.
Selected bond lengths (Å) and angles (°) for 3.5.
2.3596(5) Pd–Cl(2) 2.3148(5)
2.2265(5) Pd–S(4) 2.2864(5)
93.455(18) Cl(1)–Pd–P(1) 175.522(19)
88.984(18) Cl(2)–Pd–P(1) 90.240(18)
176.779(19) P(1)–Pd–S(4) 87.420(18)
a result of the narrow P(1)
as seen in the other examples
3.5 decreases the bite angle by 11
has a propyl backbone. The same increase in bond length due to
3.5 as in 3.4 with a elongation of the Pd-Cl bond trans to
C(2)-C(3) and C(3)-S(4) bond lengths are all a
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o compared to the
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s expected (0.50 Å,
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3.2.10 Synthesis of dichloro(di-μ-chloro)bis[1-(diphenylphosphino)-2-
(phenoxy)ethane]dipalladium(II) (3.6)
The synthesis of 1-(diphenylphosphino)-2-(phenoxy)ethane was carried out by reacting 2-chloroethyl
phenylether and potassium diphenylphosphide in THF at 0 oC (Figure 3.14).[8] The product was
extracted with DCM and purified by column chromatography (silica, pentane : diethylether 9:1) and
isolated in 63 % yield.
Figure 3.14 Synthesis of 1-(diphenylphosphino)-2-(phenoxy)ethane.[8]
Complexation of compound 3.6 with palladium (Figure 3.15) was achieved by stirring 1-
(diphenylphosphino)-2-(phenoxy)ethane and [PdCl2(COD)] in dry DCM together under N2 at room
temperature for 18 h, after which time there had been a colour change from yellow to dark red. The
reaction mixture was reduced by half and addition of hexane caused precipitation of a yellow
powder which was washed with hexane and isolated in 92 % yield. Recrystallisation was achieved by
layering a saturated solution of crude product in DCM and with pentane yielding small orange
needles suitable for X-ray diffraction studies.
Figure 3.15 Synthesis of 3.6.
3.2.11 Characterisation of 3.6
The 1H NMR spectrum shows that complexation has occurred as all the peaks have been shifted
downfield compared to the spectrum of the free ligand although to differing degrees. The CH2 group
adjacent to the phosphine has been shifted from 2.57 ppm in the free ligand to 2.96 ppm in the
complex. The shift of the CH2 protons next to the oxygen is markedly less, shifting from 4.10 ppm in
the free ligand to 4.27 ppm in the complex. This indicates that the predicted chelating P,O ligand
may not have formed. The phenyl protons follow this trend too. The phenoxy protons are clearly
defined downfield from the other phenyl protons due to the electron withdrawing effect of the
electronegative oxygen. The ortho
7.23 ppm respectively. An electrospray mass spectrum was obtained but only the ligand was
observed at 275 amu. However, crystals suitable for X
confirmed the dimeric structure.
Table 3.4
Pd(1)–Cl(1)
Pd(1)–P(1)
Cl(1)–Pd(1)–Cl(2)
Cl(1)–Pd(1)–Cl(1A)
Cl(2)–Pd(1)–Cl(1A)
Pd(1)–Cl(1)–Pd(1A)
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, para and meta protons are observed at 6.73 ppm, 6.93 ppm and
-ray diffraction were prepared which
Figure 3.16 Molecular structure of 3.6.
Selected bond lengths (Å) and angles (°) for 3.6.
2.3286(4) Pd(1)–Cl(2) 2.2738(4)
2.2233(4) Pd(1)–Cl(1A) 2.4301(4)
176.240(13) Cl(1)–Pd(1)–P(1) 93.578(13)
85.929(13) Cl(2)–Pd(1)–P(1) 89.516(14)
90.830(13) P(1)–Pd(1)–Cl(1A) 175.831(14)
94.071(12)
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The X-ray crystal structure confirmed that only the phosphorus was bound to the palladium centre
and that due to the stoichiometry of the reaction only one ligand was attached to each palladium
and a halide bridged dimer had been formed, with a central Pd2Cl2 ring, to maintain a square planar
structure about the palladium. Although the geometry is square planar around the two palladium
centres there is some distortion caused by the smaller Cl(1)-Pd(1)-Cl(1A) angle (85.93 o) produced
from the repulsion of the two metal centres. The Pd-P(1) bond length is 2.33 Å which is in agreement
with other complexes synthesised in this work. The central bridging diamond shape is asymmetric
due to the trans influence of the phosphine increasing the Pd-Cl(1A) trans to the phosphorus to 2.43
Å whereas the other Pd-Cl(1) bond lengths are 2.33 Å. This ligand illustrates the largest trans
influence seen out of all the complexes synthesised which could be due to the monophosphine
binding or the alkylphenoxy group attached to the phosphine. The terminal Pd-Cl(2) and Pd-Cl(2A)
bonds are shorter by ca. 0.05 Å than the bridging Pd-Cl bonds. All other bond lengths in the phenyl
rings and ligand backbone are as expected.
The halide bridged dimeric palladium complex prepared here has been observed before with similar
P,O ligands, such as PPh2CH2CH2OCH3, in the literature.
[9] The dimeric palladium analogues were
prepared from one equivalent of the P,O ligand and [PdCl2(COD)]. When two equivalents were used
the ligand still preferentially bonded through the softer phosphorus atom which gave a monomeric
bis-ligated complex and abstraction of the two chlorides forced chelation of the ligand. Similar
behaviour has been observed in a rhodium complex where the chelating ligand is only present in a
transition state intermediate and the ether group does not favourable coordinate to the rhodium.[8]
3.2.12 Synthesis of dichloro[bis(1-(κ-diphenylphosphino)-2-(phenoxy)ethane) 
palladium(II) (3.7)
Two equivalents of 1-(diphenylphosphino)-2-(phenoxy)ethane were added to a solution of 3.6 in
DCM and stirred overnight. A bright yellow precipitate was collected, washed with hexane (2 x 10
mL) and dried in vacuo in 53 % yield.
Figure 3.17 Synthesis of 3.7.
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3.2.13 Characterisation of 3.7
Compound 3.7 has been prepared previously in the literature although as one of three products in a
study of ligand pairing of P,S and P,O heteroligated palladium(II) complexes.[10] The 1H and 31P {1H}
NMR spectral data collected here is in agreement with the literature. The 1H NMR spectrum is
almost identical to the spectrum of 3.6 with hardly any chemical shift of any of the peaks. The 31P
{1H} NMR spectrum however indicates that a new complex has been formed as the environment of
the phosphorus atoms has changed from ~27.1 ppm to 12.6 ppm. The mass spectrum achieved from
electrospray ionisation gives the M+ minus a chlorine atom at 753 amu which is also seen in the
literature. The final compound was also characterised by elemental analysis.
3.2.14 Abstraction of Chlorides from dichloro[bis(1-(κ-diphenylphosphino)-2-
(phenoxy)ethane) palladium(II) (3.8)
It was envisaged that by treating complex 3.7 with silver triflate the two chlorides could be
abstracted to form a bis-chelated palladium(II) complex containing this ligand. Previously, the
methoxy derivative of this ligand has formed an analogous phosphorus-coordinated PdL2Cl2 complex
and the bis-chelated species was then prepared from chloride abstraction with silver
hexafluoroantimonate[9].
Figure 3.18 Synthesis of 3.8.
A solution of silver triflate in DCM was added to a solution of 3.7 in DCM under inert and dark
conditions and stirred for 17 h at room temperature. An orange powder was collected after
filteration through Celite. Recrystallisation was achieved from layering hexane onto a concentrated
solution of the orange powder in DCM.
3.2.15 Characterisation of 3.8
The 1H NMR spectrum for this compound illustrated that the protons attached to the carbon atoms
adjacent to the oxygen atom (phenyl group and CH2) have changed environment compared to 3.7 as
there is a slight shift in the peaks downfield for the phenyl group. Furthermore, there is only one
multiplet corresponding to the protons on the CH2 group adjacent to the oxygen atom indicating
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that there is only one environment for those protons which is at a different chemical shift than the
same protons in 1H NMR spectrum of 3.7 (4.03 ppm instead of 4.25 ppm). This evidence suggests
that the oxygen is now coordinated to the palladium. The molecular ion is also observed in the
positive ion electrospray mass spectrum at 719 amu which confirms that two ligands are present in
the complex.
Crystals of 3.8 suitable for X-ray diffraction were obtained by layering hexane onto a DCM solution of
3.8 which provided uniform yellow needles. The crystal structure shows that both of the chlorides
were successfully abstracted however only one of the ligands has formed a chelate ring. A water
molecule is coordinated to the palladium in place of the oxygen atom on the monoligated P,O ligand.
Aqua palladium complexes are well documented in the literature and reactions of halo palladium
complexes and silver salts with weakly coordinating anions can result in these complexes, especially
when carried out in solvents with poor donor abilities (ie. DCM).[11] Substitution of a ligand by water
can occur after crystallisation. Moisture could have entered the reaction vessel from the silver
triflate salt (hydroscopic) or from the use of solvents which were not completely anhydrous in the
work up. This structure may have formed due to the large amount of steric crowding around the
palladium centre and the poor donor ability of the oxygen atom on the phenoxy group allowing for a
water molecule to coordinate preferentially.
It is interesting to note that differences in the coordination of the two ligands and coordination of
water was not observed in the 1H NMR, 31P {1H} NMR or mass spectrum. This could indicate that this
structure only formed on crystallisation.
Table 3.5
Pd-O(60)
Pd-O(4)
O(60)-Pd-O(4)
O(60)-Pd-P(1)
O(4)-Pd-P(1)
The geometry around the palladium centre is distorted square planar.
slightly shorter than Pd-P(31) of the non
bond length between Pd-O(60) and Pd
donor ligands. The bite angle of the chelat
similar ligand seen in 3.5. The soft phosphorus atoms are coord
atoms. In the hypothetical bis-chelating complex it is
upheld or the more unfavourable electronic arrangement
phosphine’s phenyl groups.
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Figure 3.19 Molecular structure for 3.8.
Selected bond lengths (Å) and angles (°) for 3.8.
2.1164(13) Pd-P(1) 2.2190(4)
2.1682(12) Pd-P(31) 2.2522(4)
87.39(5) O(60)-Pd-P(31) 93.26(4)
165.06(4) O(4)-Pd-P(31) 177.01(4)
82.70(3) P(1)-Pd-P(31) 97.212(17)
The bond length of Pd
-chelating ligand. Furthermore, there is also a difference in
-O(4) of ~0.05 Å which may be expected from the difference
ing ligand O(4)-Pd-P(1) is 82.7 o, which is smaller than the
inated trans
not known whether this arrangement would be
would be forced due to sterics of the
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to the hard oxygen
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3.3 Synthesis of N-Benzylbenzamide via Carbonylation
The new phosphine-thioether and phosphine-ether (P,S and P,O) palladium catalyst systems
developed were tested in the model aminocarbonylation reaction used in Chapter 2 and compared
to other palladium diphosphine containing complexes (Figure 3.2). The ligands were chosen so that a
comparison could be drawn between the effect of diphosphine and hemilabile ligands with similar
backbones on aminocarbonylation reactions. The carbonylative cross-coupling of iodobenzene and
benzylamine yields N-benzylbenzamide seen in Figure 3.20. The conditions were changed compared
to the previous carbonylation runs. Toluene was used as the solvent instead of benzylamine, but a
tenfold excess of benzylamine was used in the reaction. The reactions were carried out over 3 h and
at 100 oC. The reaction vessels were opened to a flow of carbon monoxide from a manifold for the
entire 3 h. The reagents underwent two cycles of freeze-pump-thaw before use to remove any
atmospheric air, and transferred via cannula under carbon monoxide to the reaction vessel
containing the catalyst.
Figure 3.20 Synthesis of N,N’-benzylbenzamide.
After quenching with hydrochloric acid (1 M) the crude product was extracted into DCM and
isolated. The samples for gas chromatography (GC) analysis were made up from 1 mL of a 10 mL
solution of crude product in DCM and 0.5 mL of diphenyl ether solution in DCM (0.4 M). The
theoretical yield for complete conversion would result in 0.1 mmol (21.1 mg) of product in the 1 mL
sent for GC analysis. Clarity software was used to create a calibration and then determine the final
GC yield. Due to the nature of the work up before GC analysis the values stated are the isolated
yields rather than complete conversion to product.
Data collected from these carbonylations cannot be directly compared to the results from Chapter 2
because of the different conditions used. Furthermore, a different GC column was used and the
carrier gas in the GC was changed from nitrogen to helium. Full details of the GC equipment and set
up can be found in Chapter 7.
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3.3.1 Palladium Diphosphine Complexes
Carbonylation reactions were carried out with a series of diphosphine chelating ligands. The
diphosphines were chosen for their different backbone structures which can vary the flexibility of
the ligand and the range of bite angles which can also have an effect on intermediates in the
catalytic cycle.[12]
Table 3.6 GC yields of N-benzylbenzamide after 3 h and bite angles. Average of 3 runs with standard
deviations.
Run Pre-catalyst GC Yield (%)
Bite angle from
crystal structure
o
1 Pd(PPh3)4 73.3 ± 4.3 N/A
2 75.2 ± 2.8 85.8[13]
3 78.9 ± 4.5 90.6[13]
4 85.6 ± 5.2 98.0[14]
5 85.5 ± 3.0 110.0[15]
Table 3.6 shows the average of three carbonylation runs and the standard deviation for this data.
Tetrakis(triphenylphosphine)palladium(0) was used as a standard to compare the other ligands
against and performs well with 73 % isolated yield. As is expected from carbonylation reactions the
diphosphine chelating ligand complexes give improved results. [PdCl2(dppe)] (run 2) and
[PdCl2(dppp)] (run 3) give yields of 75.2 % and 78.9 % respectively. The average for run 3 is higher
than run 2 however they are not significantly different when looking at the errors. It can however be
said that [PdCl2(dppe)] (run 2) is significantly less effective as a catalyst in this reaction than
[PdCl2(dppf)] (run 4) and [PdCl2(Xantphos)] (run 5). The yield from run 4 is of interest as it did not
stand out as a particularly effective catalyst under different conditions in Chapter 1 but here it yields
similar amounts to [PdCl2(Xantphos)] which previously has been shown to be one of the most
effective catalysts found for this reaction.[16] Reasons for this change may be from the solvent effects
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of using toluene. Direct comparison of a series of solvents using [PdCl2(dppf)] would be necessary to
investigate this further.
Some of the errors indicated by the standard deviations of the averaged data points are small but
could arise from the work up procedure. Perhaps by avoiding this step and just having a direct
sample from the reaction mixture analysed by GC may give smaller discrepancies between
percentage yields and therefore, lower the standard deviations for the data.
Figure 3.21 Graph illustrating the correlation between bite angle and catalytic activity of diphosphines in 1-5.
Research has previously suggested that the bite angle of the chelate ligand is important in
carbonylations and other reactions such as rhodium-catalysed hydroformylations, nickel-catalysed
hydrocyanation and palladium-catalysed carbonylations of ethene and carbon monoxide.[12] This
relationship can be observed from these data seen in Figure 3.21. There is a positive correlation
between the increasing bite angle of the diphosphine chelate and the yield of N-benzylbenzamide.
There is a significant difference in yield between runs 3 and 5 however the error bars illustrate that
the other runs may not have significantly different yields. These data would suggest that between 98
o - 108 o there is a leveling of productivity in the catalyst. A significant decline in effectiveness of the
catalyst with an obtuse bite angle was not observed and would require phosphines with larger bite
angles than studied here in order find the optimum bite angle for this reaction. It should be noted
that the bite angles reported are obtained from X-ray diffraction data and may not reflect the ‘true’
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bite angle in solution. Furthermore, the bite angle is only part of the story, as the flexibility of the
ligand and the steric and electronic effects also play crucial roles in catalysis. For instance, it cannot
be ruled out that the efficiency of dppp (run 3) over dppe (run 2) in this reaction is not due to the
increased flexibility of the C3 backbone.
3.3.2 Palladium Phosphine-Thioether Complexes
The P,S ligands prepared for this work were chosen due to the similar alkyl backbones of 3.5 and 3.4
compared with [PdCl2(dppe)] and [PdCl2(dppp)] and the similar comparison possible between 3.1
and [PdCl2(dppf)]. The bite angles of these chelates vary from their P,P counterparts mainly due to
the steric influence of the groups attached to the sulphur donor atom. 3.5 and 3.4 have larger bite
angles due to the two methyl groups in the ortho positions on the thiophenyl group whereas 3.1 has
a smaller bite angle than [PdCl2(dppf)] due to the reduced steric hindrance from the thiomethyl
group compared to a diphenylphosphino group.
Table 3.7 GC yields of N-benzylbenzamide after 3 h. Average of 3 runs.
# Catalyst
GC Yield
(%)
Bite angle
from crystal
structure o
6
P
Ph2
S
Pd
Cl
Cl
3.5
72.4 ± 4.1 87.4
7 66.8 ± 1.1 98.4
8 73.2 ± 2.6 88.3
Overall the P,S chelating ligands perform as well as the standard [Pd(PPh3)4], however the other
diphosphines give higher yields (Table 3.7). The surprising result is that a decrease in yield is
observed in run 6 compared to run 7 (from 72.4 % to 66.8 %) which is the opposite trend to the
diphosphines where the yield increases when the alkyl backbone is increased from C2 to C3 (2 to 3).
This indicates that increased flexibility in the backbone is not favourable when one of the donor
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atoms is more labile, which may be because the sulphur substituent is too labile and cannot stabilise
the intermediate. Although the errors in these results are not large, the similarity in these results
within error means that any conclusions drawn can only be speculative.
The bite angle effect seen with the diphosphines is not observed here as the largest bite angle of
98.4 o gives the lowest yield of the three P,S ligands, in fact there is not trend. Furthermore,
[PdCl2(dppf)] (run 4) has the same bite angle as the catalyst in run 7 but the yields are markedly
different; 85.6 % and 73.2 %. This suggests that the bite angle is not the dominant factor in
determining the effectiveness of the catalyst for hemilabile ligands. The 1,1’-disubstituted P,S
ferrocene ligand (3.1, run 8) also does not perform as well as [PdCl2(dppf)] even with the same
framework.
Sterically 3.1 has less bulk around the palladium centre which could reduce performance of the
ligand but increased steric bulk in the case of the catalysts used in run 6 and run 7 still does not
improve yields. Therefore, it can be assumed from the performance of 3.1 in particular that the
electronics of the P,S chelate is not optimal for this reaction. Changing the R group on the sulphur
would be of interest to probe the effect of changing the steric versus electronic properties of the
ligand.
3.3.3 Palladium Phosphine-Ether Complexes
The P,O ligands employed in this work were chosen as analogues to the previously prepared P,P and
P,S ligands. The ferrocene-based ligand (3.2, run 9) can broadly be compared to 3.1 and
[PdCl2(dppf)]. The P,O ligand with an ethane backbone (3.6, run 10) coordinates to the palladium
through the phosphorus only. It is assumed that on reduction of the complex to palladium(0), the
oxygen might weakly coordinate to the metal centre.
Table 3.8 GC yields of N-benzylbenzamide after 3 h. a Average of 2 runs. b Average of 3 runs.
Run Catalyst
GC Yield
(%)
9a 82.3 ± 6.6
10b 82.2 ± 0.8
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The phosphine-ether ligands perform very well in the carbonylation of iodobenzene and
benzylamine. They outperform the standard tetrakis(triphenylphosphine)palladium and the P,S
ligand sets. The P,O set is shown from these results to be particularly effective for this reaction giving
results on a par with [PdCl2(dppp)], [PdCl2(dppf)] and [PdCl2(Xantphos)].
As previously discussed in Chapter 1, both P,S and P,O ligands have been used effectively in the
rhodium-catalysed carbonylation of methanol.[3a, b] A dynamic process was shown to be in place in
the mechanism of reaction using the P,O ligand but not the P,S. If this is also the case with the
palladium-catalysed reactions carried out here it could be suggested that the ‘opening and closing’
mechanism is important in this reaction as higher yields are observed for runs 9 and 10 compared to
runs 6-8.
3.4 Conclusions
Four novel palladium(II) complexes have been isolated (3.4, 3.5, 3.6, 3.7) and a novel ligand (3.3).
Also a crystal structure has been obtained for a previously synthesised complex (3.1). Furthermore,
issues involving the complexation of the phosphine-ether ferrocene ligand have been resolved (3.2).
These new complexes have been tested for the first time as catalysts in a palladium-catalysed
carbonylation reaction for the synthesis of amides. They have demonstrated very good yields (66.8-
82.3 % average GC yield) of N-benzylbenzamide, the majority of which exceed the tetrakis
(triphenylphosphine)palladium standard (73.3 % average GC yield). At best 85.6 % yield of N-
benzylbenzamide was produced by the [PdCl2(dppf)] catalyst. A correlation was observed between
the bite angle of the chelate and the percentage yield for diphosphine ligands however other data
from the runs with the phosphine-thioether ligands indicates like all catalytic processes there are a
range of factors that affect the reaction which are tied together in a delicate balance. The P,O
ligands performed particularly well out of the hemilabile systems, with average yields of 82 %. It may
be recommended that P,O ligands are the focus of future work into the use of hemilabile ligands in
PET of carbonylations and other radiolabelling procedures.
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4 Nickel/Palladium-Catalysed Carboxylation of Aliphatic and
Aromatic Zinc Reagents
4.1 Introduction and Aims
Traditional synthesis of [11C]carboxylic acids in PET radiolabelling has involved the use of Grignard
reagents (RMgBr/RMgCl) with [11C]CO2 and is still the most effective way of labelling aliphatic
carboxylic acids, but the extreme reactivity of the Grignard reagents comes with issues of low
specific activity and functional group compatibility. Low specific activity (radioactivity per unit
weight, Bq/Kg) achieved in these reactions is a matter which has been overcome by Långström et al.
by using [11C]CO (which does not suffer from high levels of isotopic dilution from atmospheric 12C like
[11C]CO2) and ammonium hydroxides in a palladium mediated carboxylation of aryl halides.
[1] Despite
the favourable specific activities, the draw back with this methodology is β-hydride elimination 
which competes with carboxylation thereby reducing the radiochemical yield of [11C]carboxylic acid
when aliphatic halides are used. A radical reaction initiated using UV light and [11C]CO has also been
used to label aliphatic carboxylic acids in good yield from alkyl halides.[2] Increasing the specific
activity for a wide range of aliphatic [11C]carboxylic acids in good radiochemical yields without the
need for UV light would be advantageous.
The area of metal-catalysed carboxylation has grown in the last five years due to interest in utilising
CO2 as a C1 source and finding milder methods than the use of organolithium and organomagnesium
halides for the synthesis of compounds containing sensitive functional groups such as aldehydes and
ketones.[3] Rhodium and copper systems have been developed which use aryl halides and boronic
esters at low temperatures enabling the synthesis of aromatic carboxylic acids with a variety of
functional groups.[4] Although the copper system is particularly attractive as it is inexpensive and
boronic acids/esters are widely commercially available, it is limited to aromatic substrates and alkyl
carboxylic acids cannot be synthesised using these methods. A nickel-catalysed system was also
developed around the same time which allows for the synthesis of aliphatic products.[5] Some acids
were reacted on to make the corresponding esters as shown in Figure 4.1. As previously described in
Chapter 1, the catalytic mechanism for this reaction has been postulated (Figure 4.3).
Figure 4.1 Synthesis of aliphatic carboxylic acids and esters from organozinc halides (e.g. R = n-C6H13) (i)
Ni(acac)2 (5 mol %), P(o-C6H11)3 (10 mol %), CO2 (1 atm, balloon), DME, r.t., 3h. ii) PhCH2Br, cat. NaI, K2CO3,
DMF, r.t.
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Figure 4.2. Possible reaction mechanism for the carboxylation of RZnI.LiCl [5] (L = PCy3).
The aim of the research presented in this chapter was to develop a new labeling method involving
nickel or palladium and alkyl zinc reagents with [11C]CO2 which would not require UV light to obtain
aliphatic carboxylic acids under mild conditions. The radiolabelled carboxylic acids could then be
converted into other functionalities such as esters, acid chlorides, amides and aldehydes.
Furthermore, the synthesis of [11C]acetic and [11C]propanoic acid was considered, which could be
reduced and converted into [11C]ethyl and [11C]butyl iodide, alleviating the need for Grignard
reagents. Several studies in the literature have illustrated the difficulty in producing [11C]alkyl halide
precursors in good radiochemical purity and it is the aim that through this novel methodology to
alkyl carboxylic acids a new route can be established.[6] It was envisaged that the milder zinc
reagents would increase the specific activity without the need for [11C]CO which has the issue of low
solubility in organic solvents and therefore often requires a trapping agent or a high pressure
autoclave set up.
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4.2 Optimisation of Catalyst and Ligand System
A template reaction was employed to optimise the reaction conditions as shown in Figure 4.3.
Figure 4.3 Model reaction for the synthesis of alkyl carboxylic acids.
Initially, npropylzinc bromide was used as it is commercially available as a solution in THF (0.5 M)
whereas the lithium chloride adduct needs to be freshly prepared and used within a few days due to
degradation. Other alkylzinc bromides (e.g. n-C5H11ZnBr)
[7] have been shown to perform this reaction
with a Ni(0) complex. [Pd(OAc)2] and [Ni(acac)2] were chosen as pre-catalysts following previous
literature findings [5, 7] with a range of electron donating bulky phosphines and other selected ligands
(Figure 4.4). The preformed palladium(0) complex, [Pd(PtBu3)2], was also screened.
Figure 4.4 Phosphines tested in the carboxylation of organozinc halides.
A standard reaction was carried out in a small pre-dried Schlenk tube charged with catalyst (5 mol %)
and THF under atmospheric CO2 from a Schlenk line manifold. The reaction mixture was then cooled
to 0 oC and stirred for 10 min. nPrZnCl was added via syringe and the mixture was allowed to warm
to room temperature prior to vigorous stirring for 110 min. Over this time the solution turned from a
light brown to a darker brown. The reaction was quenched with HCl (1 M) at which point the
solution turned colourless and effervesced. The product was extracted with ethyl acetate and dried
with MgSO4. Removal of the solvent gave a crude mixture which was then analysed by GC. A typical
chromatogram of the products from this reaction is shown in Figure 4.5.
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Figure 4.5. A chromatogram of a standard carboxylation of nPrZnBr with [Ni(acac)2] and PCy3.
The main DCM solvent peak has a retention time of 1.54 min and residual amounts of other solvents
can be observed eluting around the same time (ethyl acetate and THF). The internal standard used,
which was isobutyric acid, was detected after 1.79 min and the product soon afterwards at 1.85 min.
There are no other major products that are eluted after this time except PCy3 and P(O)Cy3 at
approximately 23.5 min and 26.5 min, respectively, both identified from GCMS data.
Table 4.1. Catalyst screening of the carboxylation of nPrZnBr. (a Average of 2 runs, b 10 mol %).
# Catalyst (5 mol %)
Butyric acid
(GC yield)
1a [Ni(acac)2] 2 PCy3 0.3 %
2b [Ni(acac)2] 2 PCy3 1.4 %
3a [Pd(OAc)2] 2 PCy3 0.3 %
4a [Ni(acac)2] dppf 1.0 %
5a [Pd(OAc)2] dppf 0.0 %
6 [Pd(PtBu3)2] N/A 0.0 %
7 [Pd(OAc)2] 2 P(P
tBu3)2(biphen) 0.1 %
The results from the catalyst screenings carried out are shown in Table 4.1. Although a range of
catalyst systems were employed the overall yields were very low. [Ni(acac)2] performed slightly
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better than others and an improvement was found on increasing the catalyst loading from 5 mol %
to 10 mol %. However, these results indicated that there might be another reason why these
reactions were not proceeding as well as expected and further investigation was required.
4.3 Optimisation of the Solvent System
Kondo et al. have demonstrated the conversion of similar organic zinc halides carboxylic acids in
transition metal free conditions, except with longer reaction times of 24 h and at 50 oC.[8] Initial
screening indicated that DMF and DMSO were the superior solvents for these reactions potentially
due to favourable solvent effects and the solubility of CO2. Therefore, it was decided to observe the
effect of altering the solvent system.
Table 4.2. Effect of solvent on the carboxylation of nPrZnBr.
# Catalyst (5 mol %) Solvent
Butyric acid
(GC yield)
8 [Ni(acac)2] 2 PCy3 DMSO 0.0 %
9 [Ni(acac)2] 2 PCy3 DMF 0.0 %
The use of DMF or DMSO proved to have an adverse effect on the yield to the previous reactions (1-
7) carried out in THF, indicating that the solvent system may not be the limiting factor in this
reaction. They are both coordinating solvents which may have complexed the Ni and prevented the
catalytic reaction from being carried out.
4.4 Lithium Chloride as an Additive and Organozinchalide·LiCl Adducts
In the non-transition metal carboxylation previously developed by Kondo et al., LiCl was used as an
additive in the reactions.[8] Other work has used RZnI·LiCl type reagents developed by Knochel,[9]
which have improved the yield of carboxylic acid. Although the exact reason for this is unknown,[5] it
has been postulated that the LiCl could coordinate to zinc forming a monomeric species which is
more efficient at transmetallation. In a similar promoter effect, it has been suggested that LiCl
breaks up polymeric aggregates making a more reactive complex in Br/Mg exchange reactions.[10] A
study using anion-mode electrospray ionisation (ESI) mass spectrometry supports this view and has
detected the monomeric species, R-Zn-Hal·LiCl in the LiCl-mediated Zn insertion into organic
halides.[11] A pronounced increase in the amount of monomeric species have been observed when
organic iodides were used compared to chlorides, an apparent contradiction to Oshima and co-
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worker’s findings which suggest better carboxylation of LiCl adducts of organozinc chlorides due to
disaggregation.[5] It has also been speculated that LiCl activates the zinc dust in the synthesis of
RZnHal·LiCl by preventing deactivation of the metal surface by rapid desorbtion made possible by
the products’ increased solubility.[9]
In this work, the effect of adding LiCl separately and synthesising nPrZnBr·LiCl and PhZnI·LiCl was
investigated. The zinc powder was dried at 160 oC under vacuum and activated with
chlorotrimethylsilane and dibromoethane in THF. The suspension was stirred with dry LiCl and
bromopropane for 24 h before the concentration of the resultant solution was determined by
titration with iodine.[12] It was necessary to use these reagents within a few days as they degrade
with time.
Figure 4.6. Insertion of Zn into nPr-Br activated by LiCl
The yields from these runs show an improvement from the previous runs (runs 1-9). In run 10,
nPrZnBr in THF (0.5 M) was stirred with 1 equivalent of LiCl (dried at 160 oC under vacuum for 30
min) to form a solution after a few minutes. The nPrZnBr and LiCl mixture dissolved in THF was then
added to a Schlenk tube containing a solution of [Ni(acac)2] and PCy3 in THF under an atmosphere of
CO2. An average of 4.8 % of butyric acid was found by GC which represents a significant
improvement on runs 1-9. Furthermore, the use of the LiCl adduct, nPrZnBr·LiCl in run 11 resulted in
a further enhanced reaction to give 7.5% yield of butyric acid.
Table 4.3. Effect of LiCl on the carboxylation of nPrZnBr. (a average of 2 runs)
# Catalyst Zn reagent
Butyric acid
(GC yield)
10a [Ni(acac)2] 2 PCy3
nPrZnBr and LiCl 4.8%
11 [Ni(acac)2] 2 PCy3
nPrZnBr·LiCl 7.5%
It is thought that the LiCl has a role to play in preventing dimerisation and by breaking up the zinc
halides makes them more accessible for transmetallation as previously discussed. A possible
mechanism is shown in Figure 4.7.
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Figure 4.7. Possible disaggregation of nPrZnBr by LiCl.
4.5 Investigation into the Pressure and Application of CO2
To further increase the yield it was postulated that the method of application of the CO2 and
pressure could be vital to the reaction; without the initial oxidative addition step the reaction would
not proceed as expected. Previously reported carboxylations of this kind carried out by Dong et al.[7]
employed a balloon of CO2 applied through a suba seal to the reaction flask. So far the runs carried
out in this work utilised a CO2 manifold fitted with a drying tube attached to a bubbler; the reaction
flask was under a constant flow of CO2. It was decided that some reactions should be carried out
under balloon pressure to assess any disparity in yields between the two methods. The application
of this method with nPrZnBr and nPrZnBr·LiCl (Table 4.4, entries 12 and 13) shows a considerable
increase in GC yield of butyric acid compared to previous reactions under flow conditions (runs 1 and
11). This illustrates that the method of application of the CO2 is crucial in this reaction and that
under balloon pressure more CO2 is taken up by the catalyst and converted into butyric acid.
Table 4.4. Effect of balloon pressure on the carboxylation of nPrZnBr, using [Ni(acac)2] (5 mol %) and PCy3 (10
mol %) as the catalyst (a Average of 2 runs).
# Zn Reagent CO2
Butyric acid
(GC yield)
1a nPrZnBr Flow 0.3%
12a nPrZnBr Balloon 18.4%
11 nPrZnBr·LiCl Flow 7.5%
13 nPrZnBr·LiCl Balloon 14.3%
Only a single run was carried out using nPrZnBr·LiCl under balloon pressure (entry 13) which yielded
less butyric acid than the nPrZnBr without any LiCl (entry 12). More runs would be needed to prove
conclusively that this is the case as it contradicts previously observed results where the LiCl adducts
perform better.
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In a bid to achieve more significant yields for this reaction the organic fragment of the substrate was
changed to a phenyl group to synthesise benzoic acid which would be a desirable [11C]-labeled
fragment for use in PET chemistry. A series of reactions were carried out using commercially
available PhZnBr and PhZnI·LiCl synthesised using the Knochel method as before.[9]
Figure 4.8. Synthesis of PhZnI·LiCl
The zinc powder and lithium chloride were dried at 160 oC under vacuum and activated with
chlorotrimethylsilane and dibromoethane. Addition of dry THF gave a suspension which was then
stirred with iodobenzene and heated to 50 oC for 24 h (Figure 4.8). The concentration and yield (47
%) of the resultant solution was determined by titration with iodine.[12] It was necessary to use these
reagents within a few days as they degraded with time even when stored under nitrogen and at low
temperatures.
Figure 4.9. A chromatogram of a standard carboxylation of PhZnBr with [Ni(acac)2] and PCy3.
The internal standard used in these GC runs was heptanoic acid, which eluted after 4.7 min and the
product, benzoic acid, at 7.0 min. As observed with all of the runs carried out with
tricyclohexylphosphine, PCy3 and P(O)Cy3 eluted between 23-27 min and were identified by GCMS
data. The chromatogram (Figure 4.9) from the reactions involving the synthesis of benzoic acid
(entries 14-18) showed some homocoupling of the phenylzinc halide reagent at 14.5 min identified
as biphenyl from GCMS data. Initially, it is likely that [Ni(acac)2] is reduced by two equivalents of
phenylzinc halide which produces biphenyl and the active [Ni(PCy3)2] species. Since 0.05 mmol of
[Ni(acac)2] was used it could be expected that 7.71 mg of biphenyl would be observed if all of the
[Ni(acac)2] was reduced. If biphenyl was being produced from another route complete conversion of
PhZnBr would result in a yield of 0.5 mmol of biphenyl. Therefore, the maximum amount of biphenyl
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that should be observed due to the reduction of the catalyst is 10 % which could account for runs
15-18; however, there is a significant amount of homocoupling associated with run 14 which may
suggest that another mechanism is in place. It would seem that either the iodine or LiCl has
promoted this reaction as even without CO2 (run 17) the reaction still produces under 10 % of
biphenyl. It is possible that increased homocoupling of PhZnI·LiCl could arise if the Ni(0) is oxidized
back to Ni(II) by an oxidant before oxidative addition of CO2. There could be iodine left in the
PhZnI·LiCl solution that carries out this oxidation. This suggests that the insertion of CO2 is slow and
possibly rate determining.
Table 4.5. Effect of balloon pressure on the carboxylation of nPrZnBr and PhZnBr, using [Ni(acac)2] (5 mol %)
and PCy3 (10 mol %) as the catalyst (
a average of 2 runs).
#
Zn
Reagent
CO2
Benzoic Acid
(GC Yield)
Biphenyl
(GC Yield)
14a PhZnI·LiCl Flow 1.8 % 52.5%
15a PhZnBr Balloon 2.5 % 11.2%
16a PhZnBr 0.25 bar 0.0 % 3.9%
17 PhZnBr No CO2 0.0 % 7.3%
18 PhZnBr Bubbling at -78oC for 10 min 4.3 % 6.2%
19 nPrZnBr Bubbling at -78oC for 10 min 14.6 % N/A
The GC yields of benzoic acid achieved show that bubbling the CO2 through the solution of reagents
and catalyst in THF at low temperatures and applying balloon pressure rather than flow of CO2 (even
when LiCl adduct is used) increases the yield (Table 4.5 entry 18, 15 and 14). However, the yields are
still low, which indicates that changing the R group used does not positively affect the reaction in
this instance. In the case of nPrZnBr, entry 19, moderate yields were observed when bubbling CO2 at
low temperature as opposed to balloon pressure reactions and flow (entries 12 and 1).
Due to the low yielding nature of the runs being carried out it was decided to repeat the work of
Dong et al.,[7] which found NMR yields of > 95 % and an isolated yield of 90 % of benzoic acid for the
reaction shown in Figure 4.10. A pre-dried Schlenk tube was charged with [Pd(OAc)2] and PCy3 and 2
mL of dry THF under N2. The solution was cooled to 0
oC and opened to CO2 (balloon) for 1h. The
reaction was then sealed off and stirred at room temperature for a further 5 h.
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Figure 4.10. Carboxylation of PhZnBr for the synthesis of benzoic acid.
Table 4.6. Carboxylation of PhZnBr for the synthesis of benzoic acid under flow and balloon pressure of CO2,
using [Pd(OAc)2] and PCy3 as the catalyst.
# Catalyst (1 mol %) Zn Reagent CO2
Benzoic Acid
(GC Yield)
Biphenyl
(GC Yield)
20 [Pd(OAc)2] PCy3 PhZnBr Flow 0.0% 10.1%
21 [Pd(OAc)2] PCy3 PhZnBr Balloon 18.4% 8.4%
The results of these experiments differed significantly from those reported in the literature giving a
modest yield of benzoic acid under balloon pressure conditions (Table 4.6, entry 21). Benzoic acid
was produced in 18.4 % yield in run 21, the conditions of which were copied exactly from the
literature.[7] The reason for the disparity in performance could be due to a different experimental
set-up or poor catalyst quality. Furthermore, exact pressures cannot be measured when using a
balloon of CO2 and it is possible that higher pressures were achieved in literature methods. It must
be noted, however, that considerably more benzoic acid was formed than when [Ni(acac)2] was
employed (Table 4.5, entry 15) which could be attributed to the longer reaction time or the use of
[Pd(OAc)2].
4.6 Conclusions
The carboxylation of alkyl and aryl zinc halides using Ni(II) and Pd(II) catalysts was carried out.
Optimisation was attempted by investigation of the catalyst system, solvent system, zinc reagent
and pressure and method of application of CO2. It was found that the addition of lithium chloride
either direct or in a pre-formed adduct aids the reaction. It has also been shown through this work
that the method of application of CO2 to the reaction is a crucial factor in improving the yields with
the best yields being obtained under balloon pressure and when bubbling CO2 through the solution
(14-18 %). This finding potentially indicates that this reaction is pressure dependant. These reactions
would need to be carried out at elevated pressures to assess the extent of the pressure dependency.
Other future work could involve investigation of these reactions with longer reaction times (16-24 h)
to observe if higher yields are obtainable over a greater timeframe.
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5 Titanium and Zirconium Imido Complexes: Synthesis and
Reactivity
5.1 Introduction and Aims
The basis of this work stems from the desire to use [11C]CO2, the primary synthon in PET, for
radiolabelling functional groups commonly found in biologically active compounds and drug
molecules. Grignard reagents are often used to manipulate [11C]CO2 for radiolabelling. However,
there are problems with contamination by atmospheric 12CO2, which reduces the specific activity of
the radiolabelled product. A particularly elegant direct incorporation of [11C]CO2 without the use of
Grignard reagents is described below and is of interest as it lends itself to an analogy which may be
potentially useful in PET radiolabelling and is investigated herein.
The one pot synthesis of [11C]urea derivatives from triphenylphosphinimines (Figure 5.1 (I)), already
discussed in the introduction, bears some resemblance to the Wittig reaction (Figure 5.1 (II)) which is
used to synthesise alkenes from aldehydes and ketones.[1] This method was shown to give good
radiochemical yields of a series of asymmetric aryl and alkyl [11C]ureas, one of the few examples of
[11C]radiolabelled asymmetric ureas in the literature.
Figure 5.1 [11C]urea synthesis via triphenylphosphinimines[1] (I) and Wittig reaction (II).[2]
The two reactions are both [2+2] cycloaddition reactions which undergo the same mechanism and
are driven by the oxophilicity of phosphorus. Tebbes reagent, (Cp2Ti(µ-Cl)(µ-Me)AlMe2), can
methylenate a carbonyl group in a similar manner to the Wittig reaction. It acts as a masked Schrock
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carbene and the active form of the reagent is formed by addition of DMAP (Figure 5.2) which then
reacts with a carbonyl group in a cycloaddition reaction. The reaction is driven by the affinity of
titanium for oxygen and the resultant titanium oxo product. The reaction using the Tebbe reagent is
more efficient than the Wittig reaction although only methylation is possible. There are other
drawbacks, such as air and moisture sensitivity due to the larger oxophilicity of titanium compared
to phosphorus.
Figure 5.2 Activation of Tebbes’ reagent.
The work proposed here will correlate this analogy; using a titanium imide complex instead of
triphenylphosphinimine. Early transition metal imido complexes have shown reactivity towards
carbon dioxide forming four-membered metallocycle intermediates quickly and in some cases
undergoing retrocycloaddition eliminating an isocyanate derivative.[3] The reaction is driven towards
the formation of the oxo-bridged titanium dimer because of the oxophilicity of titanium.
Figure 5.3 Proposed scheme of 11CO incorporation into [11C]-tbutylisocyanate.
It is anticipated that the electronics and sterics of the ancillary ligands and the substituent on the
imido group will play a large part in determining the stability of the intermediate and therefore the
mechanism for such a reaction and rate of retrocycloaddition. Variation of the ancillary group is of
interest to optimise this reaction and to expand the research. The system is not catalytic, but in PET
the amount of [11C]CO2 compared to reagents is in large excess, so regeneration of the titanium
reagent will not be necessary.
Syntheses of titanium imide species with a wide variety of ancillary ligands such as classic
cyclopentadienyl ligands,[4] amidinates, bi-and tri-dentate amines, tris(pyrazolyl)hydroborate
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ligands,[5] β-diketiminate ligands,[6] and N-heterocyclic carbenes[7] have been studied. The work of
Mountford et al. includes the extensive research into synthesising imide species and analysing their
reactivity with unsaturated substrates such as CO2 in cycloaddition type reactions.
[3b, c, 8]
In this work, therefore, titanium imide structures with cyclopentadienyl and amidinate ligands were
initially constructed from Mountford’s precursor [Ti(NtBu)py3Cl2] and metathesis reactions with
sodium cyclopentadienyl and lithiated amidinates. These complexes were chosen to be investigated
because the carbamato intermediate of a cp-amidinate titanium imide complex has previously been
identified from 1H NMR after reaction with CO2 and shown to extrude the isocyanate product after
only 12 h.[3c]
5.2 Synthesis of Titanium Imido Compounds
The precursor [Ti(NtBu)py3Cl2] was synthesised and stored in a nitrogen glove box. A series of
reactions were attempted to complex the starting material (5.1) with ancillary ligands. Reagents
such as (tetramethyl)cyclopentadienyl lithium (5.2), cyclopentadienyl sodium (5.3), lithium (N,N’-
diisopropyl)butamidinate (5.4, 5.5., 5.6), N, N’-bis(2,6-isopropylphenyl)-4,5-dihydroimidazole (5.7)
and (pentamethyl)cyclopentadienyl lithium (5.8) were reacted with 5.1 with varying success.
Figure 5.4 Schematic representation of reactions investigated for the synthesis of titanium imido
complexes. Reactions that were carried out but for which the product was not obtained are shown
with dashed reaction arrows
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5.2.1 Synthesis of [Ti(NtBu)(py)3Cl2] (5.1)[9]
The starting material (5.1) for all the titanium complexes synthesised contains the imido
functionality. Including the imide in the starting material rather than adding the imido function later
on in the synthesis has shown to work well. 5.1 is very facile to synthesise in almost stoichiometric
yield and on a multigram scale without the need for further purification.[5, 8] tert-Butylamine and
pyridine were heated to reflux over calcium hydride for several hours before collection of the
distillate.
Figure 5.5 Synthesis of 5.1.[9]
tert-Butylamine was added slowly to a cooled solution of titanium chloride. Some white fumes were
produced and a precipitate formed almost immediately. Pyridine was added after 2 h of stirring of
the mixture and then followed by stirring for another 3 h. The product was extracted from the
precipitate with DCM and a red powder was isolated without further purification in 93 % yield and
stored in a N2 glove box.
5.2.2 Characterisation of 5.1
The red powder (5.1) was characterised by 1H and 13C{1H} NMR spectroscopy. It was noted that there
were some differences to the literature and a 1H COSY NMR spectrum was also obtained to fully
characterise which pyridine peaks corresponded to the two cis pyridines and the pyridine trans to
the imido function.[10]
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Figure 5.6 1H NMR spectrum of 5.1 run in C6D6 ON 1 400 MHz spectrometer.
The tbutyl group protons can all be seen clearly as one resonance at 1.15 ppm. The other protons in
this compound arise from the pyridine peaks. The protons on the pyridine trans to the imido group
(green) are in a different environment to the protons of the two pyridines cis to the imido group
(blue). The literature 1H NMR spectrum of this compound was run in CDCl3 rather than C6D6 used
here which may have affected the order of pyridine peaks, however, the order of the six multiplet
peaks are reported as alternate cis and then trans peaks from 10 ppm towards 0 ppm. A 1H COSY
NMR experiment was carried out to confirm the connectivity of the protons. HB, HD and HG were
shown to be on the same pyridine moiety and HC, HE and HF were on the other. The integration of
the peaks suggests that these groups of protons are cis and trans to the imido group respectively.
The poorly resolved coupling of the trans protons compared to the distinct coupling of the cis
supports this correlation.
The 13C {1H} NMR spectrum gives eight carbon environments as expected. Two from the tbutyl group
and six further downfield corresponding to the cis and trans pyridine groups. Elemental analysis and
IR data have already been collected for this compound.[10]
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5.2.3 Synthesis of [Ti(NtBu)(C5(CH3)4H)(py)Cl] (5.2)
nButyl lithium and (tetramethyl)cyclopentadiene were combined in a pre-dried Schlenk tube in a
bath of acetone and solid carbon dioxide and added to a solution of 5.1 in THF via cannula and
stirred overnight under inert conditions. After work up, a small amount of red solid was obtained in
15 % yield from which crystals suitable for X-ray diffraction were grown in pentane at -30 oC.
5.2.4 Characterisation of 5.2
The 1H NMR spectrum shows a singlet for the tbutyl group at 1.28 ppm shifted downfield slightly
from the starting material. There are also four broad singlets corresponding to the protons of the
methyl groups on the (tetramethyl)cyclopentadienyl ligand from 1.43 - 2.26 ppm. These have also
been shifted from the free ligand. A broad singlet is observed at 6.63 ppm corresponding to the
proton attached to the cyclopentadienyl ring. Also, significantly only one set of proton resonances
that correspond to a pyridine group is observed for this compound.
The 13C{1H} NMR spectrum does not show all the carbon environments expected however, due to
the small amount of compound available only one fairly weak sample was run. Mass spectrometry
detected the molecular ion at 705 amu.
The X-ray diffraction data reveals an approximate tetrahedral structure around the titanium centre
with some distortion due to the electron density around the Ti(1A)-N(1A) bond. The shorter length
of this bond suggests a double bond is present as expected and the angle (171 o). All other bonds
and angles are as expected.
Figure 5.7 X-ray crystal structure of
Table 5.1
Ti(1A)-N(1A)
Ti(1A)-N(6A)
Ti(1A)-C(12A)
Ti(1A)-Cl(1A)
5.2.5 Synthesis of [Ti(NtBu)(C
Complex 5.3 was synthesised following the literature preparation, however only a very small amount
(17 % yield) of impure product was isolated as a brown powder.
was added to a solution of 5.1 in
majority of peaks expected are present. There is a large singlet at 0.99 ppm corresponding to the
tbutyl group protons and the cyclopentadienyl protons come at 6.41 ppm.
remained in the product and the integratio
completely accurate (protons on the cyclopentadienyl ring), it was decided to react
5.4.
5.2.6 Attempted Synthesis of [Ti(N
Attempts to form the amidinate
solubility of the product and impurities
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Ti(NtBu)(C5Me4H)(py)Cl 5.2 with selected bond angles and lengths.
Selected bond lengths (Å) and angles (°) for 5.2.
1.7107(18) N(1A)-Ti(1A)-N(6A) 98.05(8)
2.1842(17) N(1A)-Ti(1A)-Cl(1A) 106.34(7)
2.330(2) N(6A)-Ti(1A)-Cl(1A) 97.44(5)
2.3552(6) C(2A)-N(1A)-Ti(1A) 171.24(18)
5H5)(py)Cl] (5.3)
[4] Sodium cyclopentadiene in THF
THF and stirred for 3 h. The 1H NMR spectrum of
Although some impurities
n of some of the peaks in the 1H NMR spectrum were not
tBu)(C5H5)((iPr NC(nBu)NiPr)] (5.4)
-containing complex 5.4 from 5.3 were problematic due to high
present which could not be removed by rec
141
5.3 shows that the
5.3 on to form
rystallisation. The
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lithiated amidinate was formed from addition of nbutyl lithium to a solution of
(diisopropyl)carbodiimine which was then added via cannula to a solution of 5.3 in hexanes. The
crude product was an oil, which dissolved in cold pentane after sustained storage at -30 oC and no
solid or crystals were obtained. Crude samples analysed by 1H NMR suggest that the desired product
may have been formed however purification could not be achieved. Several different peaks are
observed between 0.80 – 1.84 ppm including some doublets and four septets between 3.01 – 4.30
ppm suggesting formation of some side products. This complex mixture of products could not be
separated out via recrystallisation and the severe air and moisture sensitivity of the products meant
that other methods such as flash column chromatography were not possible.
5.2.7 Attempted Synthesis of [Ti(NtBu)(iPrNC(nBu)NiPr)2(py)] (5.5) and
[Ti(NtBu)(iPrNC(tBu)NiPr)2(py)] (5.6)
Synthesis of amidinate titanium complexes 5.5 and 5.6 was attempted by forming the lithiated
amidinate from either nbutyl lithium or tbutyl lithium and (diisopropyl)carbodiimide. In both cases a
multitude of products were formed illustrated by the large number of overlapping peaks between
~1.0 – 2.0 ppm as was seen in 5.4. Once again purification was the issue, with no solid being
obtained for this product and recrystallisation not being successfully achieved. Complexes 5.5 and
5.6 were dissolved in toluene, layered with pentane and kept at -30 oC; but again yielded no solid or
crystals.
5.2.8 Attempted Synthesis of [Ti(NtBu)(SIPr)(C5H4N)Cl] (5.7)
In an effort to produce a pure compound in good yield, a N-heterocyclic carbene was chosen as a
potential ancillary ligand. N, N’-bis(2,6-isopropylphenyl)-4,5-dihydroimidazolinium chloride (SIPr.HCl)
was deprotonated with sodium hydride and isolated before complexation with the titanium starting
material 5.1. On isolation, the 1H NMR spectrum of 5.7 indicated that some side products had been
formed perhaps through the deprotonation of the saturated backbone. The crude product was
collected as a yellow powder, but its lack of solubility in most solvents (such as, hexane, toluene and
diethyl ether and DCM) suggested that the product had been hydrolysed to a titanium oxide
product. Therefore the 1H NMR spectrum only shows free pyridine because the yellow powder
would not dissolve. Recrystallisation was attempted from layering of hot DCM and hexane but no
crystals could be obtained.
5.2.9 Attempted Synthesis of [Ti(NtBu)(Cp*)2(C5H4N)] (5.8)
Complex 5.1 was reacted with (i) 2.25 and (ii) 3 equivalents of Cp*Li ((pentamethyl)cyclopentadiene
and nbutyl lithium) in THF at room temperature overnight in two separate reactions. Work up once
again resulted in a dark brown oil, which was difficult to purify. Some light yellow/brown solid was
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collected after trituration with cold hexane, although a very minimal amount. As previously
encountered the product can be seen in the 1H NMR of the crude material however, purification is
very difficult due to its air sensitivity and solubility in hexane.
The solid obtained seems to be a mixture of two products. Two sets of pyridine peaks are observed
in the aromatic region of the 1H NMR spectrum and then 4 singlets in the methyl region; 2 around
2.0 ppm and 2 around 1.4 ppm. Unfortunately, the integration of these peaks does not aid the
determination of which products have been formed, however, it can be postulated that any of the
compounds in Figure 5.8 may have been formed. The same pattern is also observed when 3
equivalents of Cp*Li are employed which may be due to not enough Cp*Li being formed, potentially
due to degradation of nbutyl lithium. A steric effect may be hindering the coordination of 2 Cp*
ligands around the titanium so maybe heating is necessary. Heating these compounds must be done
carefully however as they can degrade and dimerise. Unfortunately, there was not enough material
to obtain a mass spectrum to help confirm the potential structures.
Figure 5.8 Potential products from the attempted synthesis of 5.8.
5.3 Reactivity Towards Carbon Dioxide
Testing the reactivity of the titanium imido species synthesised is crucial to understand the
requirements of the ancillary ligand set and the viability of using this method for radiolabelling in
PET (high efficiency is needed due to the low concentration of 11CO2).
Preliminary analysis was carried out from a 1H NMR spectroscopy study. Carbon dioxide was bubbled
through a Young’s NMR tube containing a solution of either 5.1 or 5.2 dissolved in C6D6, which was
placed in a large Schlenk tube under an atmosphere of N2.
1H NMR spectra were analysed at four
stages of the experiment: i) starting solution, ii) after CO2 was bubbled through for 10 min, iii) after
heating for 10 min at 45 oC, iv) after 24 h at room temperature. The desired product, tbutyl
isocyanate gives rise to a singlet at 0.94 ppm in C6D6 corresponding to the
tbutyl group. The tbutyl
region from 0.5 ppm and 1.5 ppm was analysed to observe any changes during the reaction. The
phenyl region (6-8 ppm) of the 1H NMR spectrum was complex with several overlaying sets of peaks.
Therefore, the tbutyl peak was used as a handle in determining the products from this reaction.
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5.1
i)
ii)
iii)
iv)
Figure 5.9 The tbutyl region of four 1H NMR spectra of 5.1 run on a 400 MHz spectrometer. i) Sample made up
in C6D6 (approx. 10 mg). ii) CO2 bubbled through solution under N2 for 10 min. iii) Heated to 45
oC for 10 min.
iv) Stored at room temperature for 24 h.
NtBu
Ti
py
py Cl
pyCl
Chapter 5 – Titanium Imido Complexes
145
A single resonance can be observed in Figure 5.9 (i) for the tbutyl protons of the starting material at
1.17 ppm. The intermediate carbamato complex expected to form before the retrocycloaddition
step to produce the isocyanate, would give a more deshielded environment for the tbutyl group due
to the electronegativity of the oxygen atoms and the resonance of the carbonate structure.
Furthermore, non-coordinated tbutyl containing compounds may be more shielded by additional
electron density from the nitrogen atom. The tbutyl protons of tbutylisocyanate may be expected at
0.94 ppm in C6D6.
Four resonances (0.85, 0.88, 1.11, 1.13 ppm) appear after carbon dioxide has been bubbled through
the solution for 10 min which suggests that several complexes are forming and the reaction is not as
simple as first anticipated. The four resonances are unchanged after heating. Unfortunately, these
signals could not be fully attributed, but it can be postulated that one of the peaks at 0.88 ppm or
0.85 ppm could be free tbutylisocyanate and that the two peaks at 1.11 and 1.13 ppm may be free
compounds formed from reaction with tbutylisocyanate.
Additionally, the imido tbutyl protons of the starting material have shifted slightly downfield to 1.21
ppm, the significance of this is unclear. The carbamato complex may have formed, although
previously, downfield shifts of approximately 0.3 ppm have been observed.[3b, c, 11] A shift of 0.04
ppm is only minor and not enough evidence to postulate that the carbamato complex is present in
solution. After 24 h all of the peaks have reduced in relative size to the starting material (1.21 ppm)
and a new peak at 1.18 ppm has appeared. This suggests that some of the compounds previously
observed have been converted to the new compound with the tbutyl peak at 1.18 ppm.
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5.2
i)
ii)
iii)
iv)
Figure 5.10 The tbutyl region of four 1H NMR spectra of 5.2 run on a 400 MHz spectrometer. i) Sample made up
in C6D6 (approx. 10 mg). ii) CO2 bubbled through solution under N2 for 10 min. iii) Heated to 45
oC for 10 min.
iv) Left at room temperature for 24 h.
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The reaction of complex 5.2 with carbon dioxide gave a pronounced colour change from orange to
yellow over the initial 10 min, which indicated in the tbutyl region by the shift in peak at 1.27 ppm in
i) to 1.20 ppm in ii) and the appearance of smaller peaks at 1.12, 1.09, 1.07 and 0.90 ppm. Over the
four stages of the experiment a significant reduction in this peak at 1.20 ppm can be observed and a
steady increase in the peaks around 1.12 ppm. The peak at 0.90 ppm could indicate the presence of
tbutylisocyanate in solution as it is in the right region. This peak slowly increases as the peak at 1.20
ppm decreases. After 24 h the singlet at 1.13 ppm is predominant and 1.20 ppm is only just
observed. It is tentaticely proposed that the resonance at 1.20 ppm in the 1H NMR spectrum
represents the protons of the tbutyl group of a carbamato titanium complex, which is extruding
tbutylisocyanate which then, over a period of 24 h, is converted into another unidentified product.
The exact nature of these products cannot be identified due to the very complicated aromatic
region. This region of all these spectra is more complex and will require further analysis to fully
comprehend. Identification of all the products being formed is important to fully understand the
reaction taking place and could be carried out with GCMS data.
5.4 Synthesis of Zirconium Imido Complexes
A significant body of work has been carried out by Bergman et al. in the development of zirconium
imido compounds and their reactivity with unsaturated organic molecules and in C-H activation.[12] A
zirconocene backbone was used in most cases with an imido function and THF. The terminal imido is
synthesised from the thermolysis of the corresponding complex with a secondary amide and methyl
group attached to the titanium centre, which is driven by the production of methane (Figure 5.11).
Figure 5.11 Synthesis of [Cp2Zr(N
tBu)THF].[12a]
A drawback of this synthesis is that a bulky R group attached to the nitrogen (either tbutyl or a di-
ortho-substituted aryl function) is necessary to prevent dimerisation on thermolysis. Each of these
steps shown in Figure 5.11 however are high yielding (70-90 %) and relatively facile.
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Cycloaddition reactions were investigated with a variety of unsaturated hydrocarbons such as
alkynes, alkenes, ketenimines, carbodiimides and azides to form intermediate metallocycles, which
in the case of alkynes could be reacted on with an amine to complete the catalytic hydroamination
cycle. Furthermore, a study into their activity with carbonyl compounds, benzophenone, acetone,
benzylaldehyde and isobutyraldehyde, was carried out to synthesise imides, carbodiimides and
ketenes with oligomeric zirconium bridging oxo products being formed in the process, some of
which were characterised.[13]
It is expected that [Cp2Zr(N
tBu)THF] will react with carbon dioxide in a similar manner to these
carbonyl compounds which react cleanly and efficiently due to the thermodynamic stability of the
zirconium oxo side products. It was also found that reducing the steric bulk of the groups attached to
the carbonyl compounds speeded up the reaction, which may indicate that CO2 will react well.
Further work in this field is limited as the zirconium imido complex is being used as a reagent and
cannot be recycled from the oxo product. However, in a radiolabelling reaction this will not be an
issue due to the very small amounts of compound necessary for synthesis. It should also be noted
that isocyanate has been shown to react with the zirconium starting material to make carbodiimides;
therefore it will be necessary to immediately react on the isocyanate formed to a urea or carbamate.
5.4.1 Synthesis of [Cp2Zr(NtBu)(thf)]
[Cp2ZrMeCl] was synthesised from the comproportionation of [Cp2ZrCl2] and [Cp2ZrMe2] in 44 %
yield. The two reagents were suspended in toluene and DCM and heated to reflux for 30 h. The
resultant crude product formed large light yellow crystalline plates after recrystallisation from
layering hexane onto a solution of the crude product in toluene. It was found that after
recrystallisation, the product can be unstable and disproportionate to the starting materials if stored
in solution for over a week. A shift of the resonance representing the methyl protons in the 1H NMR
spectrum from -0.12 ppm in [Cp2ZrMe2] to 0.56 ppm in [Cp2ZrMeCl] confirmed the product had
formed and the remainder of the spectrum was in agreement with the literature.[14]
The next two steps shown in Figure 5.11 involved the addition of lithiated tbutylamine at -78 oC and
stirring overnight at room temperature followed by thermolysis from heating to 85 oC under vacuum
for 3.5 days. This method was attempted three times and the intermediate was isolated on one
occasion. The 1H NMR spectrum of the intermediate complex, [Cp2Zr(NH
tBu)Me], indicated that the
intermediate had successfully formed although there was still some unreacted starting material left
(Figure 5.12).
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Figure 5.12 1H NMR spectrum of the crude reaction mixture containing [Cp2Zr(NH
tBu)Me] carried out in C6D6,
on a 400 MHz spectrometer.
The methyl, tbutyl and cyclopentadienyl protons were observed at 0.14 ppm, 1.11 ppm and 5.70
ppm respectively. Importantly the NH proton was observed at 5.92 ppm indicating the successful
synthesis of the intermediate. The heating of this product to release methane and the imido
zirconcene product desired was carried out; however the crude product and the dark brown powder
afforded after attempted recrystallisation gave a very complicated 1H NMR spectrum. A range of
products had been formed which could not be purified further in order to identify the individual
components. It might be expected that due to overheating other products such as dimers and other
oligomers with bridging imide ligands may have formed. Without the desired product no testing with
CO2 could be performed.
5.5 Conclusions
The synthesis of a range of titanium imido compounds was attempted with varying success. It was
hoped that these compounds could be used to form [11C]isocyanates in radiolabelling experiments
using [11C]CO2 with the potential to then be transformed into a range of other organic fragments.
The starting material 5.1 was used in all the syntheses either by the exchange of the pyridine groups
or using lithiated reagents to react with the chloride group. Complex 5.1 was easily isolated in good
Chapter 5 – Titanium Imido Complexes
150
yield. The molecular structure was obtained for 5.2, and complex 5.3 was potentially synthesised but
in low yield. In the cases of 5.4 – 5.8 purification was extremely troublesome with various side
products being formed.
NMR scale experiments were carried out by bubbling CO2 through solutions of 5.1 and 5.2. NMR
spectra were obtainedimmediately afterwards, after heating to 45 oC and after storing at room
temperature for 24 h. Unfortunately, these products could not be characterised, however, there is
some evidence that tbutylisocyanate may have formed. Further tests such as this with additional
characterisation techniques such as IR and GCMS need to be carried out in the future. This may
require revisiting the synthetic methodology attempted here to obtain a simple titanium imide
structure which can be prepared on a large scale to perform a variety of tests with. Potential new
avenues of synthesis are outlined in Chapter 6 - Conclusions and Future Work. The attempted
production of [Cp2Zr(N
tBu)THF] was unsuccessful in the last stage of the synthesis, therefore no
testing could be carried out with CO2.
The initial aim of this body of work was to test the theory that titanium imide complexes could be
use to synthesise isocyanates for potential use in PET. This was carried out in part although more
work is needed to draw further conclusions on the effectiveness and mechanism for such a reaction.
The stumbling block was in the synthesis of good quantities and qualities of these complexes that
was required for a series of tests to be completed. A fair amount of product was required as the
titanium complexes act as reagents in a stoichiometric reaction with CO2. This work highlights issues
with the synthesis of these compounds which perhaps means that they are not suitable for use in
PET radiochemistry.
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6 Conclusions and Future work
6.1 Conclusions
In a bid to develop new methodologies for the radiolabelling of target compounds for PET imaging
with [11C]CO and [11C]CO2, a range of research areas have been investigated with the PET process in
mind. Transition metal-mediated/-catalysed carbonylations has been one of the main foci of this
work as well as carboxylation reactions and reactivity of group IV metal imide complexes.
A selection of NHC ligands have been successfully applied to the palladium-catalysed carbonylation
of benzylamine and iodobenzene with [PdCl2], [Pd(OAc)2] and [Pd2(dba)3]. Initial difficulties in the set
up were overcome and 10 min and 2 h reactions were carried out firstly with Pd/phosphine catalysts
and then with the Pd/NHC systems. It was shown that the majority of the reactions reached
between 55-60 % GC yield after 2 h, but the GC yield of amide after 10 min varied a lot more
between catalysts and between runs. This effect may be due to the rate of active catalyst formation
(although the Pd(0) pre-catalyst did not always outperform the others) or the rate of reaction at that
early stage in the reaction and minor differences in the sampling times which could lead to errors.
Most importantly, it was illustrated that the first 10 min of a reaction, which are exploited in PET, are
very important and that small changes in the set up and catalyst system used may have a larger
effect than in a reaction conducted over a longer timeframe. The 10 min reactions gave yields of 8-
21 % of amide with the NHC ligands, compared to 9-10 % with the palladium alone, this showed that
the ligand has an impact in this induction period.
It was anticipated that a study of the properties of the imidazolium salt would provide differentials
between NHCs used. The NHCs used in these reactions were chosen to observe the following factors;
the saturation on the backbone of the imidazole ring, the R group attached to the nitrogens, the
palladium source and the stoichiometry of the imidazolium salt/palladium. However, there was little
disparity between NHCs when studying these factors in this model reaction. However, it was
observed that the pre-complexed NHC palladium catalyst gave a very poor yield (4.1 %) of amide
after 10 min compared to the other systems tested, illustrating an advantage in using the palladium
and imidazolium salt in situ. One Pd-NHC system was tested in a microfluidic device and average
yields of 7 %, 19 % and 78 % were obtained at 100, 120 and 150 oC respectively with only 2 minutes
residency time on the chip.
Moderate to good radiochemical yields of 1-55 % were achieved in the radiolabelling of [11C]N-
benzylbenzamide. [PdCl2] was shown to be a poor palladium precursor at 100
oC, due to N,N’-
dibenzylurea principally being formed. The yield increased moderately when the temperature was
raised to 120 oC. It was the combination of [Pd2(dba)3] and IMes.HCl that gave the best yield of
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amide at 100 and 120 oC, 54 % and 55 % respectively. The selectivity for the amide product was
shown to be excellent (99 %) when using this system and slightly better than when [Pd2(dba)3]/dppp
was employed (87 %). Overall it has been shown that palladium-NHC systems are efficient catalysts
in aminocarbonylation reactions and can be applied in PET radiolabelling to good effect.
A series of diphosphine-, P,S- and P,O-ligated palladium(II) complexes were prepared in order to
study the ligand effects in a model aminocarbonylation reaction. The P,S and P,O ligands prepared
and used where chosen so that ligands with a similar backbone could be compared and effect of the
hybrid structure of the chelating ligands could be observed. Yields of N-benzylbenzamide ranging
from 67-86 % were achieved from reaction of iodobenzene with excess benzylamine after 3 h in
toluene at 100 oC. The chelating diphosphine ligands displayed a possible relationship between bite
angle and productivity; a larger bite angle gave higher yields. The same relationship was not
observed, however, with the other hybrid ligands. It was also interesting to note that increased
flexibility in the alkyl backbone improved yields when the diphosphine ligand was used but the
opposite was observed in P,S ligands. It must be noted however, that steric properties around the
metal centre cannot be counted out as a contributing factor to this effect. Overall it can be
concluded that the P,S ligands did not perform as well as the diphosphine and P,O ligands.
Particularly, of note was the P,O dimer, 3.6, which gave a yield of 82 % N-benzylbenzamine.
The carboxylation of alkyl and aryl zinc halides using nickel(II) and palladium(II) pre-catalysts was
carried in order to develop a new methodology that could directly use the primary synthon from the
cyclotron, [11C]CO2. It was envisaged that this method could synthesise alkyl and aryl [
11C]carboxylic
acids under mild conditions which occur in important molecules for PET imaging and can act as
intermediates to other functionalities. nPropyl and phenyl zinc bromide solutions were combined
with either a nickel/phosphine or palladium/phosphine pre-catalyst and stirred under an
atmosphere of CO2 for 2 h. Altering the catalyst and solvent system had no effect on the poor yields
butyric acid (0-1 %) obtained. It was observed however, that addition of lithium chloride or use of
nPrZnBr·LiCl promoted the reaction with average yields of 4.8 % and 7.5 % obtained using Ni(acac)2
and PCy3 respectively. Further optimisation was achieved from modifying the application of the CO2
from flow to balloon conditions. Yields of butyric acid were doubled from 7.5 % to 14.3 % when a
balloon of CO2 was employed and when
nPrZnBr·LiCl was used as the substrate. Bubbling CO2
through the solution was also shown to improve the yield of butyric acid. The reactions with nPrZnBr
under flow conditions of CO2, bubbling CO2 through the solution and application of a balloon of CO2
gave yields of 0.3 %, 14.6 % and 18.4 % respectively. These yields are only moderate and do not
reflect previous work carried out in the literature.[1] It has been shown that lithium chloride works
well as an additive in this reaction, possibly due to the breakdown of halide bridged dimers in
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solution, as monomers are more effective in the transmetallation step. It is probable to conclude
that this reaction is pressure dependant; however additional data would need to be collected to
quantify this.
The starting material, [Ti(NtBu)py3Cl2] (5.1), was used to synthesise other titanium imide complexes
from transmetallation reactions with lithiated ligands. Modest yields were obtained of 5.2 and 5.3
and other complexes (5.4-5.8) were suspected to have formed but purification was difficult due to
high solubility in non-polar solvents. Complexes 5.1 and 5.2 underwent 1H NMR experiments with
CO2 to observe any changes to the environment around the
tbutyl protons of the imide group. The
outcome was more complex than expected and requires future work to elucidate the mechanism
and characterise the individual products. In theory, this method with either titanium or zirconium
could be very effective in radiolabelling for PET, however, the work carried out here shows that the
synthesis of imido-containing group IV compounds is not trivial. Such a difficult synthesis may not be
appealing to radiochemists wishing to carry out many radiolabelling reactions with stable
compounds which are commercially available where possible. Academically it still appeals as an
interesting use of imide species in organic synthesis and in the activation of CO2. However, the
necessity to recycle the catalyst may be the stumbling block in preparing a catalytic system due to
the high stability of Ti-O and Zr-O bonds. This where other transition metal imido compounds, that
alternate between the imido and oxo product, may be of better use.
6.2 Future Work
All the work carried out in this thesis can be expanded to open new avenues of research, or re-
modeled to provide more effective and efficient systems and improved results. Firstly, the
palladium-catalysed reactions carried out using NHCs as ligands were only employed on a model
reaction and could be expanded to synthesise a range of amides including biologically-active target
molecules as previously investigated in the literature.[2] Furthermore, other [11C]radiolabelling
processes involving transition metals could be used with NHCs. One reaction that particularly stands
out is the radiolabelling of [11C]ureas, [11C]carbamates, [11C]malonates and [11C]hydroxyureas
through a rhodium-catalysed carbonylation reaction with organyl azides and amines/alcohols.[3]
These reactions were carried out with [RhCl(COD)2] and dppe forming the active catalyst in situ, and
due to the well known chemistry of NHCs and rhodium there would be scope to test a range of
rhodium reagents in this reaction, which has already shown to be viable for PET. Lastly, it may also
be of interest to look at this reaction with longer reaction times in a study less focused on
[11C]radiolabelling goals. Although the capacity for NHCs to be used as ligands in carbonylation
reactions is assumed to be poor due to acylation of the imidazole ring, these results have shown that
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they perform as well as phosphines under mild conditions and short reaction times. An in depth
study may be able to ascertain the true potential of these ligands in ‘Heck’ carbonylation reactions
for the synthesis of amides and esters which has not been carried out to date.
The hemilabile palladium complexes were not tested under PET conditions. This work would need to
be carried out to validate their use in [11C]radiolabelling and the results of this study suggests that
future work should be focused on the study of P,O ligands in the carbonylation of amines. As
mentioned above, the synthesis of [11C]ureas from rhodium complexes could be of interest. This is
especially the case due to the fair amount of research into the rhodium-catalysed carbonylation of
methanol using P,S and P,O ligands now known.[4]
The most important future work necessary to support the work already carried out with aryl and
alkyl zinc bromides and CO2 would be to systematically test a model reaction at a series of pressures
of CO2 to probe any relationship between yield and pressure of CO2. [Ni(acac)2] and PCy3 could be
employed with npropyl zinc bromide and tested at 1, 5, 10 and 20 bar pressure of CO2 in a high
pressure reactor. The necessity for high pressure of CO2 in this procedure is an issue for use in
[11C]radiolabelling. Therefore, it may be worth exploring some of the other methods that have come
to the fore using mild conditions for carboxylations.[5] For example, copper catalysts have been
employed with aryl boronic esters to synthesise carboxylic acids with excellent functional group
compatibility.[6]
To investigate the full potential of titanium imides to produce [11C]isocyanate derivates, then it is
necessary to find a simple titanium imide structure which can be synthesised in large enough
quantities and qualities to carry out a series of tests with CO2. Alternative routes to terminal imide
titanium compounds may include the oxidatively-induced α-hydrogen abstraction as illustrated by 
Mindiola et al.[7] For example, a ligated titanium (III) chloride complex is reacted with 2 equivalents
of Li(NHR) and then oxidised using silver triflate which promoted α-hydrogen abstraction and 
formation of a terminal imide (Figure 6.1).
Figure 6.1 Synthesis of a four coordinate terminal imide titanium complex from oxidatively-induced α-
hydrogen abstraction.
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There are also many other ligands which may be suitable for this work, such as amidates. A
bis(amidate)bis(amine)titanium complex has been used as a precursor in the intermolecular
hydroaminations of terminal alkynes and primary amines with good functional group tolerance.[8]
The similar nature of the mechanism for hydroamination may mean it is applicable for the
cycloaddition of carbon dioxide.
Figure 6.2 Synthesis of a bis(amidate) titanium imido species.
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7 Experimental
The method of drying solvents in the laboratory changed during the course of the PhD. For sections
7.1 and 7.4 all solvents were distilled over sodium wire except for dichloromethane, which was
distilled over calcium hydride under nitrogen and degassed before use. In sections 7.2 and 7.3 HPLC
quality THF, diethyl ether, DCM, hexane, toluene and acetonitrile were dried with alumina beads and
sparged with nitrogen. Additionally oxygen is removed from hexane and toluene with copper oxide
13 % wt. supported on alumina.
All glassware was pre-dried in the oven at 120 oC overnight prior to use. 1H, 13C {1H} and 31P {1H} NMR
spectra were recorded on a Bruker 400 MHz spectrometer. Mass spectrometry was carried out by
Mr. J. Barton at the Department of Chemistry, Imperial College, London and spectra were recorded
using EI, FAB or electrospray methods. Microanalyses were carried out by Mr. S. Boyer, London
Metropolitan University. Flash chromatography separations were carried out on silica gel 60, 240-
400 mesh ASTM. Diffraction data for all compounds were collected on an Oxford Diffraction Xcalibur
3 diffractometer and Mo-K α radiation by Dr Andrew J. P. White at Department of Chemistry, 
Imperial College London.
7.1 Synthesis of N-Benzylbenzamide via Palladium-Catalysed/Mediated
Carbonylation: A Study of N-Heterocyclic Carbenes as Ligands
Quantitative analysis was carried out via gas chromatography on a Hewlett-Packard 5890 GC fitted
with an Agilent 6690 autosampler and a flame ionization detection system. The products were
separated on a SGE forte BP1 capillary column; length 25 m, I.D. 0.22 mm, film thickness 0.25 mm.
Quantification of yield was achieved by calculating the response factor from N-benzylbenzamide and
diphenylether as the internal standard (purchased from Sigma-Aldrich). In all cases samples for GC
analysis were made up in 1.5 mL vials using 0.2 mL of reaction mixture and 1.3 mL of diphenylether
in DCM (0.0126 M) as an internal standard.
[PdCl2], [Pd2(dba)3], [Pd(OAc)2], [Pd(PPh3)4], [Pd(PPh3)2Cl2], IMes.HCl, SIMes.HCl, SIPr.HCl,
benzylamine and iodobenzene were purchased from Sigma-Aldrich, BOC Ltd. or Strem Chemicals Inc.
Further purification was carried out where stated. [PdCl2(dppp)], [PdCl2(dppf)] and [PdCl2(2,2’-
bis(diphenylphosphino)-1,1’-binaphthyl)] were formed by stirring [PdCl2(cycloocta-1,5-diene)] and 1
equivalent of corresponding diphosphine in DCM at room temperature for 30 minutes. The product
was filtered, washed with hexane and dried in vacuo.
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7.1.1 Synthesis of N, N’-bis(diisopropylphenyl)imidazolium chloride (IPr. HCl)
(2.1)[1]
This reaction was carried out following a previously reported procedure.[1]
Glyoxal-bis(2,6-diisopropylphenyl)imine
Glyoxal (40 % wt % in H2O) (0.798 mL, 5.50 mmol, 1 eq.) in
npropanol (1 mL) and water (2.5 mL) was
added to 2,6-diisopropylaniline (1.95 g, 11.0 mmol, 2 eq.) dissolved in npropanol (8 mL) and stirred at
70 oC for 1 h after which the solution had changed colour from light yellow to dark orange/yellow.
Addition of water (8 mL) yielded a light yellow precipitate which was filtered and dried in vacuo.
Yield : 93 % (5.1 mmol); 1H NMR δ(CDCl3) ppm: 1.19 (d, J = 6.9 Hz, 24 H, Ar-CH(CH3)2, 2.92 (m, J = 6.9
Hz, 4 H, CH(CH3)2), 7.16 (m, 6 H, Ar-H), 8.08 (s, 2 H, N(CH)2N).
N, N’-bis(diisopropylphenyl)imidazolium chloride
A solution of glyoxal-bis(2,6-diisopropylphenyl)imine (1.5 g, 4.0 mmol, 1 eq.) in THF (10 mL) was
added with two drops of water to a stirred solution of chloromethylethylether (0.371 mL, 4 mmol, 1
eq.) in THF (1 mL) under N2 at 40
oC. After 16 h a brown precipitate had formed which was filtered
washed with THF and dried in vacuo.
Yield: 45 % (1.8 mmol); 1H NMR δ((CD3)2SO) ppm: 1.16 (d, J = 6.9 Hz, 12 H, Ar-CH(CH3)2), 1.26 (d, J =
6.9 Hz, 12 H, Ar-CH(CH3)2), 2.35 (q, J = 6.8 Hz, 4 H, Ar-CH(CH3)2, 7.52 (d, J = 7.8 Hz, 4 H, m-Ar-H), 7.68
(t, J = 7.8 Hz, 2 H, p-Ar-H), 8.58 (s, 2 H, N(CH)2N), 10.24 (s, 1 H, N(CH)N);
13C {1H} NMR δ((CD3)2SO)
ppm: 23.6 (Ar(CH)(CH3)2), 24.6 (Ar(CH)(CH3)2), 29.1 (Ar(CH)(CH3)2), 125.1 (Ar), 126.7 (Ar), 130.5 (Ar),
132.3 (Ar), 139.8 (N(CH)2N), 145.3 (N(CH)N); MS (E.S.) m/z: 389 (M
+-Cl).
7.1.2 Synthesis of N, N’-bis(1-adamantyI)imidazolium chloride (IAd. HCl) (2.2)[2]
This reaction was carried out following a previously reported procedure.[2]
Glyoxal-bis-(1-adamantyl)imine
Glyoxal (40 % wt % in H2O) (1.92 mL, 13.2 mmol, 1 eq.) was added to a solution of 1-adamantylamine
(4.0 g, 27 mmol, 2 eq.) in methanol (20 mL) with a few drops of formic acid and stirred at room
temperature. After 3 h a yellow precipitate formed which was filtered, washed with cold methanol
and dried in vacuo.
Yield : 81 % (10.7 mmol); 1H NMR δ(CDCl3) ppm: 1.62-1.73 (m, 24 H, Ad-H), 2.12 (s, 6 H, Ad-H), 7.90
(s, 2 H, N(CH)2N); MS (E.I.) m/z : 324 (M
+), 135 (adamantyl).
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N, N’-bis(1-adamantyI)imidazolium chloride
A solution of glyoxal-bis-(1-adamantyl)imine (0.50 g, 1.5 mmol, 1 eq.) dissolved in THF (5 mL) and
one drop of water was added to a stirred solution of chloromethylethylether (0.143 mL, 1.54 mmol,
1 eq.) in THF (1 mL) under N2 in a pre-dried Schlenk. Heating to 40
oC for 16 h yielded a light yellow
precipitate which was collected, washed with THF and dried in vacuo.
Yield: 47 % (0.72 mmol); 1H NMR δ((CD3)2SO) ppm: 2.07 (s, 12 H, Ad-H), 2.15 (s, 12 H Ad-H), 2.21 (s, 6
H, Ad-H), 8.09 (s, 2 H, N(CH)2N), 9.14 (s, 1 H, N(CH)N); MS (ES
+) m/z : 337 (M+), 176 (M+ - CNAd).
7.1.3 Attempted Synthesis of N, N’-bis(1-adamantyl)-4,5-dihydroimidazolinium
chloride (SIAd. HCl)[3]
This reaction was carried out by small modifications of a previously reported procedure. [3]Method A
N, N’-Bis(1-adamantylamino)ethane
Glyoxal bis(1-adamantyl)imine (1.5 g, 8.6 mmol, 1 eq.) and sodium borohydride (3.24 g, 85.6 mmol,
10 eq.) were dissolved in MeOH/THF (1:3) (30 mL) and stirred for 2 h. The reaction was quenched
with ammonium chloride solution (20 mL) and the product extracted into diethylether (3 x 20 mL),
washed with distilled water (10 mL), dried with MgSO4 and filtered. The solvent was removed to give
a white solid.
Yield: 23 % (2.11 mmol); 1H NMR δ(CDCl3) ppm: 1.60 (m, 24 H, Ad-H), 2.03 (s, 6 H, Ad-H), 2.65 (s, 4 H,
N(CH2)N); MS (E.S.) m/z: 329 (M
+), 195 (M+-Ad), 176 (M+-H2NAd), 135 (Ad); Decomposition point:
180-190 oC.
N, N’-bis(1-adamantyl)-4,5-dihydroimidazolinium chloride
N, N’-Bis-(1-adamantylamino)ethane (200 mg, 0.609 mmol, 1 eq.), ammonium chloride (36 mg, 0.67
mmol, 1.1 eq.) and triethylorthoformate (0.253 mL, 1.52 mmol, 2.5 eq.) were dissolved in toluene
(20 mL) and refluxed for 1.5 h. The white solid that formed was collected, dissolved in chloroform
and re-precipitated from diethylether as a white solid.
1H NMR δ(CDCl3) ppm: 1.70-1.65 (m, 24 H, Ad-H), 2.10 (br s, 6 H, Ad-H), 2.80 (s, 4 H, N(CH2)N);
13C
{1H} NMR δ(CDCl3) ppm: 29.5 (C(CH2)6(CH)3), 36.5 (C(CH2)6(CH)3), 42.3 (C(CH2)6(CH)3).Method B
N,N’-bis(1-adamantyl)oxamide
Oxalyl chloride (1.4 mL, 16 mmol, 1 eq.) was added over 30 minutes to a pre-dried Schlenk
containing a stirred solution of 1-adamantylamine (4.8 g, 32 mmol, 2 eq.) and triethylamine (4.5 mL,
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32 mmol, 2 eq.) in DCM (40 mL) at 0 oC. Stirring was continued for another 30 min before water (10
mL) was slowly added to the reaction mixture at 0 oC. The reaction mixture was filtered via cannula.
Portions of hot toluene were used to extract product from the remaining salt. The organic layer was
separated and dried with MgSO4. The solvent was removed to yield a white solid. The product was
purified by recrystallisation from hexane and toluene (2:1).
Yield: 44 % (6.96 mmol); 1H NMR δ(CDCl3) ppm: 1.67 (s, 12 H, Ad-H), 1.99 (br s, ν1/2 = 4.8 Hz, 12 H,
Ad-H), 2.08 (br s, 6 H, Ad-H), 7.27 (s, 2 H, 2 NH).
N, N’-bis(1-adamantyl)ethane-1,2-diamine dihydrochloride
N, N’-bis(1-adamantyl)oxamide (1.78 g, 4.90 mmol, 1 eq.) and BH3.SMe2, (2.0 M in THF) (9.8 mL, 20
mmol, 4 eq.) were heated to reflux in toluene (15 mL) under N2 for 3 h. The yellow solution was
cooled to room temperature and hydrochloric acid (1 M) was added carefully and then shaken
vigorously until the solution was acidic (litmus paper). Sodium hydroxide (10 % by weight) was then
added to form a basic solution and a white precipitate, which was filtered off. The organic layer was
separated and the aqueous layer washed with DCM. The organic portions were combined, dried with
magnesium sulphate and the volume reduced. A few drops of concentrated hydrochloric acid were
added and shaken vigorously to give a very small amount of white precipitate which was collected
and washed with diethylether and dried in a vacuum desiccator.
1H NMR δ((CD3)2SO) ppm: 1.64 (dd, J = 12.3 Hz, 12 H, Ad-H), 1.89 (s, 12 H, Ad-H), 2.14 (s, 6 H, Ad-H),
3.29 (s, 4 H, (CH2)2), 9.45 (s, 3 H).
7.1.4 Synthesis of dichloro(bis[1,3-bis(2,4,6-trimethylphenyl)imidazol-2-
ylidene])palladium(II) (2.3)Direct deprotonation and complexation of IMes.HCl (Method A)
This reaction was carried out by small modifications of a previously reported procedure. [4]
Palladium chloride (52 mg, 0.29 mmol, 1 eq.), N,N’-bis(mesityl)imidazolium chloride (200 mg, 0.59
mmol, 2 eq.) and cesium carbonate (960 mg, 2.93 mmol, 10 eq.) were dissolved in THF in a pre-dried
Schlenk and stirred under N2 at 70
oC for 5 h. The solvent was removed to leave a light brown
powder which was purified using flash chromatography (DCM) affording a light yellow powder.
Yield: 23 % (0.07 mmol); 1H NMR δ(CDCl3) ppm: 1.94 (s, 24 H, o-Ar(CH3)2), 2.47 (s, 12 H, p-Ar(CH3)),
6.76 (s, 4 H, N(CH)2N), 6.92 (s, 8 H, m-Ar(H)); MS (E.S.) m/z: 809 ([M
+]+[Na+]), 305 (IMes); Anal. Calc.
for PdCl2C42N4H48: C 64.2 %, H 6.15 %, N 7.12 %. Found: C 64.1 %, H 6.16 %, N 7.11 %.
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Complexation via a silver transfer agent (Method B and C)[5]
This reaction was carried out by small modifications of a previously reported procedure. [5]Method BDichloro(bis[1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene])silver(I)chloride
N,N’-bis(mesityl)imidazolium chloride (50 mg, 0.15 mmol, 2 eq.) and silver oxide (17 mg, 0.073
mmol, 1 eq.) were dissolved in DCM (5 mL) and stirred under inert and dark conditions and
monitored by 1H NMR. After 1 h 30 min a grey precipitate had formed and the starting material had
been used up. The mixture was filtered and the volume of the filtrate reduced by half. A white
precipitate formed on drop wise addition of cold hexane which was filtered, washed with hexane (3
x 10 mL) and dried in vacuo.
Yield : 48 % (0.04 mmol); 1H NMR δ(CDCl3) ppm: 2.05 (s, 24 H, o-Ar(CH3)2), 2.33 (s, 12 H, p-Ar(CH3)),
6.89 (s, 8 H, m-Ar(H)), 7.11 (d, J = 1.9 Hz, 4 H, N(CH)2N).
Dichloro(bis[1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene])palladium(II)
Ag(IMes)2Cl2 (200 mg, 0.028 mmol, 1 eq.) and dichloro(acetonitrile)palladium(II) (10 mg, 0.028
mmol, 1 eq.) were dissolved in DCM (10 mL), stirred for 3 h in inert and dark conditions at room
temperature. The temperature was raised to 30 oC for 1 h until a small amount of precipitate had
formed. The precipitate was filtered. Further crude product was obtained from adding hexane
dropwise (10 mL) to the filtrate and removing the volatiles under reduced pressure and filtering the
resultant precipitate.
MS (E.S.) m/z: 896 [Ag2(IMes)2Cl2], 715 [Ag(IMes)2], 452 [Ag(IMes)Cl], 305 [IMes].Method C
Dichloro(bis[1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene])palladium(II)
N,N’-bis(mesityl)imidazolium chloride (100 mg, 0.293 mmol, 2 eq.) and silver oxide (34 mg, 0.15
mmol, 1 eq.) were dissolved in DCM (5 mL) and stirred under an inert atmosphere and dark
conditions for 1 h 30 min after which time a grey precipitate had formed. This solution was filtered
via cannula into a solution of dichloro[1,5-cyclooctadiene]palladium(II) (42 mg, 0.15 mmol, 1 eq.) in
DCM (10 mL), stirred for 3 h under an inert atmosphere and dark conditions and heated to 30 oC for
1 h until a precipitate formed. The product was collected as a dull yellow powder, washed with
hexane (3 x 10 mL) and dried in vacuo.
Yield: 70 % (0.10 mmol); 1H NMR δ(CDCl3) ppm: 1.93 (s, 24 H, o-Ar(CH3)2), 2.45 (s, 12 H, p-Ar(CH3)),
6.76 (s, 4 H, N(CH)2N), 6.91 (s, 8 H, m-Ar(H)); MS (E.S.) m/z: 809 ([M
+]+[Na+]), 305 [IMes].
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7.1.5 Palladium-Catalysed Carbonylation Reactions
All carbonylation reactions were carried out on a Radley’s Carousel 12 Place Reaction Station and a
Heidolph heating plate fitted with a temperature probe.General Procedure - Atmospheric Pressure of Carbon Monoxide
Iodobenzene (0.112 mL, 1.000 mmol, 1 eq.) was added to a stirred solution of catalyst (Table 7.1,
0.02 mmol, 2 mol %) dissolved in benzylamine (5 mL) at 100 or 150 oC under an atmosphere of
carbon monoxide. Samples (0.5 mL) were taken after 10 minutes and 2 hours and analysed using gas
chromatography.General Procedure - Static Pressure (0.2 bar) of Carbon Monoxide
Iodobenzene (0.112 mL, 1.000 mmol, 1 eq.) was added to a stirred solution of catalyst (Table 7.1,
0.02 mmol, 2 mol %) dissolved in benzylamine (5 mL) at 100 oC or 150 oC under a static atmosphere
of carbon monoxide at 0.2 bar. Samples (0.5 mL) were taken after 10 min and 2 h and analysed using
gas chromatography.
Table 7.1 Catalyst systems tested, stoichiometries and quantities used in the synthesis of N-benzylbenzamide
via carbonylation.
Catalyst Mass (mg)
[Pd(PPh3)4] 23.1
[PdCl2(PPh3)2] 14
[PdCl2(dppf)] 14.6
[PdCl2(dppp)] 11.8
[PdCl2(BINAP)] 16
Palladium Mass (mg)
Pd(OAc)2 4.5
Pd2(dba)3 9.2
PdCl2 3.5
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Imidazolium Salt Equivalents Mass (mg)
SIPr.HCl 1 (0.02 mmol) 8.5
SIMes.HCl 6.9
IMes.HCl 6.8
IPr.HCl 8.5
IAd.HCl 7.5
SIPr.HCl 2 (0.04 mmol) 17.1
SIMes.HCl 13.7
IMes.HCl 13.6
IPr.HCl 17
IAd.HCl 15
Pd(IMes)2Cl2 N/A 15.7
Calibration of N-benzylbenzamide
A 0.5 mL sample was removed from the reaction mixture at 10 min, 0.2 mL of this was used to make
up a 1.5 mL GC vial with 1.3 mL of diphenylether in DCM (0.0126 M). The response time for the N-
benzylbenzamide product was calculated by making up 4 different concentrations of product in the
diphenylether solution (0.0126 M in DCM) and the integration (area) of the corresponding peaks
were noted from the chromatograms. Then a graph was drawn up of integration of product/
integration of diphenylether standard (Ap/Astd) versus the concentration of the product/
concentration of the diphenylether standard (Cp/Cstd), which gives a linear relationship. The gradient
from this graph which links the integration of the peaks on the chromatogram with the
concentration in the vial is known as the response factor and is different for every product obtained.
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Graph 7.1 The response factor (RF) for N-benzyl benzamide.
The same equation from this graph can be rearranged to calculate the concentration of product (Cp)
in the sample vial and therefore the overall yield; Cp = (Ap x Cstd)/(Cp x RF).
The Cp can then be multiplied by 1.5 mL (volume in vial) to get the number of mmol in the vial and
divided by the 100 % theoretical molar yield of product in the vial (0.04 mmol) to give the overall
yield.
7.1.6 Microfluidic Reactions
The microfluidic device was constructed from a glass substrate using chemical wet etching
techniques.  50 μL aliquots of reagents (iodobenzene, benzylamine and Pd catalyst) were injected via
a Rheodyne switch under a continuous flow of THF. As the liquid and gaseous reagents are mixed
directly on the device an annular flow regime is formed which produces a high interfacial gas-liquid
contact area. The residence time (taken as the reaction time) of the reagents on the microfluidic
device was approximately 2 min.General Method
Pd2(dba)3 (18 mg, 0.021 mmol, 1 mol %), IMes.HCl (14 mg, 0.042 mmol, 2 mol %), iodobenzene
(0.224 mL, 2.000 mmol, 1eq.) and benzylamine (1.8 mL) were heated under N2 to 100
oC for 15
minutes until the majority of the palladium had dissolved to yield a yellow solution. This was filtered
and injected into the microfluidic device.
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Products collected after passage through the chip were analysed via gas chromatography as in
previous carbonylation reactions.
7.1.7 Palladium-mediated radiolabelling reactions using [11C]Carbon Monoxide
The ‘hot’ experiments were carried out using the GSK’s facilities at the CIC in Hammersmith hospital.
These reactions were carried out in collaboration with Dr. S. Kealey.
Radiolabelled [11C]CO2 was produced on a Siemens cyclotron from a N2 (1% O2) target, with a beam
current of 5 µA and a bombardment time of 5 minutes. The [11C]CO2 was converted to [
11C]CO via an
Eckert and Ziegler modular lab system which uses a molybdenum reductant (850 oC) and delivered
to the hot cell at a flow rate of 75 ml/min in a stream of He. Unconverted [11C]CO2 was collected on
an ascarite trap.General Radiolabelling Procedure
CuCl (1.1 mg, 11 μmol, 1 eq.) and KTp* (3.7 mg, 11 μmol, 1 eq.) was weighed into a 5 ml glass vial 
and placed under a N2 atmosphere. Dry THF (1 mL) was added to form the trapping solution. A
[11C]CO/He gas stream was delivered to the vial, forming the CuTp*[11C]CO complex. Following this,
the cross-coupling reagents (Pd2(dba)3 (1.0 mg, 1.1 μmol, 20 mol %), IMes.HCl (0.75 mg, 2.2 μmol, 20 
mol %), iodobenzene (2.3 mg, 11 μmol, 1 eq.), benzylamine (0.1 mL, excess) and triphenylphosphine 
(5.8 mg, 22 μmol, 2 eq.) in DMF (0.9 mL) were added to  the vial using an argon gas sweep.  The vial 
was sealed and the mixture heated for 10 min after which time it was quenched by addition of 1 mL
of an aqueous solution of NH4OAc (pH 4.9) by an argon gas sweep. Finally, the radioactivity of the
reaction vial was measured and the crude mixture analysed by analytical HPLC. The reaction mixture
was analysed on an analytical radio HPLC (Agilent 1100, 60:40 water:acetonitrile, flow rate 1.5
mL/min, fitted with an Agilent Eclipse XDBC18, 5 μm, 4.6 x 150 mm column).  During each step the 
radioactivity of the waste gases was measured in order to calculate incorporation of [11C]CO and
radiochemical yields based on the starting radioactivity of the CuTp*[11C]CO solution.
7.2 Synthesis of N-Benzylbenzamide via Palladium-Catalysed
Carbonylation: A Study of Hemilabile Ligands
Quantitative analysis of the N-benzylbenzamide was carried out on a Hewlett-Packard 5890 GC fitted
with an Agilent 6690 autosampler and a flame ionization detection system. The products were
separated on a J&W DB-5 column with a cross linked/surface bonded 5% phenyl, 95%
methylpolysiloxane stationary phase, length 30 m, I.D. 0.25 mm and film thickness 0.25 mm.
Dichloro[bis(diphenylphosphino)ethane]palladium(II),[6] dichloro[bis(diphenylphosphino)propane]-
palladium(II),[6] dichloro[1,1’-bis(diphenylphosphino)ferrocene]palladium(II),[7] dichloro[4,5-
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bis(diphenylphosphino)-9,9-dimethylxanthene]palladium(II),[8] 1-(diphenylphosphino)-1’-
(methylthio)ferrocene,[9] 1-(diphenylphosphino)-1’-(methoxy)ferrocene,[10] 1-(diphenylphosphino)-2-
(phenoxy)ethane,[11] dichloro[cycloocta-1,5-diene]palladium(II)[12] were prepared from literature
methods. 1-(Diphenylphosphino)-3-(2,6-dimethyl-1-thiophenyl)propane was synthesised from
unpublished work by Dr. C. Tate (PDRA to Prof. N. J. Long). All other chemicals were purchased from
Sigma-Aldrich.
7.2.1 Synthesis of dichloro[1-(diphenylphosphino)-1’-(methylthio)ferrocene]-
palladium (II) (3.1)
This reaction was carried out following a previously reported procedure.[9]
1-(Diphenylphosphino)-1’-(methylthio)ferrocene (190 mg, 0.36 mmol, 1 eq.) was dissolved in dry
DCM (5 mL) and degassed in a pre-dried Schlenk tube. The solution was then transferred under N2
via cannula into another pre-dried Schlenk tube containing dichloro[cycloocta-1,5-
diene]palladium(II) (100 mg, 0.353 mmol, 0.97 eq.) dissolved in dry DCM (7 mL) and stirred for 20 h
in which time the solution turned from yellow to dark red. Dry hexane (20 mL) was slowly added
precipitating a red solid which was collected, washed with hexane (3 x 5 mL) and dried in vacuo.
Crystals suitable for X-ray diffraction were grown by slow diffusion of diethylether into a solution of
the complex with DCM.
Yield: 69 % (0.25 mmol); 1H NMR δ(CDCl3) ppm: 2.80 (s, 3 H, SCH3), 4.38 (s, 2 H, C5H4), 4.58 (s, 2 H,
C5H4), 4.81 (s, 2 H, C5H4), 5.00 (s, 2 H, C5H4), 7.43 (m, 6 H, C6H5), 7.71 (m, 4 H, C6H5);
31P {1H} NMR
δ(CDCl3) ppm: 31.1 (s).
7.2.2 Synthesis of dichloro[1-(diphenylphosphino)-1’-(methoxy)ferrocene]-
palladium (II) (3.2)
This reaction was carried out following a previously reported procedure.[10]
1-(Diphenylphosphino)-1’-(methoxy)ferrocene (60 mg, 1.5 mmol, 1.3 eq.) was dissolved in dry
toluene (5 mL) in a pre-dried Schlenk tube under N2 and transferred via cannula into another pre-
dried Schlenk tube containing dichloro[cycloocta-1,5-diene]palladium(II) (33 mg, 1.2 mmol, 1 eq.)
dissolved in DCM (5 mL) resulting in an immediate colour change from yellow to dark red-brown.
The solution was stirred for 20 h and then reduced by half. Precipitation of a brown powder
occurred after addition of hexane (10 mL). The crude product was purified by column
chromatography (silica, DCM and DCM/acetone 4:1). Recrystallisation was attempted by layering of
pentane on DCM and slow diffusion of diethylether and DCM but no crystals were obtained.
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Yield: 44 % (0.51 mmol); 1H NMR δ(CDCl3) ppm: 3.70 (s, 3 H, OCH3), 4.52 (s, 4 H, C5H4), 4.56 (s, 2 H,
C5H4), 5.60 (s, 2 H, C5H4), 7.36 (m, 4 H, PC6H5), 7.45 (m, 2 H, PC6H5), 7.60 (dd, J = 7.5 Hz, 4 H, PC6H5);
31P{1H} NMR δ(CDCl3) ppm: 31.3 (s).
Bis[1-(diphenylphosphino-κ-P)-1’-(methoxy)ferrocene] dichloropalladium(II) (By product); 1H NMR
δ(CDCl3) ppm: 3.55 (s, 3 H, OCH3), 4.27 (s, 4 H, C5H4), 4.44 (s, 2 H, C5H4), 4.56 (s, 2 H, C5H4), 7.47 (m,
10 H, PC6H5);
31P {1H} NMR δ(CDCl3) ppm: 15.1 (s).
7.2.3 Synthesis of 1-(diphenylphosphino)-3-(2,6-dimethyl-1-thiophenyl)propane
(3.3)
A pre-dried bombe (500 mL round bottom flask fitted with Young’s tap) was charged with 1,3-
dichloropropane (5.7 mL, 60 mmol, 6 eq.) under N2 and dissolved in dry THF (60 mL). The solution
was cooled to -78 oC and potassium diphenylphosphide (0.5 M in THF) (20 mL, 10 mmol, 1 eq.) was
added dropwise over 30 min with stirring. After complete addition of the reagent the reaction
mixture was warmed to room temperature at which point the orange solution turned light yellow in
colour with some precipitate. The solution continued to stir for 16 h. The solvent was removed and
dry cesium carbonate (3.26 g, 10.0 mmol, 1 eq.) was added to the bomb in a glove box. The reagents
were suspended in dry acetonitrile and 2,6-dimethylbenzenethiol (1.3 mL, 10 mmol, 1 eq.) was
added. The solution was subjected to two cycles of freeze-pump-thaw and heated to refluxed at 110
oC under vacuum with stirring for 3 days. The reaction mixture was cooled to room temperature and
filtered through Celite under N2 to yield an orange oil. The purified product was obtained from
vacuum distillation between 140-160 oC as a brown oil.
Yield: 25 % (2.5 mmol); 1H NMR δ(CD2Cl2) ppm: 1.63 (m, 2 H, CH2CH2CH2), 2.13 (t, J = 8.0 Hz, 2 H, CH2-
P), 2.50 (s, 6 H, CH3), 2.75 (t, J = 8.0 Hz, 2 H, CH2-S), 7.09 (m, 3 H, C6H3), 7.35 (m, 10 H, P(C6H5)2);
31P
{1H} NMR δ(CD2Cl2) ppm: -17.05 (s); MS (E.I.) m/z: 364 (M
+), 259 (M+- C6H3(CH3)2); Anal. Calc. for
C23H25PS: C 75.79 %, H 6.91 %. Found: C 75.82 %, H 6.83 %.
7.2.4 Synthesis of dichloro[(1-(diphenylphosphino)-3-(2,6-dimethyl-1-thio
phenyl)propane]palladium(II) (3.4)
1-(Diphenylphosphino)-3-(2,6-dimethyl-1-thiophenyl)propane (325 mg, 0.892 mmol, 1 eq.) was
dissolved in dry DCM (2.5 mL) in a pre-dried Schlenk tube and added via cannula to a solution of
dichloro[cycloocta-1,5-diene]palladium(II) (250 mg, 0.892 mmol, 1 eq.) in dry DCM (2.5 mL). The
reaction mixture was stirred for 2 h under N2 after which time a yellow precipitate was collected,
washed with hexane (2 x 5 mL) and dried in vacuo. Crystals suitable for X-ray diffraction were
obtained from slow diffusion of diethylether into a solution of DCM.
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Yield: 41 % (0.4 mmol); 1H NMR δ(CD2Cl2) ppm: 2.09 (m, 2 H, CH2CH2CH2), 2.39 (m, 2 H, CH2-P), 2.86
(m, 2 H, CH2-S), 2.89 (s, 6 H, CH3), 7.22 (d, J = 8.0 Hz, 2 H, m-C6H3), 7.31 (t, J = 6.0 Hz, 1 H, p-C6H3),
7.58 (m, 6 H, P(C6H5)2), 7.90 (m, 4 H, P(C6H5)2);
31P{1H} NMR δ(CD2Cl2) ppm: 9.2 (s); MS (E.S.) m/z: 544
(M+), 365 (M+-PdCl2); Anal. Calc. for C23H25PSPdCl2: C 50.98 %, H 4.65 %. Found: C 51.14 %, H 4.75 %.
7.2.5 Synthesis of dichloro[(1-(diphenylphosphino)-3-(2,6-dimethyl-1-
thiophenyl)ethane]palladium (II) (3.5)
A solution of dichloro[cycloocta-1,5-diene]palladium(II) (212 mg, 0.743 mmol, 1.3 eq.) in dry DCM
(10 mL) in a pre-dried Schlenk tube under N2 was transferred via cannula to another pre-dried
Schlenk tube containing 1-(diphenylphosphino)-3-(2,6-dimethyl-1-thiophenyl)ethane (200 mg, 0.57
mmol, 1 eq.) and stirred at room temperature for 16 h. The resultant yellow precipitate was
collected and washed with hexane (3 x 5 mL) and dried in vacuo. Crystals suitable for X-ray
diffraction were obtained from slow diffusion of hexane into a solution of DCM.
Yield: 72 % (0.41 mmol); 1H NMR δ(CDCl3) ppm: 2.60 (m, 2 H, P-CH2), 2.62 (s, 6 H, CH3), 2.90 (m, 2 H,
S-CH2), 7.06 (d, J = 8.0 Hz, 2 H, m-C6H3), 7.22 (m, 1 H, p-C6H3), 7.52 (m, 4 H, P(C6H5)2), 7.61 (m, 2 H,
P(C6H5)2), 7.93 (m, 4 H, P(C6H5)2);
31P {1H} NMR δ(CDCl3) ppm: 63.0 (s); MS (E.S.) m/z: 530 (M
+), 495
(M+-35Cl); Anal. Calc. for C22H23PSPdCl2: C 50.35 % H 4.39 %. Found C 50.42 % H 4.28 %.
7.2.6 Synthesis of dichloro(di-μ-chloro)bis[1-(diphenylphosphino)-2-
(phenoxy)ethane]dipalladium(II) (3.6)
Dichloro[cycloocta-1,5-diene]palladium(II) (168 mg, 0.592 mmol, 0.9 eq.) and 1-
(diphenylphosphino)-2-(phenoxy)ethane (200 mg, 0.654 mmol, 1 eq.) were dissolved in dry DCM (10
mL) in a pre-dried Schlenk tube and stirred under N2 for 18 h. The solution turned from yellow to
dark red. Precipitation of a yellow powder was achieved after reducing the reaction mixture by half
and slowly adding hexane (20 mL). The yellow powder was collected, washed with hexane (2 x 5 mL)
and dried in vacuo. Crystals suitable for X-ray diffraction were obtained by layering pentane on a
solution of DCM and cooling to 0 oC.
Yield: 92 % (0.27 mmol); 1H NMR δ(CD2Cl2) ppm: 2.96 (m, 4 H, P(CH2)), 4.27 (m, 4 H, O(CH2)), 6.73 (d,
J = 8.0 Hz, 4 H, O(o-C6H5)), 6.93 (t, J = 7.4 Hz, 2 H, O(p-C6H5)), 7.22 (t, J = 8.0 Hz, 4 H, O(m-C6H5)), 7.40
- 8.00 (m, 20 H, P(C6H5)2;
31P {1H} NMR δ(CD2Cl2) ppm: 27.2 (s); Anal. Calc. for C40H38Pd2Cl4O2P2: C
49.68 %, H 3.96 %. Found C 49.57 % H 3.91 %.
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7.2.7 Synthesis of dichloro[bis(1-(κ-diphenylphosphino)-2-(phenoxy)ethane) 
palladium(II) (3.7)
A solution of 3.6 (79 mg, 0.080 mmol, 0.5 eq.) in DCM was added to a solution of 1-
(diphenylphosphino)-2-(phenoxy)ethane (50 mg, 0.16 mmol, 1 eq.) in DCM and stirred at room
temperature under inert conditions for 20 h. The solution was reduced by half and a yellow
precipitate was formed on addition of hexane (20 mL). The yellow powder was filtered washed with
hexane (2 x 10 mL) and dried in vacuo.
Yield: 53 % (0.09 mmol); 1H NMR δ(CDCl3) ppm: 2.99 (m, 4 H, P(CH2)), 4.25 (m, 4 H, O(CH2)), 6.71 (d, J
= 8.7 Hz, 4 H, ortho-OC6H5), 6.88 (t, J = 7.37 Hz, 2 H, para-O C6H5), 7.18 (m, 4 H, meta-O C6H5), 7.40
(m, 12 H, P(C6H5)2), 7.73 (m, 8 H, P(C6H5)2);
31P {1H} NMR δ(CDCl3) ppm: 12.6 (s). MS (E.S.) m/z: 753
(M+ - Cl), 307 (Ligand); Anal. Calc. for C40H38PdCl2O2P2: C 60.81 %, H 4.85 %. Found C 60.90 % H 4.77
%.
7.2.8 Abstraction of the chloride groups of 3.7 (3.8)
A solution of silver triflate (27 mg, 0.11 mmol, 2.1 eq.) in DCM (4 mL) was added to solution of 3.7
(40 mg, 0.05 mmol, 1 eq.) in DCM (4 mL) in a pre-dried Schlenk tube and was stirred under inert and
dark conditions for 17 h. The solution was filtered through Celite and the solvent removed leaving an
orange powder. Recrystallisation was carried out from layering of hexane on DCM yielding small
yellow needles suitable for X-ray diffraction.
Yield: 93 % (0.05 mmol); 1H NMR δ(CD2Cl2) ppm: 2.95 (m, 4 H, (CH2)PPh2), 4.03 (dt, J = 18.6 Hz, 8.01
Hz, 4 H, (CH2)OPh), 6.76 (d, J = 8.1 Hz, 4 H, ortho-OC6H5), 6.99 (t, J = 7.4 Hz, 2 H, para-OC6H5), 7.25 (t,
J = 8.0 Hz, 4 H, meta-OC6H5), 7.37 (td, J = 7.8, 3.0 Hz, 8 H, PPh2), 7.57 (dd, J = 7.6 Hz, 12 H, PPh2);
31P
{1H} NMR δ(CD2Cl2) ppm: 36.9 (s); MS (negative ion E.S.) m/z: 149 (
-OTf); MS (positive ion E.S.) m/z:
719 (M+ - -OTf), 307 (Ligand). Anal. Calc. for C44H38PdS2O8F6P2: C 49.59 %, H 3.77 % Found C 49.10 % H
4.49 %.
7.2.9 General Procedure – Synthesis of N-benzylbenzamide
A pre-dried Schlenk tube was charged with benzylamine (1.1 mL, 10 mmol, 10 eq.) and iodobenzene
(0.112 mL, 1.00 mmol, 1 eq.) and underwent two cycles of freeze-pump-thaw. The reagents were
dissolved in dry toluene (1 mL) and transferred via cannula into a pre-dried Schlenk tube containing
the palladium catalyst (2 mol %) attached to a manifold filled with carbon monoxide flowing through
it. The reaction solution was heated to 100 oC and stirred for 3 h. The reaction was then opened to
air and quenched with HCl (0.1 M)(10 mL). The product was extracted with DCM (3 x 10 mL), dried
with MgSO4, filtered and the solvent removed.
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A 10 mL solution of the crude product in DCM was prepared and a 1 mL sample taken for GC
analysis. Diphenylether (0.4 M)(0.5 mL) in DCM was also added to the sample as an internal standard
so that a GC yield could be calculated using Clarity software and the calibration curve.
N-Benzylbenzamide Calibration
Calibration was achieved by preparing 5 samples with different concentrations of N-
benzylbenzamide in DCM and a uniform concentration of internal standard solution (diphenylether,
0.4 M, 0.5 mL). The response of the product and internal standard was detected by the GC (retention
times; diphenyl ether, 11.3 min and N-benzylbenzamide, 19.2 min) and analysed using Clarity
software. This calibration could then be applied to individual chromatograms to calculate the
amount (mg) of product. The calibration graph produced from the Clarity software is shown below.
Graph 7.2 GC Calibration graph for N-Benzylbenzamide (R2 = 0.9996).
7.3 Nickel/Palladium-Catalysed Carboxylation of Aliphatic and Aromatic
Zinc Reagents
nPrZnBr and PhZnBr were purchased from Sigma Aldrich and titrated with iodine as per literature
methods.[13] Preparation of nPrZnBr.LiCl and PhZnI.LiCl was carried out via the Knochel method.[14]
Carbon dioxide was purchased from BOC Ltd. and passed through a CaCl2 and KOH drying column
before use.
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Quantitative analysis of the nbutyric acid, benzoic acid and biphenyl products was carried out on a
Hewlett-Packard 5890 GC fitted with an Agilent 6690 autosampler and a flame ionization detection
system. The products were separated on a J&W DB-5 column with a cross linked/surface bonded 5%
phenyl, 95% methylpolysiloxane stationary phase, length 30 m, I.D. 0.25 mm and film thickness 0.25
mm.
7.3.1 General Procedure - Synthesis of Butyric Acid from nPropyl Zinc Bromide
Ni(acac)2 (0.13 g, 0.05 mmol, 5 mol%) and PCy3 (0.28 g, 0.10 mmol, 10 mol %) were placed in a small
pre-dried Schlenk tube and vacuum-refilled with CO2 and left open to a steady stream of CO2 (in the
case of the balloon reactions the CO2 flow was turned off and a balloon was attached through a Suba
seal). The catalyst was dissolved in dry THF (5 mL) to give a light green solution which was stirred at
0 oC for 10 min after which time a solution of npropyl zinc bromide (0.5 M in THF) (2 mL, 1 mmol, 1
eq.) was added. The dark brown solution was stirred at room temperature for 3 h. Quenching with
HCl (1 M)(10 mL) lead to effervescence and a colourless solution. The product was extracted with
ethyl acetate (3 x 10 mL), dried with MgSO4, filtered and the solvent removed under reduced
pressure to yield an orange oil which was analysed by GC.
7.3.2 Synthesis of nPropyl Zinc Bromide·Lithium Chloride[14]
This reaction was carried out by small modification of a previously reported procedure.[14]
A pre-dried Schlenk tube was charged with lithium chloride (424 mg, 10.0 mmol, 1 eq.) and heated
to 160 oC under vacuum for 20 min. Zinc powder (981 mg, 15.0 mmol, 1.5 eq.) was added and
heated again for 20 min at 160 oC under vacuum. Dry THF (15 mL) was added along with 1,2-
dibromopropane (0.043 mL, 0.5 mmol, 5 mol %). The reaction mixture was gently warmed with a
heat gun until foaming was observed and then allowed to cool back to room temperature.[15] This
was repeated 3 times. Chlorotrimethylsilane (0.013 mL, 0.10 mmol, 1 mol %) and bromopropane
(0.91 mL, 10 mmol, 1 eq.) were added along with 5 drops of iodine in THF (1 M). The mixture was
stirred at 50 oC for 24 h and allowed to settle overnight. The solution was decanted from the excess
zinc powder. The product was titrated with iodine (254 mg, 1.00 mmol) dissolved in dry THF (5 mL).
The iodine solution turned colourless after 2.5 mL of organozinc reagent was added. Therefore, 1 /
2.5 = 0.4 M.
Yield : 52 % (5.2 mmol).
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7.3.3 Synthesis of Phenyl Zinc Iodide·Lithium Chloride[14]
This reaction was carried out by small modification of a previously reported procedure.[14]
A pre-dried Schlenk tube was charged with LiCl (424 mg, 10.0 mmol, 1 eq.) and heated to 160 oC
under vacuum for 20 min. Zinc powder (981 mg, 15.0 mmol, 1.5 eq.) was added and heated again for
20 min at 160 oC under vacuum. Dry THF (15 mL) was added along with 1,2-dibromopropane (0.04
mL, 0.5 mmol, 5 mol %). The reaction mixture was gently warmed with a heat gun until foaming was
observed and then allowed to cool back to room temperature.[15] This was repeated 3 times.
Chlorotrimethylsilane (0.013 mL, 0.10 mmol, 1 mol%) and iodobenzene (0.91 mL, 10 mmol, 1 eq.)
were added. The mixture was stirred at 50 oC for 24 h and allowed to settle overnight. The solution
was decanted from the excess zinc powder. The product was titrated with iodine (254 mg, 1 mmol)
dissolved in dry THF (5 mL). The iodine solution turned colourless after 3 mL of organozinc reagent
was added. Therefore, 1 / 3 = 0.34 M.
Yield : 47 % (4.7 mmol).
7.3.4 General Procedure – Synthesis of Benzoic AcidPhenyl Zinc Iodide·Lithium Chloride under Flow Conditions of CO2
Ni(acac)2 (13 mg, 0.050 mmol, 5 mol %) and PCy3 (28 mg, 0.10 mmol, 10 mol %) were placed in a
small pre-dried Schlenk tube and vacuum-refilled with CO2 and left open to a steady stream of CO2.
The catalyst was dissolved in dry THF (5 mL) and addition of PhZnI·LiCl in THF (2.94 mL, 0.34 M)
transformed the solution from light green to dark brown. The reaction mixture was stirred at 0 oC for
10 min and then room temperature for 110 min after which time it had turned light orange.
Quenching with HCl (10 mL)(1 M) lead to effervescence and a colourless solution. The product was
extracted with ethyl acetate (4 x 10 mL), dried with MgSO4, filtered and the solvent removed under
reduced pressure to yield a dark brown oil which was analysed by GC.Phenyl Zinc Bromide under Flow Conditions and 0.25 bar of CO2
Ni(acac)2 (13 mg, 0.050 mmol, 5 mol %) and PCy3 (28 mg, 0.10 mmol, 10 mol %) were placed in a
small pre-dried Schlenk tube and vacuum-refilled with CO2. The CO2 flow was turned off and a
balloon was attached through a suba seal (in the case of the static 0.25 bar reactions the line was
isolated and the pressure adjusted using a regulator). The catalyst was dissolved in dry THF (2 mL)
and addition of PhZnBr in THF (3.3 mL)(0.3 M) transformed the solution from light green to dark
brown. The reaction mixture was stirred at 0 oC for 10 min and then room temperature for 110 min
after which time it had turned light brown. Quenching with HCl (10 mL)(1M) lead to effervescence
and a colourless solution. The product was extracted with ethyl acetate (4 x 10 mL), dried with
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MgSO4, filtered and the solvent removed under reduced pressure to yield a dark brown oil which
was analysed by GC.
7.3.5 Gas Chromatography Analysis
Calibration was achieved by weighing out 5 different amounts of butyric acid, benzoic acid or
biphenyl (purchased from Sigma-Aldrich) and making up samples with a uniform concentration of
internal standard solution. The response of the product and internal standard was detected by the
GC and was analysed using Clarity software. These calibrations could then be applied to individual
chromatograms to calculate the amount (mg) of product. The calibration graphs produced from the
Clarity software are shown below.
In all cases the crude reaction mixture was made up in to 10 mL in a volumetric flask with a solution
of internal standard. Isobutyric acid (Sigma-Aldrich) in DCM (0.1 M) was used as an internal standard
to quantify butyric acid. Heptanoic acid (Sigma-Aldrich) in DCM (0.1 M) was the internal standard
used to quantify benzoic acid and biphenyl. A 1 mL sample of the solutions made up was taken and
submitted for GC analysis.
Graph 7.3 GC calibration graph for butyric acid (R2 = 0.9996).
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Graph 7.4 GC calibration graph for benzoic acid (R2 = 0.997).
Graph 7.5 GC calibration graph for biphenyl (R2 = 0.9989).
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7.4 Titanium and Zirconium Imido Complexes: Synthesis and Reactivity
Titanium compounds were handled under a N2 atmosphere using standard Schlenk techniques and
stored in a N2 glove box. Benzene-d
6 was distilled over potassium and transferred via vacuum
distillation. It was then degassed and stored in a Young’s ampoule in a N2 glove box. All glassware
was dried thoroughly overnight in an oven. Carbon dioxide was purchased from BOC Ltd. and passed
through a CaCl2 and KOH drying column before use. TiCl4 and Cp2ZrCl2 were purchased from Sigma-
Aldrich. Cp2ZrMe2 was prepared from literature methods.
[16]
7.4.1 Synthesis of [Ti(NtBu)(py)3Cl2] (5.1)[17]
This reaction was carried out following a previously reported procedure.[17]
tert-Butylamine (6.1 mL, 58.0 mmol, 6 eq.), pre-distilled over calcium hydride, was added to a 1 M
solution of homoleptic titanium chloride in DCM (9.7 mL, 9.7 mmol, 1 eq.) at -50 oC over 15 min
under nitrogen. An orange precipitate formed immediately and the solution was stirred at room
temperature for a further 2 h. Pyridine, distilled over calcium hydride, (3.1 mL, 38.6 mmol, 3.9 eq.)
was added and stirred for 2 h to yield a red suspension. The suspension was filtered via cannula and
the red powder was washed with DCM (2 x 10 mL). The filtrate was reduced to yield a light red solid
which was washed with hexane (3 x 10 mL) and dried under vacuum to yield an orange solid.
Yield: 93 % (9.02 mmol); 1H NMR δ(C6D6) ppm: 1.15 (s, 9 H, C(CH3)3), 6.52 (m, 2 H, cis m-(C4H5N)),
6.57 (m, 2 H, trans m-(C4H5N)), 6.78 (t, J = 7.6 Hz, 2 H, cis p-(C4H5N)), 6.89 (t, J = 7.5 Hz, 1 H, trans p-
(C4H5N)), 8.72 (s, 2 H, trans o-(C4H5N)), 9.55 (d, J = 4.9 Hz, 4 H, cis o-(C4H5N));
13C {1H} NMR δ(C6D6)
ppm: 30.4 (C(CH3)3) 70.7 (C(CH3)3), 123.1 (cis m-(C4H5N)), 123.2 (trans m-(C4H5N)), 135.4 (cis p-(C4H-
5N)), 137.6 (trans p-(C4H5N)), 150.5 (trans o-(C4H5N)), 152.4 (cis o-(C4H5N)).
7.4.2 Synthesis of [Ti(NtBu)(C5(CH3)4H)(py)Cl] (5.2)
nButyl lithium in hexanes (2.5 M) (1.1 mL, 2.7 mmol, 2 eq.) was added at -78 oC to a stirred solution
of tetramethyl(cyclopentadiene) (410 mL, 2.70 mmol, 2 eq.) in THF (7 mL) and stirred for 15 minutes
after which time it was added to 5.1 (560 mg, 1.35 mmol, 1 eq.) dissolved in THF (5 mL) via cannula.
After stirring at room temperature for 15 h the solution had turned a dark brown with some
precipitate. The solvent was removed and the resultant brown solid was extracted with diethyl ether
(3 x 5 mL), filtered and solvents removed in vacuo. The brown residue was washed with cold
pentane (2 x 5 mL) yielding a red solid. Crystals were obtained from pentane after a week at -30 oC.
Yield: 15 % (0.20 mmol); 1H NMR δ(C6D6) ppm: 1.28 (s, 9 H, NC(CH3)3), 1.43 (br s, ν1/2 = 24 Hz, 3 H,
C5(CH3)4H), 1.89 (br s, ν1/2 = 24 Hz, 3 H, C5(CH3)4H), 2.08 (br s, ν1/2 = 24 Hz, 3 H, C5(CH3)4H), 2.26 (br s,
ν1/2 = 24 Hz, 3 H, C5(CH3)4H), 6.33 (s, 2 H, m-(C5H4N)), 6.60 (s, 1 H, C5(CH3)4H), 6.63 (s, 1 H, p-(C5H4N)),
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8.46 (s, 2 H, o-(C5H4N));
13C {1H} NMR δ(C6D6) ppm: 32.1 (NC(CH3)3), 108.1 (C5(CH3)4H), 123.8 (C5H4N),
150.9 (C5H4N); MS (FAB) m/z : 705 [2 M
+], 670 [2 M+-Cl].
7.4.3 Synthesis of [Ti(NtBu)(C5H5)(py)Cl] (5.3)[18]
This reaction was carried out following a previously reported procedure. [18]
A solution of sodium cyclopentadiene in THF (2.0 M) (0.45 mL, 4.8 mmol, 1 eq.) was added to a
stirred solution of 5.1 (2.0 g, 4.8 mmol, 1 eq.) in THF at 0 oC over a period of 5 min and then stirred
for 3 h. The dark red solution was reduced to a brown oil which was extracted with diethyl ether (7 x
5 mL) and filtered via cannula. The volatiles were removed to yield a brown oil which was dissolved
in hexane/diethylether (1:1) and left at -30 oC overnight. An oily solid was filtered, washed with cold
hexane (2 x 20 mL) and dried in vacuo to yield a brown powder. Crude NMR data is reported as
recrystallisation was not achieved.
Yield: 17 % (0.80 mmol); 1H NMR δ(C6D6) ppm: 0.99 (s, 9 H, CH3), 6.41 (s, 3H, C5H5), 6.66 (s, 2 H, m-
py), 6.98 (s, 1 H, p-py), 8.55 (s, 2 H, o-py); 13C {1H} NMR δ(C6D6) ppm: 32.5 (NC(CH3)3) 119.1 (C5H5).
7.4.4 Attempted Synthesis of [Ti(NtBu)(C5H5)((iPr NC(nBu)NiPr)] (5.4)
A solution of nbutyl lithium in hexanes (2.5 M) (0.27 mL, 0.67 mmol, 1 eq.) was added to a stirred
solution of N, N’-diisopropylcarbodiimine (0.1 mL, 0.67 mmol, 1 eq.) in hexane (5 mL) at -78 oC and
allowed to warm up to room temperature over 30 min. The resulting red solution was added via
cannula to a suspension of 5.3 in hexanes (10 mL) and stirred at room temperature for 20 h. The
resultant dark brown solution containing some precipitate was filtered and volatiles removed to
yield a dark brown oil which was soluble in cold pentane. Further purification via recrystallisation
was not possible.
7.4.5 Attempted Synthesis of [Ti(NtBu)(iPrNC(nBu)NiPr)2(py)] (5.5)
A solution of nbutyl lithium in hexanes (1.6 M) (0.8 mL, 1.2 mmol, 2 eq.) was added to a stirred
solution of 1,3-diisopropylcarbodiimide (0.2 mL, 1.2 mmol, 2 eq.) dissolved in diethyl ether (5 mL) at
-78oC and allowed to warm to room temperature over 30 min. The solution was then added to a
suspension of 5.1 (250 mg, 0.603 mmol, 1 eq.) in diethyl ether (5 mL) and stirred for 30 min resulting
in a precipitate forming. The volatiles were removed and the solid extracted with hexane (2 x 5 mL),
filtered and reduced to give an orange oil which yielded no solid on trituration with cold pentane
and prolonged cooling at -30 oC.
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7.4.6 Attempted Synthesis of [Ti(NtBu)(iPrNC(tBu)NiPr)2(py)] (5.6)
A solution of tbutyl lithium (1.7 M) in pentane (0.7 mL, 1.2 mmol, 2 eq.) was added to a solution of
1,3-diisopropylcarbodiimide (0.2 mL, 1.2 mmol, 2 eq.) dissolved in diethyl ether (5 mL) at -78 oC and
allowed to warm to room temperature over 30 min. The solution was then added to a suspension of
5.1 (250 mg, 0.603 mmol, 1 eq.) in diethyl ether (5 mL) via cannula and stirred at room temperature
for 22 hours. The precipitate was filtered off and washed with hexane (2 x 5 mL) and volatiles
removed from the filtrate to give a brown oil which yielded no solid on trituration with cold pentane
and prolonged cooling at -30 oC.
7.4.7 Attempted Synthesis of [Ti(NtBu)(SIPr)(C5H4N)Cl] (5.7)
A solution of N, N’-bis(2,6-isopropylphenyl)-4,5-dihydroimidazolinium chloride (SIPr.HCl) (12.0 mg,
0.281 mmol, 1 eq.) dissolved in THF (5 mL) was added to sodium hydride in mineral oil (60 % by
weight) (11.2 mg, 0.281 mmol, 1 eq.), which had been washed with hexane (2 x 2 mL), and stirred at
room temperature for 2 h. The solution turned bright yellow with a white solid precipitate. The
white solid was filtered off and extracted with THF (2 x 2 mL). The filtrate was reduced to a yellow
solid which was triturated with hexane (2 x 2 mL) to yield a white solid.
The solid was dissolved in THF (5 mL) and added to 5.1 (100 mg, 0.234 mmol, 1 eq.) and stirred at
room temperature for 16 h. The solution was filtered and reduced to a yellow powder which was
washed with hexane (2 x 4 mL) dried in vacuo.
7.4.8 Synthesis of [Ti(NtBu)(Cp*)2(C5H4N)] (5.8)(i) (Pentamethyl)cyclopentadienyl Lithium (2.25 eq.)
nButyl lithium (2.5 M in hexanes) (0.50 mL, 1.4 mmol, 2.25 eq.) was added dropwise to a solution of
(pentamethyl)cyclopentadiene (0.220 mL, 1.36 mmol, 2.25 eq.) in THF (10 mL) at -78oC and stirred
for 30 min. The solution was warmed to room temperature and added to a stirring suspension of 5.1
(250 mg, 0.603 mmol, 1 eq.) in THF (10 mL) and stirred at room temperature for 17 h under N2. The
volatiles were removed and the product extracted into toluene (2 x 5 mL) and filtered. Removal of
solvent gave a dark brown oil which was washed with hexane (2 x 5 mL) to give a small amount of
light yellow powder.
Yield: 4 % (10 mg); 1H NMR δ(C6D6) ppm: 1.25 (s,
tBu), 1.36 (s, 9 H, tBu), 1.89 (s, cp*),2.03 (s, 30 H,
Cp*),6.35 (s, py), 6.65 (s, py), 6.96 (br s, py),8.47 (s, py), 8.65 (s, py), 9.36 (s, py).
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(ii) (Pentamethyl)cyclopentadienyl Lithium (3 eq.)
nButyl lithium (2.5 M in hexanes) (0.72 mL, 1.81 mmol, 3 eq.) was added dropwise to a solution of
pentamethylcyclopentadiene (0.291 mL, 1.81 mmol, 3 eq.) in THF (10 mL) at -78 oC and stirred for 20
min and then added via cannula to a suspension of 5.1 (250 mg, 0.603 mmol, 1 eq.) in THF (10 mL)
and stirred at room temperature for 16 h. The solvents were removed to leave a dark brown oily
solid which was extracted with toluene (2 x 4 mL) and filtered. Removal of toluene left a dark brown
oil which was washed with cold hexane (3 x 5 mL) leaving a small amount of light brown solid. The
crude mixture was left in the freezer in a minimal amount of hexane for a week by which time some
small yellow crystals had formed around the edge of the Schlenk tube; however, they were not
suitable for X-ray diffraction studies.
Yield: 6 % (17 mg); 1H NMR δ(C6D6) ppm: 1.25 (s,
tBu), 1.36 (s, tBu), 1.89 (s, Cp*), 2.03 (s, Cp*), 6.35
(s, py), 6.71 (s, py), 6.96 (s, py), 8.47 (s, py), 8.68 (s, py), 9.36 (s, py).
7.4.9 1H NMR Experiments using Titanium Imido Complexes and CO2Reaction with 5.1
5.1 (10 mg) was dissolved in dry C6D6 in a Young’s NMR tube and placed in a large Schlenk tube
under an atmosphere of N2. Carbon dioxide was bubbled through the solution for 10 minutes. The
solution was heated to 45 oC for 10 min and left at room temperature for 24 h. At each of the three
stages the sample was monitored by 1H NMR spectroscopy. This process was repeated.Reaction with 5.2
5.2 (10 mg) was dissolved in dry C6D6 in a Young’s NMR tube and placed in a large Schlenk tube
under an atmosphere of N2. Carbon dioxide was bubbled through the solution for 10 minutes. The
solution was heated to 45 oC for 10 min and left at room temperature for 24 h. At each of the three
stages the sample was monitored by 1H NMR spectroscopy. This process was repeated.
7.4.10 Synthesis of [ZrCp2(NtBu)thf]
These reactions were carried out following previously reported procedures. [19] [20]Synthesis of [ZrCp2ClMe][19]
ZrCp2Cl2 (1.42 g, 4.85 mmol, 1 eq.) and ZrCp2Me2 (1.22 g, 4.85 mmol, 1 eq.) were suspended in
toluene and DCM and refluxed to 130 oC in a bomb (500 mL round botton flask fitted with a Young’s
tap) under vacuum for 30 h. A white powder was left after removal of the solvent which was
recrystallised from layering with toluene and hexane.
Yield : 75 % (7.29 mmol); 1H NMR δ(C6D6) ppm: 5.87 (s, 10 H, Cp-H), 0.56 (s, 3 H, CH3).
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Attempted Synthesis of [ZrCp2(NtBu)thf][20]
nButyllithium (2.5 M in hexanes) (0.70 ml, 1.8 mmol, 1.2 eq.) was added to a solution of tert-
butylamine in dry THF (5 mL) in a pre-dried Schlenk tube cooled to -78 oC and stirred for 1 h. The
mixture was warmed to room temperature and added to a solution of [Cp2ZrClMe] (400 mg, 1.47
mmol, 1 eq.) in THF (10 mL) and stirred at room temperature for 18 h. The solvent was removed and
the product extracted into hexanes (3 x 10 mL) and filtered via cannula into a pre-dried bomb. The
volatiles were removed and the crude product was re-dissolved in THF (20 mL), freeze-pump-thawed
twice and heated to 85 oC under vacuum for 3.5 days. The THF was removed in vacuo and the crude
product was dissolved in toluene (4 mL) and filtered into a pre-dried Schlenk and layered with
hexane (10 mL) and stored at -30 oC for 2 days yielding a dark brown powder.
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Table 1. Crystal data and structure refinement for 3.1.
Identification code NL1005
Formula C23 H21 Cl2 Fe P Pd S
Formula weight 593.58
Temperature 173(2) K
Diffractometer, wavelength OD Xcalibur PX Ultra, 1.54184 Å
Crystal system, space group Monoclinic, C2/c
Unit cell dimensions a = 11.30094(10) Å  = 90°
b = 22.13550(16) Å  = 107.1799(9)°
c = 17.99008(14) Å  = 90°
Volume, Z 4299.46(6) Å3, 8
Density (calculated) 1.834 Mg/m3
Absorption coefficient 16.116 mm-1
F(000) 2368
Crystal colour / morphology Orange blocks
Crystal size 0.21 x 0.06 x 0.01 mm3
 range for data collection 3.99 to 72.54°
Index ranges -13<=h<=11, -27<=k<=24, -22<=l<=17
Reflns collected / unique 10442 / 4122 [R(int) = 0.0301]
Reflns observed [F>4(F)] 3568
Absorption correction Analytical
Max. and min. transmission 0.836 and 0.292
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 4122 / 0 / 264
Goodness-of-fit on F2 1.015
Final R indices [F>4(F)] R1 = 0.0294, wR2 = 0.0752
R indices (all data) R1 = 0.0350, wR2 = 0.0774
Extinction coefficient 0.000061(12)
Largest diff. peak, hole 0.449, -0.703 eÅ-3
Mean and maximum shift/error 0.000 and 0.003
Table 2. Bond lengths [Å] and angles [°] for 3.1.
Pd-P(12) 2.2620(7)
Pd-Cl(1) 2.2898(7)
Pd-S(1) 2.3208(7)
Pd-Cl(2) 2.3564(7)
Fe-C(2) 2.013(3)
Fe-C(8) 2.027(3)
Fe-C(6) 2.032(3)
Fe-C(7) 2.034(3)
Fe-C(11) 2.041(3)
Fe-C(3) 2.047(3)
Fe-C(9) 2.047(3)
Fe-C(5) 2.050(3)
Fe-C(10) 2.053(3)
Fe-C(4) 2.061(3)
S(1)-C(2) 1.753(3)
S(1)-C(13) 1.814(3)
C(2)-C(6) 1.431(4)
C(2)-C(3) 1.435(4)
C(3)-C(4) 1.426(5)
C(4)-C(5) 1.417(5)
C(5)-C(6) 1.428(5)
C(7)-C(11) 1.433(5)
C(7)-C(8) 1.440(4)
C(7)-P(12) 1.802(3)
C(8)-C(9) 1.420(5)
C(9)-C(10) 1.423(5)
C(10)-C(11) 1.416(5)
P(12)-C(20) 1.815(3)
P(12)-C(14) 1.830(3)
C(14)-C(19) 1.386(5)
C(14)-C(15) 1.392(5)
C(15)-C(16) 1.388(4)
C(16)-C(17) 1.390(5)
C(17)-C(18) 1.381(5)
C(18)-C(19) 1.394(4)
C(20)-C(21) 1.388(4)
C(20)-C(25) 1.398(4)
C(21)-C(22) 1.411(4)
C(22)-C(23) 1.384(5)
C(23)-C(24) 1.389(5)
C(24)-C(25) 1.387(4)
P(12)-Pd-Cl(1) 88.49(3)
P(12)-Pd-S(1) 88.32(2)
Cl(1)-Pd-S(1) 176.68(3)
P(12)-Pd-Cl(2) 167.21(3)
Cl(1)-Pd-Cl(2) 89.53(3)
S(1)-Pd-Cl(2) 93.78(3)
C(2)-Fe-C(8) 122.35(14)
C(2)-Fe-C(6) 41.42(12)
C(8)-Fe-C(6) 105.61(14)
C(2)-Fe-C(7) 107.50(12)
C(8)-Fe-C(7) 41.54(12)
C(6)-Fe-C(7) 122.43(13)
C(2)-Fe-C(11) 124.20(13)
C(8)-Fe-C(11) 69.12(13)
C(6)-Fe-C(11) 160.25(14)
C(7)-Fe-C(11) 41.16(13)
C(2)-Fe-C(3) 41.39(12)
C(8)-Fe-C(3) 160.12(14)
C(6)-Fe-C(3) 69.43(12)
C(7)-Fe-C(3) 123.79(12)
C(11)-Fe-C(3) 108.71(13)
C(2)-Fe-C(9) 157.98(14)
C(8)-Fe-C(9) 40.79(15)
C(6)-Fe-C(9) 120.69(14)
C(7)-Fe-C(9) 69.19(13)
C(11)-Fe-C(9) 68.50(14)
C(3)-Fe-C(9) 158.36(14)
C(2)-Fe-C(5) 68.93(13)
C(8)-Fe-C(5) 121.23(14)
C(6)-Fe-C(5) 40.94(14)
C(7)-Fe-C(5) 158.58(13)
C(11)-Fe-C(5) 158.12(14)
C(3)-Fe-C(5) 68.37(13)
C(9)-Fe-C(5) 105.80(14)
C(2)-Fe-C(10) 160.29(14)
C(8)-Fe-C(10) 68.65(15)
C(6)-Fe-C(10) 157.04(15)
C(7)-Fe-C(10) 68.89(13)
C(11)-Fe-C(10) 40.47(15)
C(3)-Fe-C(10) 123.36(14)
C(9)-Fe-C(10) 40.61(16)
C(5)-Fe-C(10) 121.64(14)
C(2)-Fe-C(4) 69.00(12)
C(8)-Fe-C(4) 157.18(13)
C(6)-Fe-C(4) 68.85(13)
C(7)-Fe-C(4) 159.95(12)
C(11)-Fe-C(4) 123.35(14)
C(3)-Fe-C(4) 40.64(13)
C(9)-Fe-C(4) 121.62(14)
C(5)-Fe-C(4) 40.30(14)
C(10)-Fe-C(4) 107.37(14)
C(2)-S(1)-C(13) 99.81(14)
C(2)-S(1)-Pd 104.31(10)
C(13)-S(1)-Pd 112.81(11)
C(6)-C(2)-C(3) 108.3(3)
C(6)-C(2)-S(1) 127.9(2)
C(3)-C(2)-S(1) 123.8(2)
C(6)-C(2)-Fe 70.00(17)
C(3)-C(2)-Fe 70.57(17)
S(1)-C(2)-Fe 123.50(15)
C(4)-C(3)-C(2) 107.5(3)
C(4)-C(3)-Fe 70.22(18)
C(2)-C(3)-Fe 68.04(16)
C(5)-C(4)-C(3) 108.1(3)
C(5)-C(4)-Fe 69.44(19)
C(3)-C(4)-Fe 69.15(18)
C(4)-C(5)-C(6) 108.9(3)
C(4)-C(5)-Fe 70.25(18)
C(6)-C(5)-Fe 68.84(17)
C(5)-C(6)-C(2) 107.1(3)
C(5)-C(6)-Fe 70.22(18)
C(2)-C(6)-Fe 68.58(16)
C(11)-C(7)-C(8) 106.9(3)
C(11)-C(7)-P(12) 130.9(2)
C(8)-C(7)-P(12) 122.2(2)
C(11)-C(7)-Fe 69.69(17)
C(8)-C(7)-Fe 68.96(17)
P(12)-C(7)-Fe 126.35(16)
C(9)-C(8)-C(7) 108.2(3)
C(9)-C(8)-Fe 70.37(18)
C(7)-C(8)-Fe 69.50(16)
C(8)-C(9)-C(10) 108.1(3)
C(8)-C(9)-Fe 68.85(18)
C(10)-C(9)-Fe 69.91(19)
C(11)-C(10)-C(9) 108.3(3)
C(11)-C(10)-Fe 69.33(19)
C(9)-C(10)-Fe 69.48(19)
C(10)-C(11)-C(7) 108.5(3)
C(10)-C(11)-Fe 70.19(18)
C(7)-C(11)-Fe 69.15(17)
C(7)-P(12)-C(20) 107.62(14)
C(7)-P(12)-C(14) 104.31(14)
C(20)-P(12)-C(14) 100.95(13)
C(7)-P(12)-Pd 105.36(9)
C(20)-P(12)-Pd 120.04(10)
C(14)-P(12)-Pd 117.32(10)
C(19)-C(14)-C(15) 120.0(3)
C(19)-C(14)-P(12) 117.9(2)
C(15)-C(14)-P(12) 122.1(2)
C(16)-C(15)-C(14) 119.8(3)
C(15)-C(16)-C(17) 120.3(3)
C(18)-C(17)-C(16) 119.9(3)
C(17)-C(18)-C(19) 120.2(3)
C(14)-C(19)-C(18) 120.0(3)
C(21)-C(20)-C(25) 119.7(3)
C(21)-C(20)-P(12) 120.7(2)
C(25)-C(20)-P(12) 119.0(2)
C(20)-C(21)-C(22) 119.7(3)
C(23)-C(22)-C(21) 119.8(3)
C(22)-C(23)-C(24) 120.4(3)
C(25)-C(24)-C(23) 119.9(3)
C(24)-C(25)-C(20) 120.4(3)
Table 3. Crystal data and structure refinement for 3.4.
Identification code NL1006
Formula C23 H25 Cl2 P Pd S
Formula weight 541.76
Temperature 173(2) K
Diffractometer, wavelength OD Xcalibur 3, 0.71073 Å
Crystal system, space group Monoclinic, P2(1)/c
Unit cell dimensions a = 15.0709(4) Å  = 90°
b = 8.3116(2) Å  = 101.899(3)°
c = 18.7819(5) Å  = 90°
Volume, Z 2302.13(11) Å3, 4
Density (calculated) 1.563 Mg/m3
Absorption coefficient 1.206 mm-1
F(000) 1096
Crystal colour / morphology Yellow needles
Crystal size 0.46 x 0.05 x 0.02 mm3
 range for data collection 3.13 to 29.87°
Index ranges -13<=h<=19, -7<=k<=11, -23<=l<=26
Reflns collected / unique 11073 / 5551 [R(int) = 0.0294]
Reflns observed [F>4(F)] 3862
Absorption correction Analytical
Max. and min. transmission 0.973 and 0.742
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 5551 / 0 / 276
Goodness-of-fit on F2 0.988
Final R indices [F>4(F)] R1 = 0.0328, wR2 = 0.0705
R indices (all data) R1 = 0.0555, wR2 = 0.0730
Largest diff. peak, hole 1.182, -0.633 eÅ-3
Mean and maximum shift/error 0.000 and 0.002
Table 4. Bond lengths [Å] and angles [°] for 3.4.
Pd-P(1) 2.2383(9)
Pd-S(5) 2.2789(9)
Pd-Cl(2) 2.3063(8)
Pd-Cl(1) 2.3605(8)
P(1)-C(6) 1.815(3)
P(1)-C(2) 1.820(3)
P(1)-C(12) 1.826(3)
C(2)-C(3) 1.512(4)
C(3)-C(4) 1.511(4)
C(4)-S(5) 1.821(3)
S(5)-C(18) 1.787(3)
C(6)-C(11) 1.384(4)
C(6)-C(7) 1.390(4)
C(7)-C(8) 1.375(5)
C(8)-C(9) 1.363(5)
C(9)-C(10) 1.375(5)
C(10)-C(11) 1.383(4)
C(12)-C(17) 1.370(4)
C(12)-C(13) 1.393(4)
C(13)-C(14) 1.388(5)
C(14)-C(15) 1.365(5)
C(15)-C(16) 1.371(5)
C(16)-C(17) 1.380(4)
C(18)-C(23) 1.403(4)
C(18)-C(19) 1.407(4)
C(19)-C(20) 1.389(5)
C(19)-C(24) 1.502(4)
C(20)-C(21) 1.380(5)
C(21)-C(22) 1.383(5)
C(22)-C(23) 1.377(4)
C(23)-C(25) 1.517(4)
Pd'-P(1') 2.15(5)
Pd'-Cl(1') 2.24(4)
Pd'-Cl(2') 2.26(3)
Pd'-S(5') 2.27(4)
P(1)-Pd-S(5) 98.35(3)
P(1)-Pd-Cl(2) 84.40(3)
S(5)-Pd-Cl(2) 174.90(3)
P(1)-Pd-Cl(1) 174.91(3)
S(5)-Pd-Cl(1) 83.55(3)
Cl(2)-Pd-Cl(1) 93.36(3)
C(6)-P(1)-C(2) 104.76(15)
C(6)-P(1)-C(12) 108.05(14)
C(2)-P(1)-C(12) 104.27(15)
C(6)-P(1)-Pd 113.44(10)
C(2)-P(1)-Pd 115.42(11)
C(12)-P(1)-Pd 110.24(11)
C(3)-C(2)-P(1) 113.5(2)
C(4)-C(3)-C(2) 113.8(3)
C(3)-C(4)-S(5) 111.7(2)
C(18)-S(5)-C(4) 101.20(15)
C(18)-S(5)-Pd 112.05(11)
C(4)-S(5)-Pd 116.03(12)
C(11)-C(6)-C(7) 118.8(3)
C(11)-C(6)-P(1) 122.6(2)
C(7)-C(6)-P(1) 118.5(2)
C(8)-C(7)-C(6) 120.3(3)
C(9)-C(8)-C(7) 120.7(3)
C(8)-C(9)-C(10) 119.8(3)
C(9)-C(10)-C(11) 120.3(3)
C(10)-C(11)-C(6) 120.1(3)
C(17)-C(12)-C(13) 119.2(3)
C(17)-C(12)-P(1) 121.2(2)
C(13)-C(12)-P(1) 119.5(2)
C(14)-C(13)-C(12) 119.7(3)
C(15)-C(14)-C(13) 120.1(4)
C(14)-C(15)-C(16) 120.3(3)
C(15)-C(16)-C(17) 119.9(3)
C(12)-C(17)-C(16) 120.7(3)
C(23)-C(18)-C(19) 121.6(3)
C(23)-C(18)-S(5) 122.8(2)
C(19)-C(18)-S(5) 115.6(2)
C(20)-C(19)-C(18) 117.3(3)
C(20)-C(19)-C(24) 120.5(3)
C(18)-C(19)-C(24) 122.1(3)
C(21)-C(20)-C(19) 121.7(3)
C(20)-C(21)-C(22) 119.6(3)
C(23)-C(22)-C(21) 121.3(3)
C(22)-C(23)-C(18) 118.3(3)
C(22)-C(23)-C(25) 118.4(3)
C(18)-C(23)-C(25) 123.3(3)
P(1')-Pd'-Cl(1') 166.1(16)
P(1')-Pd'-Cl(2') 83.4(15)
Cl(1')-Pd'-Cl(2') 96.1(13)
P(1')-Pd'-S(5') 96.0(16)
Cl(1')-Pd'-S(5') 83.7(14)
Cl(2')-Pd'-S(5') 176.5(12)
Table 5. Crystal data and structure refinement for 3.5.
Identification code NL1003
Formula C22 H23 Cl2 P Pd S
Formula weight 527.73
Temperature 173 K
Diffractometer, wavelength OD Xcalibur 3, 0.71073 Å
Crystal system, space group Monoclinic, P2(1)/n
Unit cell dimensions a = 12.4415(3) Å  = 90°
b = 11.2434(2) Å  = 103.798(2)°
c = 15.6501(3) Å  = 90°
Volume, Z 2126.04(8) Å3, 4
Density (calculated) 1.649 Mg/m3
Absorption coefficient 1.303 mm-1
F(000) 1064
Crystal colour / morphology Yellow thin plates
Crystal size 0.41 x 0.15 x 0.02 mm3
 range for data collection 3.00 to 32.88°
Index ranges -18<=h<=8, -13<=k<=17, -21<=l<=23
Reflns collected / unique 14636 / 7061 [R(int) = 0.0220]
Reflns observed [F>4(F)] 4713
Absorption correction Analytical
Max. and min. transmission 0.973 and 0.828
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 7061 / 0 / 246
Goodness-of-fit on F2 0.859
Final R indices [F>4(F)] R1 = 0.0260, wR2 = 0.0494
R indices (all data) R1 = 0.0526, wR2 = 0.0516
Largest diff. peak, hole 0.646, -0.368 eÅ-3
Mean and maximum shift/error 0.000 and 0.001
Table 6. Bond lengths [Å] and angles [°] for 3.5.
Pd-P(1) 2.2265(5)
Pd-S(4) 2.2864(5)
Pd-Cl(2) 2.3148(5)
Pd-Cl(1) 2.3596(5)
P(1)-C(11) 1.8071(18)
P(1)-C(5) 1.8127(18)
P(1)-C(2) 1.8381(18)
C(2)-C(3) 1.517(3)
C(3)-S(4) 1.831(2)
S(4)-C(17) 1.7899(18)
C(5)-C(10) 1.391(3)
C(5)-C(6) 1.398(2)
C(6)-C(7) 1.381(3)
C(7)-C(8) 1.380(3)
C(8)-C(9) 1.373(3)
C(9)-C(10) 1.386(3)
C(11)-C(12) 1.381(3)
C(11)-C(16) 1.381(3)
C(12)-C(13) 1.388(3)
C(13)-C(14) 1.379(3)
C(14)-C(15) 1.376(3)
C(15)-C(16) 1.393(3)
C(17)-C(22) 1.405(2)
C(17)-C(18) 1.406(3)
C(18)-C(19) 1.396(3)
C(18)-C(23) 1.507(3)
C(19)-C(20) 1.370(3)
C(20)-C(21) 1.375(3)
C(21)-C(22) 1.393(3)
C(22)-C(24) 1.500(3)
P(1)-Pd-S(4) 87.420(18)
P(1)-Pd-Cl(2) 90.240(18)
S(4)-Pd-Cl(2) 176.779(19)
P(1)-Pd-Cl(1) 175.522(19)
S(4)-Pd-Cl(1) 88.984(18)
Cl(2)-Pd-Cl(1) 93.455(18)
C(11)-P(1)-C(5) 107.75(9)
C(11)-P(1)-C(2) 104.80(8)
C(5)-P(1)-C(2) 106.49(9)
C(11)-P(1)-Pd 119.66(7)
C(5)-P(1)-Pd 111.59(6)
C(2)-P(1)-Pd 105.58(7)
C(3)-C(2)-P(1) 109.62(12)
C(2)-C(3)-S(4) 107.23(13)
C(17)-S(4)-C(3) 102.56(9)
C(17)-S(4)-Pd 114.79(6)
C(3)-S(4)-Pd 105.40(6)
C(10)-C(5)-C(6) 119.30(17)
C(10)-C(5)-P(1) 122.03(14)
C(6)-C(5)-P(1) 118.66(14)
C(7)-C(6)-C(5) 119.76(18)
C(8)-C(7)-C(6) 120.21(18)
C(9)-C(8)-C(7) 120.60(18)
C(8)-C(9)-C(10) 119.87(19)
C(9)-C(10)-C(5) 120.24(18)
C(12)-C(11)-C(16) 119.74(18)
C(12)-C(11)-P(1) 121.79(15)
C(16)-C(11)-P(1) 118.40(16)
C(11)-C(12)-C(13) 120.54(19)
C(14)-C(13)-C(12) 119.4(2)
C(15)-C(14)-C(13) 120.47(19)
C(14)-C(15)-C(16) 120.0(2)
C(11)-C(16)-C(15) 119.8(2)
C(22)-C(17)-C(18) 122.07(17)
C(22)-C(17)-S(4) 122.20(15)
C(18)-C(17)-S(4) 115.72(14)
C(19)-C(18)-C(17) 117.77(18)
C(19)-C(18)-C(23) 118.99(18)
C(17)-C(18)-C(23) 123.23(17)
C(20)-C(19)-C(18) 120.6(2)
C(19)-C(20)-C(21) 121.15(19)
C(20)-C(21)-C(22) 121.09(19)
C(21)-C(22)-C(17) 117.29(18)
C(21)-C(22)-C(24) 119.17(17)
C(17)-C(22)-C(24) 123.49(16)
Table 7. Crystal data and structure refinement for 3.6.
Identification code NL1009
Formula C40 H38 Cl4 O2 P2 Pd2
Formula weight 967.24
Temperature 173(2) K
Diffractometer, wavelength OD Xcalibur 3, 0.71073 Å
Crystal system, space group Monoclinic, P2(1)/n
Unit cell dimensions a = 9.28195(13) Å  = 90°
b = 18.8796(2) Å  = 105.9023(15)°
c = 11.46797(18) Å  = 90°
Volume, Z 1932.73(5) Å3, 2
Density (calculated) 1.662 Mg/m3
Absorption coefficient 1.325 mm-1
F(000) 968
Crystal colour / morphology Orange blocky needles
Crystal size 0.25 x 0.16 x 0.09 mm3
 range for data collection 3.31 to 32.95°
Index ranges -13<=h<=14, -28<=k<=27, -14<=l<=17
Reflns collected / unique 21013 / 6551 [R(int) = 0.0207]
Reflns observed [F>4(F)] 5086
Absorption correction Analytical
Max. and min. transmission 0.903 and 0.809
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 6551 / 0 / 226
Goodness-of-fit on F2 0.983
Final R indices [F>4(F)] R1 = 0.0220, wR2 = 0.0504
R indices (all data) R1 = 0.0355, wR2 = 0.0521
Largest diff. peak, hole 0.500, -0.479 eÅ-3
Mean and maximum shift/error 0.000 and 0.005
Table 8. Bond lengths [Å] and angles [°] for 3.6.
Pd(1)-P(1) 2.2233(4)
Pd(1)-Cl(2) 2.2738(4)
Pd(1)-Cl(1) 2.3286(4)
Pd(1)-Cl(1)#1 2.4301(4)
Cl(1)-Pd(1)#1 2.4301(3)
P(1)-C(5) 1.8081(14)
P(1)-C(11) 1.8087(14)
P(1)-C(2) 1.8210(15)
C(2)-C(3) 1.524(2)
C(3)-O(4) 1.4329(18)
O(4)-C(17) 1.3736(19)
C(5)-C(10) 1.386(2)
C(5)-C(6) 1.394(2)
C(6)-C(7) 1.380(2)
C(7)-C(8) 1.364(3)
C(8)-C(9) 1.374(3)
C(9)-C(10) 1.389(2)
C(11)-C(16) 1.3966(19)
C(11)-C(12) 1.3983(19)
C(12)-C(13) 1.391(2)
C(13)-C(14) 1.374(2)
C(14)-C(15) 1.383(2)
C(15)-C(16) 1.387(2)
C(17)-C(22) 1.389(2)
C(17)-C(18) 1.390(2)
C(18)-C(19) 1.378(2)
C(19)-C(20) 1.384(2)
C(20)-C(21) 1.378(2)
C(21)-C(22) 1.384(2)
P(1)-Pd(1)-Cl(2) 89.516(14)
P(1)-Pd(1)-Cl(1) 93.578(13)
Cl(2)-Pd(1)-Cl(1) 176.240(13)
P(1)-Pd(1)-Cl(1)#1 175.831(14)
Cl(2)-Pd(1)-Cl(1)#1 90.830(13)
Cl(1)-Pd(1)-Cl(1)#1 85.929(13)
Pd(1)-Cl(1)-Pd(1)#1 94.071(12)
C(5)-P(1)-C(11) 107.01(6)
C(5)-P(1)-C(2) 107.17(7)
C(11)-P(1)-C(2) 102.92(7)
C(5)-P(1)-Pd(1) 108.83(5)
C(11)-P(1)-Pd(1) 113.87(5)
C(2)-P(1)-Pd(1) 116.44(5)
C(3)-C(2)-P(1) 111.58(10)
O(4)-C(3)-C(2) 112.22(12)
C(17)-O(4)-C(3) 119.38(11)
C(10)-C(5)-C(6) 119.06(14)
C(10)-C(5)-P(1) 118.09(12)
C(6)-C(5)-P(1) 122.84(12)
C(7)-C(6)-C(5) 119.70(16)
C(8)-C(7)-C(6) 121.12(17)
C(7)-C(8)-C(9) 119.77(16)
C(8)-C(9)-C(10) 120.25(19)
C(5)-C(10)-C(9) 120.09(17)
C(16)-C(11)-C(12) 119.48(13)
C(16)-C(11)-P(1) 119.03(10)
C(12)-C(11)-P(1) 121.16(10)
C(13)-C(12)-C(11) 119.48(13)
C(14)-C(13)-C(12) 120.47(14)
C(13)-C(14)-C(15) 120.58(13)
C(14)-C(15)-C(16) 119.75(14)
C(15)-C(16)-C(11) 120.21(13)
O(4)-C(17)-C(22) 125.21(14)
O(4)-C(17)-C(18) 114.87(13)
C(22)-C(17)-C(18) 119.92(15)
C(19)-C(18)-C(17) 119.99(14)
C(18)-C(19)-C(20) 120.63(16)
C(21)-C(20)-C(19) 118.89(17)
C(20)-C(21)-C(22) 121.57(15)
C(21)-C(22)-C(17) 118.95(15)
Symmetry transformations used to generate equivalent atoms:
#1 -x+1,-y+1,-z+2
Table 9. Crystal data and structure refinement for 3.8.
Identification code NL1010
Formula [C40 H40 O3 P2 Pd](C F3 S O3)2 . H2 O
Formula weight 1053.22
Temperature 173(2) K
Diffractometer, wavelength OD Xcalibur 3, 0.71073 Å
Crystal system, space group Triclinic, P-1
Unit cell dimensions a = 11.5888(2) Å  = 79.2153(17)°
b = 14.1314(3) Å  = 73.1483(17)°
c = 14.3872(3) Å  = 89.8908(17)°
Volume, Z 2211.69(8) Å3, 2
Density (calculated) 1.582 Mg/m3
Absorption coefficient 0.668 mm-1
F(000) 1072
Crystal colour / morphology Yellow blocky needles
Crystal size 0.40 x 0.19 x 0.06 mm3
 range for data collection 2.88 to 32.91°
Index ranges -17<=h<=12, -21<=k<=20, -21<=l<=20
Reflns collected / unique 26160 / 14482 [R(int) = 0.0267]
Reflns observed [F>4(F)] 12371
Absorption correction Analytical
Max. and min. transmission 0.967 and 0.857
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 14482 / 119 / 617
Goodness-of-fit on F2 1.075
Final R indices [F>4(F)] R1 = 0.0364, wR2 = 0.0952
R indices (all data) R1 = 0.0465, wR2 = 0.0997
Largest diff. peak, hole 1.334, -0.772 eÅ-3
Mean and maximum shift/error 0.000 and 0.003
Table 10. Bond lengths [Å] and angles [°] for 3.8.
Pd-O(60) 2.1164(13)
Pd-O(4) 2.1682(12)
Pd-P(1) 2.2190(4)
Pd-P(31) 2.2522(4)
P(1)-C(11) 1.7974(19)
P(1)-C(5) 1.8000(18)
P(1)-C(2) 1.8341(18)
C(2)-C(3) 1.509(3)
C(3)-O(4) 1.459(2)
O(4)-C(17) 1.413(2)
C(5)-C(10) 1.395(3)
C(5)-C(6) 1.401(3)
C(6)-C(7) 1.390(3)
C(7)-C(8) 1.381(3)
C(8)-C(9) 1.378(3)
C(9)-C(10) 1.396(3)
C(11)-C(16) 1.396(3)
C(11)-C(12) 1.401(3)
C(12)-C(13) 1.388(3)
C(13)-C(14) 1.383(4)
C(14)-C(15) 1.372(4)
C(15)-C(16) 1.388(3)
C(17)-C(18) 1.375(3)
C(17)-C(22) 1.380(3)
C(18)-C(19) 1.392(3)
C(19)-C(20) 1.377(4)
C(20)-C(21) 1.383(4)
C(21)-C(22) 1.394(3)
P(31)-C(41) 1.8024(19)
P(31)-C(35) 1.8071(19)
P(31)-C(32) 1.8340(19)
C(32)-C(33) 1.514(3)
C(33)-O(34) 1.423(2)
O(34)-C(47) 1.373(2)
C(35)-C(40) 1.391(3)
C(35)-C(36) 1.402(3)
C(36)-C(37) 1.389(3)
C(37)-C(38) 1.374(5)
C(38)-C(39) 1.363(5)
C(39)-C(40) 1.409(4)
C(41)-C(42) 1.396(3)
C(41)-C(46) 1.398(3)
C(42)-C(43) 1.395(3)
C(43)-C(44) 1.375(4)
C(44)-C(45) 1.383(4)
C(45)-C(46) 1.388(3)
C(47)-C(48) 1.384(3)
C(47)-C(52) 1.392(3)
C(48)-C(49) 1.391(3)
C(49)-C(50) 1.383(4)
C(50)-C(51) 1.378(4)
C(51)-C(52) 1.383(3)
O(60)-Pd-O(4) 87.39(5)
O(60)-Pd-P(1) 165.06(4)
O(4)-Pd-P(1) 82.70(3)
O(60)-Pd-P(31) 93.26(4)
O(4)-Pd-P(31) 177.01(4)
P(1)-Pd-P(31) 97.212(17)
C(11)-P(1)-C(5) 110.16(9)
C(11)-P(1)-C(2) 105.38(8)
C(5)-P(1)-C(2) 103.90(8)
C(11)-P(1)-Pd 117.63(6)
C(5)-P(1)-Pd 119.04(6)
C(2)-P(1)-Pd 97.79(6)
C(3)-C(2)-P(1) 111.24(12)
O(4)-C(3)-C(2) 107.72(14)
C(17)-O(4)-C(3) 112.96(13)
C(17)-O(4)-Pd 122.31(10)
C(3)-O(4)-Pd 119.10(10)
C(10)-C(5)-C(6) 120.02(17)
C(10)-C(5)-P(1) 123.07(15)
C(6)-C(5)-P(1) 116.92(14)
C(7)-C(6)-C(5) 119.38(18)
C(8)-C(7)-C(6) 120.3(2)
C(9)-C(8)-C(7) 120.70(19)
C(8)-C(9)-C(10) 120.02(19)
C(5)-C(10)-C(9) 119.59(19)
C(16)-C(11)-C(12) 119.84(18)
C(16)-C(11)-P(1) 119.91(14)
C(12)-C(11)-P(1) 120.04(15)
C(13)-C(12)-C(11) 119.8(2)
C(14)-C(13)-C(12) 119.8(2)
C(15)-C(14)-C(13) 120.5(2)
C(14)-C(15)-C(16) 120.8(2)
C(15)-C(16)-C(11) 119.2(2)
C(18)-C(17)-C(22) 122.44(19)
C(18)-C(17)-O(4) 119.06(17)
C(22)-C(17)-O(4) 118.50(19)
C(17)-C(18)-C(19) 118.7(2)
C(20)-C(19)-C(18) 120.1(2)
C(19)-C(20)-C(21) 120.2(2)
C(20)-C(21)-C(22) 120.5(2)
C(17)-C(22)-C(21) 118.0(2)
C(41)-P(31)-C(35) 109.45(9)
C(41)-P(31)-C(32) 106.72(9)
C(35)-P(31)-C(32) 106.98(10)
C(41)-P(31)-Pd 110.37(6)
C(35)-P(31)-Pd 117.14(6)
C(32)-P(31)-Pd 105.58(6)
C(33)-C(32)-P(31) 115.47(14)
O(34)-C(33)-C(32) 108.99(15)
C(47)-O(34)-C(33) 116.41(15)
C(40)-C(35)-C(36) 119.5(2)
C(40)-C(35)-P(31) 118.82(18)
C(36)-C(35)-P(31) 121.57(17)
C(37)-C(36)-C(35) 120.4(3)
C(38)-C(37)-C(36) 120.0(3)
C(39)-C(38)-C(37) 120.1(2)
C(38)-C(39)-C(40) 121.6(3)
C(35)-C(40)-C(39) 118.4(3)
C(42)-C(41)-C(46) 119.05(19)
C(42)-C(41)-P(31) 117.93(15)
C(46)-C(41)-P(31) 122.95(16)
C(43)-C(42)-C(41) 120.4(2)
C(44)-C(43)-C(42) 119.7(2)
C(43)-C(44)-C(45) 120.6(2)
C(44)-C(45)-C(46) 120.2(2)
C(45)-C(46)-C(41) 120.0(2)
O(34)-C(47)-C(48) 124.53(18)
O(34)-C(47)-C(52) 115.29(17)
C(48)-C(47)-C(52) 120.18(19)
C(47)-C(48)-C(49) 119.2(2)
C(50)-C(49)-C(48) 120.9(2)
C(51)-C(50)-C(49) 119.4(2)
C(50)-C(51)-C(52) 120.7(2)
C(51)-C(52)-C(47) 119.7(2)
Table 11. Crystal data and structure refinement for 5.2.
Identification code NL0902
Empirical formula C18 H27 Cl N2 Ti
Formula weight 354.77
Temperature 173(2) K
Diffractometer, wavelength OD Xcalibur PX Ultra, 1.54184 Å
Crystal system, space group Triclinic, P-1
Unit cell dimensions a = 10.3307(4) Å  = 85.842(3)°
b = 13.6295(4) Å  = 80.344(3)°
c = 14.4963(4) Å  = 74.331(3)°
Volume, Z 1936.62(11) Å3, 4
Density (calculated) 1.217 Mg/m3
Absorption coefficient 4.982 mm-1
F(000) 752
Crystal colour / morphology Orange plates
Crystal size 0.25 x 0.13 x 0.03 mm3
 range for data collection 3.09 to 72.48°
Index ranges -12<=h<=12, -16<=k<=13, -17<=l<=17
Reflns collected / unique 12607 / 7344 [R(int) = 0.0316]
Reflns observed [F>4(F)] 5770
Absorption correction Analytical
Max. and min. transmission 0.889 and 0.470
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 7344 / 54 / 418
Goodness-of-fit on F2 0.975
Final R indices [F>4(F)] R1 = 0.0398, wR2 = 0.1010
R indices (all data) R1 = 0.0528, wR2 = 0.1061
Largest diff. peak, hole 0.387, -0.402 eÅ-3
Mean and maximum shift/error 0.000 and 0.001
Table 12. Bond lengths [Å] and angles [°] for 5.2.
Ti(1A)-N(1A) 1.7107(18)
Ti(1A)-N(6A) 2.1842(17)
Ti(1A)-C(12A) 2.330(2)
Ti(1A)-Cl(1A) 2.3552(6)
Ti(1A)-C(13A) 2.360(2)
Ti(1A)-C(16A) 2.390(2)
Ti(1A)-C(14A) 2.446(2)
Ti(1A)-C(15A) 2.461(2)
N(1A)-C(2A) 1.444(3)
C(2A)-C(3') 1.478(14)
C(2A)-C(4A) 1.498(5)
C(2A)-C(5') 1.498(13)
C(2A)-C(3A) 1.524(4)
C(2A)-C(4') 1.544(15)
C(2A)-C(5A) 1.546(5)
N(6A)-C(11A) 1.345(3)
N(6A)-C(7A) 1.345(3)
C(7A)-C(8A) 1.380(3)
C(8A)-C(9A) 1.375(4)
C(9A)-C(10A) 1.387(4)
C(10A)-C(11A) 1.373(3)
C(12A)-C(16A) 1.408(3)
C(12A)-C(13A) 1.410(3)
C(13A)-C(14A) 1.420(3)
C(13A)-C(17A) 1.499(4)
C(14A)-C(15A) 1.408(4)
C(14A)-C(18A) 1.507(3)
C(15A)-C(16A) 1.419(3)
C(15A)-C(19A) 1.500(3)
C(16A)-C(20A) 1.500(3)
Ti(1B)-N(1B) 1.7111(19)
Ti(1B)-N(6B) 2.1800(18)
Ti(1B)-C(12B) 2.319(2)
Ti(1B)-Cl(1B) 2.3526(7)
Ti(1B)-C(13B) 2.355(2)
Ti(1B)-C(16B) 2.400(2)
Ti(1B)-C(14B) 2.441(2)
Ti(1B)-C(15B) 2.463(2)
N(1B)-C(2B) 1.446(3)
C(2B)-C(5B) 1.491(4)
C(2B)-C(3B) 1.514(4)
C(2B)-C(4B) 1.553(5)
N(6B)-C(7B) 1.341(3)
N(6B)-C(11B) 1.344(3)
C(7B)-C(8B) 1.380(3)
C(8B)-C(9B) 1.373(4)
C(9B)-C(10B) 1.382(5)
C(10B)-C(11B) 1.388(4)
C(12B)-C(13B) 1.412(3)
C(12B)-C(16B) 1.418(4)
C(13B)-C(14B) 1.412(3)
C(13B)-C(17B) 1.499(3)
C(14B)-C(15B) 1.412(4)
C(14B)-C(18B) 1.510(4)
C(15B)-C(16B) 1.403(5)
C(15B)-C(19B) 1.508(4)
C(16B)-C(20B) 1.500(4)
N(1A)-Ti(1A)-N(6A) 98.05(8)
N(1A)-Ti(1A)-C(12A) 95.35(9)
N(6A)-Ti(1A)-C(12A) 132.31(8)
N(1A)-Ti(1A)-Cl(1A) 106.34(7)
N(6A)-Ti(1A)-Cl(1A) 97.44(5)
C(12A)-Ti(1A)-Cl(1A) 122.04(6)
N(1A)-Ti(1A)-C(13A) 101.83(9)
N(6A)-Ti(1A)-C(13A) 97.38(8)
C(12A)-Ti(1A)-C(13A) 34.97(8)
Cl(1A)-Ti(1A)-C(13A) 145.83(6)
N(1A)-Ti(1A)-C(16A) 121.30(8)
N(6A)-Ti(1A)-C(16A) 135.65(7)
C(12A)-Ti(1A)-C(16A) 34.68(8)
Cl(1A)-Ti(1A)-C(16A) 90.68(6)
C(13A)-Ti(1A)-C(16A) 57.78(8)
N(1A)-Ti(1A)-C(14A) 134.44(9)
N(6A)-Ti(1A)-C(14A) 82.17(7)
C(12A)-Ti(1A)-C(14A) 56.76(7)
Cl(1A)-Ti(1A)-C(14A) 118.87(6)
C(13A)-Ti(1A)-C(14A) 34.31(8)
C(16A)-Ti(1A)-C(14A) 56.30(8)
N(1A)-Ti(1A)-C(15A) 152.12(8)
N(6A)-Ti(1A)-C(15A) 102.24(7)
C(12A)-Ti(1A)-C(15A) 56.79(7)
Cl(1A)-Ti(1A)-C(15A) 89.86(6)
C(13A)-Ti(1A)-C(15A) 56.91(8)
C(16A)-Ti(1A)-C(15A) 33.97(7)
C(14A)-Ti(1A)-C(15A) 33.35(8)
C(2A)-N(1A)-Ti(1A) 171.24(18)
N(1A)-C(2A)-C(3') 115.1(19)
N(1A)-C(2A)-C(4A) 108.5(2)
N(1A)-C(2A)-C(5') 111.3(11)
N(1A)-C(2A)-C(3A) 108.7(2)
N(1A)-C(2A)-C(4') 93(3)
N(1A)-C(2A)-C(5A) 110.0(2)
C(3')-C(2A)-C(5') 115.3(13)
C(4A)-C(2A)-C(3A) 110.9(3)
C(3')-C(2A)-C(4') 111.3(14)
C(5')-C(2A)-C(4') 109.0(13)
C(4A)-C(2A)-C(5A) 111.8(3)
C(3A)-C(2A)-C(5A) 106.9(3)
C(11A)-N(6A)-C(7A) 117.45(18)
C(11A)-N(6A)-Ti(1A) 121.44(14)
C(7A)-N(6A)-Ti(1A) 121.08(14)
N(6A)-C(7A)-C(8A) 122.5(2)
C(9A)-C(8A)-C(7A) 119.6(2)
C(8A)-C(9A)-C(10A) 118.1(2)
C(11A)-C(10A)-C(9A) 119.3(2)
N(6A)-C(11A)-C(10A) 122.9(2)
C(16A)-C(12A)-C(13A) 109.07(19)
C(16A)-C(12A)-Ti(1A) 74.96(12)
C(13A)-C(12A)-Ti(1A) 73.65(12)
C(12A)-C(13A)-C(14A) 106.9(2)
C(12A)-C(13A)-C(17A) 126.3(2)
C(14A)-C(13A)-C(17A) 126.6(2)
C(12A)-C(13A)-Ti(1A) 71.38(12)
C(14A)-C(13A)-Ti(1A) 76.17(13)
C(17A)-C(13A)-Ti(1A) 122.02(18)
C(15A)-C(14A)-C(13A) 108.7(2)
C(15A)-C(14A)-C(18A) 124.9(2)
C(13A)-C(14A)-C(18A) 126.2(2)
C(15A)-C(14A)-Ti(1A) 73.93(13)
C(13A)-C(14A)-Ti(1A) 69.52(12)
C(18A)-C(14A)-Ti(1A) 125.96(16)
C(14A)-C(15A)-C(16A) 107.64(19)
C(14A)-C(15A)-C(19A) 127.5(2)
C(16A)-C(15A)-C(19A) 124.8(2)
C(14A)-C(15A)-Ti(1A) 72.72(13)
C(16A)-C(15A)-Ti(1A) 70.23(12)
C(19A)-C(15A)-Ti(1A) 124.19(16)
C(12A)-C(16A)-C(15A) 107.7(2)
C(12A)-C(16A)-C(20A) 126.4(2)
C(15A)-C(16A)-C(20A) 125.9(2)
C(12A)-C(16A)-Ti(1A) 70.36(12)
C(15A)-C(16A)-Ti(1A) 75.79(12)
C(20A)-C(16A)-Ti(1A) 121.97(15)
N(1B)-Ti(1B)-N(6B) 99.26(8)
N(1B)-Ti(1B)-C(12B) 97.47(9)
N(6B)-Ti(1B)-C(12B) 136.07(8)
N(1B)-Ti(1B)-Cl(1B) 106.88(7)
N(6B)-Ti(1B)-Cl(1B) 96.83(5)
C(12B)-Ti(1B)-Cl(1B) 116.50(6)
N(1B)-Ti(1B)-C(13B) 98.26(9)
N(6B)-Ti(1B)-C(13B) 102.05(7)
C(12B)-Ti(1B)-C(13B) 35.16(9)
Cl(1B)-Ti(1B)-C(13B) 145.54(6)
N(1B)-Ti(1B)-C(16B) 127.51(10)
N(6B)-Ti(1B)-C(16B) 129.22(10)
C(12B)-Ti(1B)-C(16B) 34.93(9)
Cl(1B)-Ti(1B)-C(16B) 88.18(6)
C(13B)-Ti(1B)-C(16B) 57.58(8)
N(1B)-Ti(1B)-C(14B) 128.30(9)
N(6B)-Ti(1B)-C(14B) 80.86(8)
C(12B)-Ti(1B)-C(14B) 57.16(9)
Cl(1B)-Ti(1B)-C(14B) 124.56(6)
C(13B)-Ti(1B)-C(14B) 34.19(8)
C(16B)-Ti(1B)-C(14B) 56.17(10)
N(1B)-Ti(1B)-C(15B) 153.15(9)
N(6B)-Ti(1B)-C(15B) 95.73(9)
C(12B)-Ti(1B)-C(15B) 56.90(9)
Cl(1B)-Ti(1B)-C(15B) 93.20(6)
C(13B)-Ti(1B)-C(15B) 56.65(8)
C(16B)-Ti(1B)-C(15B) 33.50(11)
C(14B)-Ti(1B)-C(15B) 33.47(9)
C(2B)-N(1B)-Ti(1B) 170.31(16)
N(1B)-C(2B)-C(5B) 109.9(2)
N(1B)-C(2B)-C(3B) 109.9(2)
C(5B)-C(2B)-C(3B) 113.2(3)
N(1B)-C(2B)-C(4B) 106.8(2)
C(5B)-C(2B)-C(4B) 109.8(3)
C(3B)-C(2B)-C(4B) 107.0(3)
C(7B)-N(6B)-C(11B) 118.0(2)
C(7B)-N(6B)-Ti(1B) 120.99(15)
C(11B)-N(6B)-Ti(1B) 120.96(17)
N(6B)-C(7B)-C(8B) 122.9(2)
C(9B)-C(8B)-C(7B) 119.1(3)
C(8B)-C(9B)-C(10B) 118.7(2)
C(9B)-C(10B)-C(11B) 119.3(3)
N(6B)-C(11B)-C(10B) 121.9(3)
C(13B)-C(12B)-C(16B) 108.0(2)
C(13B)-C(12B)-Ti(1B) 73.77(12)
C(16B)-C(12B)-Ti(1B) 75.66(13)
C(12B)-C(13B)-C(14B) 107.7(2)
C(12B)-C(13B)-C(17B) 126.4(2)
C(14B)-C(13B)-C(17B) 125.7(2)
C(12B)-C(13B)-Ti(1B) 71.07(12)
C(14B)-C(13B)-Ti(1B) 76.26(13)
C(17B)-C(13B)-Ti(1B) 123.18(16)
C(13B)-C(14B)-C(15B) 108.2(2)
C(13B)-C(14B)-C(18B) 124.5(2)
C(15B)-C(14B)-C(18B) 127.2(3)
C(13B)-C(14B)-Ti(1B) 69.55(12)
C(15B)-C(14B)-Ti(1B) 74.11(14)
C(18B)-C(14B)-Ti(1B) 124.90(17)
C(16B)-C(15B)-C(14B) 108.2(2)
C(16B)-C(15B)-C(19B) 125.9(3)
C(14B)-C(15B)-C(19B) 125.9(3)
C(16B)-C(15B)-Ti(1B) 70.82(14)
C(14B)-C(15B)-Ti(1B) 72.42(13)
C(19B)-C(15B)-Ti(1B) 124.90(19)
C(15B)-C(16B)-C(12B) 107.9(2)
C(15B)-C(16B)-C(20B) 126.4(3)
C(12B)-C(16B)-C(20B) 125.6(3)
C(15B)-C(16B)-Ti(1B) 75.69(14)
C(12B)-C(16B)-Ti(1B) 69.42(13)
C(20B)-C(16B)-Ti(1B) 123.4(2)
‘Two is better than one’—probes for dual-modality molecular imaging
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Molecular or personalised medicine is the future of patient management and healthcare, and
molecular imaging plays a key role towards this goal. However, amongst molecular imaging
techniques, no single modality is perfect and suﬃcient to gain all the necessary information. For
instance, optical ﬂuorescence imaging is diﬃcult to quantify—especially in tissue more than a few
millimetres in depth within a subject; magnetic resonance imaging (MRI) has superb resolution
but low sensitivity and positron emission tomography (PET) has very high sensitivity but poor
resolution. The combination of multiple molecular imaging techniques can therefore oﬀer
synergistic advantages over any modality alone. However, the problem cannot be solved by
simply adding two diﬀerent classes of imaging probes together, unless they happen to have
identical pharmacodynamic properties. Therefore, multi-modal contrast agents or imaging probes
have been developed to solve this problem. Despite the great wealth of information that such
probes can provide, their development is far from trivial and represents an important challenge to
synthetic chemists. In this feature article, we provide an overview of recent ﬁndings in the
synthesis, evaluation and application of dual-modality molecular imaging probes.
1. Introduction and context
Molecular imaging—the ability to ‘see’ within the living human
body and understand its biological complexities for the
treatment of disease—is one of the most exciting and rapidly
growing areas of science. It involves the non-invasive study of
biological processes in vivo at the cellular and molecular level
and a key role for chemists is the design of imaging agents that
make molecular processes visible, quantiﬁable and traceable
over time, aiming to probe molecular abnormalities. The key is
to scrutinise the molecular abnormalities that are the basis of
disease rather than to image the end eﬀects of these molecular
alterations i.e. earlier detection and characterisation of
disease, earlier and direct molecular assessment of treatment
eﬀects, and a more fundamental understanding of the disease
process. Various imaging modalities (e.g. positron emission
tomography (PET), single photon emission computed tomo-
graphy (SPECT), magnetic resonance imaging (MRI), optical,
ultrasound) can be used to assess speciﬁc molecular targets.
Certain modalities are well suited for some applications, whilst
very poorly suited for other applications. As no one imaging
modality can provide information on all aspects of structure
and function, interrogation of a subject using multiple imaging
modalities is clearly attractive.
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Dual- or multi-modality molecular imaging is the synergistic
combination of two or more detection techniques, made
possible by multi-modal probes and imaging agents and
ensures enhanced visualisation of biological materials and
better reliability of collected data. No single modality is perfect
and suﬃcient to obtain all the necessary information.
The advantages of one technique can be combined with the
advantages of another, whilst at the same time reducing the
disadvantages of both. Dual-imaging agents have exciting
potential as, for example, they can be used in surgery to guide
the scalpel (via ﬂuorescence imaging), to ensure that all
cancerous material has been removed (MR imaging), and to
track and identify tumour cells and physiological processes
(PET or SPECT imaging). Examples of the ‘‘dual modality’’
approach include: (i) nanoparticles combining ﬂuorescence
and magnetic resonance imaging are receiving attention
because they ally the high sensitivity of the ﬂuorescence
phenomenon to the high spatial resolution of MRI; (ii)
PET/MR combines the high soft tissue contrast of MRI and
the functional information of PET. MRI gives high resolution,
PET high sensitivity—thus, overall giving anatomy and
function. With regard to oncology, this leads to improved
diagnostic accuracy and radiotherapy planning.
For more in-depth information on the individual imaging
techniques and probe development please consult the
referenced review articles and monographs.1–3 Whilst there is
a wealth of information on single modality probes and
contrast agents, this article will focus on recent developments
in the design of chemical probes that possess two signalling
components thus oﬀering dual-modality molecular imaging.
2. Magnetic resonance imaging/optical imaging
agents
The area of MRI/optical imaging is the most well developed in
terms of dual-modality imaging and applications have been
found in biomedical research and clinical practice. The last
5 years have seen a signiﬁcant increase in MRI/optical probe
development4 with particular interest in, for example, the
utilisation of gadolinium chelates, functionalised quantum
dots and iron oxide nanoparticles. Various combinations of
signalling components will now be detailed.
2.1 Gadolinium chelates and organic ﬂuorophores
MRI relies on the enhancement of local water proton
relaxation in the presence of a contrast agent. The most
commonly used contrast agents nowadays are thermo-
dynamically and kinetically stable low molecular weight
gadolinium compounds. The unique magnetic properties of
the gadolinium(III) ion are instrumental in enhancing the
relaxation rate of water protons in tissues. The toxicity of
Gd3+ is reduced by complexation using stabilising chelates
such as DTPA (diethylenetriaminepentaacetic acid)5 and
DOTA (1,4,7,10-tetraazacyclododecane-N,N0,N00,N0 0 0-tetra-
acetic acid)6 enabling the use of these agents in humans.
Indeed, the commercially available Magnevists and
Dotarems are comprised of a Gd3+ atom within chelating
ligands based on a polyaminocarboxylate motif.
The starting point for the development of a dual
MRI/optical probe has involved adaptation of the gadolinium
chemistry used in the vast majority of clinical MRI.
Manipulation of the cyclen-based macrocycles is possible
without disruption of the ligand’s chelating possibilities.
Covalent attachment of an organic ﬂuorophore, such as
ﬂuorescein, to a chelating backbone has been shown to
yield an eﬀective dual-imaging agent. DO3A-ethylthioureido-
ﬂuorescein ([4,7-bis-carboxymethyl-10-(2-(ﬂuorescein thioureido)-
ethyl)-1,4,7,10-tetraaza-cyclododec-1-yl]-acetic acid) has the
capacity to act in a bimodal fashion when complexed with
Gd3+ ions, as shown in Fig. 1.7 Labelling with ﬂuorescein was
possible by coupling ﬂuorescein isothiocyanate (FITC) to
an amino group on the cyclen ring; alkaline conditions
(pH 8.0–8.5) were necessary to prevent decomposition of the
ﬂuorescein moiety.
Other ﬂuorescent dyes such as tetramethylrhodamine-
5-isothiocyanate (TRITC) have been covalently attached
directly onto the macrocycle backbone of DOTA and complexed
to Gd3+ to yield a bimodal-imaging agent which showed
promise in in vitro studies. However, problems arose when
the imaging agent was applied to living embryos.8 The ﬂuorescent
signal was visible; however, the hydrophobic nature of the
probe meant that it was absorbed into fatty tissue where little
water exchange can take place resulting in no observable MR
signal. A more impermeable probe that remained in the
aqueous phase was achieved by grafting the two imaging
moieties (TRITC and DOTA) onto a polymer (dextran and
poly-D-lysine) scaﬀold, illustrated in Fig. 2, which were then
employed to track cell lineage in embryos. The synthesis of
Gd(DTPA)-tetramethylrhodamine-aminedextran (GRID)8
consists of attachment of DTPA to the amine side arms
followed by complexation with Gd3+ and treatment with
TRITC to couple the dye to the polymeric amine-functionalised
dextran framework. The same synthetic route was taken to
Gd(DTPA)-tetramethylrhodamine-hydroxypropyl poly(D-lysine)
(GRIP) using poly(D-lysine) as the backbone.
It is not just organic dyes that have been used as ﬂuoro-
phores in MRI/optical imaging. Recently, a chelated Gd
moiety has been attached to a rhenium(I) carbonyl complex
([fac-Re(CO)3(Bpy)Cl]) which acts as a ﬂuorescent sensitiser
(Fig. 3).9 The luminescent lifetimes of this dual-imaging
agent are long enough to permit eﬃcient gating of any
ﬂuorescent background (for which lifetimes of o10 ns are
typical) whilst the Gd ion provides MR contrast. Finally,
a preliminary communication reports the tethering of a
spiropyran group to a Gd–DO3A moiety to form a
Fig. 1 The ﬂuorescent probe Gd-DO3A-ethylthioureido-ﬂuorescein.7
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photochromically-controlled, reversibly-activated MRI and
optical contrast agent. Although no biological data have been
elucidated, this probe shows some most interesting behaviour
through isomerism of the ligand binding—it has higher
relaxivity and ﬂuorescence intensity in the dark whilst these
parameters decrease after irradiation with visible light.10
2.2 Gadolinium chelates and nanoparticles
Multi-modal imaging using a small molecule-based probe is
challenging due to the limited number of attachment points
and the potential interference with its receptor binding aﬃnity.
However, nanoparticles have large surface areas where multiple
functional moieties can be incorporated for multi-modality
molecular imaging.11 Hybrid lipid nanoparticles consisting of
lipids functionalised with a Gd chelate and ﬂuorescently
tagged lipids have been used to label tumour cells for in vivo
tracking. Monitoring the migration of transplanted cells
in vivo is of considerable interest in stem cell research. Stem
cells are used to replace injured or diseased cells and can
diﬀerentiate into almost any cell type. MRI/optical probes
present the possibility of tracking cells in the body on a cellular
scale through optical imaging but with additional cross-
sectional anatomical information from MRI. Gd–lipid,
rhodamine–lipid and two other standard lipids were combined
to form a dual-imaging lipid nanoparticle (Gd-Rh-NP).12
In vitro studies were also carried out on breast cancer
cells which illustrated eﬃcient uptake of Gd-Rh-NP after
two hours of incubation. Furthermore, the probes are
evenly distributed throughout the cytoplasm evident from
ﬂuorescence microscopy. The nature of these probes implies
that the ratio of optical to MR signal can be adjusted by
altering the stoichiometry of the moieties during synthesis.
This can be exploited to complement the sensitivities of the
two methods which give an additional control over the quality
of imaging being carried out.
In addition, lipid nanoparticles such as these can be
functionalised to target speciﬁc cells within the body. Targeting
dying cells is useful for monitoring disease progression and
therapy eﬃciency for a range of diseases aﬀected by the
deregulation of apoptosis. Annexin A5 was used to label a
lipid-based imaging agent due to its high binding aﬃnity for a
protein expressed by a cell undergoing apoptosis. Bilayer lipid
micelles have been prepared with Gd–lipids and ﬂuorescein-
containing lipids as well as additional PEGylated lipids to aid
in biocompatibility and to create a platform for functionalisation
with a targeting agent.13 Annexin A5 contains a terminal
cysteine group which can be coupled with a maleimide group
attached to some of the PEG coating of the lipid micelle. In the
same study a lipid layer containing the same ﬂuorophore as
used previously was formed around an iron oxide nanoparticle
and functionalised with annexin A5. Other targeting proteins
include a cyclic peptide (cNGR) which binds to a protein only
produced by cells involved in angiogenesis and therefore
potentially acts as a good targeting agent for detecting the
growth of tumours. A three component system was built
around a small peptide chain functionalised with DTPA
and the organic dye Oregon Green 488 (OG488) prior to
cyclisation of the terminal peptide links.14 Complexation
can then take place with GdCl3 to eﬃciently synthesise a
target-speciﬁc MRI/optical probe.
Another method of dual-modality imaging has been
performed where a ‘cocktail’ of two complexes of Eu3+ and
Gd3+ using the same chelate can be combined in varying
ratios. A particular advantage of this technique is the ability to
control the doses of each reagent as larger concentrations of
the Gd complex will be needed compared to the ﬂuorescent
component due to the diﬀering sensitivities of the two
techniques. A cyclen-based chelate has been conjugated to a
ligand which targets the peripheral benzodiazepine receptor,
overexpressed in patients with neurodegenerative diseases.15
The lanthanide chelate (QM-CTMC), illustrated in Fig. 4,
contains two phosphonic acid groups for chelation and a
quinoline chromophore antenna for lanthanide sensitisation.
The chelate has been shown to remain luminescent for up to a
Fig. 2 A dual MRI and optical probe, Gd(DTPA)-tetramethyl-
rhodamine-aminedextran (GRID).8
Fig. 3 A heterobimetallic rhenium–gadolinium dual-imaging agent.9
This journal is c The Royal Society of Chemistry 2009 Chem. Commun., 2009, 3511–3524 | 3513
D
ow
nl
oa
de
d 
by
 IM
PE
RI
A
L 
CO
LL
EG
E 
O
F 
SC
IE
N
CE
 &
 T
EC
H
N
O
LO
G
Y
  o
n 
18
 A
ug
us
t 2
01
0
Pu
bl
ish
ed
 o
n 
05
 M
ay
 2
00
9 
on
 h
ttp
://
pu
bs
.rs
c.o
rg
 | d
oi:
10.
103
9/B
821
903
F
View Online
month after excitation.15 The targeting agent (PK11195—a
well-established tumour-speciﬁc ligand) was attached to the
chelate through an alkyl spacer with a terminal amine group
and the carboxylic acid group was also attached to the
cyclen ring. This reaction was undertaken using an aqueous
coupling agent [O-(N-succinimidyl)-1,1,3,3-tetramethyluronium
tetraﬂuoroborate (TSTU)] unlike most anhydrous peptide
couplings. Aqueous/organic conditions were necessary due
to the poor solubility of the chelating moiety. Complexation
of the derivatised chelate with GdCl3 was facile and gave
relaxivities comparable to Magnevists, the Gd-containing
agent most commonly used in practice.16 More recently,
Laurent et al. have complexed [2,6-pyridine diyl bis(methylene
nitrilo)] (PMN) tetraacetic acid with Eu3+ and Gd3+ which
yield compounds with good luminescent and MR properties,
respectively.17 A ‘cocktail’ of two such complexes may be
suitable for MRI/optical imaging as the complexes have good
stability in physiological media.
2.3 Gadolinium chelates and dendrimers
Polyamidoamine (PAMAM) dendrimers provide a good
framework to attach Gd chelates in the production of MRI
contrast agents.18 The internal structures of PAMAM
dendrimers lend themselves to biological setting. The terminal
amine groups are ideal for functionalisation with optical dyes
and chelating structures to complex gadolinium for MRI.
Biotinylated bimodal-imaging dendrimers have been prepared
as probes for targeting ovarian cancer cells with rhodamine
green and DTPA chelates.19 The dendrimers used in this case
were linked by a disulﬁde bridge which could be cleaved and
coupled to a maleimide group in biotin. Other methods
have used Cy5.5, a near infrared (NIRF) dye, which is
advantageous over other ﬂuorophores due to increased
imaging penetration through living tissue and reduced
background interference. Cy5.5 and Gd(DTPA) were
conjugated to a generation 6 (G6) PAMAM-based dendrimer
(Fig. 5)20 and used to image sentinel lymph nodes in vivo for
use in MRI prior to surgery and optical imaging. This aids in
resection during surgery without the use of dyes which stain
the skin or ionising radiation.21 As with Gd-Rh-NPs the ratio
of MRI to optical tags on the surface of the probe can be
controlled. A balance between the sensitivities of the two
imaging techniques was made possible by increasing the
number of Gd chelates to Cy5.5 ﬂuorescent markers on each
dendrimer. In the past few years dendrimers have proven
to be eﬀective, biocompatible and versatile platforms for
dual-modality imaging agents although they are not trivial
to synthesise.
2.4 Quantum dots and an MRI contrast agent
Quantum dots (QDs) are nanoparticulate clusters of
semiconductor material that show quantum conﬁnement
eﬀects—meaning that the optical properties of these nano-
particles are controlled by their size, rather than their
composition, thus rendering them useful optical imaging
agents. (See some recent review articles highlighting the use
of QDs in molecular and cellular imaging.22) The size of their
band gap dictates the energy of the photon emitted and also
the wavelength of emitted light. QDs are of great interest
due to their biological imaging capabilities, their bright
ﬂuorescence, photostability and their narrow and size tuneable
emission spectrum. Solubility and toxicity issues are potential
problems though and hydrophilic surface passivating ligands
need to be introduced around the QDs prior to any in vitro and
in vivo investigations.23,24 A recent example features the
synthesis of GdIII-functionalised quantum dots on ﬂuorescent
dye-doped silica.25 Polymeric materials often swell and
change shape and can be chemically unstable in variable pH,
whereas silica has the advantage of being inert and facile to
functionalise allowing conjugation to target ligands or MRI
agents. A DOTA derivative with an aryl amine group attached
to the chelating macrocycle was complexed to Gd prior to
transformation of the amine group to a maleimide group and
coupling with thiol groups on the silica surface.25 The surface
area of the silica shells permits the linking of 250–300 Gd–DOTA
species, resulting in impressive relaxivities in excess of
15 000 mM1 s1 at RT and 1.4 T. In addition, preliminary
MRI experiments in mice revealed that the silica-coated
probes are cleared from the renal system into the bladder with
no observable eﬀects on the health of the animal. A similar
structure of quantum dot was synthesised with a diﬀerent
chelating fragment (n-(trimethoxysilylpropyl)ethyldiamine
Fig. 4 A trifunctional cyclen-based lanthanide chelate,
QM-CTMC.15
Fig. 5 Sentinel lymph node images of a normal mouse. (A) Optical
image obtained under simultaneous white light and ﬁltered
(615–665 nm) excitation light detected with the emission ﬁlter set to
720 nm demonstrating ﬂuorescence in the auxiliary lymph node of the
mouse. The injection site cannot be seen because it is on the front of
the mouse. (B) Image from A is shown in false colour. (C) Maximum
intensity projection calculated from a 3D spoiled gradient echo
MRI acquired using a GE Signa Excite 3T 30 min postinjection
(TR = 9.5 ms, TE = 2.3 ms, FA = 301), which illustrates the
injection site in the mammary fat pad, the draining lymphatics, and
the auxiliary lymph node depicted in B (reproduced from reference
20 by kind permission of ACS publications).
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triacetic acid (TSPETE)) attached to the CdS:Mn/ZnS/SiO2
yellow ﬂuorescent quantum dot, which was also functionalised
by phosphonate and amine groups for further conjugation.26
Large relaxivities of GdIII-functionalised quantum dots
(R1 = 20.5 mM
1 s1, R2 = 151 mM
1 s1) were rationalised
by slow tumbling rates caused by anchoring the paramagnetic
Gd ions to the high molecular weight quantum dots, reducing
the free rotation of the Gd chelates.
Other techniques for encapsulating quantum dots mimic
previously reported methods for introducing Gd chelates into
an imaging probe. A biotinylated lysine dendrimeric wedge
containing Gd(DTPA) chelates has been designed to attach to
a quantum dot functionalised with the Annexin A5 (AnxA5)
ligand to target phosphatidylserine on the cell surface,
necessary for visualisation of apoptosis and other forms of
programmed cell death.27 The wedge contains eight chelating
sites on the terminal groups and thereby increases Gd loading
and the relaxivity (R1 = 3000–4500 mM
1 s1) whilst
maintaining a very small nanoparticulate size (B7 nm) in
comparison to other AnxA5-containing bimodality-imaging
agents. In vitro experiments show that the nanoparticles
are suitable for both anatomic and subcellular imaging of
structures in the vessel wall. Mulder et al. have developed a
targeting PEG-lipid-coated quantum dot using the same
methodology as seen before when forming micelles from Gd
and ﬂuorophore-containing lipids.28 avb3-speciﬁc RGD
peptides for the detection of angiogenic and tumour cells were
attached using maleimide–thiol coupling. These water-soluble
quantum dots yielded very high relaxivities (B2000 mM1 s1)
suitable for MRI and good selectivity for endothelial cells
observed from an in vitro study using ﬂuorescence microscopy.
The authors state that the nanoparticulate bimodal contrast
agent could be of great use in the detection of tumour
angiogenesis. In a similar vein, chitosan, a biocompatible
polymer, has been used to form a mesh material encapsulating
quantum dots and Gd(DTPA) and then taken on to form
nanobeads small enough to label subcellular components.29
There was, however, only a slight decrease in relaxivity
compared to free Gd(DTPA) and no variation in the
optical properties of the nanobead in comparison to quantum
dots (Fig. 6).
Quantum dots are not the only method of creating a
ﬂuorescent nanoparticle suitable for functionalisation. Silica
can be doped with the ﬂuorescent [Ru(bpy)3]Cl2 forming a
core of a probe with a layer of gadolinium doped silica
surrounding it, suitable for MRI/optical imaging.30 The
familiar chelating ligands, DTTA and DTPA, were derivatised
with silica once and twice, respectively, which led to either a
monolayer or multiple layers of gadolinium ions on the
ruthenium surface. The MRI relaxivities were considerably
higher than the gadolinium complexes on their own. This
eﬀect was attributed to slow tumbling caused by the Gd
chelate being ﬁxed to a structure of higher molecular weight.
The attempt to optimise this technique by increasing the
gadolinium loading of the quantum dot was not successful
in signiﬁcantly increasing the relaxation rate of the MRI
probe. Bis(silylated)-Gd(DTPA) allowed for the complex to
be fully incorporated into the silica structure and form layers
around the nanoparticle. This technique was not successful,
however, because the water molecules could not access the
inner layers necessary for full exploitation of the additional Gd
loading. Therefore the surface area was essentially the same
implying that the same number of water molecules could move
into close proximity to the Gd centres. The two nanoparticles
prepared are illustrated in Fig. 7. In a related study, the same
group has developed self-assembled hydrid nanoparticles
for cancer-speciﬁc multi-modal imaging, again featuring a
luminescent [Ru(bipy)3]Cl2 core.
31
2.5 Iron oxide nanoparticles and an optical probe
Superparamagnetic iron oxide (SPIO) nanoparticles have
been extensively studied as MR imaging agents due to their
ability to enhance the T2-weighted MRI signal, and as
Fig. 6 Schematic representation of the preparation of QDs with a paramagnetic micellular coating (reproduced from reference 28 by kind
permission of ACS publications).
Fig. 7 Synthesis of hybrid silica nanoparticles.30
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biologically-benign alternatives to Gd-based systems. With
conventional paramagnetic contrast agents 10–100 mM
concentrations are required, but with SPIO nanoparticles
(ca. 20 nm in size) these agents can be detected by T2-weighted
imaging at sub-micromolar particle concentrations. For in vivo
applications, these non-toxic magnetic particles must be
coated with a biocompatible polymer during or after the
synthesis process to prevent the formation of large aggregates
and biodegradation when exposed to the biological system.
The polymer can also allow binding by drugs by covalent
attachment, adsorption or entrapment on the particles. One of
the earliest examples of a dual MRI and optical probe was that
of a cross-linked iron oxide (CLIO) nanoparticle consisting of
a surface of cross-linked dextran functionalised with amine
groups.32 Attachment of the near infrared ﬂuorescent (NIRF)
indocyanine dye Cy5.5 through a polypeptide link was facile
using the coupling of a terminal amine group and a maleimide
group attached to Cy5.5, and conjugation of CLIO occurred
through a disulﬁde link or a thioester linker. Enhanced levels
of NIRF indicated the presence of a protease which cleaves the
molecule, separating the NIRF dye and the iron oxide nano-
particle and activating the ﬂuorescence. This gave information
on the environment that the tracer was in, as the peptide linker
would be cleaved in the presence of a protease and a signal
would be detected. The structure of the peptide linkage is
illustrated in Fig. 8.
Iron oxide nanoparticles have been covalently attached to a
dye-doped silica nanoparticle forming satellites around the
outside of the ﬂuorescent core.33 Rhodamine dye-doped silica
nanoparticles were synthesised with surface amine groups,
which could be conjugated with a linker featuring a terminal
maleimide group. Thiol groups on the outside of the iron oxide
nanoparticles could then be used to couple them to the surface
of the silica, as is illustrated in Fig. 9. These core–satellite
probes have enhanced MRI properties due to a synergistic
magnetism of the multiple iron oxide nanoparticles attached
to the silica core. They also show improved ﬂuorescence
(B1.7 times more intense emission) when compared to a
covalently attached rhodamine-iron oxide agent, which is
due to the larger loadings possible in the silica framework.
The silica matrix also aids the photostability of the dye and
has good biocompatibility. In related work, it has also been
possible to graft both iron oxide nanoparticles and CdSe/ZnS
quantum dots into silica to form a nanocomposite material
capable of ﬂuorescent and MR imaging although the quantum
yield of the emission in the ﬂuorescence spectrum for the
nanocomposite (4.8%) was reduced in comparison to free
CdSe/ZnS nanoparticles (14.5%).34
A variety of materials have been used to stabilise the iron
oxide nanoparticles prior to functionalisation. As seen
previously silica is a popular choice to encompass the nano-
particles due to good biocompatibility and facile manipulation.
Silica doped with FITC can be used to cover iron oxide cores
by sol–gel methods and have a targeting function attached to
the silica framework by aminating it ﬁrst.35 This form of probe
has been shown to give good results when using chlorotoxin to
speciﬁcally target glioma cells. Incorporation of a ﬂuorophore
is also possible through covalent attachment to cross-linked
aminated dextran, prepared from initial cross-linking of the
dextran with epichlorohydrin and then reacting the nano-
particles with ammonia to form amine groups capable of
conjugating a ﬂuorescent probe or a targeting agent.36 In this
case the HIV-Tat peptide was functionalised with FITC and
covalently attached to the nanoparticle for in vivo tracking of
haematopoietic and neural progenitor cells. In a similar
vein, cell tracking studies have been shown to be a useful
application of iron oxide coated in cyanine dye-doped
polystyrene.37 1,10-Dioctadecyl-3,3,30,30-tetramethylindodi-
carbocyanine (DiD) and the ﬂuorescein derivative, dragon
green, were integrated into polystyrene which could then be
used to coat the iron oxide nanoparticles via simple incubation.
Fluorescent calcium indicators, Rhod-2 and Fura-2, were
also utilised in this study yielding information on the cell
morphology. Once the dye-doped iron oxide nanoparticles
have entered the cell via endocytosis the dye comes oﬀ staining
the cell. The coating that the dye is in has been shown to play
an important role in the delivery process.
A novel class of dual-imaging probes has been developed
involving iron oxide nanoparticles coordinated by phosphine
oxide head groups with poly(ethylene glycol) (PEG) tails.38
They were derivatised with PEG to aid biocompatibility.
These PEG-derivatised phosphine oxide (PO-PEG) ligands
were synthesised in a facile procedure from phosphoryl
trichloride and poly(ethylene glycol) methyl ether to yield a
mixture of mono-, bi-, and tri-substituted derivatives. An
excess of 1,2-ethylenediamine was used to functionalise the
PO-PEG ligands so that conjugation of the isothiocyanate
group in FITC with the iron oxide nanoparticles was possible
to create a dual-imaging agent. The agent was found to exhibit
Fig. 8 Peptide framework for attachment of a NIRF dye and MRI
contrast agent.32
Fig. 9 A schematic diagram for the synthesis of core–satellite
rhodamine dye-doped silica–Fe3O4 nanoparticles.
33
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no appreciable toxicity in cells and is therefore of great
potential use in biomedical imaging.
2.5.1 Near infrared ﬂuorescent probes. Fluorescent imaging
agents are most widely used in in vitro studies39 and in small
animal studies whereas a NIRF tag can be used in in vivo
studies in humans because of its penetrative properties. NIRF
optical probes can provide a non-invasive assessment of
enzyme activity for a number of diﬀerent enzymes and types
of pathology. For example, Cy7 has been used in conjunction
with Cy5.5 and cross-linked iron oxide nanoparticle labelled
peptides as it can act as an internal standard indicating the
true level of probe concentration independent of varying levels
of probe transport.40 The use of NIRF continues to become
more widespread and a combined probe like Cy5.5-CLIO
has shown potential in brain tumour imaging, supplying
pre-operative topographical information through MRI of
the tumour cells where contrast agent has accumulated, as
well as in optical imaging during surgical resection.41 Preparation
of the combined probe does not need rigorous chemistry, just
incubation of the dye with the CLIO nanoparticles overnight
at 4 1C and any unreacted Cy5.5 was removed by gel ﬁltration.
This synthesis has been applied many times to create these
dual probes which have found uses in many areas of
biomedical research; furthermore due to the nature of the
aminated dextran coating they can be functionalised further
with targeting moieties for the detection of a range of
processes and cell types.41
Underglycosylation and overexpression of the mucin-1
tumour antigen is an early sign of tumourigenesis.42 Early
detection has been shown to be possible in vivo using an
Cy5.5-CLIO imaging probe functionalised with a protein
which has a speciﬁc aﬃnity for the antigen. The same probe
has also been shown to be able to track tumour response to
chemotherapy in real time in vivo with the potential of saving a
great deal of time and cost in the development of cancer
therapeutics.43 Targeting NIRF iron oxide nanoparticles has
been shown to be useful in other applications including the
detection and monitoring of apoptosis and atherosclerosis.44,45
In a recent innovation, a method of incorporating Cy5.5 onto
an iron oxide nanoparticle has been developed without the
need for chemical cross-linking of the dextran shell. Instead a
silane–PEG co-polymer uses the Si–OH groups to induce
thermal cross-linking.46 The polymer contains silane groups
for cross-linking, PEG groups to prevent biofouling of the
particles and a protected carboxylic acid for conversion into
an amine for conjugation with the NIRF dye. Although there
are no targeting ligands on its surface, the nanoparticulate
species is highly eﬀective for tumour detection in vivo by dual
imaging.
2.5.2 Other MR active nanoparticles. Manganese has been
shown to be an advantageous source of longitudinal (T1)
enhancing relaxivity, and particularly useful when in the form
of MnO nanoparticles.47 The uniformly-sized nanoparticles
were synthesised by the thermal decomposition of a Mn–oleate
complex—the particle size being controlled by varying
either the solvent or the reaction time. They were rendered
biocompatible via PEG encapsulation. By conjugation with a
tumour-speciﬁc antibody, the nanoparticles could selectively
image breast cancer cells in a metastatic brain tumour. Easy
delivery, good clearance from body organs and tolerable
cellular toxicity raise hope for future human clinical appli-
cation. In a study also utilising manganese, a series of
CdSe/Zn1xMnxS nanoparticles have shown promise as
eﬀective dual-modality agents48 with high quantum yield and
relaxivity. Introduction of a paramagnetic source into the
capping ZnS coating of the quantum dot creates a simple
structure without the need for silica. The amount of para-
magnetic dopant can be varied and water solubility of these
particles is achieved by capping with an amphiphilic polymer.
Finally in this MRI/optical section, an elegant piece of work
has been reported involving water-soluble porphyrins as a
dual-function molecular imaging platform for MRI and
ﬂuorescence zinc sensing.49 A water-soluble Mn(III) scaﬀold
is used—these being known as eﬃcient and stable MRI
contrast agents. Dipicolylamine substituents around the peri-
phery of the macrocycle allow excellent ﬂuorescent zinc
sensing, this ﬂuorescence ‘turn on’ being highly selective for
zinc versus other divalent metal ions. In the presence of zinc,
the MRI characteristics on the Mn centre are switched on via
the coordination of two water molecules. Preliminary data
illustrate that this dual-functional zinc sensor can operate in
both solution and mammalian cells.
3. Radionuclear imaging/optical imaging agents
3.1 PET/Optical
The fusion of optical and radionuclear methods has the
potential for widespread use in biomedical imaging—building
on the strengths of both techniques, whilst reducing any
disadvantages.50 The development of an optical/PET detector
has been established and preliminary results are encouraging,
suggesting that a combined technique for dual imaging may
just be over the horizon.51 With the development of new
technology there is a need to design new probes suitable for
both techniques to be carried out simultaneously. The
fusion of radionuclear and optical methods is still a less
frequently used multi-modal imaging strategy, perhaps due
to misconceptions and technical diﬃculties including the
absence of a standard optical imaging system and the lack of
FDA-approved target-speciﬁc optical molecular probes. As
such, the development and design of new probes for a dual
PET/optical imaging strategy is still in its infancy and has
mostly focused on larger radioisotopes that can be bound
in a similar fashion to the Gd imaging agents developed
for MRI/optical, as illustrated in the previous section.
Radionuclides that emit gamma rays, utilised in the single
photon emission computed tomography (SPECT) techniques,
can be chelated in this manner as well. Of the probes
developed for PET/optical dual imaging, many have been
tested alongside isotopes for SPECT, and have now been
applied in vitro and in small animal imaging.52
PET is a powerful and rapidly developing area of molecular
imaging that is used to study and visualise human physiology
by the detection of positron-emitting radiopharmaceuticals.
Information about metabolism, receptor/enzyme function and
This journal is c The Royal Society of Chemistry 2009 Chem. Commun., 2009, 3511–3524 | 3517
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biochemical mechanisms in living tissue can be gained, with
PET measuring chemical changes that occur before the
macroscopic anatomical signs of a disease are observed.3,53,54
Short-lived radioisotopes such as 11C and 18F are of great
interest due to their biogenicity and low atomic mass; thus it is
possible to directly label molecules/drugs of interest without
interfering with their biological activity. The main challenge
with these short-lived isotopes is time, with the labelled probe
having to be synthesised, puriﬁed, analysed and formulated
usually within the order of a few minutes. Some biological
molecules have long half-lifetimes and require radionuclides
with equally long-lasting half-lives to study them. Large
isotopes suitable for PET such as 86Y, 64Cu, 68Ga and 124I
(t1/2 = 4.2 days) are better suited in these cases than
11C and
18F. Their chelating properties also make it easier for them to
be incorporated into imaging probes.
Radiolabelling with 124I for PET studies involving
monoclonal antibodies and photosensitisers are appropriate
because there is a long accumulation time in tumours; on the
hour rather than the minute scale and 124I has a half-lifetime of
4.2 days. 124I has been used to label a porphyrin-based
photosensitiser to allow for accumulation of the probe in a
tumour for photodynamic therapy.55 The iodo-containing
photosensitiser underwent a palladium-catalysed reaction
with hexamethyleneditin to functionalise the molecule with
tetramethyltin which was then displaced with Na124I to give
the labelled product. The natural ﬂuorescence of photosensitisers
meant that no additional tagging was necessary. A mono-
molecular multi-modal imaging agent has also been designed
for the somatostatin receptor.56 Here, reporters for both
optical (via the NIRF ﬂuorescent dye cypate) and SPECT
(117Lu) or PET (64Cu) (via the ubiquitous macrocyclic species
DOTA) have been incorporated into a single molecule. In this
study, however, the anticipated receptor-mediated accumulation
in target tissues was not observed but there was excellent
agreement between the optical and radiochemical bio-
distributions. Similar studies using a ‘cys-tag’ for imaging of
VEGF receptors utilised the NIRF dye Cy5.5 plus a 99mTc
chelator for SPECT imaging or a 64Cu-DOTA unit for PET
imaging.57 The probes were shown to retain VEGF activities
in vitro and undergo selective and highly speciﬁc focal uptake
into the vasculature of tumours and surrounding host tissue
in vivo. The ﬂuorescence contrast agent showed long-term
persistence and co-localised with endothelial cell markers,
indicating that internalisation is mediated by the receptors.
Copper-64 has also been the focus in the drive towards
site-speciﬁc pharmaceuticals. Functionalised bis(thiosemi-
carbazone) ligands possess an inherent ﬂuorescence when
bound to metals such as ZnII and CuII and provide excellent
tetradentate chelation. The radionuclear 64Cu–bis(thiosemi-
carbazonate) complex was formed easily via transmetallation
from the corresponding ZnII species using 64Cu(OAc)2 to give
dual-modality probes. Several derivatives, including a glucose
conjugate, have been prepared and preliminary cell washout
studies indicate rapid and reversible cellular uptake being
potentially hypoxia-selective.58,59
Detecting reporter gene expression is one of the ﬁelds in
which small PET radionuclides combined with bioluminescence
have proven useful. Two separate reporter genes (HSV1 sr39
thymidine kinase and renilla luciferase) which had been used
for studies in their own right were fused together with a
linker to form a vector for studies on the role of genes
in cancer development.60 The HSV1 sr39-tk contained a
9-(4-[18F]ﬂuoro-3-hydroxymethylbutyl)guanine (FBDG) tag
and the renilla luciferase contained the bioluminescence tag,
coelenterazine. Bioluminescence has a higher signal to
background ratio which is an advantage compared to the
use of other ﬂuorescence techniques. The presence of the
PET reporter gene in the fusion protein is compatible with
tomographic tools for measuring reporter gene expression and
thus provides a unique tool of validating diﬀerent approaches
quickly in small animal models at a very low number of cells,
ultimately translating to clinical use.
PET imaging is being used to understand the propensity of a
PET-labelled drug to bind to a lipid membrane, and how this
may interfere enhances a molecule’s ability to bind to and
ultimately interact with a targeted enzyme or receptor.61,62
Cationic amphiphilic drugs (CADs)63 can be 11C labelled
coupled with the incorporation of a small organic ﬂuorophore
e.g. derivatised spiperone—a well-known CAD and
doperminergic ligand (Fig. 10).64 The small ﬂuorophores are
advantageous as their lower molecular weights will limit any
tag distortion eﬀects and will allow crossing of the blood–brain
barrier. With these optical/PET probes, a chemically identical
molecule could be used to image drug binding in thin tissue
sections and ex vivo cell lines whilst a positron-emitting
equivalent can be measured in vivo.
NIRF oﬀers considerable improvements in penetration over
regular ﬂuorescence and has been used in conjunction with
SPECT via a dual-imaging probe. Such an agent involves a
lysine derivative with Cy5.5 (NIRF dye) and CHX-A00 chelating
111In attached.65 The trifunctional agent shown in Fig. 11
was attached to the tumour-speciﬁc monoclonal antibody,
trastuzumab, through an eﬃcient maleimide–thiol coupling
Fig. 10 The CAD and doperminergic ligand spiperone.64
Fig. 11 The trifunctional chelate Cy5.5-Lys(SMCC)-CHX-A00.65
3518 | Chem. Commun., 2009, 3511–3524 This journal is c The Royal Society of Chemistry 2009
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reaction, followed by complexation with 111In. Binding of
Cy5.5-Lys(SMCC)-CHX-A00 to SKOV3 tumour cells was
shown to be competitive with trastuzumab in binding assays,
and there is also the potential to bind 86Y for use in PET.
Although optical imaging is important in its own right, it is
best utilised within in vitro and small animal studies. When
studies are required in humans, a combined imaging method
to back up the ﬂuorescent data can only be advantageous.
PET/optical imaging techniques may be able to overcome
some of the diﬃculties seen with MRI/optical such as the
quenching of ﬂuorescence, aggregation and biochemical
disruption that some of the larger constructs (nanoparticles
and dendrimers) can cause. From the perspective of 11C and
18F PET a combined probe may also be useful to track the
ﬂuorescence when the radionuclide has degraded. This would
be advantageous both in research and in drug development to
ascertain the distribution and metabolic breakdown of the
drug once it has served its purpose.
The formation of complex structures made up of
several components linked together can involve lengthy and
complicated syntheses. Development of nanoparticles as
optical/MRI agents which can be functionalised easily and
have a larger surface area to mass ratio can overcome these
issues. However, very few examples exist of nanoparticulate
PET tracers although 64Cu66 and 68Ga isotopes67 have been
reported. A range of 64Cu-radiolabelled folate-conjugated
shell cross-linked nanoparticles (SCKs) have been evaluated
as candidate agents to shuttle radionuclides and drugs
into tumours overexpressing the folate receptor. Tumour
accumulation of the 64Cu-labelled SCKs was higher in
small-size tumours where a competitive block of SCK-folate
uptake with excess folate was observed. These species are
therefore promising drug delivery agents for imaging and
therapy of early-stage solid tumours. In the latter, more recent
case, poly-glycidylmethacrylate (EPMA) (used in artiﬁcial
implants) nanoparticles were used because of their known
low toxicity and biocompatibility. These were doped with
68Ga before being used in a PET study on the behaviour of
nanoparticles in the body. In the same study the nanoparticles
were doped with rhodamine B and used in ﬂuorescent studies.
The highly carboxylated nature of the latex nanoparticles also
allowed binding of 111In for quantitative gamma scintography
or Gd3+ for MRI.
The development of a dual-function PET/NIRF probe has
allowed for the accurate assessment of the pharmacodynamics
and tumour-targeting eﬃcacy of QDs. A CdTe QD with an
amine-functionalised surface has been modiﬁed with RGD
peptides and DOTA chelators for integrin avb3-targeted
PET/NIRF imaging.68 About 90 RGD peptides per QD
particle were found, and the DOTA eﬃciently chelated the
64Cu PET label. Quantitative targeted imaging in deep tissue
was facilitated with the probes overcoming the tissue penetra-
tion limitation of optical imaging and signiﬁcantly reducing
potential toxicity. Many studies involving the in vivo imaging
of QDs have been rather qualitative but dual-function
PET/NIRF probes can allow the accurate assessment of the
tumour-targeting eﬃciency of QDs. One example featuring an
amine-functionalised QD conjugated with VEGF protein was
recently reported.69 The structure of the dual-modality probe
is shown in Fig. 12. The DOTA ligand can chelate 64Cu which
allows for PET imaging. The dual-modality probes were
shown to speciﬁcally target tumour vascular VEGFR-2 and
quantitatively evaluate the targeting eﬃcacy for the ﬁrst time.
Another nanoparticulate species has involved the generation
of a 6-PAMAM dendrimer with an ethylenediamine core
as the platform component, incorporating 111In-labelled
radionuclide/ﬁve-colour NIR optical dual-modal imaging
probes.70 The probes were applied for in vivo lymphatic
imaging of the head and neck regions of mice. Radionuclide
imaging provided semiquantitative information, while
optical imaging gave qualitative information on each of the
ﬁve lymphatic basins, with excellent spatial resolution. It is
hoped that the method will ﬁnd application in sentinel node
imaging of human tumours.70
A recent report has utilised small animal PET and bio-
luminescence imaging as an important tool in cancer research.
This technology was combined with small animal CT to obtain
fusion images with both anatomical and molecular information.
The multi-modal imaging was used to detect xenografts of
diﬀerent cell lines and metastases of a melanoma cell line, and
validation studies showed a good coregistration of images
from both PET and CT. The 18F-labelled PET/CT allowed
detection and localisation of lesions that were not seen with
CT because of poor contrast resolution. The study shows that
the combination of PET, small animal CT and bioluminescence
allows a sensitive and improved quantiﬁcation of tumours in
mice.71
3.2 SPECT/Optical
As mentioned previously, SPECT involves imaging of a
g (gamma) emitting nucleus with the most utilised and
investigated SPECT nuclei being 67Ga, 111In, 123I and the
most common single isotope being 99mTc. 99mTc having a
half-life of 6 h is produced in a generator and so is accessible
and economic—with SPECT scanners being cheaper and more
common than their PET equivalents. The 6 h half-life is
suﬃciently long to allow pharmaceutical preparation and
in vivo accumulation in the target tissue, but is still short
enough duration to minimise the radiation dose to the patient.
The main issue with technetium is with its transition metal
chemistry and thus variable oxidation states and so complicating
its radiolabelling chemistry. Two recent articles have
highlighted the use of technetium radiopharmaceuticals in
molecular imaging.72,73
Fig. 12 The structure of the DOTA–QD–VEGF conjugate.69
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Combination of the two most widely employed biomedical
imaging techniques—ﬂuorescence microscopy and radio-
imaging—has been demonstrated by the formation of
complementary pairs of ﬂuorescent and radioactive probes
featuring technetium and rhenium.74 Fluorescent rhenium
complexes can elucidate biological processes in vitro due to their
long lifetime, polarised emission and large Stokes shift. The
authors have reported the synthesis of a Tc(I)/Re(I) binding
ligand based on lysine-derived bis(pyridyl) amine i.e. a single
amino acid chelate (SAAC). The ﬂuorescent probe was delivered
to speciﬁc receptors by bioconjugation within fMLF, a targeting
sequence to give the peptide fMLF-[(SAACQ-Re(CO)3)
+]G
(Fig. 13). The 99mTc labelled analogue of the species was
prepared by reaction of the ligand with [99mTc(CO)3(OH2)3]
.
These complementary ﬂuorescent and radioactive peptide probes
allow the direct correlation of in vitro and in vivo imaging studies.
Derivatives of these isostructural ﬂuorescent and radioactive
probes have also been recently utilised for monitoring neural
stem and progenitor cell transplants.75
A similar strategy has been utilised for receptor-speciﬁc
nuclear targeting via trifunctional metal complexes. Alberto
and co-workers76 have synthesised [M(L2-pept)(L1-acr)(CO)3]
(pept = peptide; acr = acridine-based agent) in which the
fac-[M(CO)3]
+ moiety (1st function, M = 99mTc, Re) couples
an acridine-based nuclear-targeting agent (2nd function,
L1-acr) and the speciﬁc cell-receptor-binding peptide bombesin
(3rd function, L2-pept). The nuclear-targeting agents involved
an isocyanide group for monodentate (L1) and bombesin
(BBN) with a bidentate ligand (L2) for complexation to
fac-[M(CO)3]
+. For radiopharmaceutical studies, the 99mTc
analogues were prepared and the radioactivity distribution
conﬁrmed the ﬂuorescence results. Fluorescence microscopy
on PC3 cells bearing the BBN receptor showed high and rapid
uptake by receptor-mediated endocytosis into the cytoplasm
but not into the nucleus.
4. Magnetic resonance imaging/positron emission
tomography probes
Combining PET and X-ray computerised tomography
technologies has proven to give valuable opportunities in
imaging by the collection of physiological data and physical
mapping. There has been a great deal of interest in combining
PET and MRI (or fMRI)77 which would be able to collect
information in a similar way. PET and MRI are largely
complementary techniques and combination would certainly
be a ‘marriage of convenience’—with PET (exceptionally
sensitive, metabolically functional but with poor spatial
resolution) synergistically linked to MRI (giving supremely
high-resolution anatomic information in the sub-millimetre
range). The advent of attempts to build a scanner with the
capabilities to simultaneously image MRI and PET have been
under construction for over a decade.78 The drawbacks to date
have hindered the development of this technique; however, the
past two years have seen the development of new integrated
MRI/PET scanners.79,80 The main issue to be overcome is the
cost plus the deleterious interactions caused by the high
magnetic ﬁeld environment of the MR scanner and the
radiofrequency (RF) interference between the PET and MRI
systems i.e. conventional photomultipliers needed for PET
cannot operate within the high magnetic ﬁelds of an MRI.81
Raylman and co-workers79,82 have formed a prototype
MR-compatible PET system that features two opposed
detector heads, with each detector consisting of an array of
detector elements coupled through a ﬁbre optic light guide to a
single positron-sensitive photomultiplier tube. The light guide
allows the magnetic ﬁeld sensitive elements of the PET imager
to be positioned outside the strong magnetic ﬁeld of the 3T
MRI scanner. Contemporous MRI and PET images of small
animals were obtained without any indication of loss in image
or data quality.
Catana and co-workers have designed a multislice PET
scanner to ﬁt inside a pre-clinical MRI. Initial testing on
mouse models with the PET insert and 7T MRI scanner again
detected no deleterious interactions with no visible artefacts
being noted on the mouse images.81 The group produced the
ﬁrst PET/MR image of a mouse head using the prototype
Fig. 13 The structure of fMLF-[(SAACQ-M(CO)3)
+]G containing
all L-isomers.74
Fig. 14 Simultaneously acquired PET (ﬁltered back projection,
2.5 mm Gaussian post-smoothing ﬁlter) and coronal unenhanced fast
low-angle shot MR (394/5.9, 401 ﬂip angle, six signals acquired, 1 mm
section thickness, 256  256 pixels) images of a mouse head injected
with FDG. The fused PET/MR images show good alignment of
images acquired with the two imaging modalities. The increased
uptake of the PET images correlates with the location of the Harderian
glands behind the eyes in the MR images (reproduced from reference 83
by kind permission of the author, Bernd Pichler, and the Radiological
Society of North America).
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device, simultaneously acquiring both sets of information and
using computer software to fuse the data together.83 Physical
alignment of the mouse in both scans allowed for facile fusion
of the images as shown in Fig. 14.83 The 18FDG-enhanced
image of the mouse’s head showed no reduction in quality for
either MRI or PET, and the fused PET and MR images
showed an excellent anatomical match. The group also com-
mented that the scanning of a human brain via full body
scanning is possible within 5–10 years.
However, it is most interesting to note that virtually no
combined PET/MRI probes have been reported to date.
One classical report from Weissleder’s group84 showed that
progenitor and stem cells could be eﬃciently tagged and
therefore tracked by novel triple-label (magnetic, ﬂuorescent,
isotope) superparamagnetic nanoparticles, termed CLIO-Tat.
These nanoparticles consisted of a small (5 nm) monocrystalline
superparamagnetic iron oxide core, stabilized by a cross-linked,
aminated dextran coating—giving an overall size of ca. 45 nm.
Various amino acid residues could be attached—cysteine
included for bioconjugation, lysine for ﬂuorescein (optical
signal) attachment. The dextran coating was reacted with
diethylenetriamine pentaacetic acid (DTPA) so that it could
be labelled with 111In for concomitant nuclear imaging.
The resultant particles were thus ﬂuorescent, magnetic and
contained a radiotracer (111In) for nuclear imaging (Fig. 15).84
Now, with the development of suitable equipment, there is
huge scope for development of novel multi-modal MRI/PET
probes i.e. incorporating a paramagnetic ion or superpara-
magnetic material, such as Gd3+ or iron oxide, and a positron-
emitting nucleotide on its own or attached to a targeting
ligand or drug. The issue to be tackled is the large diﬀerence
in sensitivities of the two techniques. PET agents are generally
extremely small and can be used in tiny concentrations
whilst MR probes must be administered in much higher
concentrations—typically a thousand-fold higher than PET
agents. Of course, individual PET and MRI agents could be
injected simultaneously but there are likely to be validation
and registration problems unless they have identical pharmaco-
dynamics properties. Thus, a far more elegant approach would
be the use of a combined probe and this is part of the rationale
for all the dual-agents detailed in this review.
5. Conclusions and the future
The area of multi-modality molecular imaging is moving from
a research curiosity to one having real pre-clinical and
clinical application—this is clear from the number of diverse
examples reported in the previous sections. By facilitating the
development, validation and testing of new reporter systems in
animals and translating into humans, multi-modal probes are
substantially greater than the sum of their individual parts.
One of the key growth areas will be ‘theranostics’—where a
diagnostic and a therapeutic can be combined into the same
compound or probe. As the cellular processes imaged by
probes are often the same processes that a therapeutic can
target, a diagnostic imaging agent can be equipped to deliver a
therapeutic compound directly to a diseased site—an exciting
and powerful combination. Nanoparticles, oﬀering multi-
functional nanoplatforms, certainly have a role to play here
with the ultimate goal for nanoplatform-based agents being
eﬃcient, speciﬁc in vivo delivery of drugs without systemic
toxicity—and that the dose delivered as well as the therapeutic
eﬃcacy can be accurately measured non-invasively over time.
Of course, factors such as biocompatibility, pharmacokinetics,
targeting eﬃcacy and toxicity need to be fully addressed. Of
considerable importance in the use of nanomaterials (and in
particular QDs) in imaging is the generation of undesirable
side products, and a recent study has shown that
CdTe-containing dots generate reactive species detrimental
to biological systems85,86 and so this needs to be taken into
account when designing imaging experiments that incorporate
cadmium-containing QDs. A recent report on superparamagnetic
iron oxide (SPIO) nanoparticles highlights their biocompatibility
and reviews toxicity issues.87 Particle interactions with their
environment are greatly aﬀected by surface functionality i.e.
coating with biocompatible silica preserves the intrinsic
properties of the iron oxide cores by preventing degradation
and aggregation of the inner Fe2O3/Fe3O4 core. Possibly more
important are size eﬀects as SPIO nanoparticle diameter
greatly aﬀects in vivo biodistribution i.e. particles from 60 to
150 nm are taken up by the reticulo endothelial system leading
to rapid uptake in the liver and spleen.88 Particles with
diameters of 10–40 nm, including ultra-small SPIO, are
optimal for prolonged blood circulation, can cross capillary
walls, and are often phagocytosed by macrophages which
traﬃc to lymph nodes and bone marrow. Large particles
(4300 nm) are highly eﬀective at imaging the gastrointestinal
tract.89 In another recent study, the in vivo application of
carbohydrate-functionalised iron oxide nanoparticles has been
reported.90 These ﬁrst examples of MRI-visible glyconano-
particles allow detection of endothelial markers E-/-P selectin
in acute inﬂammation. The probes were well tolerated in all
models with no signs of ill eﬀect on toxicity. Simple, ﬁrst
generation, unfunctionalised, high-Fe content particles are
currently undergoing approval for clinical use, with associated
lack of toxicity—and so utilisation of the next generation,
functionalised species in early, pre-clinical detection of MS
and other neuropathologies can be anticipated.
Fig. 15 Schematic diagram of triple-label CLIO-Tat. The developed
magnetic particle consists of a central superparamagnetic iron oxide
core (yellow), sterically shielded by cross-linked dextran (green). The
particle core measures B5 nm and the overall particle size is 45 nm.
The FITC-derivatised Tat peptide (blue) was attached to the aminated
dextran, yielding an average of four peptides per particle. The dextran
surface was also modiﬁed with the chelator DTPA (red) for isotope
labelling (reproduced from reference 84 by kind permission of Nature
Publishing Group and Macmillan Publishers Ltd).
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Looking towards biology for delivery and biocompatibility
is sure to be a focus in the coming years. For instance, a very
recent report91 details the attachment of multiple functional
moieties to a peptide scaﬀold featuring a single reactive site.
Two types of multi-functional single-attachment point scaﬀold
are described. Bifunctional scaﬀolds consist of a dipeptide
of lysine and cysteine; trifunctional scaﬀolds are made of
tetrapeptides with two lysines, b-alanine and cysteine. This
approach via the peptide scaﬀold is controllable and reproducible
in the production of multi-functional probes. Nanoparticles
consisting of a plasmonic layer and an iron oxide moiety
could provide a promising platform for the development of
multi-modal imaging and therapy approaches in future
medicine e.g. with gold-coated iron oxide hybrid nanoparticles
combined molecular-speciﬁc MRI/optical imaging and photo-
thermal therapy of cancer cells can be accomplished.92 There
has also been a recent example of ﬂuorescent bacterial
magnetic nanoparticles acting as bimodal contrast agents.93
The nanoparticles were isolated from the magnetic bacterium
Magnetospirillum gryphiswaldense and covalently bound to the
near infrared ﬂuorescent dye ﬂuorochrome DY-676.
Forming ‘smart’ or switchable probes or new ways to deliver
reagents with enhanced properties will also be ‘hot topics’. For
instance, enzyme-activated optical probes can be harnessed
where the probes have a low ﬂuorescence signal until they are
activated by target enzymes such as proteases, after which
their signal is ampliﬁed. In a seminal paper by Meade and
co-workers (focussing on the MRmodality only), biochemically-
activated contrast agents based on gadolinium chelates were
reported94 and shown to be able to indicate reporter gene
expression in living animals. The coordination sphere of
the Gd chelate is initially blocked (from access to water)
by a substrate, galactopyranose, which can be removed by
enzymatic cleavage. Following cleavage, the paramagnetic ion
can interact directly with the water protons, thus increasing
the MR signal. Engineering extra modality into these systems
must be possible. For enhanced probe delivery, directions will
include the search for new multi-functional materials i.e. by
using hybrid gadolinium oxide nanoparticles95 and nanoscale
metal–organic frameworks (NMOFs).96
Alongside probe development, advances in imaging techno-
logy and equipment will be sought. It is clear that prototype
PET/MRI scanners are already in production and eventually
these will become mainstream. The technology is challenging
due to the radiofrequency interference between the two
imaging systems that has to be avoided and the PET detectors
must work in relatively high magnetic ﬁelds. The major uses of
PET/MRI scanners will initially be in research, both human
and animal—applications driving the commercial success of
PET/MRI are perhaps not yet apparent but they will come. It
will be interesting to see the impact of the fully functional
PET/MRI systems, and what will be their role in clinical
diagnostics, clinical research, molecular imaging and drug
development.
In summary, multi-modal molecular imaging approaches
will have a signiﬁcant impact on biomedical research and
drug discovery and development—indeed many industrial
companies have set up medical imaging divisions and are
integrating molecular imaging into their drug development
eﬀorts. Imaging targets in body/cell/tissue, and investigating
interaction of targets with substrates and receptor occupancy
are vital in pre-clinical and clinical research. The design
of the appropriate (multi-modal) imaging probe is key
and any real advances in molecular imaging will be due to
the interdisciplinary eﬀorts of synthetic chemists, molecular
biologists, biomedical and imaging scientists.
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Abstract: The evaluation and selection of the most
appropriate catalyst for a chemical transformation is
an important process in many areas of synthetic
chemistry. Conventional catalyst screening involving
batch reactor systems can be both time-consuming
and expensive, resulting in a large number of individ-
ual chemical reactions. Continuous flow microfluidic
reactors are increasingly viewed as a powerful alter-
native format for reacting and processing larger
numbers of small-scale reactions in a rapid, more
controlled and safer fashion. In this study we demon-
strate the use of a planar glass microfluidic reactor
for performing the three-component palladium-cata-
lysed aminocarbonylation reaction of iodobenzene,
benzylamine and carbon monoxide to form N-ben-
zylbenzamide, and screen a series of palladium cata-
lysts over a range of temperatures. N-Benzylbenz-
ACHTUNGTRENNUNGamide product yields for this reaction were found to
be highly dependent on the nature of the catalyst
and reaction temperature. The majority of catalysts
gave good to high yields under typical flow condi-
tions at high temperatures (150 8C), however the pal-
ladium(II) chloride-Xantphos complex [PdCl2
ACHTUNGTRENNUNG(Xantphos)] proved to be far superior as a catalyst at
lower temperatures (75–120 8C). The utilised method
was found to be an efficent and reliable way for
screening a large number of palladium-catalysed car-
bonylation reactions and may prove useful in screen-
ing other gas/liquid phase reactions.
Keywords: carbonylation; catalysis; catalyst screen-
ing; microfluidics; micro-reactor; palladium
Introduction
Since its initial discovery,[1–3] the palladium-catalysed
carbonylation reaction of aryl, heteroaryl, vinyl and
benzyl halides has developed into a highly versatile
and effective synthetic route to an array of organic
molecules possessing a carbonyl functional group.[4–6]
Carboxylic acid derivatives, ketones, aldehydes, carbo-
nates, carbamates and ureas may be readily prepared
in one pot via the three-component reaction of an or-
ganic electrophile, nucleophile and carbon monoxide
in the presence of a suitable palladium catalyst. Car-
bonylation reactions are of high interest in the fine
chemical and pharmaceutical sectors where they are
viewed as an atom-efficient method for preparing val-
uable carbonyl compounds from readily available aryl
and vinyl halide precursors.[7–9] Although carbonyla-
tion reactions have attracted significant interest in
recent years from academic groups, especially with re-
gards to catalyst discovery and development, there
are however several factors which have prevented the
wider exploitation of this method within the academic
field. Firstly, there are the obvious safety concerns of
handling a poisonous gas such as carbon monoxide
which may additionally need to be used at high pres-
sures. This may also necessitate the use of specialised
and expensive equipment. Secondly, carbonylation re-
actions are not as well characterised as other palladi-
um-catalysed reactions such as cross-coupling reac-
tions for CC, CN and CO bond formation. Yields
are highly dependent on the aryl substrates and nucle-
ophiles and, moreover, can vary widely depending on
the CO pressure, solvent and reaction temperature. In
addition, the nature of the catalyst is known to have a
particularly noticeable effect on the yield and reaction
rates of particular carbonylation reactions.[10] Conse-
quently much emphasis has been placed on catalyst
development in recent years to permit reactions
under milder temperatures and pressures in addition
to allowing more challenging aryl chloride or tosylate
substrates to be coupled.[7,11–18] The characteristics of
the ligand bound to the metal centre are of significant
importance for catalyst development. The most
widely investigated ligand systems with regards to car-
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bonylation reactions have been tertiary phosphines al-
though carbene ligands are receiving much current in-
terest.[19,20] Generally, however, chelating diphosphines
are viewed as having ideal characteristics for control-
ling geometry at the palladium centre and for stabilis-
ing the active catalyst at higher temperatures by pre-
venting the formation of Pd-black and Pd-carbonyl
clusters which are thought to inhibit the reaction.[21,22]
Determining the reaction conditions that achieve
the highest chemical yields in the shortest possible
times (space-time yields) usually involves striking the
right balance between the main variables in the reac-
tion.[23] This is often an arduous and iterative process,
and can inevitably lead to delays and bottlenecks in
process development. For carbonylation reactions CO
pressure, temperature and catalyst are the key varia-
bles. Optimal pressures are normally in the range 5–
20 atm while temperatures range from 50 to 150 8C
depending on the solvent. However, there is an obvi-
ous desire to reduce both the pressures and tempera-
tures of these reactions. Selecting the best catalyst can
be more demanding because related ligands with
structures that are seemingly very similar may pro-
duce contrasting results. Take the wide range of palla-
dium diphosphine complexes, for example, where
ligand structures and bite angles can vary by a few
atoms or degrees with the result of profound changes
in catalytic activities.[24]
Parallel reactor systems, where a number of reac-
tions are run in tandem, are most commonly used for
rapidly conducting catalyst and reaction condition
screening. This equipment, extensively used in indus-
try, is rather specialised and can be prohibitively ex-
pensive for smaller academic groups or more isolated
investigations. An alternative to these batch reactors
are continuous flow microfluidic systems which are
particularly adept at handling, reacting and processing
extremely small amounts of substrates and/or cata-
lysts on the mg to low mg scale.[25,26] In recent times,
microfluidic devices have gained recognition for effi-
ciently performing a wide range of chemical reactions
on extremely small scales.[27–30] Additionally, micro-
fluidic reactors have a number of advantages over
commonly used conventional laboratory batch reac-
tors. These include the obvious reduction in reagent
consumption which can be important when dealing
with high value or precious substrates and catalysts.
The unique environment within microfluidic channels
can provide other less obvious advantages which in-
clude greater reaction control and enhancement of
mass transport between reagent streams. Heat trans-
fer into or out of the microchannels is also much im-
proved because of the small convective distances and
large surface-to-volume areas involved. Such advan-
tages have been proven to have a positive impact on
the rates, yields and/or selectivities of chemical reac-
tions.[31–33]
Multiphase gas-liquid reactions such as hydrogena-
tions,[34–36] oxidations,[37,38] fluorinations[39–41] and more
recently carbonylations[42–45] are well suited for adap-
tation to a microfluidic format. This is because, in ad-
dition to the advantages stated above, significant
gains in interfacial gas-liquid contact areas can lead to
enhanced reactivity. This is particularly appealing for
carbonylations because the low solubility and resul-
tant poor reactivity of carbon monoxide may be en-
hanced without the need for excessively high pres-
sures. Palladium-catalysed carbonylation reactions are
proposed to proceed via three distinct steps in the cat-
alytic cycle: oxidative addition of the aryl/vinyl halide
to the active Pd catalyst; migratory insertion of
carbon monoxide to form an acyl-Pd intermediate;
nucleophilic attack followed quickly by reductive
elimination to give the carbonyl compound and re-
generate the active Pd species. At lower carbon mon-
oxide pressures the migratory insertion of CO is
thought to be rate-limiting. Thus there is the real pos-
sibility of enhancing the rate-limiting migratory inser-
tion step of carbon monoxide at lower pressures
which is both technically appealing and safer. We re-
cently reported the first example of a palladium-cata-
lysed carbonylation reaction on a microfluidic
device[42] which showed significant advantages in
terms of product yield and reaction rates over compa-
rable batch reactions for the synthesis of secondary
amides. In this study we specifically investigated the
effects of aryl halide substrates and liquid flow rates
on the product yields and distributions. Interestingly
we found that two amide products were formed in the
reaction; the expected single carbonyl amide and the
double carbonyl alpha-ketoamide in varying amounts.
The distribution of these products is known to be de-
pendent on the catalyst and reaction conditions, with
temperature playing a dominant role.[45] Herein we
wish to extend these studies and report a method for
the screening of a range of catalysts for a model ami-
nocarbonylation reaction using microfluidic technolo-
gy with the aim of rapidly identifying the best catalyst
and reaction conditions.
Results and Discussion
The well characterised model aminocarbonylation re-
action of iodobenzene, carbon monoxide and benzyl-
ACHTUNGTRENNUNGamine to form N-benzylbenzamide (Scheme 1) was
Scheme 1. The aminocarbonylation reaction of iodobenzene
with carbon monoxide gas and benzylamine forming N-ben-
zylbenzamide.
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selected to assess a number of palladium-based cata-
lysts over a range of temperatures. The catalysts se-
lected for testing include a range of palladium mono-
dentate phosphine, bidentate phosphine, carbene and
palladium dimer complexes (Table 1) which may
allow us to infer the effect that catalyst stability, elec-
tronic effects, sterics and bite angles could have on
these types of carbonylation reactions. Our microflui-
dic testing rig (Figure 1) is based around a soda-lime
glass device (Figure 2) consisting of two inlets (for in-
troducing liquid reagents and carbon monoxide), a T-
junction to allow mixing, a long continuous serpentine
channel with dimensions of l=5 m, w=200 mm, d=
75 mm and an outlet port for product collection. From
our previous studies it was found that this long ser-
pentine channel was necessary to retain the liquid re-
agents long enough on the device to react under an
annular-type flow regime. Annular flow results when
a gas stream flows through the centre of a channel or
pipe and forces the liquid to adhere and flow along its
internal walls.[46] This type of flow provides the largest
gas-liquid contact surface area and therefore would
be expected to give the highest chemical yields in the
shortest time.
An injector port with a 50 mL sample loop was in-
corporated between the solvent pump and the micro-
fluidic reactor to allow a measured volume of cata-
lyst/iodobenzene/benzylamine solution to be injected
into a continuous flow of solvent and onto the device.
Carbon monoxide was introduced and regulated into
Table 1. Catalyst screen.
Catalyst structure Catalyst Bite angle
ACHTUNGTRENNUNG[PdCl2(Biphenphos)] 928
ACHTUNGTRENNUNG[PdCl2 ACHTUNGTRENNUNG(Synphos)] 938
ACHTUNGTRENNUNG[PdCl2 ACHTUNGTRENNUNG(Xantphos)] 1088
ACHTUNGTRENNUNG[PdCl2 ACHTUNGTRENNUNG(DPEphos)] 1048
ACHTUNGTRENNUNG[PdCl2 ACHTUNGTRENNUNG(dppf)] 998
Rac-[PdCl2 ACHTUNGTRENNUNG(BINAP)] 938
ACHTUNGTRENNUNG[PdCl2 ACHTUNGTRENNUNG(dppp)] 918
ACHTUNGTRENNUNG[PdCl2 ACHTUNGTRENNUNG(PPh3)2] –
[Pd ACHTUNGTRENNUNG(PPh3)4] –
Table 1. (Continued)
Catalyst structure Catalyst Bite angle
1,3-bis(2,6-diisopropyl-
phenyl)imidazolinium
chloride+Pd acetate
–
{Pd[P ACHTUNGTRENNUNG(t-Bu3)]2} –
ACHTUNGTRENNUNG{Pd2ACHTUNGTRENNUNG(m-Cl)Cl ACHTUNGTRENNUNG[m-P ACHTUNGTRENNUNG(t-Bu)2
ACHTUNGTRENNUNG(Bph-H)]}
–
Figure 1. Schematic drawing of the reactor set-up.
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the chip device using a gas flow controller and me-
tered at a constant flow rate. A pressure gauge was
used to monitor the back pressure in the system. The
chip device was heated using a heating plate with an
associated thermocouple to ensure constant tempera-
tures.
Reaction solutions consisted of a 1M solution of io-
dobenzene in benzylamine, which has the role of re-
agent, base and solvent, and 2 mol% of palladium cat-
alyst. In each reaction a 50 mL injection of the cata-
lyst/reagent solution was introduced into a continuous
flow of THF solvent driving the mixture on to the
chip where it mixed and reacted with carbon monox-
ide. Each 50 mL slug of reagent solution contained
10.2 mg of iodobenzene and approximately 1 mg of
the catalyst. Although it could be expected that much
smaller quantities of reagents and catalysts could be
used we found these quantities convenient for testing.
The residence time of the liquid reagents on the chip,
which can be taken as the reaction time, was previ-
ously measured[42] to be approximately 2 min while
the total processing time for each independent reac-
tion was 12 min from initial injection to collection of
the reacted product. In total 12 different catalysts
were tested and approximately 100 reactions per-
formed at temperatures ranging from 75 8C to 150 8C.
The reaction temperature was found to have a pro-
nounced effect on the yields of N-benzylbenzamide.
As may be expected, chemical yields were found to
increase with temperature, however, it should be
noted this is not always the case with carbonylation
reactions since higher temperatures can degrade the
catalyst.[47] Yields were significantly increased when
the temperatures were increased from 120 8C to
150 8C compared to changes from 100 8C to 120 8C.
The higher temperature regimes also resulted in the
exclusive formation of N-benzylbenzamide with no
evidence of the double carbonylation a-ketoamide
product previously observed at lower temperatures.[42]
The reaction catalysed by [PdCl2ACHTUNGTRENNUNG(dppf)] (Figure 3),
for example, gave average yields of 14% at 100 8C
and 36% at 120 8C, however when the temperature
Figure 2. Glass fabricated microfluidic device used to per-
form gas-liquid aminocarbonylation reactions.
Figure 3. Results of a catalyst screen of 4 palladium diphosphine complexes. Each data point represents the average yield
(GC). Error bars show the standard deviation about the mean value (n=3).
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was increased to 150 8C yields were almost quantita-
tive. This indicates that some of the catalysts, such as
[PdCl2 ACHTUNGTRENNUNG(dppf)] and [Pd ACHTUNGTRENNUNG(PPh3)4], are much more active
at higher temperatures than might otherwise be ex-
pected on simple extrapolation of the lower tempera-
ture data. Reaction yields were generally good to ex-
cellent at higher temperatures despite the short resi-
dence times (~2 min) of the liquid reagents on the
device. Normally, such carbonylation reactions are
considered sluggish taking several hours to reach
completion at higher pressures. However, under the
right reaction conditions and with the appropriate cat-
alysts, they can be surprisingly fast and high yielding
as seen with our system, albeit with a relatively reac-
tive aryl iodide substrate.
Diphosphine-based catalysts have been widely used
for a range of catalytic reactions. The effect of PM
P bite angle of the diphosphine complexes has been
extensively investigated and known to be important
in determining the selectivities and rates of catalytic
reactions.[48,49] In this study we tested seven palladium
diphosphine catalysts which have bite angles ranging
from 928 to 1088. Ligands with wider bite angles, such
as Xantphos, have been generally recognised as
having a positive effect on hydroformylation, hydro-
cyanation, CO/alkene copolymerisation, cross-cou-
pling and carbonylation reactions.[24,50,51] At higher
temperatures (150 8C) all the palladium diphosphine
catalysts gave good yields (>75%, Figure 3 and
Figure 4) of N-benzylbenzamide, the only exception
being the [PdCl2ACHTUNGTRENNUNG(binap)] complex which gave a mod-
erate yield of 45%. This was surprising considering its
structural similarity to the biphenphos and synphos li-
gands, and previous reports of highly successful me-
thoxycarbonylation reactions of heteroaryl chlor-
ides.[13] However, a recent report showed the binap
ligand to be completely ineffective for the preparation
of N-methoxy-N-methylamides (Weinreb amides) via
the aminocarbonylation of aryl bromides.[47] At lower
temperatures (100 8C and 120 8C) moderate to low
yields of amide were obtained for all the diphosphine
ligand complexes except for the Xantphos complex
which showed remarkable conversions at both 100 8C
and 120 8C. Average yields of amide in excess of 94%
(Figure 4) were obtained for the Pd-Xantphos catalyst
which greatly surpassed any of the other catalysts we
tested at these lower temperatures. The Pd-Xantphos
complex still showed remarkable activity giving an
average yield of 83% even when the reaction temper-
ature was lowered to 75 8C.
Tetrakis(triphenylphosphine)palladium is often
used as a benchmark catalyst for cross-coupling reac-
tions. Carbonylation reactions using catalysts based
on monodentate phosphines have often been ob-
served to degrade at higher temperatures to catalyti-
cally inactive Pd-black or Pd-CO clusters. Under our
reaction conditions [Pd ACHTUNGTRENNUNG(PPh3)4] performed on-par
with the diphosphine catalysts at the higher tempera-
ture of 150 8C achieving average yields >75%. At this
temperature, however, palladium black was observed
to coat the channels of the microfluidic chip.
The other triphenylphosphine-based catalyst,
ACHTUNGTRENNUNG[PdCl2 ACHTUNGTRENNUNG(PPh3)2], gave lower yields and also produced
significant quantities of Pd-black at 120 8C. The palla-
Figure 4. Results of a catalyst screen of 4 palladium complexes. Each data point represents the average yield (GC). Error
bars show the standard deviation about the mean value (n=3).
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dium dimer complex [Pd ACHTUNGTRENNUNG(m-Cl)Cl(t-Bu-biphen)] was
of particular interest because of recent reports of its
high catalytic activity for cross-coupling reactions at
low temperatures.[52] Unfortunately [Pd ACHTUNGTRENNUNG(m-Cl)Cl(t-Bu-
biphen)]was only sparingly soluble in the iodoben-
zene/benzylamine solution and therefore the reaction
was conducted in DMF. Disappointingly low yields of
amide (<30%, Figure 5) were obtained at 100 8C and
120 8C with significant amounts of palladium black
obscuring the microchannels of the reactor. The
{Pd[P ACHTUNGTRENNUNG(t-Bu3)2]} complex bearing the highly bulky and
electron rich tri-tert-butylphosphines has also been re-
garded as a highly active catalyst for cross-coupling
and carbonylation reactions[10,53] and was therefore of
high interest to test. A low average yield of 22% was
obtained at 100 8C, while at 120 8C an encouraging
yield of 43% was obtained which is the highest of the
monodentate ligand catalysts at this temperature.
N-heterocyclic carbene (NHC) ligands have attract-
ed much attention as alternative ligand systems to
phosphines, and have consequently been tested for a
range of catalytic reactions including, quite recently,
carbonylation reactions.[19] NHC ligands have widely
been considered to supersede phosphines under more
harsh reaction conditions because of the degradation
of PC bonds in phosphine-based catalyst systems at
higher temperatures. Pd-NHC complexes are also
often less sensitive to oxygen and moisture, in addi-
tion to having a higher thermal stability, which poten-
tially makes them more catalytically robust than Pd-
phosphine catalysts. Unlike the previous preformed
Pd-phosphine catalysts, the Pd-NHC catalyst we used
was generated in situ from palladium acetate and 1,3-
bis(2,6-diisopropylphenyl)imidazolinium chloride.
Yields of N-benzylbenzamide obtained using this cat-
alyst system at 100 8C were very low (<10%) but im-
proved to >75% when the temperature was increased
to 150 8C (Figure 5). At this higher temperature, how-
ever, a significant amount of palladium black was ob-
served in the microchannels of the device suggesting
that the catalyst was degrading.
The bidentate phosphine catalysts appear to have a
greater thermal stability, producing less palladium
black, than the monophosphine or NHC complexes
and are therefore better suited to higher temperature
aminocarbonylation reactions. The Xantphos catalyst
was a clear outlier, performing significantly better
than all the other catalysts we tested under these re-
action conditions. The wide bite angle (1088) and flex-
ible nature of the Xantphos ligand has been widely
reported to have a beneficial effect on a number of
catalytic reactions compared to other diphosphine li-
gands.[50] It is suggested to provide a dynamic and
flexible coordination environment which is important
for stabilising the metal centre in various oxidation
states and geometries. Although DPEphos and dppf
have similar bite angles to Xantphos they gave much
less impressive yields at lower temperatures which
suggests that the flexibility of the Xantphos ligand
may play an important role in these reactions. Xant-
phos has, in fact, recently been reported to be an
active ligand for aminocarbonylation reactions giving
impressive conversions when other bidentate and
monodentate phosphine ligand systems failed com-
Figure 5. Results of a catalyst screen of 4 palladium complexes. Each data point represents the average yield (GC). Error
bars show the standard deviation about the mean value; n=3 for [PdCl2ACHTUNGTRENNUNG(PPh3)2] and [Pd ACHTUNGTRENNUNG(OAc)2carbene]; n=2 for {Pd[P ACHTUNGTRENNUNG(t-
Bu)2]} and [Pd2ACHTUNGTRENNUNG(m-Cl)ClACHTUNGTRENNUNG{m-P ACHTUNGTRENNUNG(t-Bu)2-(Bph-H)].
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pletely.[47] However, in another report involving a pal-
ladium-catalysed aminocarbonylation/amidation cas-
cade reaction for the one-pot synthesis of quinolones,
the Xantphos catalyst system did not perform as well
as the other catalysts that were screened.[54] Although
the positive effects of the Xantphos ligand are well
recognised with regards to Rh-catalysed hydroformy-
lation reactions, its effect on palladium-catalysed ami-
nocarbonylation, as seen with our results and
others,[47] are particularly encouraging.
A key feature of our system is that reactions are
performed in microfluidic channels and in continuous
flow whereby the annular gas/liquid arrangement pro-
vides a high surface area for enhancing reactivity. Al-
though we have found that this leads to much im-
proved space-time yields when compared to equiva-
lent batch carbonylation reactions, the system is limit-
ed by the fact that reaction (or residence) times are
very short (~2 min). While such short reaction times
proved sufficient to achieve excellent yields of amides
via the aminocarbonylation of aryl iodides, they may
prove too short to provide good yields for more chal-
lenging carbonylations such as the reaction of deacti-
vated aryl bromides or aryl chloride substrates. How-
ever, one straightforward solution to this would be to
impose a different flow regime on the gas and liquid
mixture such as alternate slugs of gas and liquid (i.e.,
a segmented flow). Although this method can give
more controlled residence times of the gas and liquid
mixtures (that would be suitable for longer reaction
times), this may be at the expense of surface area ef-
fects seen for the annular flow regime. An added fea-
ture of our reaction system is the speed and reliability
with which reactions could be performed, with each
reaction taking only 12 min. In total 12 different cata-
lysts were tested at various temperatures, with 2 or 3
reactions being run at each temperature to ensure re-
producibility. Although no attempt was made to
scale-up any of the reactions under study, the data ob-
tained clearly suggest that the Xantphos ligand
system at a minimum temperature of 100 8C is best
for the aminocarbonylation of iodobenzene. This
rapid methodology for screening reactions may there-
fore provide a useful snap-shot of catalyst activity,
and may prove important in identifying the best cata-
lysts and reaction conditions at an early stage of de-
velopment prior to in-depth catalyst screening or
scale-up using standard batch reaction methods.
Conclusions
Microfluidic reactors are playing an increasingly im-
portant role in chemical synthesis especially in areas
such as high throughput synthesis and analysis where
there is a drive to perform large numbers of reactions
on smaller volumes of material within shorter time
frames. The method we have described for the amino-
carbonylation of aryl halides possesses certain advan-
tages over conventional batch reactor systems for
these types of reactions. It is a safer approach using
only minute quantities of reagents and small volumes
of poisonous carbon monoxide. Although the quanti-
ties of reagent used for our amminocarbonylation re-
actions were small by normal laboratory standards
(10.2 mg iodobenzene, ~1 mg catalyst) these reactions
could be conducted on a much smaller scale (at least
an order of magnitude smaller) without the need to
modify our existing experimental set-up. The equip-
ment is relatively unsophisticated, inexpensive and
commercially available; standard and bespoke glass
fabricated microfluidic devices are now readily avail-
able from a number of commercial suppliers. In addi-
tion to these technical advantages, performing reac-
tions within a continuous flow microfluidic format
also often gives enhanced reactivities compared to
batch systems. Under our reaction conditions moder-
ate to excellent yields of N-benzylbenzamide were ob-
tained within extremely short reaction times, albeit at
high temperatures. The notable exception to this was
the Xantphos ligand system which showed excellent
conversions at much lower temperatures. Interestingly
this was in agreement with a previous carbonylation
study using Xantphos as a ligand[47] and further high-
lights the beneficial effect of such wide bite angle di-
phosphine ligands. As mentioned above, the short re-
action times imposed by the flow regimes in this
system may be considered as a limitation to its wider
applicability. Nevertheless this system has proven ex-
tremely useful for rapidly identifying the most suita-
ble reaction conditions for a given aminocarbonyla-
tion reaction.
Experimental Section
General Considerations
All preparations were carried out using standard Schlenk
line techniques under an inert atmosphere of N2 unless oth-
erwise stated. Solvents were dried over standard drying
agents and freshly distilled under nitrogen before use. All
starting materials and ligands were of reagent grade and
purchased from either Sigma–Aldrich Chemical Company
or Strem Chemicals. 1H and 31P{1H} NMR spectra were re-
corded on Bruker Av-400, DRX-400, Av-500 spectrometers.
Chemical shifts are reported in ppm using the residual
proton impurities in the solvents.
Catalyst Preparation
Preformed diphosphine catalysts were prepared by the reac-
tion of 1:1 stoichiometry amounts of the appropriate diphos-
phine ligand and [PdCl2ACHTUNGTRENNUNG(COD)] in dichloromethane. Cata-
lysts [Pd ACHTUNGTRENNUNG(PPh3)4] and [PdCl2ACHTUNGTRENNUNG(PPh3)2] were purchased from
commercial sources. The palladium N-heterocyclic carbene
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complex was prepared in situ by the 1:1 stoichiometric reac-
tion of 1,3-bis(2,6-diisopropylphenyl)imidazolinium chloride
and palladium acetate. The palladium dimer complex [Pd2
ACHTUNGTRENNUNG(m-Cl)Cl ACHTUNGTRENNUNG{m-P ACHTUNGTRENNUNG(t-Bu)2ACHTUNGTRENNUNG(Bph-H)] (Bph-H=biphenyl) was pre-
pared according to the literatutre procedure.[55] The {Pd[P ACHTUNGTRENNUNG(t-
Bu)3]2} complex was prepared by a modified procedure to
that previously reported in the literature.[56] To a suspension
of [Pd2ACHTUNGTRENNUNG(dba)3] (1.0 mmol, 0.916 g) in toluene (80 mL) was
added tri-tert-butylphosphine (4.95 mmol, 1.0 g) and the re-
action mixture stirred for 48 h at ambient temperature. The
solution was then filtered into a new flask via cannula and
toluene removed under reduced pressure. This crude solid
was then dissolved in dry diethyl ether (30 mL) and placed
in a freezer at 35 8C overnight to yield white crystals. The
supernatant was removed using a cannula and the crystals
washed with dry diethyl ether (24 mL) and dried under re-
duced pressure; yield. 0.56 g (55%) 1H NMR (benzene-d6,
400 MHz): d=1.65–1.62 (m, 54H), (3JP,H=5.7 Hz);
31P{1H} NMR (benzene-d6, 162 MHz): d=84.9 (s).
Microfluidic Reactor Set-Up
A detailed description of the microfluidic reactor structure
and design has been previously reported.[42] Briefly, the
device was fabricated from a soda-lime glass substrate with
channels being etched into the glass using an HF/NH4F solu-
tion. External holes were drilled at the reagent entry and
exit points prior to thermal bonding of the glass cover plate.
Nanoports (part no. N-333) were bonded to the entrance
and exit holes of the device which allowed external tubing
to be easily connected. The flow of carbon monoxide gas
was regulated directly from the gas cylinder using a Sierra
100 series Smart-Trak mass flow controller and metered at 2
sccm into the chip device. A Harvard syringe pump (pump
11) was used to continuously infuse THF into the chip
device at a flow rate of 10 mL/min via a six-way Rheodyne
injector (part no. 7725i) complete with a 50 mL sample loop.
Microfluidic Reactions
Reaction mixtures were prepared by dissolving the required
catalyst (2 mol%) in a 1M iodobenzene/benzylamine solu-
tion. In a typical reaction 0.02 mmol of catalyst was dis-
solved in iodobenzene/benzylamine solution (1 mL, 1M).
The reaction solution was loaded into the 50 mL loop and
the injector switched to redirect the flow of THF into the
sample loop which drives the reaction mixture into the chip
device where it mixes and reacts with CO gas. The device
was heated to the required temperature using a heating
block and the product solution collected at the device outlet
into a sample vial. After a processing time of 10 min the
flow rate of the THF from the pump was increased to flush
off any residual product on the device and collected into the
sample vial. The collected samples were allowed to evapo-
rate and then diluted using a dichoromethane/phenyl ether
standard solution. GC samples were run on an HP5890
series II fitted with a Supelco Omegawax column (dimen-
sions; 30 m, 0.25 mm, and 250 mm film thickness) using
helium as the carrier gas. Quantitative analysis was conduct-
ed by gas chromatography using the peak area of the prod-
uct N-benzylbenzamide normalised in response to the inter-
nal diphenyl ether standard.
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N-heterocyclic carbenes as ligands in
palladium-mediated [11C]radiolabelling
of [11C]amides for positron emission
tomography
Lucy E. Jennings,a Steven Kealey,b Philip W. Miller,a Antony D. Gee,a,b
and Nicholas J. Longa
A model palladium-mediated carbonylation reaction synthesizing N-benzylbenzamide from iodobenzene and benzylamine
was used to investigate the potential of four N-heterocyclic carbenes (N,N0-bis(diisopropylphenyl)-4,5-dihydroimidazoli-
nium chloride (I), N,N0-bis(1-mesityl)-4,5-dihydroimidazolinium chloride (II), N,N0-bis(1-mesityl)imidazolium chloride (III) and
N,N0-bis(1-adamantyl)imidazolium chloride (IV)) to act as supporting ligands in combination with Pd2(dba)3. Their activities
were compared with other Pd-diphosphine complexes after reaction times of 10 and 120min. Pd2(dba)3 and III were the
best performing after 10min reaction (20%) and was used to synthesize radiolabelled [11C]N-benzylbenzamide in good
radiochemical yield (55%) and excellent radiochemical purity (99%). A Cu(Tp*) complex was used to trap the typically
unreactive and insoluble [11C]CO which was then released and reacted via the Pd-mediated carbonylation process.
Potentially useful side products [11C]N,N0-dibenzylurea and [11C]benzoic acid were also observed. Increased amounts of
[11C]N,N0-dibenzylurea were yielded when PdCl2 was the Pd precursor. Reduced yields of [
11C]benzoic acid and therefore
improved RCP were seen for III/Pd2(dba)3 over commonly used dppp/Pd2(dba)3 making it more favourable in this case.
Keywords: 11-carbon; carbon monoxide; palladium-catalysis
Introduction
There has been a significant growth in the use of the molecular
imaging technique, positron emission tomography (PET), in
biological research and drug development over the last 20
years.1,2 Radiolabelled compounds can be tracked in real time
giving an insight into drug delivery as well as biochemical
processes. However, significant challenges still remain in the
development of new radiolabelled compounds for imaging
biological processes.3 The most commonly used positron
emitters are 11C, 18F, 15O and 13N and one of the key challenges
in PET is to utilize the radionuclides within approximately three
half-lives in order to maintain enough radioactivity for the scan.
Carbon-11 is of particular interest due to its biocompatibility;
however its short half-lifetime of 20.4min drives the need for
new methods to accelerate radiolabelling methodologies. The
most common method for 11C incorporation is methylation
using [11C]methyl iodide4 or the more reactive [11C]methyl
triflate5,6 but interest in utilizing [11C]carbon monoxide7 and
[11C]carbon dioxide8 is growing as new techniques open up
the field9,10.
In [11C]radiolabelling, transition metal-mediated processes
play an important role due to their ability to speed up
incorporation via activation of [11C]carbon monoxide. Pd-
mediated [11C]carbonylation reactions have been widely applied
in Suzuki-Miyaura, Stille and carboxyamination reactions for PET
radiolabelling.11–13 Here, the picomolar amounts of [11C]CO
used mean that the catalyst is actually in vast excess, so the
process can be considered to be Pd-mediated rather than Pd-
catalysed. The amide functionality is frequently found in
biologically active compounds such as DAA1106 and analogues
which are potential ligands for the peripheral benzodiazepine
receptor.14 La˚ngstro¨m et al. have extensively studied palladium-
mediated [11C]carboxyamination as a route to [11C]amides,
combining a wide range of organic halides and triflates with
amines, utilizing a microautoclave system and high pres-
sures.15–19 Recent low-pressure trapping and reaction methods
using either borane10 or copper complexes9 present certain
advantages in terms of their simplicity and ease of use.
As an alternative to the commonly used organophosphines,
N-heterocyclic carbenes (NHC) have shown potential as
ancillary ligands for many palladium-catalysed cross-coupling
reactions,20–22 including Suzuki–Miyaura coupling reactions,23
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Sonagashira cross-coupling24 and Buchwald–Hartwig amina-
tion.25 Their use in the carbonylation of aryl halides is a relatively
unexplored area. Some work has been carried out investigating
the use of NHCs in palladium-catalysed carbonylative Suzuki–-
Miyaura cross couplings26,27 and oxidative carbonylations,
employing a copper co-catalyst to synthesize ureas, carbamates
and 2-oxazolidinones;28 however, the majority of the research
has been carried out on hydroformylation reactions.29 NHCs are
considered to be more catalytically robust than phosphines and
are found to be generally superior under harsher conditions
owing to their greater stability at higher temperatures and
greater tolerances to oxygen and moisture.
Amide synthesis from palladium carbonylation using NHCs as
ligands has been carried out with aryl diazonium salts and aryl
boronic acids in the only reported production of amides
through carbonylation using NHCs.30 The full capability of NHCs
in Pd-catalysed carbonylation reactions for the synthesis of
amides – an important functional group found in many
pharmaceuticals – has not yet been fully explored. In this
manuscript, we illustrate the comparable ability of NHC versus
commonly used mono- and bi-dentate phosphines in the
synthesis of amides over the timeframes of 10min and 2 h,
and the novel utilization of these ligands in PET radiolabelling
experiments using [11C]carbon monoxide via the use of a carbon
monoxide trapping complex recently developed in our group.
Results and discussion
Ligand/catalyst evaluation
The initial target was to find an efficient Pd-NHC system to be
applied to PET radiolabelling experiments. Thus, a series of
imidazolinium and imidazolium salts were tested as ligands as
well as palladium catalysts with phosphine and diphosphine
ligands. Diphosphines are generally favoured in carbonylation
reactions to monodentate phosphines31 and it has been
suggested that the bite angle plays a key role in improving
the rate of related reactions.32 A model reaction was used in
order to evaluate the effect of the catalyst system on the
formation of amide. In this case iodobenzene and benzylamine
(used in excess as the solvent) were combined under static
0.2 bar pressure of carbon monoxide to synthesize N,N-
benzylbenzamide (Figure 1). Pd-NHC species were prepared in
situ by the reaction of imidazolinium or imidazolium salts
(Figure 2) with the palladium(0) precursor Pd2(dba)3 in
benzylamine. Reaction of the imidazolinium and imidazolium
salts in the presence of excess benzylamine base resulted in the
deprotonation of the salts and dissolution of the Pd-NHC
complex when heated to 1501C. The relatively high tempera-
tures used for these reactions may be expected to enhance the
yields over short time periods (10min) compared with lower
temperatures and then eventually degrade the catalyst over
sustained periods at this high temperature (2 h).
A range of well-known and widely used benchmark Pd-
phosphine complexes (Figure 3) were also investigated for the
model carbonylation reaction. Pd-monophosphine and chelat-
ing diphosphine catalysts have been widely investigated for a
range of carbonylation reactions33,34 and as such are useful
for comparative purposes with the Pd-NHC catalysts. The
results from the model aminocarbonylation reactions using
phosphine ligands are shown in Table 1. In the case of
Figure 1. The model palladium-catalysed carbonylation reaction for the formation
of N-benzylbenzamide.
Figure 2. Structures of the four imidazolinium (I) and (II), and imidazolium (III) and (IV) salts used as NHC ligands.
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Figure 3. Palladium(II) diphosphine chloride complexes used for comparison
within the model carbonylation reaction.
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tetrakis(triphenylphosphine)palladium there is no need for
reduction of palladium(II) to form the catalytically active Pd(0)
species prior to oxidative addition which could account for it
having the highest yield after 10min (Table 1, entry 1).
Diphosphine ligands such as bis(diphenylphosphino)propane
(dppp) and bis(diphenylphosphino)ferrocene (dppf) are used
extensively in catalysis and here they show moderate yields after
10min. After 2 h, all the Pd-phoshine catalysts performed
equally well giving yields of between 55 and 57%, suggesting
that while the ligand–palladium system is important to the
initial rate of the reaction it does not affect the yield over the
longer timeframe.
Four imidazolinium and imidazolium chloride salts (N,N0-bis
(diisopropylphenyl)-4,5-dihydroimidazolinium chloride (I), N,N0-
bis(1-mesityl)-4,5-dihydroimidazolinium chloride (II), N,N0-bis
(1-mesityl)imidazolium chloride (III) and N,N0-bis(1-adamantyl)
imidazolium chloride (IV)) with varying electronic and steric
properties (Figure 2) were investigated for the model carbonyla-
tion reaction. The objective was to examine the effect that the
R groups and the saturated or unsaturated imidazole ring have
on the reaction. It has been established that the electronic
backbone of the imidazole rings can affect the rate of the
oxidative addition step in the catalytic cycle.35 Furthermore,
bulky R groups such as adamantyl could aid the reductive
elimination step, while the electronic effect of the R group on
the system is not thought to contribute significantly.36
As seen previously for the phosphine ligands, similar yields in
excess of 50% are observed after 2 h with the Pd-NHC catalysts;
however, considerable variation is observed after 10min
(Table 2). Yields of the carbonylated product N-benzylbenza-
mide using the Pd-NHC catalysts over the 10-minute timeframe
ranged from a low 4% (entry 10) with the preformed catalyst
Pd(III)2Cl2 to a reasonable 20% (entry 8) for the in situ catalyst
(formed from Pd2(dba)3 and ligand III). The lower yields of the
preformed catalyst Pd(III)2Cl2 obtained after 10min, initially
surprising, are likely to be due to the slower reduction of this
complex to the catalytically active Pd(0) species compared with
its in situ equivalent which is prepared directly from the Pd(0)
source Pd2(dba)3. There is evidence, however, that having two
IMes moieties on the palladium can result in too strong an
electron-donating effect which can prevent reductive elimina-
tion and therefore deactivation of the catalyst.37 Pd2dba3 was
used as the Pd source due to its good solubility in benzylamine
which was used in excess as solvent. The basic environment was
assumed to aid in the active complex formation although the
exact structure of this is unknown. Supporting data for this
assumption is shown by entry 11 in which Pd2dba3 on its own
gives lower yields of amide after 10min than the systems with
imidazolium and imidazolinium hydrochloride salts (entries 6–9).
The Pd-NHC catalyst system with ligand III (Entry 8) was chosen
for subsequent radiolabelling studies using [11C]carbon mon-
oxide as it was the best performing catalyst system overall.
Radiolabelling experiments
Although [11C]carbon monoxide is a valuable resource in
radiolabelling, the low reactivity of carbon monoxide, as a
result of its low solubility in most organic solvents, and high
dilution in the inert carrier gas has prevented it from widespread
use in PET chemistry. Previously, these issues have been
overcome by the use of microautoclave systems which increase
the pressure and therefore enhance the key carbon monoxide
insertion step effectively but these methods require specialized
equipment.38,39 Chemical complexation can also be an effective
method of improving [11C]CO reactivity by increasing its
solubility at low partial pressures. Such systems include
BH3.THF
10 and Cu(I)9 solutions; the latter can trap [11C]CO with
efficiencies of over 95% compared with approximately 1% in
solvent alone. The novel [11C]CO chemical trapping method,
exploiting a [Cu(Tp)] complex, recently developed in our
group9 was used to test the best performing Pd-NHC catalyst
system for [11C] carbonylation radiolabelling. The CuTp
trapping system was chosen for the NHC carbonylation
radiolabelling experiments as the trapping process can be
carried out at room temperature in a one-pot process. Following
formation of the Cu(Tp)[11C]CO complex, the cross coupling
reagents (Pd precursor, ligand, iodobenzene, benzylamine) were
added to the trapping vial and the reaction mixture heated for
10min. The reaction was quenched and the crude product
mixture analysed by analytical radio-HPLC (Table 3). The results
of the [Cu(Tp)] radiolabelling procedure for the model
carbonylation reaction using the best performing NHC ligand
(III) from the initial screening as well as the phosphine ligand
dppp for comparison are shown in Table 3. Labelling reactions
using III and Pd2(dba)3 in situ at 1001C produced three labelled
products; two minor products [11C]benzoic acid and [11C]N,N0-
dibenzylurea along with the major labelled product [11C]N-
benzylbenzamide (Table 3, entry 1). [11C]N,N0-dibenzylurea was
observed in significant yield when using PdCl2, which is in
agreement with previous findings when a Pd(II) starting material
is used9. Interestingly this product is not observed in the
corresponding cold reactions, and the formation is attributed to
the vastly different stoichiometries encountered between the
‘cold’ and ‘hot’ regimes potentially leading to an oxidative
carbonylation mechanism. It is thought that the excess
amount of Pd compared with [11C]CO may cause this effect.
Table 1. Average yields of N-benzylbenzamide calculated
by GC after 10min and 2 h (average of three runs)
Entry Pd source GC Yield (%)
10min 2 h
1 Pd(PPh3)4 1877 5672
2 Pd(PPh3)2Cl2 1375 5671
3 Pd(dppf)Cl2 1477 5572
4 Pd(dppp)Cl2 1575 5772
5 Pd(BINAP)Cl2 1072 5771
Table 2. Average yields of N-benzylbenzamide after
10min and 2 h (average of three runs)
Entry Pd source Ligand GC Yield (%)
10min 2 h
6 Pd2(dba)3 I 1276 5673
7 Pd2(dba)3 II 1674 5571
8 Pd2(dba)3 III 2073 5871
9a Pd2(dba)3 IV 1171 5570.2
10a Pd(IMes)2Cl2 — 470.2 5771
11a Pd2(dba)3 — 970.1 5772
aAverage of two runs.
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The resultant loss of radiolabelled N,N0-benzylbenzamide at
1201C (Entry 3) leads to a lowering of the radiochemical yield
compared with the yields when using Pd2dba3 (Entry 2). This
could be due to the poor solubility of PdCl2 in DMF, but also
because the required oxidative addition of iodobenzene is
suppressed owing to the slower generation of the active Pd(0)
catalyst from PdCl2 compared with directly using Pd2(dba)3. The
copper(I) complex used for the trapping step is not thought to
play a role in the oxidative carbonylation process in the case.9
An increase in temperature from 100 to 1201C has a
significant effect on the amount of [11C]benzoic acid formed
from the hydrolysis of the Pd(II)-acyl complex. This indicates that
less of the acyl intermediate is present at the end of the reaction
before addition of the aqueous quench due to a more efficient
reductive elimination at higher temperatures. Interestingly,
when ligand III is used (Entry 2) a significant improvement in
the radiochemical purity of [11C]N-benzylbenzamide formation is
observed compared with when the chelating diphosphine 1,2-
bis(diphenylphosphinopropane) is used as the ligand (Entry 4).
Almost full conversion to [11C]N,N0-benzylbenzamide (99%) is
observed with the NHC system whereas there is still a significant
amount of [11C]benzoic acid (14%) using the diphosphine which
diminishes the amount of amide formed. This indicates that the
reductive elimination step is slower using dppp/Pd2(dba)3 than
for III/Pd2(dba)3 which has a noticeable impact on the yield of
the desired labelled amide compound. The overall, greater
efficiency may be attributed to the greater electron-donating
ability of carbenes versus phosphines and their stability at
higher temperatures.
Conclusion
In conclusion, NHC ligands perform similarly to a range of
commonly used phosphine ligands for palladium-catalysed
aminocarbonylation reactions over a 2 h reaction period. When
reaction times were reduced to 10min significant differences
were observed with the in situ NHC catalyst system III/Pd2(dba)3
giving the highest yield. When applied to [11C]CO palladium-
mediated aminocarbonylation reactions, using the [Cu(Tp)]
trapping technique, the NHC ligand III proved to give good
RCYs and excellent RCPs that surpassed a commonly used Pd-
phosphine ligand system. Interestingly, there appears to be an
enhancement of the reductive elimination step for the NHC
catalyst at higher temperatures, which is evident by the
suppression of [11C]benzoic acid formation. We are currently
investing the scope of using NHC ligands for a wider range of
substrates for [11C]CO Pd-mediated reactions under high-
temperature reaction conditions.
Experimental
General
All carbonylation reactions were carried out on a Radley’s
Carousel 12 Place Reaction Station and a Heidolph heating plate
fitted with a temperature probe. Quantitative analysis was
carried out via gas chromatography on a Hewlett-Packard 5890
GC fitted with an Agilent 6690 autosampler and a flame
ionization detection system. The products were separated on a
SGE forte BP1 capillary column; length 25m, I.D. 0.22mm, film
thickness 0.25mm. Quantification was achieved by calculating
the response factor from N-benzylbenzamide and diphenylether
as the internal standard (purchased from Sigma-Aldrich). In all
cases samples for GC analysis were made up in 1.5mL vials using
0.2mL of reaction mixture and 1.3mL of diphenylether in DCM
(0.0126M) as an internal standard. All other chemicals were
purchased from Sigma-Aldrich, BOC Ltd. or Strem Chemicals Inc.
Further purification was carried out where stated. [PdCl2(dppp)],
[PdCl2(dppf)] and [PdCl2(BINAP)] were formed by stirring
[PdCl2(cod)] and 1 equivalent of corresponding diphosphine in
DCM at room temperature for 30min. The product was filtered
and washed with hexane and dried in vacuo.
General catalyst evaluation procedures
Iodobenzene (1mmol, 0.112mL, 1 eq.) was added to a stirred
solution of the catalyst (0.02mmol, 2mol%) dissolved in
benzylamine (5mL) at 1501C under an atmosphere of carbon
monoxide; this was taken to be the start of the reaction.
Samples (0.5mL) were taken after 10min and 2 h and analysed
using gas chromatography.
Radiochemistry
Radiolabelled [11C]CO2 was produced on a Siemens cyclotron
from a N2 (1% O2) target, with a beam current of 5 mA and a
bombardment time of 5min. The [11C]CO2 was converted to
[11C]CO via an Eckert and Ziegler modular lab system which uses
Table 3. Pd-mediated [11C]carbonylation reactions using [Cu(Tp)11CO] and various Pd precursors and ligands
] Pd source Ligand Temp. (1C) RCP (%)a
[11C]benzoic acid [11C]N,N-dibenzylurea [11C]N,N-benzyl benzamide RCY (%)b
1 Pd2(dba)3 III 100 9 5 86 54710
2 Pd2(dba)3 III 120 0 1 99 55710
3 PdCl2 III 120 3 59 38 11710
4 Pd2(dba)3 dppp 120 14 0 86 6175
Average of two runs for each entry.
aRadiochemical purity determined from radio-analytical HPLC.
bRadiochemical yield based on the starting radioactivity of the [Cu(Tp)11CO] complex and corrected for decay to end of
bombardment.
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a molybdenum reductant (8501C) and delivered to the hot cell.
Unconverted [11C]CO2 was collected on an ascarite trap.
General radiolabelling procedure
CuCl (11 mmol, 1.1mg, 1 eq.) and KTp (11 mmol, 3.7mg, 1 eq.)
was weighed into a 5mL glass vial and placed under a N2
atmosphere. Dry THF (1mL) was added to form the trapping
solution. A [11C]CO/He gas stream was delivered to the vial,
forming the CuTp[11C]CO complex. Following this, the cross-
coupling reagents (Pd2(dba)3 (1.01mg, 1.1 mmol, 20mol %),
IMes.HCl (0.75mg, 2.2 mmol, 20mol %), iodobenzene (2.3mg,
11mmol, 1 eq.), benzylamine (0.1mL, excess) and triphenylphos-
phine (5.8mg, 22 mmol, 2 eq.) in 0.9mL DMF) were added to the
vial using an Argon gas sweep. The vial was sealed and the
mixture heated for 10min after which time it was quenched by
addition of 1mL NH4OAc (pH 4.9) under an Argon gas sweep.
Finally, the radioactivity of the reaction vial was measured and
the crude mixture analysed by analytical HPLC. The reaction
mixture was analysed on an analytical radio HPLC (Agilent 1100,
60:40 water:acetonitrile, flow rate 1.5mL/min, fitted with an
Agilent Eclipse XDBC18, 5 mm, 4.6 150mm column). During
each step the radioactivity of the waste gases was measured in
order to calculate incorporation of [11C]CO and radiochemical
yields based on the starting radioactivity of the CuTp[11C]CO
solution.
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